
<html lang="en"     class="pb-page"  data-request-id="fa7d6d04-9481-4320-a079-ac8250cc5377"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2010.53.issue-19;website:website:acspubs;article:article:10.1021/jm100863x;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of a β-d-2′-Deoxy-2′-α-fluoro-2′-β-C-methyluridine Nucleotide Prodrug (PSI-7977) for the Treatment of Hepatitis C Virus" /></meta><meta name="dc.Creator" content="Michael J.  Sofia" /></meta><meta name="dc.Creator" content="Donghui  Bao" /></meta><meta name="dc.Creator" content="Wonsuk  Chang" /></meta><meta name="dc.Creator" content="Jinfa  Du" /></meta><meta name="dc.Creator" content="Dhanapalan  Nagarathnam" /></meta><meta name="dc.Creator" content="Suguna  Rachakonda" /></meta><meta name="dc.Creator" content="P. Ganapati  Reddy" /></meta><meta name="dc.Creator" content="Bruce S.  Ross" /></meta><meta name="dc.Creator" content="Peiyuan  Wang" /></meta><meta name="dc.Creator" content="Hai-Ren  Zhang" /></meta><meta name="dc.Creator" content="Shalini  Bansal" /></meta><meta name="dc.Creator" content="Christine  Espiritu" /></meta><meta name="dc.Creator" content="Meg  Keilman" /></meta><meta name="dc.Creator" content="Angela M.  Lam" /></meta><meta name="dc.Creator" content="Holly M. Micolochick  Steuer" /></meta><meta name="dc.Creator" content="Congrong  Niu" /></meta><meta name="dc.Creator" content="Michael J.  Otto" /></meta><meta name="dc.Creator" content="Phillip A.  Furman" /></meta><meta name="dc.Description" content="Hepatitis C virus (HCV) is a global health problem requiring novel approaches for effective treatment of this disease. The HCV NS5B polymerase has been demonstrated to be a viable target for the de..." /></meta><meta name="Description" content="Hepatitis C virus (HCV) is a global health problem requiring novel approaches for effective treatment of this disease. The HCV NS5B polymerase has been demonstrated to be a viable target for the de..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 16, 2010" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm100863x" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2010 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm100863x" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm100863x" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm100863x" /></link>
        
    
    

<title>Discovery of a β-d-2′-Deoxy-2′-α-fluoro-2′-β-C-methyluridine Nucleotide Prodrug (PSI-7977) for the Treatment of Hepatitis C Virus | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm100863x" /></meta><meta property="og:title" content="Discovery of a β-d-2′-Deoxy-2′-α-fluoro-2′-β-C-methyluridine Nucleotide Prodrug (PSI-7977) for the Treatment of Hepatitis C Virus" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/large/jm-2010-00863x_0001.jpeg" /></meta><meta property="og:description" content="Hepatitis C virus (HCV) is a global health problem requiring novel approaches for effective treatment of this disease. The HCV NS5B polymerase has been demonstrated to be a viable target for the development of HCV therapies. β-d-2′-Deoxy-2′-α-fluoro-2′-β-C-methyl nucleosides are selective inhibitors of the HCV NS5B polymerase and have demonstrated potent activity in the clinic. Phosphoramidate prodrugs of the 5′-phosphate derivative of the β-d-2′-deoxy-2′-α-fluoro-2′-β-C-methyluridine nucleoside were prepared and showed significant potency in the HCV subgenomic replicon assay (&lt;1 μM) and produced high levels of triphosphate 6 in primary hepatocytes and in the livers of rats, dogs, and monkeys when administered in vivo. The single diastereomer 51 of diastereomeric mixture 14 was crystallized, and an X-ray structure was determined establishing the phosphoramidate stereochemistry as Sp, thus correlating for the first time the stereochemistry of a phosphoramidate prodrug with biological activity. 51 (PSI-7977) was selected as a clinical development candidate." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm100863x"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm100863x">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm100863x&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm100863x&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm100863x&amp;href=/doi/10.1021/jm100863x" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2010</span><span class="cit-fg-volume">, 53</span><span class="cit-fg-issue">, 19</span><span class="cit-fg-pageRange">, 7202-7218</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/53/19" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm100834y" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm100899z" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of a β-<span class="smallcaps smallerCapital">d</span>-2′-Deoxy-2′-α-fluoro-2′-β-<i>C</i>-methyluridine Nucleotide Prodrug (PSI-7977) for the Treatment of Hepatitis C Virus</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+J.++Sofia">Michael J. Sofia</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Donghui++Bao">Donghui Bao</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wonsuk++Chang">Wonsuk Chang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jinfa++Du">Jinfa Du</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dhanapalan++Nagarathnam">Dhanapalan Nagarathnam</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Suguna++Rachakonda">Suguna Rachakonda</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=P.+Ganapati++Reddy">P. Ganapati Reddy</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bruce+S.++Ross">Bruce S. Ross</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peiyuan++Wang">Peiyuan Wang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hai-Ren++Zhang">Hai-Ren Zhang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shalini++Bansal">Shalini Bansal</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christine++Espiritu">Christine Espiritu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Meg++Keilman">Meg Keilman</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Angela+M.++Lam">Angela M. Lam</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Holly+M.+Micolochick++Steuer">Holly M. Micolochick Steuer</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Congrong++Niu">Congrong Niu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+J.++Otto">Michael J. Otto</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Phillip+A.++Furman">Phillip A. Furman</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Pharmasset, Inc., 303A College Road East, Princeton, New Jersey 08540</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone: (609) 613-4123. Fax: 609-613-4150. E-mail: <a href="/cdn-cgi/l/email-protection#0f62666c676e6a63217c6069666e4f7f676e7d626e7c7c6a7b216c6062"><span class="__cf_email__" data-cfemail="91fcf8f2f9f0f4fdbfe2fef7f8f0d1e1f9f0e3fcf0e2e2f4e5bff2fefc">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm100863x&amp;href=/doi/10.1021%2Fjm100863x" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2010</span></span><span class="cit-volume">, 53</span><span class="cit-issue">, 19</span><span class="cit-pageRange">, 7202–7218</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 16, 2010</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>10 July 2010</li><li><span class="item_label"><b>Published</b> online</span>16 September 2010</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 October 2010</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm100863x" title="DOI URL">https://doi.org/10.1021/jm100863x</a></div><div class="article_header-article-copyright"><strong>Copyright © 2010 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7202%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMichael%2BJ.%2BSofia%252C%2BDonghui%2BBao%252C%2BWonsuk%2BChang%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D53%26issueNum%3D19%26contentID%3Djm100863x%26title%3DDiscovery%2Bof%2Ba%2B%25CE%25B2-d-2%25E2%2580%25B2-Deoxy-2%25E2%2580%25B2-%25CE%25B1-fluoro-2%25E2%2580%25B2-%25CE%25B2-C-methyluridine%2BNucleotide%2BProdrug%2B%2528PSI-7977%2529%2Bfor%2Bthe%2BTreatment%2Bof%2BHepatitis%2BC%2BVirus%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7218%26publicationDate%3DOctober%2B2010">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm100863x"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">12906</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">414</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm100863x" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of a β-d-2′-Deoxy-2′-α-fluoro-2′-β-C-methyluridine Nucleotide Prodrug (PSI-7977) for the Treatment of Hepatitis C Virus&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;J. Sofia&quot;},{&quot;first_name&quot;:&quot;Donghui&quot;,&quot;last_name&quot;:&quot;Bao&quot;},{&quot;first_name&quot;:&quot;Wonsuk&quot;,&quot;last_name&quot;:&quot;Chang&quot;},{&quot;first_name&quot;:&quot;Jinfa&quot;,&quot;last_name&quot;:&quot;Du&quot;},{&quot;first_name&quot;:&quot;Dhanapalan&quot;,&quot;last_name&quot;:&quot;Nagarathnam&quot;},{&quot;first_name&quot;:&quot;Suguna&quot;,&quot;last_name&quot;:&quot;Rachakonda&quot;},{&quot;first_name&quot;:&quot;P.&quot;,&quot;last_name&quot;:&quot;Ganapati Reddy&quot;},{&quot;first_name&quot;:&quot;Bruce&quot;,&quot;last_name&quot;:&quot;S. Ross&quot;},{&quot;first_name&quot;:&quot;Peiyuan&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Hai-Ren&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Shalini&quot;,&quot;last_name&quot;:&quot;Bansal&quot;},{&quot;first_name&quot;:&quot;Christine&quot;,&quot;last_name&quot;:&quot;Espiritu&quot;},{&quot;first_name&quot;:&quot;Meg&quot;,&quot;last_name&quot;:&quot;Keilman&quot;},{&quot;first_name&quot;:&quot;Angela&quot;,&quot;last_name&quot;:&quot;M. Lam&quot;},{&quot;first_name&quot;:&quot;Holly&quot;,&quot;last_name&quot;:&quot;M. Micolochick Steuer&quot;},{&quot;first_name&quot;:&quot;Congrong&quot;,&quot;last_name&quot;:&quot;Niu&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;J. Otto&quot;},{&quot;first_name&quot;:&quot;Phillip&quot;,&quot;last_name&quot;:&quot;A. Furman&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2010&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;16&quot;,&quot;issue&quot;:&quot;19&quot;,&quot;volume&quot;:&quot;53&quot;,&quot;pages&quot;:&quot;7202-7218&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm100863x&quot;},&quot;abstract&quot;:&quot;Hepatitis C virus (HCV) is a global health problem requiring novel approaches for effective treatment of this disease. The HCV NS5B polymerase has been demonstrated to be a viable target for the development of HCV therapies. β-d-2′-Deoxy-2′-α-fluoro-2′-β-C-methyl nucleosides are selective inhibitors of the HCV NS5B polymerase and have demonstrated potent activity in the clinic. Phosphoramidate prodrugs of the 5′-phosphate derivative of the β-d-2′-deoxy-2′-α-fluoro-2′-β-C-methyluridine nucleoside were prepared and showed significant potency in the HCV subgenomic replicon assay (&lt;1 μM) and produced high levels of triphosphate 6 in primary hepatocytes and in the livers of rats, dogs, and monkeys when administered in vivo. The single diastereomer 51 of diastereomeric mixture 14 was crystallized, and an X-ray structure was determined establishing the phosphoramidate stereochemistry as Sp, thus correlating for the first time the stereochemistry of a phosphoramidate prodrug with biological activity. 51 (PSI-7977) wa&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100863x&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100863x" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100863x&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100863x" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100863x&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100863x" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm100863x&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100863x&amp;href=/doi/10.1021/jm100863x" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm100863x" /></input><a href="/doi/pdf/10.1021/jm100863x" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm100863x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm100863x%26sid%3Dliteratum%253Aachs%26pmid%3D20845908%26genre%3Darticle%26aulast%3DSofia%26date%3D2010%26atitle%3DDiscovery%2Bof%2Ba%2B%25CE%25B2-d-2%25E2%2580%25B2-Deoxy-2%25E2%2580%25B2-%25CE%25B1-fluoro-2%25E2%2580%25B2-%25CE%25B2-C-methyluridine%2BNucleotide%2BProdrug%2B%2528PSI-7977%2529%2Bfor%2Bthe%2BTreatment%2Bof%2BHepatitis%2BC%2BVirus%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D53%26issue%3D19%26spage%3D7202%26epage%3D7218%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=291308" title="Nucleic acids">Nucleic acids</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292444" title="Molecular structure">Molecular structure</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/53/19" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jmcmar.2010.53.issue-19/production/jmcmar.2010.53.issue-19.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/medium/jm-2010-00863x_0001.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/large/jm-2010-00863x_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100863x&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Hepatitis C virus (HCV) is a global health problem requiring novel approaches for effective treatment of this disease. The HCV NS5B polymerase has been demonstrated to be a viable target for the development of HCV therapies. β-<span class="smallcaps smallerCapital">d</span>-2′-Deoxy-2′-α-fluoro-2′-β-<i>C</i>-methyl nucleosides are selective inhibitors of the HCV NS5B polymerase and have demonstrated potent activity in the clinic. Phosphoramidate prodrugs of the 5′-phosphate derivative of the β-<span class="smallcaps smallerCapital">d</span>-2′-deoxy-2′-α-fluoro-2′-β-<i>C</i>-methyluridine nucleoside were prepared and showed significant potency in the HCV subgenomic replicon assay (<1 μM) and produced high levels of triphosphate <b>6</b> in primary hepatocytes and in the livers of rats, dogs, and monkeys when administered in vivo. The single diastereomer <b>51</b> of diastereomeric mixture <b>14</b> was crystallized, and an X-ray structure was determined establishing the phosphoramidate stereochemistry as <i>S</i>p, thus correlating for the first time the stereochemistry of a phosphoramidate prodrug with biological activity. <b>51</b> (PSI-7977) was selected as a clinical development candidate.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65582" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65582" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The hepatitis C virus (HCV<a class="ref internalNav" href="#fnabbrev" aria-label="a">a</a>) <div class="NLM_fn" id="fnabbrev">a<p class="last">Abbreviations: HCV, hepatitis C virus; SOC, standard of care; IFN, interferon; RBV, ribavirin; DAA, direct acting antiviral; RdRp, RNA dependent RNA polymerase; b.i.d., twice daily; q.d., once daily; YMPK, uridine−cytidine monophosphate kinase; NDPK, nucleoside diphosphate kinase; SAR, structure−activity relationship; NMI, <i>N</i>-methylimidazole; DCM, dichloromethane; EC<sub>90</sub>, compound concentration that returns 90% of inhibition; SGF, simulated gastric fluid; SIF, simulated intestinal fluid; NTP, nucleoside triphosphate; PK, pharmacokinetic; <i>C</i><sub>max</sub>, maximum concentration; AUC, area under the curve; <i>t</i><sub>max</sub>, time at maximum concentration; PAMPA, parallel artificial membrane permeability assay; IC<sub>50</sub>, compound concentration that returns 50% of inhibition; NOAEL, no observed adverse effect level; TFA, trifluoroacetic acid, THF, tetrahydrofuran; IPE, isopropyl ether; DMSO, dimethylsulfoxide.</p></div>presents a global health problem with approximately 180 million individuals infected worldwide with 80% of those progressing to chronic HCV infection.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Of those chronically infected individuals, approximately 30% will develop liver cirrhosis and 10% will go on to develop hepatocellular carcinoma.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> The current standard of care (SOC) for HCV infected patients consists of regular injections of pegylated interferon (IFN) and oral ribavirin (RBV) administration. However, SOC has proven to be effective in producing a sustained virological response in only 40−60% of patients treated, dependent on viral genotype and other predictors of host immune responsiveness. In addition, drug discontinuations may be high because of adverse side effects associated with the SOC treatment regimen.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a> Consequently, the development of alternative treatment options is greatly needed. The search for novel therapies for the treatment of HCV infection has focused on the development of direct acting antiviral agents (DAAs).<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a></div><div class="NLM_p">HCV is a plus strand RNA virus of the <i>Flaviviridea</i> family with a 9.6 kb genome encoding for 10 proteins: three structural proteins and seven nonstructural proteins. The nonstructural proteins, which include the NS5B RNA dependent RNA polymerase (RdRp), provide several attractive targets for the development of anti-HCV therapy.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> The HCV RdRp is part of a membrane associated replication complex that is composed of other viral proteins, viral RNA, and altered cellular membranes.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The NS5B polymerase is responsible for replicating the viral RNA genome and thus is absolutely required for HCV replication. As in the case of other viral polymerases, two approaches have been pursued to identify small molecule HCV NS5B polymerase inhibitors. These approaches include the identification of nucleoside analogues that function as alternative substrate inhibitors that induce a chain termination event and non-nucleoside inhibitors that bind to allosteric sites on the polymerase leading to a nonfunctional enzyme.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a></div><div class="NLM_p">Several nucleoside classes have been or continue to be in development as inhibitors of HCV. These classes include the β-<span class="smallcaps smallerCapital">d</span>-2′-deoxy-2′-α-F-2′-β-<i>C</i>-methylribose, the β-<span class="smallcaps smallerCapital">d</span>-2′-β-methylribose, and the 4′-azidoribose classes.<a onclick="showRef(event, 'ref9 ref10 ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref12 ref13">(9-13)</a> These classes are represented by the clinical candidates <b>1</b> (RG7128), <b>2</b> (NM-283), and <b>3</b> (R1626), respectively (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/medium/jm-2010-00863x_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/large/jm-2010-00863x_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of HCV nucleoside inhibitors <b>1</b>, <b>2</b>, <b>3</b>, and <b>4</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/large/jm-2010-00863x_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100863x&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>1</b> is a 3′,5′-diisobutyrate ester prodrug of the cytidine nucleoside <b>4</b>. In clinical studies when administered at 1000 mg b.i.d., <b>1</b> demonstrated efficacy in genotype 1 infected patients (reduction of HCV RNA levels) in a 14-day monotherapy study (−2.7 log<sub>10</sub> decrease in HCV RNA) and produced a 88% RVR in a 4-week combination study with SOC−pegylated interferon plus ribavirin.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a> In addition, <b>1</b> was shown to be efficacious in HCV genotype 2,3 patients who had not responded to prior therapy, the first direct-acting antiviral to show multiple genotype coverage in the clinic.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> However, even with the positive clinical attributes of <b>1</b>, we were interested in investigating second generation agents with improved potency, enhanced pharmacokinetic properties (i.e., q.d. dosing), and the potential for generating high concentrations of the active triphosphate in the liver to enable low doses and potentially fixed-dose combinations of DAAs. To achieve this objective, we focused on β-<span class="smallcaps smallerCapital">d</span>-2′-deoxy-2′-α-F-2′-β-<i>C</i>-methyluridine (<b>5</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Earlier studies had shown that while <b>5</b> was inactive in the HCV replicon assay, its triphosphate was a potent inhibitor of HCV NS5B with a <i>K</i><sub>i</sub> of 0.42 μM.<a onclick="showRef(event, 'ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19">(17-19)</a> In addition, metabolism studies with <b>4</b> showed that the monophosphate of <b>4</b> can be deaminated to the uridine monophosphate derivative and subsequently anabolized to the triphosphate <b>6</b> by uridine−cytidine monophosphate kinase (YMPK) and nucleoside diphosphate kinase (NDPK) (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). This uridine triphosphate was shown to have an intracellular half-life of 38 h.<a onclick="showRef(event, 'ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19">(17-19)</a> Therefore, in order to leverage the desired attributes of the uridine derivative, we needed to deliver the monophosphate of uridine nucleoside <b>5</b>. To accomplish this, we required a monophosphate prodrug that would bypass the nonproductive phosphorylation step and that would potentially accomplish our other objective: the delivery of high liver concentrations of the desired triphosphate <b>6</b>.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/medium/jm-2010-00863x_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/large/jm-2010-00863x_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Metabolism of <b>4</b> leads to both the active triphosphate and the inactive nucleoside <b>5</b>. The monophosphate metabolite of <b>4</b> is also metabolized to the uridine monophosphate derivative which is then further phosphorylated to the active uridine triphosphate <b>6</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/large/jm-2010-00863x_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100863x&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Phosphoramidate prodrug strategies had been shown to enhance nucleoside potency in cell culture presumably by increasing intracellular concentrations of the active nucleotide.<a onclick="showRef(event, 'ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22">(20-22)</a> However, at the time we began our work there was no example where phosphoramidate prodrug technology was applied to the inhibition of HCV. We speculated that application of the phosphoramidate prodrug method would be an ideal approach for delivering the desired uridine monophosphate to hepatocytes in an in vivo setting (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). We hoped to take advantage of first pass metabolism where the liver enzymes would hydrolyze the terminal carboxylic acid ester of the phosphoramidate moiety triggering a cascade of chemical and enzymatic events that would produce the desired uridine monophosphate at the desired site of action, the liver. Subsequently, several reports demonstrated that phosphoramidates of several other anti-HCV nucleosides were able to improve potency, but these reports did not translate this improved in vitro potency into a clinical development candidate.<a onclick="showRef(event, 'ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25">(23-25)</a> Here we describe the discovery of phosphoramidate prodrugs of 2′-deoxy-2′-α-F-2′-β-<i>C</i>-methyluridine 5′<b>-</b>monophosphate and the selection of <b>14</b> and ultimately of its single isomer <b>51</b> as clinical development candidates.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/medium/jm-2010-00863x_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/large/jm-2010-00863x_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. First pass metabolism of the phosphoramidate prodrug derivative of the monophosphate of <b>5</b> releases the monophosphate in the liver at the desired site of action.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/large/jm-2010-00863x_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100863x&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15035" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15035" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The development of phosphoramidate prodrugs of <b>5</b> began with the investigation of the anti-HCV SAR around the phosphoramidate portion of the molecule. The synthesis of the 2′-deoxy-2′-α-F-2′-β-<i>C</i>-methyluridine phosphoramidates began with the preparation of the uridine nucleoside <b>5</b>. To obtain the uridine nucleoside <b>5</b>, we started with the benzoyl protected 2′-deoxy-2′-α-F-2′-β-<i>C</i>-methylcytidine (<b>7</b>). We recently reported on the efficient synthesis of <b>7</b>.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> From <b>7</b>, preparation of the uridine nucleoside was efficiently accomplished by a two-step process (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). The benzoyl cytidine <b>7</b> was heated with 80% acetic acid overnight to afford the protected uridine <b>8</b>, which was then treated at room temperature with methanolic ammonia to provide <b>5</b> in 78% yield.</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/medium/jm-2010-00863x_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/large/jm-2010-00863x_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/large/jm-2010-00863x_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100863x&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) 70% aqueous acetic acid, 100 °C; (b) 25% methanolic ammonia, 0−15 °C.</p></p></figure><div class="NLM_p">The phosphoramidate derivatives of the uridine nucleoside were prepared as shown in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. The phosphoramidate moiety was appended by reacting <b>5</b> with a freshly prepared chlorophosphoramidate reagent <b>11</b> in the presence of NMI.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Each chlorophosphoramidate reagent was prepared by stirring an amino acid ester <b>9</b> with the appropriate phosphorodichloridate reagent <b>10</b> in the presence of an amine base (Et<sub>3</sub>N or NMI) in either THF or dichloromethane. The reaction provided the desired 5′-phosphoramidates <b>12</b>−<b>49</b> as the major product with lesser amounts of the 3′- and 3′,5′-phosphoramidate derivatives. The desired 5′-phosphoramidates were purified by chromatography as a 1:1 mixture of diastereomers at the phosphorus center.</div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/medium/jm-2010-00863x_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/large/jm-2010-00863x_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/large/jm-2010-00863x_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100863x&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>NMI, DCM, −5 to 5 °C; (b) NMI, DCM, 5−25 °C.</p></p></figure><div class="NLM_p">The anti-HCV activity of these prodrugs was assessed using the clone A replicon and a quantitative real time PCR assay.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Each compound was simultaneously evaluated for cytotoxicity by assessing for the levels of cellular rRNA.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> The objective was to identify phosphoramidate prodrugs that exhibited submicromolar activity with the hope that this increased activity would translate into reduced drug load in the clinic relative to <b>1</b>. A survey of the terminal carboxylic acid ester of the phosphoramidate moiety in which the amino acid was alanine and the phosphate ester was simply phenyl showed that small simple alkyl and branched alkyl groups provided the desired submicromolar activity; however, in the case of the <i>n</i>-butyl (<b>15</b>), 2-butyl (<b>16</b>), and <i>n</i>-pentyl (<b>17</b>) esters, cytotoxicity was observed (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Small cycloalkyl (<b>18</b>) and benzyl (<b>22</b>,<b> 23</b>) esters were also compatible; however, phenyl (<b>21</b>) and halogenated alkyl groups (<b>19</b>,<b> 20</b>) did not provide the desired potency enhancement.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. HCV Replicon Activity of Phosphoramidate Prodrugs <b>12</b>−<b>23</b>: Modification of the Phosphoramidate Ester Moiety</div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/medium/jm-2010-00863x_0010.gif" alt="" id="fx1" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">EC<sub>90</sub> cloneA (μM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">inhibition of cellular rRNA replication at 50 μM (%)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">3.9</td><td class="colsep0 rowsep0" align="left">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">0.91</td><td class="colsep0 rowsep0" align="left">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">0.98</td><td class="colsep0 rowsep0" align="left">36.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="left">0.52</td><td class="colsep0 rowsep0" align="left">25.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left"><i>n</i>-Bu</td><td class="colsep0 rowsep0" align="left">0.09</td><td class="colsep0 rowsep0" align="left">79.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">2-Bu</td><td class="colsep0 rowsep0" align="left">0.06</td><td class="colsep0 rowsep0" align="left">93.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left"><i>n</i>-Pen</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">92</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left"><i>c</i>-Hex</td><td class="colsep0 rowsep0" align="left">0.25</td><td class="colsep0 rowsep0" align="left">61</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">FCH<sub>2</sub>CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">1.72</td><td class="colsep0 rowsep0" align="left">43.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">F<sub>2</sub>CHCH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">6.80</td><td class="colsep0 rowsep0" align="left">38.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">18.50</td><td class="colsep0 rowsep0" align="left">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">Bn</td><td class="colsep0 rowsep0" align="left">0.13</td><td class="colsep0 rowsep0" align="left">74.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">4-F-Bn</td><td class="colsep0 rowsep0" align="left">0.24</td><td class="colsep0 rowsep0" align="left">0</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Each value is a result of <i>n</i> = 2 determinations.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Clone A cells.</p></div></div></div><div class="NLM_p">A survey of the phosphoramidate phosphate ester substituent (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) demonstrated that the 1-naphthyl ester <b>29</b> provided the greatest potency and that mono- and dihalogenated phenolic esters also gave inhibitors with submicromolar potency. The derivative with a simple alkyl phosphate ester (<b>30</b>) was not active against HCV. Although the 1-naphthol ester substitution produced the most potent HCV inhibitor, this substitution also led to substantial cytotoxicity and was therefore not considered a viable substituent.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. HCV Replicon Activity of Phosphoramidate Prodrugs <b>12</b> and <b>24</b>−<b>30</b>: Modification of the Phosphoramidate Phenolic Ester Substituent</div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/medium/jm-2010-00863x_0011.gif" alt="" id="fx2" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th><th class="colsep0 rowsep0" align="center">EC<sub>90</sub> cloneA (μM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">inhibition of cellular rRNA replication at 50 μM (%)<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">0.91</td><td class="colsep0 rowsep0" align="left">0.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">4-F-Ph</td><td class="colsep0 rowsep0" align="left">0.69</td><td class="colsep0 rowsep0" align="left">16.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">4-Cl-Ph</td><td class="colsep0 rowsep0" align="left">0.58</td><td class="colsep0 rowsep0" align="left">62.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">4-Br-Ph</td><td class="colsep0 rowsep0" align="left">2.11</td><td class="colsep0 rowsep0" align="left">30.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">3,4-Cl-Ph</td><td class="colsep0 rowsep0" align="left">0.45</td><td class="colsep0 rowsep0" align="left">63.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">2,4-Cl-Ph</td><td class="colsep0 rowsep0" align="left">0.69</td><td class="colsep0 rowsep0" align="left">10.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">1-Napth</td><td class="colsep0 rowsep0" align="left">0.09</td><td class="colsep0 rowsep0" align="left">95.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">16.8</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Each value is a result of <i>n</i> = 2 determinations.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Clone A cells.</p></div></div></div><div class="NLM_p">Study of the amino acid side chain demonstrated that a small alkyl group (<b>12</b>, <b>32</b>) was accommodated, but α-substitution larger than ethyl showed substantial reduction in potency (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). α-Disubstituted amino acids that included an α-cyclopropanylamino acid derivative <b>39</b> did not provide the target submicromolar potency (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Additionally, it was shown that the natural <span class="smallcaps smallerCapital">l</span>-amino acid was required for activity, since the <span class="smallcaps smallerCapital">d</span>-alanine derivative <b>40</b> was inactive (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. HCV Replicon Activity of Phosphoramidate Prodrugs <b>12</b> and <b>31</b>−<b>37</b>: Modification of the Amino Acid Side Chain</div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/medium/jm-2010-00863x_0012.gif" alt="" id="fx3" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">EC<sub>90</sub> clone A (μM)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">inhibition of cellular rRNA replication at 50 μM (%)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">22.11</td><td class="colsep0 rowsep0" align="left">0.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">0.91</td><td class="colsep0 rowsep0" align="left">0.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">1.61</td><td class="colsep0 rowsep0" align="left">0.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">Me<sub>2</sub>CH</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">0.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">Me<sub>2</sub>CHCH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">5.4</td><td class="colsep0 rowsep0" align="left">0.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">MeSCH<sub>2</sub>CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">60.13</td><td class="colsep0 rowsep0" align="left">24.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">PhCH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">57.65</td><td class="colsep0 rowsep0" align="left">20.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">indole-3-CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">15.6</td><td class="colsep0 rowsep0" align="left">68.4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Each value is a result of <i>n</i> = 2 determinations.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Clone A cells.</p></div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. HCV Replicon Activity of Phosphoramidate Prodrugs <b>24</b> and <b>38</b>−<b>40</b>: α-Disubstituted Amino Acid Side Chains</div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/medium/jm-2010-00863x_0013.gif" alt="" id="fx4" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">EC<sub>90</sub> clone A (μM)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">inhibition of cellular rRNA replication at 50 μM (%)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">0.69</td><td class="colsep0 rowsep0" align="left">16.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">2.20</td><td class="colsep0 rowsep0" align="left">0.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">0.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">0.09</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Each value is a result of <i>n</i> = 2 determinations.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Clone A cells.</p></div></div></div><div class="NLM_p">Results of the phosphoramidate moiety single substituent modifications showed that <span class="smallcaps smallerCapital">l</span>-alanine was the preferred amino acid moiety, that methyl, ethyl, isopropyl, or cyclohexyl carboxylate esters provided the desired potency enhancement, and that the phosphate ester accommodated simple phenyl or halogenated phenyl substituents. Subsequently, select combinations of these preferred substitutions were prepared in which only the phenyl or para-halogenated phenyl phosphate ester analogues were examined. Polyhalogenated phosphate esters were excluded from further evaluation in order to preempt any potential toxicity issues that may arise from the release of polyhalogenated phenols upon conversion of the phosphoramidate to the desired nucleoside monophosphate (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>).<a onclick="showRef(event, 'ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29">(27-29)</a> The most dramatic difference observed in the SAR for the phosphoramidate substituent combinations was associated with the terminal carboxylic acid ester substituent where the cyclohexyl ester derivatives (<b>18</b>, <b>47</b>−<b>49</b>) showed as much as a 10-fold improvement in potency relative to their methyl, ethyl, or isopropyl analogues. On the basis of replicon potency, initial cytotoxicity profile, and structural diversity, a select set of seven compounds (<b>12</b>, <b>14</b>, <b>18</b>, <b>41</b>, <b>44</b>, <b>45</b>, and <b>47</b>) was chosen for further evaluation.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. HCV Replicon Activity of Phosphoramidate Prodrugs: Simultaneous Carboxylate and Phenolic Ester Modification of the Phosphoramidate Moiety</div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/medium/jm-2010-00863x_0014.gif" alt="" id="fx5" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th><th class="colsep0 rowsep0" align="center">EC<sub>90</sub> cloneA (μM)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">inhibition of cellular rRNA replication at 50 μM (%)<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">1.62</td><td class="colsep0 rowsep0" align="left">0.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">4-F-Ph</td><td class="colsep0 rowsep0" align="left">0.69</td><td class="colsep0 rowsep0" align="left">16.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">4-Cl-Ph</td><td class="colsep0 rowsep0" align="left">0.58</td><td class="colsep0 rowsep0" align="left">62.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">4-Br-Ph</td><td class="colsep0 rowsep0" align="left">2.11</td><td class="colsep0 rowsep0" align="left">30.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">0.98</td><td class="colsep0 rowsep0" align="left">36.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">4-F-Ph</td><td class="colsep0 rowsep0" align="left">0.76</td><td class="colsep0 rowsep0" align="left">55.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">4-Cl-Ph</td><td class="colsep0 rowsep0" align="left">0.39</td><td class="colsep0 rowsep0" align="left">0.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">4-Br-Ph</td><td class="colsep0 rowsep0" align="left">0.36</td><td class="colsep0 rowsep0" align="left">80.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">0.52</td><td class="colsep0 rowsep0" align="left">25.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="left"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="left">4-F-Ph</td><td class="colsep0 rowsep0" align="left">0.77</td><td class="colsep0 rowsep0" align="left">0.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="left"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="left">4-Cl-Ph</td><td class="colsep0 rowsep0" align="left">0.42</td><td class="colsep0 rowsep0" align="left">0.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="left"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="left">4-Br-Ph</td><td class="colsep0 rowsep0" align="left">0.57</td><td class="colsep0 rowsep0" align="left">0.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left"><i>c</i>-Hex</td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">0.25</td><td class="colsep0 rowsep0" align="left">61.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="left"><i>c</i>-Hex</td><td class="colsep0 rowsep0" align="left">4-F-Ph</td><td class="colsep0 rowsep0" align="left">0.04</td><td class="colsep0 rowsep0" align="left">52.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="left"><i>c</i>-Hex</td><td class="colsep0 rowsep0" align="left">4-Cl-Ph</td><td class="colsep0 rowsep0" align="left">0.054</td><td class="colsep0 rowsep0" align="left">66.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="left"><i>c</i>-Hex</td><td class="colsep0 rowsep0" align="left">4-Br-Ph</td><td class="colsep0 rowsep0" align="left">0.039</td><td class="colsep0 rowsep0" align="left">91.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Each value is a result of <i>n</i> = 2 determinations.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">Clone A cells.</p></div></div></div><div class="NLM_p">To achieve the objective of identifying a phosphoramidate prodrug of the 2′-α-F-2′-β-<i>C</i>-methyluridine monophosphate suitable for clinical studies as a treatment for HCV, the prodrug moiety would need to survive exposure in the gastrointestinal tract and preferentially release the nucleotide monophosphate in the liver. Consequently, compounds <b>12</b>, <b>14</b>, <b>18</b>, <b>41</b>, <b>44</b>, <b>45</b>, and <b>47</b> were further evaluated for gastrointestinal stability using simulated gastric fluid (SGF) and simulated intestinal fluid (SIF). In addition, stability in human plasma and stability on exposure to human liver S9 fraction were also evaluated (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). The human liver S9 fraction was chosen as a surrogate in vitro model to test for liver stability. The ultimate objective was to select compounds that showed improved potency relative to <b>4</b> in the HCV replicon and stability in SGF, SIF, and plasma but showed a short half-life in liver S9, which could indicate rapid release in hepatocytes. Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a> shows the in vitro stability data for the key compounds selected from combinations of the preferred phosphoramidate substituents. Each of these compounds exhibited prolonged stability (<i>t</i><sub>1/2</sub> > 15 h) in SGF, SIF, and human plasma but decomposed quickly to the monophosphate when incubated with human liver S9 fraction.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Stability Assessment in SGF, SIF, Human Plasma, and Human Liver S9 Fraction for Compounds <b>12</b>, <b>14</b>, <b>18</b>, <b>41</b>, <b>44</b>, <b>45</b>, and <b>47</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="4" align="center">stability <i>t</i><sub>1/2</sub> (h)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">SGF<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">SIF<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">human plasma<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">human S9<a class="ref internalNav" href="#t6fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">15.5</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">16.7</td><td class="colsep0 rowsep0" align="left">0.18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">22</td><td class="colsep0 rowsep0" align="left">>24</td><td class="colsep0 rowsep0" align="left">>24</td><td class="colsep0 rowsep0" align="left">0.57</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">>24</td><td class="colsep0 rowsep0" align="left">1.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">>8</td><td class="colsep0 rowsep0" align="left">0.23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">>24</td><td class="colsep0 rowsep0" align="left">0.42</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">>24</td><td class="colsep0 rowsep0" align="left">0.35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">>24</td><td class="colsep0 rowsep0" align="left">0.18</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">SGF = simulated gastric fluid, pH 1.2, 50 μg/mL concentration, 37 °C, 20 h.</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">SIF = simulated intestinal fluid, pH 7.5, 50 μg/mL concentration, 37 °C, 20 h.</p></div><div class="footnote" id="t6fn3"><sup>c</sup><p class="last">100 μM, 37 °C, 24 h.</p></div><div class="footnote" id="t6fn4"><sup>d</sup><p class="last">100 μM, 37 °C, 24 h, pH 7.4.</p></div></div></div><div class="NLM_p">Having the desired target activity and stability profile, compounds <b>12</b>, <b>14</b>, <b>18</b>, <b>41</b>, <b>44</b>, <b>45</b>, and <b>47</b> were evaluated in vivo to determine liver levels of the active uridine triphosphate <b>6</b> after oral administration. Since HCV replicates in liver cells, measurable levels of nucleoside triphosphate (NTP) should be a strong indication of in vivo efficacy, the assumption being the larger the amount of NTP, the greater the potential efficacy. Therefore, each of the seven key compounds was evaluated in a screening rat PK study where each compound was administered as a single 50 mg/kg oral dose, livers were removed, and liver extracts were assayed for levels of the 2′-deoxy-2′-α-F-2′-β-<i>C</i>-methyluridine triphosphate. The relative levels of triphosphate found in the liver samples would be an indication of anticipated in vivo potency and would be used to select which of the key compounds would progress further. Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a> shows the PK parameters for each of the key compounds. Among the seven compounds, compounds <b>12</b>, <b>14</b>, and <b>47</b> produced the highest <i>C</i><sub>max</sub> and AUC values. These results strongly suggest that each of these compounds was able to traverse the GI tract, remain intact during the absorption phase, and arrive intact at the target organ, ultimately resulting in high drug exposure in the liver.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. PK Parameters of Uridine Triphosphate <b>6</b> in Rat Liver after an Oral Dose of 50 mg/kg Phosphoramidate Prodrugs <b>12</b>, <b>14</b>, <b>18</b>, <b>41</b>, <b>44</b>, <b>45</b>, and <b>47</b><a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (ng/g)</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>max</sub> (h)</th><th class="colsep0 rowsep0" align="center" char=".">AUC(0−<i>t</i>) (ng·h/g)</th><th class="colsep0 rowsep0" align="center" char=".">AUC(inf) (ng·h/g)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="char" char=".">1985</td><td class="colsep0 rowsep0" align="char" char=".">6.00</td><td class="colsep0 rowsep0" align="char" char=".">14206</td><td class="colsep0 rowsep0" align="char" char=".">18968</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="char" char=".">1934</td><td class="colsep0 rowsep0" align="char" char=".">4.00</td><td class="colsep0 rowsep0" align="char" char=".">16796</td><td class="colsep0 rowsep0" align="char" char=".">18080</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="char" char=".">557</td><td class="colsep0 rowsep0" align="char" char=".">2.00</td><td class="colsep0 rowsep0" align="char" char=".">6487</td><td class="colsep0 rowsep0" align="char" char=".">8831</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="char" char=".">291</td><td class="colsep0 rowsep0" align="char" char=".">4.00</td><td class="colsep0 rowsep0" align="char" char=".">4191</td><td class="colsep0 rowsep0" align="char" char=".">5423</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="char" char=".">519</td><td class="colsep0 rowsep0" align="char" char=".">6.00</td><td class="colsep0 rowsep0" align="char" char=".">6140</td><td class="colsep0 rowsep0" align="char" char=".">7375</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="char" char=".">339</td><td class="colsep0 rowsep0" align="char" char=".">1.00</td><td class="colsep0 rowsep0" align="char" char=".">5143</td><td class="colsep0 rowsep0" align="char" char=".">8468</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="char" char=".">716</td><td class="colsep0 rowsep0" align="char" char=".">4.00</td><td class="colsep0 rowsep0" align="char" char=".">8937</td><td class="colsep0 rowsep0" align="char" char=".">9888</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">Livers were removed at time points 0.5, 1, 2, 4, 6, and 12 h postdose.</p></div></div></div><div class="NLM_p">Since little is known about which species is predictive of human exposure for nucleoside phosphoramidates, additional in vivo PK assessment was undertaken in dog and cynomolgus monkeys to provide a cross-species comparison of liver exposure to determine whether a dramatic species difference in PK behavior existed among compounds <b>12</b>, <b>14</b>, and <b>47</b>. Comparison of the in vivo PK characteristic in dogs and cynomolgus monkeys was accomplished by evaluating both plasma and liver exposures upon oral q.d. dosing over 4 days with a 50 mg/kg daily dose. Plasma samples were taken on day 3, and liver samples were taken on day 4. Liver levels were determined at a single time point 4 h postdose on day 4 and therefore reflect a single concentration at a single point in time. Plasma and liver levels of phosphoramidate prodrug and liver triphosphate levels were analyzed by LC/MS/MS. In the dog study, compound <b>14</b> showed a 16- and 110-fold higher overall plasma exposure (AUC) of the parent prodrug than compounds <b>12</b> and <b>47</b>, respectively (Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>). In the monkey compound <b>14</b> also provided greater (>3-fold) plasma exposure than did compounds <b>12</b> and <b>47</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a>). Similarly, liver exposures in dog and monkey of the parent prodrugs were higher for compound <b>14</b> than for compounds <b>12</b> and <b>47</b>. Triphosphate levels in the liver demonstrated the same relative trends. In dog and monkey compound <b>14</b> produced higher triphosphate levels relative to compounds <b>12</b> and <b>47</b>. However, it should be noted that the liver triphosphate data were only used for an intraspecies comparison of compounds. One should not compare the relative dog to monkey liver triphosphate levels because of the liver single time point sampling protocol.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Dog Plasma and Liver PK Profile after Oral Administration of Compounds <b>12</b>, <b>14</b>, and <b>47</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="5" align="center" char=".">plasma (prodrug)<a class="ref internalNav" href="#t8fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" colspan="2" align="center">liver<a class="ref internalNav" href="#t8fn3" aria-label="c">c</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>max</sub> (h)</th><th class="colsep0 rowsep0" align="center" char=".">AUC(inf) (ng·h/mL)</th><th class="colsep0 rowsep0" align="center" char=".">AUC(0−<i>t</i>) (ng·h/mL)</th><th class="colsep0 rowsep0" align="center">prodrug (ng/g liver)</th><th class="colsep0 rowsep0" align="center" char=".">uridine triphosphate <b>6</b> (ng/g liver)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">317</td><td class="colsep0 rowsep0" align="char" char=".">1.00</td><td class="colsep0 rowsep0" align="char" char=".">420</td><td class="colsep0 rowsep0" align="char" char=".">418</td><td class="colsep0 rowsep0" align="left">5.24</td><td class="colsep0 rowsep0" align="char" char=".">4960</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">6179</td><td class="colsep0 rowsep0" align="char" char=".">0.50</td><td class="colsep0 rowsep0" align="char" char=".">6903</td><td class="colsep0 rowsep0" align="char" char=".">6894</td><td class="colsep0 rowsep0" align="left">612</td><td class="colsep0 rowsep0" align="char" char=".">10560</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">36</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td><td class="colsep0 rowsep0" align="char" char=".">62</td><td class="colsep0 rowsep0" align="char" char=".">54</td><td class="colsep0 rowsep0" align="left">8.72</td><td class="colsep0 rowsep0" align="char" char=".">476</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup>a</sup><p class="last">Dose of 50 mg/kg for 4 consecutive days.</p></div><div class="footnote" id="t8fn2"><sup>b</sup><p class="last">Blood samples collected at 1, 2, 4, 6, 12, and 24 h postdose on day 3.</p></div><div class="footnote" id="t8fn3"><sup>c</sup><p class="last">Livers removed at 4 h time point postdose on day 4.</p></div></div></div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. Cynomolgus Monkey Plasma and Liver PK Profile after Oral Administration of Compounds <b>12</b>, <b>14</b>, and <b>47</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="5" align="center">plasma (prodrug)<a class="ref internalNav" href="#t9fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" colspan="2" align="center">liver<a class="ref internalNav" href="#t9fn3" aria-label="c">c</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd<a class="ref internalNav" href="#t9fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center"><i>T</i><sub>max</sub> (h)</th><th class="colsep0 rowsep0" align="center">AUC(inf) (ng·h/mL)</th><th class="colsep0 rowsep0" align="center">AUC(0−<i>t</i>) (ng·h/mL)</th><th class="colsep0 rowsep0" align="center">prodrug (ng/g liver)</th><th class="colsep0 rowsep0" align="center">uridine triphosphate <b>6</b> (ng/g liver)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left">0.25</td><td class="colsep0 rowsep0" align="left">34</td><td class="colsep0 rowsep0" align="left">27</td><td class="colsep0 rowsep0" align="left">4.66</td><td class="colsep0 rowsep0" align="left">26</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">33</td><td class="colsep0 rowsep0" align="left">1.00</td><td class="colsep0 rowsep0" align="left">170</td><td class="colsep0 rowsep0" align="left">86</td><td class="colsep0 rowsep0" align="left">177</td><td class="colsep0 rowsep0" align="left">57</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">1.8</td><td class="colsep0 rowsep0" align="left">6.00</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left">NA</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t9fn1"><div class="footnote" id="t9fn1"><sup>a</sup><p class="last">Dose of 50 mg/kg for 4 consecutive days.</p></div><div class="footnote" id="t9fn2"><sup>b</sup><p class="last">Blood samples collected at 1, 2, 4, 6, 12, and 24 h postdose on day 3.</p></div><div class="footnote" id="t9fn3"><sup>c</sup><p class="last">Livers removed at 4 h time point postdose on day 4.</p></div></div></div><div class="NLM_p">Since the generation of triphosphate levels is critical to predicting in vivo potency of nucleos(t)ide analogues, in vitro triphosphate production in primary human hepatocytes was examined and compared to in vitro triphosphate levels determined in primary hepatocytes from rat, dog, and monkey when incubated with compounds <b>12</b>, <b>14</b>, and <b>47</b>. An analysis of uridine triphosphate (<b>6</b>) production in these primary hepatocyte studies would provide a comparison of the inherent capacity of each nucleotide phosphoramidate to both enter hepatocytes and be converted to the target triphosphate. In vitro analysis of triphosphate production was accomplished by incubating each compound for 48 h with primary hepatocytes from rat, dog, monkey, and human and then extracting the cells and analyzing the extracts by HPLC.<a onclick="showRef(event, 'ref19 ref30'); return false;" href="javascript:void(0);" class="ref ref19 ref30">(19, 30)</a> The triphosphate levels generated in the primary hepatocytes were compared to triphosphate levels generated in clone A replicon cells and to the triphosphate levels generated on exposure to a known clinically efficacious agent, <b>4</b>. Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> shows that for compounds <b>12</b>, <b>14</b>, and <b>47</b> 2′-F,2′-<i>C</i>-methyluridine 5′-triphosphate levels in clone A cells were 6- to 16-fold greater than 2′-F,2′-<i>C</i>-methylcytidine 5′-triphosphate levels generated by cells when incubated with cytidine nucleoside <b>4</b>. These enhanced triphosphate levels in clone A cells are consistent with the increased potency observed for compounds <b>12</b>, <b>14</b>, and <b>47</b> when compared to <b>4</b>. 2′-F,2′-<i>C</i>-methyluridine 5′-triphosphate levels in primary hepatocytes of human, rat, dog, and monkey incubated with compounds <b>12</b>, <b>14</b>, and <b>47</b> were also shown to be high, whereas in each case the triphosphate levels following incubation with <b>4</b> were shown to be below the limit of detection. Compound <b>47</b> consistently showed the lowest triphosphate levels of the three phosphoramidate analogues. Compound <b>14</b> demonstrated 3- to 4-fold higher triphosphate levels in human primary hepatocytes relative to compounds <b>12</b> and <b>47</b>. Compounds <b>12</b> and <b>14</b> produced comparable amounts of triphosphate in monkey and rat hepatocytes, whereas in dog hepatocytes compound <b>12</b> showed 2-fold higher levels than <b>14</b>. The interspecies differences observed regarding conversion of phosphoramidates <b>12</b>, <b>14</b>, and <b>47</b> to the active triphosphate <b>6</b> may be attributed to either cross-species differences in the level of enzymes needed to convert the phosphoramidates to the intermediate monophosphate or to differences in cell penetration. Similarly, since each of the phosphoramidates <b>12</b>, <b>14</b>, and <b>47</b> is converted to the same triphosphate metabolite, intraspecies differences could be attributed to the selectivity of processing enzymes or to the ability to penetrate the species specific hepatocytes by each of the different analogues. To assess relative membrane permeability characteristics, both calculated AlogP values and parallel artificial membrane permeability (PAMPA) were evaluated. Both AlogP and PAMPA results indicate that the predicted order of cell permeability would be <b>47</b> > <b>14</b> > <b>12</b>, in line with lipophilic character (Table <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a>).<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31, 32)</a> This relative order tracks well with the relative replicon EC<sub>90</sub> values; however, the order does not necessarily correlate to triphosphate levels observed in hepatocytes. Therefore, it is possible that other factors such as selectivity for processing enzymes or relative levels of processing enzymes in hepatocytes from different species are contributing to the relative difference in cellular triphosphate levels observed.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/medium/jm-2010-00863x_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/large/jm-2010-00863x_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Uridine triphosphate (<b>6</b>) levels in human, rat, dog, and monkey primary hepatocytes when treated with <b>4</b> and uridine phosphoramidates <b>12</b>, <b>14</b>, and <b>47</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/large/jm-2010-00863x_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100863x&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl10"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 10. AlogP and PAMPA Profile of Compounds <b>12</b>, <b>14</b>, and <b>47</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">AlogP <a class="ref internalNav" href="#t10fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">PAMPA permeability (nm/s)<a class="ref internalNav" href="#t10fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="char" char=".">0.19</td><td class="colsep0 rowsep0" align="char" char=".">0.07</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="char" char=".">0.92</td><td class="colsep0 rowsep0" align="char" char=".">0.46</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="char" char=".">2.26</td><td class="colsep0 rowsep0" align="char" char=".">4.88</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t10fn1"><div class="footnote" id="t10fn1"><sup>a</sup><p class="last">Reference <a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">31</a>.</p></div><div class="footnote" id="t10fn2"><sup>b</sup><p class="last">pH 7.4, incubated for 12−24 h.</p></div></div></div><div class="NLM_p">Nucleos(t)ide toxicity can be correlated to several cellular effects. Mitochondrial toxicity has been reported to be associated with the long-term use of certain nucleos(t)ide analogues resulting in myopathy, peripheral neuropathy, and pancreatitis.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33, 34)</a> Hematotoxicity, which can lead to neutropenia, severe anemia, and thrombocytopenia, has also been associated with several nucleoside analogues including the HCV polymerase inhibitor <b>3</b>.<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35, 36)</a> One cause of hematotoxicity is bone marrow toxicity.<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35, 36)</a> To examine for these possible toxicities, compounds <b>12</b>, <b>14</b>, and <b>47</b> were evaluated for general cytotoxicity against an expanded cell panel and evaluated in vitro for both mitochondrial toxicity and toxicity to bone marrow progenitor cells. In an expanded cell panel that included two human hepatocyte cell lines, Huh7 and HepG2, a human pancreatic cell line, BxBC3, and a human T lymphoblast cell line, CEM, compounds <b>12</b>, <b>14</b>, and <b>47</b> were found to show no cytotoxicity up to 100 μM, the highest concentration tested. Compounds <b>12</b>, <b>14</b>, and <b>47</b> were assessed for mitochondrial toxicity in both CEM and HepG2 cells by incubating each compound for 14 days. Percentage inhibition of mitochondrial DNA production was determined relative to a no drug control. No inhibition of mitochondrial DNA synthesis up to the highest concentration tested (50 μM) was observed for the three compounds. To evaluate the potential for bone marrow toxicity, compounds <b>12</b>, <b>14</b>, and <b>47</b> were screened from 0.1 to 50 μM for their effect on human erythroid and myeloid progenitor cell colony proliferation. Differentiation of hematopoietic progenitors into erythroid or granulocyte-myeloid cell lineages over 14 days was measured. The results showed that compounds <b>12</b> and <b>14</b> had IC<sub>50</sub> values of >50 μM for both erythroid and myeloid progenitor cells. Erythroid and myeloid progenitor cells were more sensitive to compound <b>47</b> which showed IC<sub>50</sub> values of 37 ± 5 μM and 30 ± 5 μM for erythroid and myeloid progenitor cells, respectively. Since each phosphoramidate derivative leads to the same metabolic intermediates, it is unlikely that the metabolic intermediates leading to the triphosphate active metabolite contribute to the effects on erythroid or myeloid progenitor cells. Therefore, since the only difference between compounds <b>12</b>, <b>14</b>, and <b>47</b> resides in the nature of the carboxylic acid ester and the phenolic ester substituents, it would appear that the character of the carboxylate and/or phenolic esters contributes significantly to the effect on erythroid and myeloid progenitor cells and therefore the potential for bone marrow toxicity. The effect on progenitor cells observed for compound <b>47</b> could be a result of the phosphoramidate itself or from the released ester moieties after prodrug metabolism.</div><div class="NLM_p">A comparison of in vivo acute toxicity of compounds <b>12</b>, <b>14</b>, and <b>47</b> was undertaken by single dose oral administration in rats with a 14-day postdose observation period. Rats (three males and three females) were dosed with each compound at doses of 50, 300, and 1800 mg/kg. Fourteen days after dose administration, all rats were euthanized and daily clinical observations, body weights, macroscopic pathology including kidney and liver weights were assessed. For each of the compounds, no test-article-related mortality, clinical signs of toxicity, body weight changes, macroscopic pathology, or organ weight changes for liver and kidney were observed in any of the treatment groups. Consequently, for each of the compounds studied the NOAEL was established at >1800 mg/kg.</div><div class="NLM_p">In vitro hepatocyte triphosphate levels and in vivo PK profiles and effects on bone marrow progenitor cells were factors that differentiated compounds <b>12</b>, <b>14</b>, and <b>47</b>. Compound <b>14</b> consistently produced high levels of triphosphate across all species and in particular showed the greatest triphosphate levels in primary human hepatocytes by as much as 3-fold over compounds <b>12</b> and <b>47</b>. The in vivo PK assessment showed that compound <b>14</b> consistently demonstrated the highest liver triphosphate levels across species. Bone marrow toxicity studies showed that no difference in safety profile was observed between compounds <b>12</b> and <b>14</b>; however, bone marrow progenitor cells were more sensitive to the presence of compound <b>47</b>. On the basis of the overall profile, compound <b>14</b> (PSI-7851) was selected for further development.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div><div class="NLM_p"><b>14</b> is a 1:1 mixture of diastereomers at the phosphorus center of the phosphoramidate moiety and is a low melting point (mp = 66−75 °C) amorphous solid. The diastereomers of <b>14</b> were separated by HPLC chromatography to give the two pure diastereomers <b>50</b> (fast moving isomer) and <b>51</b> (slow moving isomer). In the clone A replicon assay, compounds <b>50</b> and <b>51</b> produced anti-HCV activity with EC<sub>90</sub> values of 7.5 and 0.42 μM, respectively, thus demonstrating a >10-fold difference in activity between the two isomers. Diastereomer <b>51</b> was subsequently crystallized using methylene chloride as the solvent, and a single crystal X-ray structure of <b>51</b> was obtained, definitively establishing the configuration of the phosphorus center as <i>S</i>p and by corollary the configuration of <b>50</b> as <i>R</i>p (Figures <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a> and <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). This is the first demonstrated crystallization and X-ray structure determination of a phosphoramidate nucleotide prodrug and the first example where stereochemistry at phosphorus could be correlated unequivocally to  nucleotide phosphoramidate activity.</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/medium/jm-2010-00863x_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/large/jm-2010-00863x_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. X-ray crystal structure of <b>51</b> crystallized from CH<sub>2</sub>Cl<sub>2</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/large/jm-2010-00863x_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100863x&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/medium/jm-2010-00863x_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/large/jm-2010-00863x_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Structures of diastereomers <b>50</b> and <b>51</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/large/jm-2010-00863x_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100863x&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Each diastereomer was also evaluated against replicons containing known nucleoside resistant mutations. The S282T NS5B polymerase mutation was shown to afford a low level of resistance to the 2′-deoxy-2′-α-F-2′-β-<i>C</i>-methylcytidine nucleoside <b>4</b>, and the S96T mutation was shown to afford resistance to the 4′-azidocytidine nucleoside <b>3</b>.<a onclick="showRef(event, 'ref38 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref38 ref39 ref40">(38-40)</a> The individual uridine phosphoramidate isomers <b>50</b> and <b>51</b> were evaluated against these known nucleoside resistant mutants, and as expected, the S282T mutant was resistant to both isomers <b>50</b> and <b>51</b> with EC<sub>90</sub> fold increases of >13 and 18.6, respectively. No cross-resistance was observed when each isomer was tested against the S96T mutation (Table <a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">11</a>).</div><div class="NLM_table-wrap" id="tbl11"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 11. Cross-Resistance Studies Using Replicon Mutants (S282T and S96T/N142T) Resistant to Nucleotide Inhibitors <b>50</b> and <b>51</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="2" align="center">clone A: EC<sub>90</sub> (μM)<a class="ref internalNav" href="#t11fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="2" align="center">ET-lunet: EC<sub>90</sub> (μM)<a class="ref internalNav" href="#t11fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd<a class="ref internalNav" href="#t11fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">WT</th><th class="colsep0 rowsep0" align="center">S282T</th><th class="colsep0 rowsep0" align="center">EC<sub>90</sub> fold increase<a class="ref internalNav" href="#t11fn2" aria-label="b">b</a><br /></br>S282T/WT</th><th class="colsep0 rowsep0" align="center">WT</th><th class="colsep0 rowsep0" align="center">S96T</th><th class="colsep0 rowsep0" align="center">EC<sub>90</sub> fold increase<a class="ref internalNav" href="#t11fn2" aria-label="b">b</a><br /></br>S96T/WT</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="left">7.5 ± 3.0</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>13</td><td class="colsep0 rowsep0" align="left">3.3 ± 1.4</td><td class="colsep0 rowsep0" align="left">1.3 ± 0.3</td><td class="colsep0 rowsep0" align="left">0.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="left">0.42 ± 0.23</td><td class="colsep0 rowsep0" align="left">7.8 ± 5.3</td><td class="colsep0 rowsep0" align="left">18.6</td><td class="colsep0 rowsep0" align="left">0.23 ± 0.15</td><td class="colsep0 rowsep0" align="left">0.11 ± 0.039</td><td class="colsep0 rowsep0" align="left">0.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t11fn1"><div class="footnote" id="t11fn1"><sup>a</sup><p class="last">Increasing concentrations of <b>50</b> or <b>51</b> were added to wild type (WT), S282T, or S96T/N142T replicon cells (clone A or ET-lunet). The concentration at which 90% inhibition (EC<sub>90</sub>) occurred was calculated.</p></div><div class="footnote" id="t11fn2"><sup>b</sup><p class="last">The fold change in EC<sub>90</sub> of the inhibitor against the S282T or S96T/N142T mutant replicon compared to the wild type replicon was determined.</p></div><div class="footnote" id="t11fn3"><sup>c</sup><p class="last">At least three independent experiments were performed for the compounds in each cell line.</p></div></div></div><div class="NLM_p">Diastereoisomers <b>50</b> and <b>51</b> were evaluated for their ability to generate intracellular levels of the active uridine triphosphate <b>6</b> in clone A and primary human hepatocytes.<a onclick="showRef(event, 'ref19 ref30'); return false;" href="javascript:void(0);" class="ref ref19 ref30">(19, 30)</a> When clone A cells were incubated for 24 h in the presence of <b>50</b> or <b>51</b> (5 μM), diastereoisomer <b>51</b> produced 29.3 μM of triphosphate while compound <b>50</b> produced only 2.7 μM, a 10-fold difference in favor of <b>51</b>. When incubated with primary human hepatocytes under the same conditions, the level of triphosphate produced with diastereomer <b>51</b> (45.0 μM) was 14% greater than that produced with diastereomer <b>50</b> (39.5 μM). It is interesting to note that the overall levels of triphosphate produced in human hepatocytes is significantly greater than seen in clone A replicon cell line. In addition, it is clear that there is a diastereomer preference for triphosphate formation favoring diastereomer <b>51</b> over <b>50</b>.</div><div class="NLM_p">Comparison of cytotoxicity profiles for each isomer (<b>50</b> and <b>51</b>) demonstrated that both compounds were essentially devoid of cytotoxicity when assessed in an 8-day cytotoxicity assay against an expanded cell panel (Huh7, HepG2, BxPC3, and CEM cells) at concentrations up to 100 μM. When mitochondrial toxicity (CC<sub>90</sub>) was evaluated by incubating CEM and HepG2 cells with compounds <b>50</b> and <b>51</b> for 14 days and then measuring the levels of mitochondrial COXII DNA (mtDNA) and ribosomal DNA (rDNA) using real time PCR, both compounds demonstrated no measurable mitochondrial toxicity up to 100 μM in CEM cells but compound <b>51</b> showed a CC<sub>90</sub> of 72.1 and 68.6 μM for the inhibition of mtDNA and rDNA, respectively, in HepG2 cells.</div><div class="NLM_p last">On the basis of its superior potency and ability to produce higher intracellular triphosphate levels, diastereomer <b>51</b> was selected as the preferred diastereomer for further study. Subsequently, we have applied the above crystallization conditions to selectively crystallize the more active diastereomer <b>51</b> from the diastereomeric mixture <b>14</b>. These crystallization conditions have been applied on multikilogram scale to support further development of <b>51</b>. The uridine phosphoramidate <b>51</b> (PSI-7977) is currently in phase II clinical trials for the treatment of HCV infection.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28635" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28635" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We have demonstrated that application of the phosphoramidate prodrug approach to the 5′-monophosphate of 2′-deoxy-2′-α-F-2′-β-<i>C</i>-methyluridine produced nucleotide derivatives with potent anti-HCV activity and that these phosphoramidates were effective at delivering high levels of active triphosphate both in vitro and in vivo. <b>14</b> was selected as a development candidate and demonstrated early clinical proof of concept for the treatment of HCV infection by a 2′-α-F-2′-β-<i>C</i>-methyluridine phosphoramidate. Identification of <b>51</b> as the preferred single diastereomer resulted in the first crystallization and X-ray structure determination of a nucleotide phosphoramidate and correlation of phosphoramidate stereochemistry with biological potency. The <i>S</i>p diastereomer <b>51</b> is currently in phase II clinical development for the treatment of HCV infection.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56125" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56125" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Nuclear magnetic resonance (NMR) spectra were recorded on a Bruker advance II 400 MHz and a Varian Unity Plus 400 MHz spectrometers at room temperature, with tetramethylsilane as an internal standard. Chemical shifts (δ) are reported in parts per million (ppm), and signals are reported as s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), or br s (broad singlet). Purities of the final compounds were determined by HPLC and were greater 95%. HPLC conditions to assess purity were as follows: Shimadzu HPLC 20AB Sepax HP-C18 4.6 mm × 50 mm (5 μm); flow rate, 3.0 mL/min; acquire time, 6 min; wavelength, UV 220 nm; oven temperature, 40 °C. Chiral HPLC was conducted on Shimadzu HPLC 20A. The preparative HPLC system includes two sets of Gilson 306 pumps, a Gilson 156 UV/vis detector, and a Gilson 215 injector and fraction collector, with Unipoint control software. A YMC 25 mm × 30 mm × 2 mm column was used. The mobile phase was HPLC grade water (A) and HPLC grade acetonitrile (B) system. SFC was conducted on Berger MultiGram SFC from Mettler Toledo Co, Ltd. LC/MS was conducted on Shimadzu LCMS 2010EV using electrospray positive [ES+ve to give MH<sup>+</sup>] equipped with a Shim-pack XR-ODS 2.2 μm column (3.0 mm × 30 mm, 3.0 mm i.d.), eluting with 0.0375% TFA in water (solvent A) and 0.01875% TFA in acetonitrile (solvent B). High-resolution mass spectra were obtained on a Agilent G1969a spectrometer.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> 2′-Deoxy-2′-fluoro-2′-C-methyluridine (<b>5</b>)</h3><div class="NLM_p last">3′,5′-<i>O</i>-Dibenozyl-2′-deoxy-2′-fluoro-2′-<i>C</i>-methyl-<i>N</i>4-benzoylcytidine (<b>7</b>, 500 g, 0.874 mol) was added to 70% aqueous acetic acid (7.5 L). The solution was heated to reflux (110 °C) for 20 h. The mixture was cooled to ambient temperature and diluted with water (2 L). After the mixture was stirred for 2 h, the resulting precipitate was collected by filtration and the solid was rinsed with water (5 L) and dried in the atmosphere at ambient temperature for 12 h to afford 360 g (88%) of the dibenzoyluridine intermediate <b>8</b>. This in turn was used as is in the next step by adding it all to freshly prepared 25% methanolic ammonia (5.4 L) at 0 °C. This temperature was maintained for 3 h and then allowed to warm to 15 °C for 24 h. The reaction mixture was filtered through a Celite bed and concentrated under reduced pressure to give the crude product (216 g). The crude product was stirred with ethyl acetate (325 mL) for 3 h at ambient temperature. The resulting solid was collected by filtration and washed with ethyl acetate (200 mL). The solid was dried under vacuum at ambient temperature for 4 h to afford 160 g (78%) of the desired product <b>5</b> in 98.7% HPLC purity. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) d 11.44 (br s, 1H, NH), 7.95 (d, 1H, C-6H), 5.97 (d, 1H, C-1′H), 5.64 (d, 1H, C-5H), 3.84−3.77 (m, 3H, C-5′-Ha, C-3′H, C-4′H), 3.63−3.60 (m, 1H, C5′-Hb), 1.23 (d, 3H, C-2′-CH<sub>3</sub>). ES-MS M − 1, 259.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> General Procedure for the Preparation of Compounds <b>12</b>−<b>49</b></h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> Preparation of Intermediates <b>11</b></h4><div class="NLM_p last">To a solution of compound <b>10</b><a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> (5 mmol) and compound <b>9</b> (5 mmol) in dichloromethane (25 mL), triethylamine or <i>N</i>-methylimidazole (1 g, 10 mmol) in anhydrous dichloromethane (25 mL) was added dropwise with vigorous stirring at −78 or −5 °C over a period of 2 h. The mixture was allowed to warm to 5 °C or room temperature gradually and stirred for an additional 0.5 h. Solvent was evaporated under reduced pressure, and the residue was treated with anhydrous ether (20 mL). The precipitated triethylammonium chloride salt was filtered and washed with ether (10 mL). Solvent was evaporated from the combined filtrate to give the crude product <b>11</b> as colorless oil, and they were used in the next step without further purification.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> Preparation of Products <b>12</b>−<b>49</b></h4><div class="NLM_p">To a well-stirred mixture of 2′-deoxy-2′-fluoro-2′-<i>C</i>-methyluridine (<b>5</b>, 0.15 g,1 equiv) and <i>N</i>-methylimidazole (0.3 g, 8 equiv) in THF (3 mL) at room temperature, the phosphorochloridate intermediate (<b>11</b>, 6.5 equiv) in THF (3 mL) was added in one lot and the mixture was vigorously stirred at room temperature overnight. Solvent was evaporated under reduced pressure. The resulting crude product was dissolved in methanol and purified by preparative HPLC on a YMC 25 mm × 30 mm × 2 mm column using a water/acetonitrile gradient elution mobile phase. The acetonitrile and water were removed under reduced pressure to give the desired product. The final products were characterized by LC/MS and <sup>1</sup>H NMR.</div><div id="sec4_2_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i20" class="anchor-spacer"></div><h5 class="article-section__title" id="_i20"> (<i>S</i>)-2-{[(2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>)-5-(2,4-Dioxo-3,4-dihydro-2<i>H</i>-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-ylmethoxy]phenoxyphosphorylamino}propionic Acid Methyl Ester (<b>12</b>)</h5><div class="NLM_p last">Yield: 15.6%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.20−1.27 (m, 6H), 3.58 (d, <i>J</i> = 16.0 Hz, 3H), 3.76−3.92 (m, 2H), 4.02−4.38 (m, 2H), 5.54 (t, <i>J</i> = 10.2 Hz, 1H), 5.84−5.91 (m, 1H), 6.00−6.16 (m, 1H), 7.18 (d, <i>J</i> = 8.0 Hz, 2H), 7.22 (s, 1H), 7.35 (t, <i>J</i> = 4.4 Hz, 2H), 7.55 (s, 1H), 11.52 (s, 1H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 174.61, 174.57, 174.51, 174.46, 163.69, 151.60, 151.54, 151.39, 140.27, 130.61, 125.55, 121.04, 120.99, 120.96, 103.26, 103.18, 102.17, 100.37, 89.50, 80.36, 72.34, 65.55, 65.28, 52.82, 50.73, 50.58, 27.77, 20.71, 20.65, 20.58, 20.51, 17.60, 17.35; MS, <i>m</i>/<i>e</i> 502 (M + 1)<sup>+</sup>. HRMS, calcd for C<sub>20</sub>H<sub>26</sub>FN<sub>3</sub>O<sub>9</sub>P (M<sup>+</sup> + H), 502.1385; found, 502.1372.</div></div><div id="sec4_2_2_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i21" class="anchor-spacer"></div><h5 class="article-section__title" id="_i21"> (<i>S</i>)-2-{[(2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>)-5-(2,4-Dioxo-3,4-dihydro-2<i>H</i>-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-ylmethoxy]phenoxyphosphorylamino}propionic Acid Ethyl Ester (<b>13</b>)</h5><div class="NLM_p last">Yield: 19.6%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.13−1.16 (m, 3H), 1.20−1.28 (m, 6H), 3.70−3.90 (m, 2H), 4.00−4.08 (m, 3H), 4.18−4.39 (m, 2H), 5.53−5.58 (m, 1H), 5.86−5.98 (m, 1H), 6.01−6.13 (m, 2H), 7.16−7.23 (m, 3H), 7.37−7.40 (m, 2H), 7.54−7.57(m, 1H), 11.54 (s,1H); MS, <i>m</i>/<i>e</i> 516.1 (M + 1)<sup>+</sup>. HRMS, calcd for C<sub>21</sub>H<sub>28</sub>FN<sub>3</sub>O<sub>9</sub>P (M<sup>+</sup> + H), 516.1542; found, 516.1526.</div></div><div id="sec4_2_2_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i22" class="anchor-spacer"></div><h5 class="article-section__title" id="_i22"> (<i>S</i>)-2-{[(2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>)-5-(2,4-Dioxo-3,4-dihydro-2<i>H</i>-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-ylmethoxy]phenoxyphosphorylamino}propionic Acid Isopropyl Ester (<b>14</b>)</h5><div class="NLM_p last">Yield: 6%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.13−1.28 (m, 12H), 3.75−3.81 (m, 2H), 3.95−4.08 (m,1H), 4.20−4.45 (m, 2H), 4.83−4.86 (m, 1H), 5.53−5.58 (m, 1H), 5.84−6.15 (m, 3H), 7.18−7.23 (m, 3H), 7.35−7.39 (m, 2H), 7.54−7.57 (m, 1H), 11.50 (s, 1H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 173.70, 173.66, 173.59, 173.54, 163.70, 151.60, 151.40, 140.25, 130.63, 125.55, 121.04, 120.99, 120.95, 103.28, 103.21, 102.20, 100.37, 89.42, 80.33, 72.33, 68.98, 68.95, 65.60, 65.14, 50.88, 50.72, 27.79, 22.37, 22.32, 20.77, 20.71, 20.64, 20.57, 17.60, 17.36; MS, <i>m</i>/<i>e</i> 530.2 (M + 1)<sup>+</sup>. HRMS, calcd for C<sub>22</sub>H<sub>30</sub>FN<sub>3</sub>O<sub>9</sub>P (M<sup>+</sup> + H), 530.1698; found, 530.1685. The two diastereomers were separated using column chromatography on silica gel using 2−5% isopropanol in dichloromethane as the eluent.</div></div><div id="sec4_2_2_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i23" class="anchor-spacer"></div><h5 class="article-section__title" id="_i23"> (<i>S</i>)-2-{(<i>R</i>)-[(2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>)-5-(2,4-Dioxo-3,4-dihydro-2<i>H</i>-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-ylmethoxy]phenoxyphosphorylamino}propionic Acid Isopropyl Ester (<b>50</b>)</h5><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 11.53 (s, 1H), 7.56 (d, <i>J</i> = 8.0 Hz, 1H), 7.39−7.35 (m, 2H), 7.20−7.15 (m, 3H), 6.13−6.07 (m, 1H), 5.91 (d, <i>J</i> = 7.2 Hz, 1H), 5.57 (dd, <i>J</i> = 2.0, 8.0 Hz, 1H), 4.85 (sextet, <i>J</i> = 6.4 Hz, 1H), 4.43−4.38 (m, 1H), 4.30−4.23 (m, 1H), 4.05 (dm, <i>J</i> = 6.4 Hz, 1H), 3.80−3.72 (m, 2H), 1.24 (d, <i>J</i> = 22.4 Hz, 3H), 1.20 (d, <i>J</i> = 6.8 Hz, 3H), 1.15 (dd, <i>J</i> = 2.8, 6.0 Hz, 6H); <sup>31</sup>P NMR (DMSO-<i>d</i><sub>6</sub>) δ 4.76; MS (ESI) (M + H)<sup>+</sup> 530.1. HRMS, calcd for C<sub>22</sub>H<sub>30</sub>FN<sub>3</sub>O<sub>9</sub>P (M<sup>+</sup> + H), 530.1698; found, 530.1686.</div></div><div id="sec4_2_2_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i24" class="anchor-spacer"></div><h5 class="article-section__title" id="_i24"> (<i>S</i>)-2-{[(1<i>R</i>,4<i>R</i>,5<i>R</i>)-5-(2,4-Dioxo-3,4-dihydro-2<i>H</i>-pyrimidin-1-yl)-4-(<i>R</i>)-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-ylmethoxy]phenoxyphosphorylamino}propionic Acid (<i>S</i>)-Isopropyl Ester (<b>51</b>)</h5><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 11.50 (s, 1H), 7.54 (d, <i>J</i> = 8.0 Hz, 1H), 7.38−7.33 (m, 2H), 7.21−7.15 (m, 3H), 6.06−5.99 (m, 2H), 5.82 (m, 1H), 5.52 (d, <i>J</i> = 8.0 Hz, 1H), 4.84 (quintet, <i>J</i> = 6.4 Hz, 1H), 4.38−4.32 (m, 1H), 4.23−4.18 (m, 1H), 4.01−3.96 (m, 1H), 3.84−3.72 (m, 2H), 1.24 (d, <i>J</i> = 17.2 Hz, 3H), 1.21 (d, <i>J</i> = 6.4 Hz, 3H), 1.13 (d, <i>J</i> = 6.0 Hz, 6H); <sup>31</sup>P NMR (DMSO-<i>d</i><sub>6</sub>) δ 4.89; MS (ESI) (M + H)<sup>+</sup> 530.1. HRMS, calcd for C<sub>22</sub>H<sub>30</sub>FN<sub>3</sub>O<sub>9</sub>P (M<sup>+</sup> + H), 530.1698; found, 530.1683.</div></div><div id="sec4_2_2_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i25" class="anchor-spacer"></div><h5 class="article-section__title" id="_i25"> (<i>S</i>)-2-{[(2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>)-5-(2,4-Dioxo-3,4-dihydro-2<i>H</i>-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-ylmethoxy]phenoxyphosphorylamino}propionic Acid Butyl Ester (<b>15</b>)</h5><div class="NLM_p last">Yield: 12.7%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 0.81−0.85 (m, 3H), 1.20−1.30 (m, 8H), 1.47−1.51 (m, 2H), 3.78−3.88 (m, 2H), 3.95−4.08 (m, 3H), 4.22−4.45 (m, 2H), 5.56−5.58 (t, 1H), 5.85−6.18 (m, 3H), 7.18−7.23 (m, 3H), 7.37−7.39 (m, 2H), 7.51−7.60 (d, 1H), 11.50 (s.1H); MS, <i>m</i>/<i>e</i> 544.2 (M + 1)<sup>+</sup>. HRMS, calcd for C<sub>23</sub>H<sub>32</sub>FN<sub>3</sub>O<sub>9</sub>P (M<sup>+</sup> + H), 544.1855; found, 544.1839.</div></div><div id="sec4_2_2_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i26" class="anchor-spacer"></div><h5 class="article-section__title" id="_i26"> (<i>S</i>)-2-{[(2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>)-5-(2,4-Dioxo-3,4-dihydro-2<i>H</i>-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-ylmethoxy]phenoxyphosphorylamino}propionic Acid <i>sec</i>-Butyl Ester (<b>16</b>)</h5><div class="NLM_p last">Yield: 6.3%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 0.89 (d, <i>J</i> = 6.8 Hz, 6H), 1.20−1.26 (m, 6H), 1.79−1.86 (m, 1H), 3.37−3.90 (m, 4H), 4.01 (t, <i>J</i> = 11.2 Hz, 1H), 4.21−4.28 (m, 1H), 4.33−4.42 (m, 1H), 5.54 (t, <i>J</i> = 7.6 Hz, 1H), 5.85−5.92 (m, 1H), 5.99−6.13 (m, 2H), 7.19 (t, <i>J</i> = 8 Hz, 3H), 7.36 (t, <i>J</i> = 7.6 Hz, 2H), 7.53 (d, <i>J</i> = 7.6 Hz, 1H), 11.52 (s, 1H); MS, <i>m</i>/<i>e</i> 544.00 (M + 1)<sup>+</sup>. HRMS, calcd for C<sub>23</sub>H<sub>32</sub>FN<sub>3</sub>O<sub>9</sub>P (M<sup>+</sup> + H), 544.1855; found, 544.1840.</div></div><div id="sec4_2_2_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> (<i>S</i>)-2-{[(2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>)-5-(2,4-Dioxo-3,4-dihydro-2<i>H</i>-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-ylmethoxy]phenoxyphosphorylamino}propionic Acid Pentyl Ester (<b>17</b>)</h5><div class="NLM_p last">Yield: 32.2%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 0.80−0.81 (m, 3H), 1.17−1.23 (m, 10H), 1.47−1.50 (m, 2H), 3.77−3.81 (m, 2H), 3.94−3.96 (m, 3H), 4.21−4.36 (m, 2H), 5.52−5.54 (m, 1H), 5.87−6.01 (m, 3H), 7.14−7.19 (m, 3H), 7.32−7.35 (m, 2H), 7.51 (d, <i>J</i> = 8 Hz, 1H), 11.49 (s, 1H); MS, <i>m</i>/<i>e</i> 557.9 (M + 1)<sup>+</sup>; 1136.88 (2M + 23)<sup>+</sup>. HRMS, calcd for C<sub>24</sub>H<sub>34</sub>FN<sub>3</sub>O<sub>9</sub>P (M<sup>+</sup> + H), 558.2011; found, 558.1998.</div></div><div id="sec4_2_2_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i28" class="anchor-spacer"></div><h5 class="article-section__title" id="_i28"> (<i>S</i>)-2-{[(2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>)-5-(2,4-Dioxo-3,4-dihydro-2<i>H</i>-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-ylmethoxy]phenoxyphosphorylamino}propionic Acid Cyclohexyl Ester (<b>18</b>)</h5><div class="NLM_p last">Yield: 19.3%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.18−1.41 (m, 12H), 1.59−1.67 (m, 4H), 3.74−3.80 (m, 1H), 3.96−4.02 (m, 1H), 4.19−4.26 (m, 1H), 4.31−4.39 (m, 1H), 4.59 (s, 1H), 5.52 (t, <i>J</i> = 7.8 Hz, 1H), 5.80−6.09 (m, 3H), 7.15−7.20 (m, 3H), 7.32−7.36 (m, 2H), 7.52 (d, <i>J</i> = 8 Hz, 1H), 11.50 (s, 1H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 173.61, 173.57, 173.50, 173.45, 163.68, 151.64, 151.58, 151.40, 140.18, 130.63, 125.55, 121.04, 120.99, 120.95, 103.28, 103.22, 102.19, 100.39, 89.37, 80.37, 73.48, 72.35, 65.15, 50.92, 50.75, 31.80, 31.72, 25.76, 23.94, 20.86, 20.80, 20.73, 20.66, 17.60, 17.35; MS, <i>m</i>/<i>e</i> 569.98 (M + 1)<sup>+</sup>; 592.14 (M + 23)<sup>+</sup>. HRMS, calcd for C<sub>25</sub>H<sub>34</sub>FN<sub>3</sub>O<sub>9</sub>P (M<sup>+</sup> + H), 570.2011; found, 570.1999.</div></div><div id="sec4_2_2_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29"> (<i>S</i>)-2-{[(2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>)-5-(2,4-Dioxo-3,4-dihydro-2<i>H</i>-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-ylmethoxy]phenoxyphosphorylamino}propionic Acid 2-Fluoroethyl Ester (<b>19</b>)</h5><div class="NLM_p last">Yield: 7%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.18−1.25 (m, 6H), 3.71−3.89 (m, 2H), 3.92−3.99 (m, 1H), 4.19−4.27 (m, 4H), 4.48−4.61 (m, 2H), 5.52 (m, 1H), 5.90−6.14 (m, 2H), 7.15−7.21 (m, 3H), 7.32−7.36 (m, 2H), 7.46−7.57 (m, 1H), 11.49 (s,1H); MS, <i>m</i>/<i>e</i> 533.86 (M + 1)<sup>+</sup>. HRMS, calcd for C<sub>21</sub>H<sub>27</sub>F<sub>2</sub>N<sub>3</sub>O<sub>9</sub>P (M<sup>+</sup> + H), 534.1447; found, 534.1434.</div></div><div id="sec4_2_2_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> (<i>S</i>)-2-{[(2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>)-5-(2,4-Dioxo-3,4-dihydro-2<i>H</i>-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-ylmethoxy]phenoxyphosphorylamino}propionic Acid 2,2-Difluoroethyl Ester (<b>20</b>)</h5><div class="NLM_p last">Yield: 7%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.17−1.24 (m, 6H), 3.67−3.81 (m, 1H), 3.89−3.98 (m, 2H), 4.21−4.36 (m, 4H), 5.48−5.53 (m, 1H), 5.82−6.05 (m, 2H), 6.18−6.22 (m, 2H), 7.15−7.20 (m, 3H), 7.32−7.36 (m, 2H), 7.51 (s, 1H), 11.50 (s, 1H); MS, <i>m</i>/<i>e</i> 551.92 (M + 1)<sup>+</sup>. HRMS, calcd for C<sub>21</sub>H<sub>26</sub>F<sub>3</sub>N<sub>3</sub>O<sub>9</sub>P (M<sup>+</sup> + H), 552.1353; found, 552.1342.</div></div><div id="sec4_2_2_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> (<i>S</i>)-2-{[(2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>)-5-(2,4-Dioxo-3,4-dihydro-2<i>H</i>-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-ylmethoxy]phenoxyphosphorylamino}propionic Acid Phenyl Ester (<b>21</b>)</h5><div class="NLM_p last">Yield: 21%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.19−1.25 (m, 3H), 1.38−1.41 (m, 3H), 3.72−3.91 (m, 1H), 4.04−4.14 (m, 2H), 4.28−4.31 (m, 1H), 4.41−4.43 (m, 1H), 5.49−5.55 (m, 1H), 5.88−6.07 (m, 2H), 6.33−6.36 (m,1H), 7.03−7.06 (m, 2H), 7.16−7.27 (m, 4H), 7. 35−7. 39 (m, 4H), 7.41−7.54 (m, 1H), 11.51 (s, 1H); MS, <i>m</i>/<i>e</i> 563.91 (M + 1)<sup>+</sup>, 1148.82 (2M + 23)<sup>+</sup>. HRMS, calcd for C<sub>25</sub>H<sub>28</sub>FN<sub>3</sub>O<sub>9</sub>P (M<sup>+</sup> + H), 564.1542; found, 564.1529.</div></div><div id="sec4_2_2_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> (<i>S</i>)-2-{[(2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>)-5-(2,4-Dioxo-3,4-dihydro-2<i>H</i>-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-ylmethoxy]phenoxyphosphorylamino}propionic Acid Benzyl Ester (<b>22</b>)</h5><div class="NLM_p last">Yield: 12.5%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.20−1.28 (m, 6H), 3.72−4.01 (m, 3H), 4.23−4.26 (m, 1H), 4.37−4.38 (m, 1H), 5.08−5.09 (t, 2H), 5.52−5.56 (t, 1H), 5.86−6.04 (m, 2H), 6.16−6.19 (m,1H), 7.15−7.21 (m, 3H), 7.30−7.36 (m, 7H), 7.54−7.56 (d, 1H), 11.50 (s.1H); MS, <i>m</i>/<i>e</i> 578.2 (M + 1)<sup>+</sup>. HRMS, calcd for C<sub>26</sub>H<sub>30</sub>FN<sub>3</sub>O<sub>9</sub>P (M<sup>+</sup> + H), 578.1698; found, 578.1689.</div></div><div id="sec4_2_2_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> (<i>S</i>)-2-{[(2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>)-5-(2,4-Dioxo-3,4-dihydro-2<i>H</i>-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-ylmethoxy]phenoxyphosphorylamino}propionic Acid 4-Fluorobenzyl Ester (<b>23</b>)</h5><div class="NLM_p last">Yield: 27.6%. <sup>1</sup>HNMR (DMSO-<i>d</i><sub>6</sub>): δ 1.20−1.27 (m, 6H), 3.80−3.98 (m, 2H), 4.01 (s, 1H), 4.25−4.26 (m, 1H), 4.37−4.38 (m, 1H), 5.07 (s, 2H), 5.52−5.56 (m, 1H), 5.86−5.87 (m, 1H), 5.99−6.05 (m, 1H), 6.15−6.17 (m, 1H), 7.15−7.21 (m, 5H), 7.36 (dd, <i>J =</i> 20.0, 8.0 Hz, 4H), 7.54 (s, 1H), 11.55 (s, 1H); MS, <i>m</i>/<i>e</i> 595.95 (M + 1)<sup>+</sup>. HRMS, calcd for C<sub>26</sub>H<sub>29</sub>F<sub>2</sub>N<sub>3</sub>O<sub>9</sub>P (M<sup>+</sup> + H), 596.1604; found, 596.1594.</div></div><div id="sec4_2_2_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i34" class="anchor-spacer"></div><h5 class="article-section__title" id="_i34"> (<i>S</i>)-2-[[(2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>)-5-(2,4-Dioxo-3,4-dihydro-2<i>H</i>-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-ylmethoxy]-(4-fluorophenoxy)phosphorylamino]propionic Acid Methyl Ester (<b>24</b>)</h5><div class="NLM_p last">Yield: 5.8%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.28−1.34 (m, 6H), 3.65 (d, <i>J</i> = 4 Hz, 3H), 3.85−3.96 (m, 2H), 4.06−4.12 (m, 1H), 4.30−4.34 (m, 1H), 4.40−4.47 (m, 1H), 5.62−5.67 (m, 1H), 5.94−6.01 (m, 1H), 6.09 (d, <i>J</i> = 18.8 Hz, 1H), 6.17−6.26 (m, 1H), 7.27−7.33 (m, 4H), 7.62 (d, <i>J</i> = 7.6 Hz, 1H), 11.61 (s, 1H); MS, <i>m</i>/<i>e</i> 519.94 (M + 1)<sup>+</sup>. HRMS, calcd for C<sub>20</sub>H<sub>25</sub>F<sub>2</sub>N<sub>3</sub>O<sub>9</sub>P (M<sup>+</sup> + H), 520.1291; found, 520.1276.</div></div><div id="sec4_2_2_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35"> (<i>S</i>)-2-{(4-Chlorophenoxy)-[(2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>)-5-(2,4-dioxo-3,4-dihydro-2<i>H</i>-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-ylmethoxy]phosphorylamino}propionic Acid Methyl Ester (<b>25</b>)</h5><div class="NLM_p last">Yield: 4.4%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.23−1.28 (m, 6H), 3.58 (d, 2H), 3.81−3.89 (m, 2H), 3.99−4.02 (m,1H), 4.24−4.39 (m, 2H), 5.56−5.61 (t, 1H), 5.86−6.10 (m, 2H), 6.17−6.20 (m, 1H), 7.21−7.26 (m, 2H), 7.43−7.46 (m, 2H), 7.54−7.57 (d, 1H), 11.50 (s.1H); MS, <i>m</i>/<i>e</i> 536.1 (M + 1)<sup>+</sup>. HRMS, calcd for C<sub>20</sub>H<sub>25</sub>ClFN<sub>3</sub>O<sub>9</sub>P (M<sup>+</sup> + H), 536.0995; found, 536.0981.</div></div><div id="sec4_2_2_17" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> (<i>S</i>)-2-{(4-Bromophenoxy)-[(2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>)-5-(2,4-dioxo-3,4-dihydro-2<i>H</i>-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-ylmethoxy]phosphorylamino}propionic Acid Methyl Ester (<b>26</b>)</h5><div class="NLM_p last">Yield: 12%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.20−1.26 (m, 6H), 3.57 (d, <i>J</i> = 2.8 Hz, 3H), 3.84 (s, 1H), 3.97−4.03 (m, 1H), 4.21−4.25 (m, 1H), 4.33−4.37 (m, 2H), 5.54−5.60 (m, 1H), 5.83−5.89 (m, 1H), 5.98−6.19 (m, 1H), 7.16 (t, <i>J</i> = 10.2 Hz, 2H), 7.52−7.57 (m, 3H), 11.52 (s, 1 H); MS, <i>m</i>/<i>e</i> 580 (M + 1)<sup>+</sup>. HRMS, calcd for C<sub>20</sub>H<sub>25</sub>BrFN<sub>3</sub>O<sub>9</sub>P (M<sup>+</sup> + H), 580.0490; found, 580.0490.</div></div><div id="sec4_2_2_18" class="NLM_sec NLM_sec_level_4"><div id="ac_i37" class="anchor-spacer"></div><h5 class="article-section__title" id="_i37"> (<i>S</i>)-2-{(3,4-Dichlorophenoxy)-[(2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>)-5-(2,4-dioxo-3,4-dihydro-2<i>H</i>-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-ylmethoxy]phosphorylamino}propionic Acid Methyl Ester (<b>27</b>)</h5><div class="NLM_p last">Yield: 4%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.13 (m, 6H), 3.49 (s, 3H), 3.61−3.85 (m, 2H), 3.90−3.93 (m, 1H), 4.16−4.22 (m, 1H), 4.27−4.31 (m, 1H), 5.47−5.52 (m, 1H), 5.82 (d, <i>J</i> = 11.6 Hz, 1H), 5.93 (d, <i>J</i> = 19.2 Hz, 1H), 6.15−6.25 (m, 1H), 7.13 (t, <i>J</i> = 9.6 Hz, 1H), 7.43 (d, <i>J</i> = 12 Hz, 2H), 7.57 (d, <i>J</i> = 6.0 Hz, 1H), 11.43 (s, 1H); MS, <i>m</i>/<i>e</i> 569.85 (M + 1)<sup>+</sup>. HRMS, calcd for C<sub>20</sub>H<sub>24</sub>Cl<sub>2</sub>FN<sub>3</sub>O<sub>9</sub>P (M<sup>+</sup> + H), 570.0606; found, 570.0595.</div></div><div id="sec4_2_2_19" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38"> (<i>S</i>)-2-{(2,4-Dichlorophenoxy)-[(2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>)-5-(2,4-dioxo-3,4-dihydro-2<i>H</i>-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-ylmethoxy]phosphorylamino}propionic Acid Methyl Ester (<b>28</b>)</h5><div class="NLM_p last">Yield: 11.5%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.22−1.28 (m, 6H), 3.58−3.60 (m, 3H), 3.85−3.92 (m, 2H), 4.00−4.04 (m, 1H), 4.31−4.44 (m, 2 H), 5.55−5.61 (m, 1H), 5.86−6.10 (m, 2H), 6.33−6.39 (m, 1H), 7.44−7.54 (m, 3H), 7.72−7.75 (m, 1H), 11.54 (s.1H); MS, <i>m</i>/<i>e</i> 570.2 (M + 1)<sup>+</sup>. HRMS, calcd for C<sub>20</sub>H<sub>24</sub>Cl<sub>2</sub>FN<sub>3</sub>O<sub>9</sub>P (M<sup>+</sup> + H), 570.0606; found, 570.0597.</div></div><div id="sec4_2_2_20" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> (<i>S</i>)-2-[[(2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>)-5-(2,4-Dioxo-3,4-dihydro-2<i>H</i>-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-ylmethoxy](naphthalen-1-yloxy)phosphorylamino]propionic Acid Methyl Ester (<b>29</b>)</h5><div class="NLM_p last">Yield: 18.3%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.16−1.27 (m, 6H), 3.51−3.55 (d, 3H), 3.85−3.96 (m, 2H), 4.06−4.09 (m, 1H), 4.31−4.46 (m, 2H), 5.31−5.39 (m, 1H), 5.90−6.04 (m, 2H), 6.22−6.34 (m, 1H), 7.45−7.59 (m, 5H), 7.73−7.77 (m, 1H), 7.94−7.96 (m, 1H), 8.12−8.14 (m, 1H), 11.50 (s.1H); MS, <i>m</i>/<i>e</i> 552.1 (M + 1)<sup>+</sup>. HRMS, calcd for C<sub>24</sub>H<sub>28</sub>FN<sub>3</sub>O<sub>9</sub>P (M<sup>+</sup> + H), 552.1542; found, 552.1529.</div></div><div id="sec4_2_2_21" class="NLM_sec NLM_sec_level_4"><div id="ac_i40" class="anchor-spacer"></div><h5 class="article-section__title" id="_i40"> (<i>S</i>)-2-{[(2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>)-5-(2,4-Dioxo-3,4-dihydro-2<i>H</i>-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-ylmethoxy]ethoxyphosphorylamino}propionic Acid Methyl Ester (<b>30</b>)</h5><div class="NLM_p last">Yield: 43.8%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.18−1.27 (m, 9H), 3.62 (s, 3H), 3.64−3.85 (m, 2H), 3.90−4.10 (m, 4H), 4.19−4.23 (m, 1H), 5.60−5.67 (m, 2H), 5.82−6.10 (m, 2H), 7.58−7.63 (m, 1H), 11.52 (s, 1H); MS, <i>m</i>/<i>e</i> 454.05 (M + 1)<sup>+</sup>. HRMS, calcd for C<sub>16</sub>H<sub>26</sub>FN<sub>3</sub>O<sub>9</sub>P (M<sup>+</sup> + H), 454.1385; found, 454.1366.</div></div><div id="sec4_2_2_22" class="NLM_sec NLM_sec_level_4"><div id="ac_i41" class="anchor-spacer"></div><h5 class="article-section__title" id="_i41"> {[(2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>)-5-(2,4-Dioxo-3,4-dihydro-2<i>H</i>-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-ylmethoxy]phenoxyphosphorylamino}acetic Acid Methyl Ester (<b>31</b>)</h5><div class="NLM_p last">Yield: 22%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.19−1.28 (m, 3H), 3.59 (s, 3H), 3.63−3.70 (m, 2H), 3.74−3.80 (m, 1H), 4.02 (d, <i>J</i> = 11.2 Hz, 1H), 4.23−4.28 (m, 1H), 4.40−4.43 (m, 1H), 5.57−5.59 (m, 1H), 5.89 (d, <i>J</i> = 6.8 Hz, 1H), 6.01−6.05 (m, 2H), 7.16−7.23 (m, 3H), 7.35−7.39 (m, 2H), 7.52(d, <i>J</i> = 8 Hz, 1H), 11.52 (s, 1H); MS, <i>m</i>/<i>e</i> 487.97 (M + 1)<sup>+</sup>. HRMS, calcd for C<sub>19</sub>H<sub>24</sub>FN<sub>3</sub>O<sub>9</sub>P (M<sup>+</sup> + H), 488.1229; found, 488.1215.</div></div><div id="sec4_2_2_23" class="NLM_sec NLM_sec_level_4"><div id="ac_i42" class="anchor-spacer"></div><h5 class="article-section__title" id="_i42"> (<i>S</i>)-2-{[(2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>)-5-(2,4-Dioxo-3,4-dihydro-2<i>H</i>-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-ylmethoxy]phenoxyphosphorylamino}butyric Acid Methyl Ester (<b>32</b>)</h5><div class="NLM_p last">Yield: 14%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 0.72−0.79 (m, 3H), 1.18−1.25 (m, 3H), 1.42−1.61 (m, 2H), 3.53−3.57 (m, 3H), 3.58−3.80 (m, 2H), 3.91−4.02 (m, 1H), 4.12−4.38 (m, 2H), 5.54−5.59 (m,1H), 5.90−6.03 (m, 1H), 7.14−7.18 (m, 3H), 7.33−7.37 (m, 2H), 7.49 (t,1H), 11.45 (s, 1H); MS, <i>m</i>/<i>e</i> 515.95 (M + 1)<sup>+</sup>; 1052.82 (2M + 23)<sup>+</sup>. HRMS, calcd for C<sub>21</sub>H<sub>28</sub>FN<sub>3</sub>O<sub>9</sub>P (M<sup>+</sup> + H), 516.1542; found, 516.1526.</div></div><div id="sec4_2_2_24" class="NLM_sec NLM_sec_level_4"><div id="ac_i43" class="anchor-spacer"></div><h5 class="article-section__title" id="_i43"> (<i>S</i>)-2-{[(2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>)-5-(2,4-Dioxo-3,4-dihydro-2<i>H</i>-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-ylmethoxy]phenoxyphosphorylamino}-3-methylbutyric Acid Methyl Ester (<b>33</b>)</h5><div class="NLM_p last">Yield: 20%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 0.75−0.85 (m, 6H), 1.21−1.29 (m, 3H), 1.89−1.94 (m, 1H), 3.51−3.55 (m, 1H), 3.58 (d, <i>J</i> = 10.4 Hz, 3H), 3.72−3.95 (m, 1H), 4.03−4.05 (m, 1H), 4.23−4.37 (m, 2H), 5.56 (t, <i>J</i> = 16.0 Hz, 1H), 5.85−5.92 (m, 1H), 6.01−6.07 (m, 1H), 7.16−7.21 (m, 3H), 7.37 (t, <i>J</i> = 8 Hz, 2H), 7.55−7.60 (m, 1H), 11.52 (s, 1H); MS, <i>m</i>/<i>e</i> 530 (M + 1)<sup>+</sup>. HRMS, calcd for C<sub>22</sub>H<sub>30</sub>FN<sub>3</sub>O<sub>9</sub>P (M<sup>+</sup> + H), 530.1698; found, 530.1684.</div></div><div id="sec4_2_2_25" class="NLM_sec NLM_sec_level_4"><div id="ac_i44" class="anchor-spacer"></div><h5 class="article-section__title" id="_i44"> (<i>S</i>)-2-{[(2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>)-5-(2,4-Dioxo-3,4-dihydro-2<i>H</i>-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-ylmethoxy]phenoxyphosphorylamino}-4-methylpentanoic Acid Methyl Ester (<b>34</b>)</h5><div class="NLM_p last">Yield: 21%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 0.68−0.89 (m, 6H), 1.26 (d, <i>J</i> = 7.2 Hz, 3H), 1.41−1.64 (m, 3H), 3.70 (s, 3H), 3.73−3.79 (m, 2H), 3.99−4.04 (m, 1H), 4.19−4.27 (m, 1H), 4.34−4.38 (m, 1H), 5.55 (t, <i>J</i> = 9.0 Hz, 1H), 5.86−5.92 (m, 1H), 5.99−6.12 (m, 2H), 7.15−7.20 (m, 3H), 7.34−7.39 (m, 2H), 7.55 (s, 1H), 11.53 (s, 1H); MS, <i>m</i>/<i>e</i> 543.99 (M + 1)<sup>+</sup>. HRMS, calcd for C<sub>23</sub>H<sub>32</sub>FN<sub>3</sub>O<sub>9</sub>P (M<sup>+</sup> + H), 544.1855; found, 544.1841.</div></div><div id="sec4_2_2_26" class="NLM_sec NLM_sec_level_4"><div id="ac_i45" class="anchor-spacer"></div><h5 class="article-section__title" id="_i45"> (<i>S</i>)-2-{[(2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>)-5-(2,4-Dioxo-3,4-dihydro-2<i>H</i>-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-ylmethoxy]phenoxyphosphorylamino}-4-methylsulfanylbutyric Acid Methyl Ester (<b>35</b>)</h5><div class="NLM_p last">Yield: 27.4%. <sup>1</sup>HNMR (DMSO-<i>d</i><sub>6</sub>): δ 1.25 (dd, <i>J =</i> 22.8 Hz, 5.6 Hz, 3H), 1.77−1.85 (m, 2H), 1.95 (d, <i>J =</i> 10.0 Hz, 3H), 2.31−2.36 (m, 1H), 2.40−2.44 (m, 1H), 3.59−3.64 (m, 3H), 3.88−3.91 (m, 2H), 4.05 (m, 1H), 4.25−4.26 (m, 1H), 4.29−4.40 (m, 1H), 5.56 (t, <i>J =</i> 8.0 Hz, 1H), 5.90−5.92 (m, 1H), 6.13−6.16 (m, 2H), 7.16−7.23 (m, 3H), 7.36−7.40 (m, 2H), 7.55 (d, <i>J =</i> 8.4 Hz, 1H), 11.51 (s, 1H); MS, <i>m</i>/<i>e</i> 562.52(M + 1)<sup>+</sup>. HRMS, calcd for C<sub>22</sub>H<sub>30</sub>FN<sub>3</sub>O<sub>9</sub>PS (M<sup>+</sup> + H), 562.1419; found, 562.1406.</div></div><div id="sec4_2_2_27" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46"> (<i>S</i>)-2-{[(2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>)-5-(2,4-Dioxo-3,4-dihydro-2<i>H</i>-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-ylmethoxy]phenoxyphosphorylamino}-3-phenylpropionic Acid Methyl Ester (<b>36</b>)</h5><div class="NLM_p last">Yield: 6.6%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.19−1.34 (m, 3H), 2.79−2.97 (m, 2H), 3.51−3.57 (m, 3H), 3.60−3.85 (m, 1H), 3.91−4.13 (m, 4H), 5.50−5.52 (m, 1H), 5.80−6.10 (m, 2H), 6.20−6.35 (m, 1H), 7.01−7.05 (m, 2H), 7.14−7.32 (m, 8H), 7.47 (s, 1H), 11.50 (s.1H); MS, <i>m</i>/<i>e</i> 578.2 (M + 1)<sup>+</sup>. HRMS, calcd for C<sub>26</sub>H<sub>30</sub>FN<sub>3</sub>O<sub>9</sub>P (M<sup>+</sup> + H), 578.1698; found, 578.1687.</div></div><div id="sec4_2_2_28" class="NLM_sec NLM_sec_level_4"><div id="ac_i47" class="anchor-spacer"></div><h5 class="article-section__title" id="_i47"> (<i>S</i>)-2-{[(2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>)-5-(2,4-Dioxo-3,4-dihydro-2<i>H</i>-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-ylmethoxy]phenoxyphosphorylamino}-3-(1<i>H</i>-indol-3-yl)propionic Acid Methyl Ester (<b>37</b>)</h5><div class="NLM_p last">Yield: 8.1%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 0.96 (d, <i>J =</i> 22.8 Hz, 3H), 2.90−2.94 (m, 1H), 3.03−3.08 (m, 1H), 3.42−3.48 (m, 3H) 3.60−3.65 (m, 1H), 3.92−3.94 (m, 2H), 4.17−4.19 (m, 2H), 5.48 (d, <i>J =</i> 8.4 Hz, 1H), 5.87 (d, <i>J =</i> 6.4 Hz, 1H), 5.95−6.00 (m, 1H), 6.21 (t, <i>J</i> = 11.4 Hz, 1H), 6.87−6.91 (m, 1H), 6.99−7.03 (m, 4H), 7.07−7.11 (m, 1H), 7.22−7.30 (m, 3H), 7.37 (d, <i>J</i> = 8 Hz 1H), 7.45 (d, <i>J</i> = 8 Hz, 1H), 10.80 (s, 1H), 11.48 (s, 1H); MS, <i>m</i>/<i>e</i> 616.96 (M + 1)<sup>+</sup>; 1254.84 (2M + 23)<sup>+</sup>. HRMS, calcd for C<sub>28</sub>H<sub>31</sub>FN<sub>4</sub>O<sub>9</sub>P (M<sup>+</sup> + H), 617.1807; found, 617.1799.</div></div><div id="sec4_2_2_29" class="NLM_sec NLM_sec_level_4"><div id="ac_i48" class="anchor-spacer"></div><h5 class="article-section__title" id="_i48"> 2-[(<i>S</i>)-[(2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>)-5-(2,4-Dioxo-3,4-dihydro-2<i>H</i>-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-ylmethoxy]-(4-fluorophenoxy)phosphorylamino]-2-methylpropionic Acid Methyl Ester (<b>38</b>)</h5><div class="NLM_p last">Yield: 22%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.19−1.36 (m, 9H), 3.54 (s, 3H), 3.56−3.89 (m, 1H), 4.00 (s, 1H), 4.22−4.26 (m, 1H), 4.35−4.38 (m, 1H), 5.52−5.55 (m, 1H), 5.87−6.04 (m, 3H), 7.17−7.23 (m, 4H), 7.58−7.60 (m, 1H), 11.55 (s, 1H); MS, <i>m</i>/<i>e</i> 534.01 (M + 1)<sup>+</sup>. HRMS, calcd for C<sub>21</sub>H<sub>27</sub>F<sub>2</sub>N<sub>3</sub>O<sub>9</sub>P (M<sup>+</sup> + H), 534.1447; found, 534.1435.</div></div><div id="sec4_2_2_30" class="NLM_sec NLM_sec_level_4"><div id="ac_i49" class="anchor-spacer"></div><h5 class="article-section__title" id="_i49"> 1-[(<i>S</i>)-[(2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>)-5-(2,4-Dioxo-3,4-dihydro-2<i>H</i>-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-ylmethoxy]-(4-fluorophenoxy)phosphorylamino]cyclopropanecarboxylic Acid Methyl Ester (<b>39</b>)</h5><div class="NLM_p last">Yield: 40%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 0.97−0.99 (m, 1H), 1.06−1.12 (m, 1H), 1.21−1.29 (m, 5H), 3.55 (s, 3H), 3.73−3.90 (m, 1H), 4.01 (s, 1H), 4.25−4.29 (m, 1H), 4.38−4.43 (m, 1H), 5.56−5.60 (m, 1H), 5.88 (s, 1H), 5.92−6.10 (m, 1H), 6.59 (t, <i>J</i> = 16 Hz, 1H), 7.21−7.23 (m, 4H), 7.56 (dd, <i>J</i> = 8.0, 28.0 Hz, 1H), 11.55 (s, 1H); MS, <i>m</i>/<i>e</i> 532.00 (M + 1)<sup>+</sup>. HRMS, calcd for C<sub>21</sub>H<sub>25</sub>F<sub>2</sub>N<sub>3</sub>O<sub>9</sub>P (M<sup>+</sup> + H), 532.1291; found, 532.1280.</div></div><div id="sec4_2_2_31" class="NLM_sec NLM_sec_level_4"><div id="ac_i50" class="anchor-spacer"></div><h5 class="article-section__title" id="_i50"> (<i>R</i>)-2-{[(2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>)-5-(2,4-Dioxo-3,4-dihydro-2<i>H</i>-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-ylmethoxy]phenoxyphosphorylamino}propionic Acid Isopropyl Ester (<b>40</b>)</h5><div class="NLM_p last">Yield: 8.57%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.19−1.29 (m, 12H), 3.65−3.75 (m, 2H), 3.95−4.05 (m, 1H), 4.24−4.25 (m, 1H), 4.35−4.37 (m, 1H), 4.84−4.86 (m, 1H), 5.53−5.61 (m, 1H), 5.88 (m, 1H), 6.01−6.14 (m, 2H), 7.14−7.39 (m, 5H), 7.48−7.60 (m, 1H), 11.53 (s, 1H); MS, <i>m</i>/<i>e</i> 529.96 (M + 1)<sup>+</sup>. HRMS, calcd for C<sub>22</sub>H<sub>30</sub>FN<sub>3</sub>O<sub>9</sub>P (M<sup>+</sup> + H), 530.1698; found, 530.1684.</div></div><div id="sec4_2_2_32" class="NLM_sec NLM_sec_level_4"><div id="ac_i51" class="anchor-spacer"></div><h5 class="article-section__title" id="_i51"> (<i>S</i>)-2-[[(2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>)-5-(2,4-Dioxo-3,4-dihydro-2<i>H</i>-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-ylmethoxy]-(4-fluorophenoxy)phosphorylamino]propionic Acid Ethyl Ester (<b>41</b>)</h5><div class="NLM_p last">Yield: 15.4%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.13−1.28 (m, 9H), 3.72−3.94(m, 2H), 3.98−4.10 (m, 3H), 4.21−4.42 (m, 2H), 5.56−5.61 (m, 1H), 5.85−6.20 (m, 3H), 7.21−7.24 (m, 4H), 7.55−7.58 (d, 1H), 11.50 (s, 1H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 174.01, 173.97, 173.87, 163.60, 160.87, 158.48, 151.32, 147.65, 140.34, 130.52, 122.73, 122.68, 122.65, 120.92, 117.14, 116.90, 103.21, 102.10, 100.29, 89.53, 80.32, 72.40, 72.22, 65.41, 61.46, 61.43, 50.72, 50.60, 20.70, 20.63, 20.56, 20.49, 17.53, 17.28, 14.82; MS, <i>m</i>/<i>e</i> 533.90 (M + 1)<sup>+</sup>; HRMS, calcd for C<sub>21</sub>H<sub>27</sub>F<sub>2</sub>N<sub>3</sub>O<sub>9</sub>P (M<sup>+</sup> + H), 534.1453; found, 534.1434.</div></div><div id="sec4_2_2_33" class="NLM_sec NLM_sec_level_4"><div id="ac_i52" class="anchor-spacer"></div><h5 class="article-section__title" id="_i52"> (<i>S</i>)-2-{(4-Chlorophenoxy)-[(2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>)-5-(2,4-dioxo-3,4-dihydro-2<i>H</i>-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-ylmethoxy]phosphorylamino}propionic Acid Ethyl Ester (<b>42</b>)</h5><div class="NLM_p last">Yield: 30.17%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.14 (t, <i>J</i> = 7.0 Hz, 3H), 1.21−1.28 (m, 6H),3.77−3.89 (m, 2H), 4.00−4.08 (m, 3H), 4.24−4.27 (m, 1H), 4.34−4.43 (m, 1H), 5.56−5.61 (m, 1H), 5.86−6.13 (m, 2H), 6.17−6.24 (m, 1H), 7.21−7.26 (m, 2H), 7.44 (d, <i>J</i> = 7.6 Hz, 2H), 7.55 (d, <i>J</i> = 7.6 Hz, 1H), 11.55 (s, 1H); MS, <i>m</i>/<i>e</i> 549.11 (M + 1)<sup>+</sup>; HRMS, calcd for C<sub>21</sub>H<sub>27</sub>ClFN<sub>3</sub>O<sub>9</sub>P (M<sup>+</sup> + H), 550.1157; found, 550.1141.</div></div><div id="sec4_2_2_34" class="NLM_sec NLM_sec_level_4"><div id="ac_i53" class="anchor-spacer"></div><h5 class="article-section__title" id="_i53"> (<i>S</i>)-2-{(4-Bromophenoxy)-[(2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>)-5-(2,4-dioxo-3,4-dihydro-2<i>H</i>-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-ylmethoxy]phosphorylamino}propionic Acid Ethyl Ester (<b>43</b>)</h5><div class="NLM_p last">Yield: 35.86%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.13 (t, <i>J</i> = 7.2 Hz, 3H), 1.16−1.28 (m, 6H), 3.78−3.86 (m, 2H), 4.01−4.07 (m, 3H), 4.24−4.28 (m, 1H), 4.39−4.40 (m, 1H), 5.56−5.61 (m, 1H), 5.82−5.90 (m, 1H), 5.93−6.07 (m, 1H), 6.14−6.19 (m, 1H), 7.18 (dd, <i>J</i> = 11.2, 8.8 Hz, 2H), 7.53−7.58 (m, 3H), 11.53 (s, 1H); MS, <i>m</i>/<i>e</i> 593.90(M + 1)<sup>+</sup>. HRMS, calcd for C<sub>21</sub>H<sub>27</sub>BrFN<sub>3</sub>O<sub>9</sub>P (M<sup>+</sup> + H), 594.0652; found, 594.0640.</div></div><div id="sec4_2_2_35" class="NLM_sec NLM_sec_level_4"><div id="ac_i54" class="anchor-spacer"></div><h5 class="article-section__title" id="_i54"> (<i>S</i>)-2-[[(2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>)-5-(2,4-Dioxo-3,4-dihydro-2<i>H</i>-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-ylmethoxy]-(4-fluorophenoxy)phosphorylamino]propionic Acid Isopropyl Ester (<b>44</b>)</h5><div class="NLM_p last">Yield: 11.3%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.14−1.28 (m, 12H), 3.74−3.84 (m,2H), 3.99−4.06 (m, 1H), 4.23−4.39 (m, 2H), 4.83−4.86 (m, 1H), 5.56−5.60 (t, 1H), 5.85−6.12 (m, 3H), 7.19−7.24 (m, 4H), 7.56−7.57 (d, 1H), 11.50 (s, 1H); MS, <i>m</i>/<i>e</i> 547.91 (M + 1)<sup>+</sup>. HRMS, calcd for C<sub>22</sub>H<sub>29</sub>F<sub>2</sub>N<sub>3</sub>O<sub>9</sub>P (M<sup>+</sup> + H), 548.1604; found, 548.1591.</div></div><div id="sec4_2_2_36" class="NLM_sec NLM_sec_level_4"><div id="ac_i55" class="anchor-spacer"></div><h5 class="article-section__title" id="_i55"> (<i>S</i>)-2-{(4-Chlorophenoxy)-[(2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>)-5-(2,4-dioxo-3,4-dihydro-2<i>H</i>-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-ylmethoxy]phosphorylamino}propionic Acid Isopropyl Ester (<b>45</b>)</h5><div class="NLM_p last">Yield: 24%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.05−1.19 (m, 12H), 3.76−3.80 (m, 2H), 3.98−4.08 (m, 1H), 4.31 (m, 2H), 4.73−4.77 (m, 1H), 5.49−5.54 (m, 1H), 5.80−6.20 (m, 3H), 7.20−7.2 5 (m, 2H), 7.43 (d, <i>J</i> = 8.8 Hz, 1H), 7.54 (d, <i>J</i> = 8 Hz, 1H), 11.51 (s, 1H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 173.63, 173.59, 173.54, 173.48, 163.71, 151.39, 150.47, 150.42, 140.30, 130.51, 129.61, 122.95, 122.90, 122.83, 103.31, 103.23, 102.18, 100.39, 89.43, 80.32, 72.37, 69.04, 68.99, 65.85, 65.43, 50.86, 50.71, 22.35, 22.34, 22.31, 20.78, 20.71, 20.64, 20.57, 17.62, 17.37; MS, <i>m</i>/<i>e</i> 563.88 (M + 1)<sup>+</sup>; 1148.73 (2M + 23)<sup>+</sup>. HRMS, calcd for C<sub>22</sub>H<sub>29</sub>ClFN<sub>3</sub>O<sub>9</sub>P (M<sup>+</sup> + H), 564.1308; found, 564.1297.</div></div><div id="sec4_2_2_37" class="NLM_sec NLM_sec_level_4"><div id="ac_i56" class="anchor-spacer"></div><h5 class="article-section__title" id="_i56"> (<i>S</i>)-2-{(4-Bromophenoxy)-[(2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>)-5-(2,4-dioxo-3,4-dihydro-2<i>H</i>-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-ylmethoxy]phosphorylamino}propionic Acid Isopropyl Ester (<b>46</b>)</h5><div class="NLM_p last">Yield: 21.2%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 1.10−1.14 (m, 6H), 1.20−1.28 (m, 6H), 3.77−3.82 (m, 2H), 3.99−4.01 (m, 1H), 4.21−4.25 (m, 1H), 4.37−4.38 (m, 1H), 4.81−4.86 (m, 1H), 5.58 (dd, <i>J =</i> 8.0, 4.0 Hz, 1H), 5.82−5.95 (m, 1H), 5.96−6.09 (m, 1H), 6.10−6.14 (m, 1H), 7.18 (dd, <i>J =</i> 12.0, 8.0 Hz, 2H), 7.54−7.57 (m, 3H), 11.52 (s, 1H); MS, <i>m</i>/<i>e</i> 607.90 (M + 1)<sup>+</sup>; 1238.64 (2M + 23)<sup>+</sup>. HRMS, calcd for C<sub>22</sub>H<sub>29</sub>BrFN<sub>3</sub>O<sub>9</sub>P (M<sup>+</sup> + H), 608.0803; found, 608.0795.</div></div><div id="sec4_2_2_38" class="NLM_sec NLM_sec_level_4"><div id="ac_i57" class="anchor-spacer"></div><h5 class="article-section__title" id="_i57"> (<i>S</i>)-2-[[(2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>)-5-(2,4-Dioxo-3,4-dihydro-2<i>H</i>-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-ylmethoxy]-(4-fluorophenoxy)phosphorylamino]propionic Acid Cyclohexyl Ester (<b>47</b>)</h5><div class="NLM_p last">Yield: 9.5%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.20−1.44 (m, 12H), 1.62−1.71 (m, 4H), 3.75−4.02 (m, 2H), 3.94−4.02 (m, 1H), 4.19−4.26 (m, 2H), 4.59−4.61 (m, 1H), 5.57 (t, <i>J</i> = 8.4 Hz, 1H), 5.85−6.06 (m, 3H), 7.17−7.23 (m, 4H), 7.54 (d, <i>J</i> = 8.4 Hz, 1H), 11.51 (s, 1H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 173.58, 173.54, 163.70, 160.94, 158.55, 151.40, 147.76, 140.20, 122.85, 122.81, 122.76, 122.72, 122.68, 117.25, 117.02, 103.30, 102.18, 100.39, 89.40, 80.32, 73.53, 73.48, 72.38, 65.86, 65.36, 50.90, 50.74, 31.79, 31.72, 25.75, 23.94, 20.88, 20.81, 20.74, 20.68, 17.60, 17.35; MS, <i>m</i>/<i>e</i> 587.92 (M + 1)<sup>+</sup>. HRMS, calcd for C<sub>25</sub>H<sub>33</sub>F<sub>2</sub>N<sub>3</sub>O<sub>9</sub>P (M<sup>+</sup> + H), 588.1917; found, 588.1906.</div></div><div id="sec4_2_2_39" class="NLM_sec NLM_sec_level_4"><div id="ac_i58" class="anchor-spacer"></div><h5 class="article-section__title" id="_i58"> (<i>S</i>)-2-{(4-Chlorophenoxy)-[(2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>)-5-(2,4-dioxo-3,4-dihydro-2<i>H</i>-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-ylmethoxy]phosphorylamino}propionic Acid Cyclohexyl Ester (<b>48</b>)</h5><div class="NLM_p last">Yield: 13.7%. <sup>1</sup>HNMR (DMSO-<i>d</i><sub>6</sub>): δ 1.21−1.46 (m, 12H), 1.62−1.69 (m, 4H), 3.77−3.83 (m, 2H), 3.98−4.10 (m, 1H), 4.26 (s, 1H), 4.32−4.45 (m, 1H), 4.61 (s, 1H), 5.55−5.60 (m, 1H), 5.82−5.95 (m, 1H), 5.98−6.20 (m, 2H), 7.21−7.26 (m, 2H), 7.43 (d, <i>J</i> = 8.8 Hz, 2H), 7.54 (d, <i>J</i> = 8.0 Hz, 1H), 11.55 (s, 1H); MS, <i>m</i>/<i>e</i> 603.97 (M + 1)<sup>+</sup>, 626.10 (M + 23)<sup>+</sup>. HRMS, calcd for C<sub>25</sub>H<sub>33</sub>ClFN<sub>3</sub>O<sub>9</sub>P (M<sup>+</sup> + H), 604.1621; found, 604.1615.</div></div><div id="sec4_2_2_40" class="NLM_sec NLM_sec_level_4"><div id="ac_i59" class="anchor-spacer"></div><h5 class="article-section__title" id="_i59"> (<i>S</i>)-2-{(4-Bromophenoxy)-[(2<i>R</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>)-5-(2,4-dioxo-3,4-dihydro-2<i>H</i>-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-ylmethoxy]phosphorylamino}propionic Acid Cyclohexyl Ester (<b>49</b>)</h5><div class="NLM_p last">Yield: 13.7%. <sup>1</sup>HNMR (DMSO-<i>d</i><sub>6</sub>): δ 1.19−1.46 (m, 12H), 1.62−1.69 (m, 4H), 3.76−3.83 (m, 2H), 3.95−4.08 (m, 1H), 4.25−4.28 (m, 1H), 4.38 (s, 1H), 4.60−4.62 (m, 1H), 5.56−5.61 (m, 1H), 5.82−5.95 (m, 1H), 6.02−6.20 (m, 2H), 7.09−7.20 (m, 2H), 7.53−7.57 (m, 3H), 11.53 (s, 1H); MS, <i>m</i>/<i>e</i> 650.0 (M + 3)<sup>+</sup>. HRMS, calcd for C<sub>25</sub>H<sub>33</sub>BrFN<sub>3</sub>O<sub>9</sub>P (M<sup>+</sup> + H), 648.1116; found, 648.1114.</div></div></div><div id="sec4_2_2_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> Crystallization of <b>50</b> from Column Purified Amorphous <b>50</b></h4><div class="NLM_p last">The chromatographed fraction containing the first eluting isomer <b>(50</b>, 3.8 g, 97% pure) was dissolved in isopropanol (36 g) and diluted with heptanes until cloudy (72 g). The solution was seeded and stirred at ambient temperature for 5 h. The resulting solid was collected by vacuum filtration, washed with heptanes (2 × 20 mL), and dried (50 °C, 0.2 mm, 24 h) to 2.3 g of very small white needles that were not suitable for single crystal X-ray analysis: mp 136.2−137.8 °C; HPLC purity, 99.02%.</div></div><div id="sec4_2_2_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> Crystallization of <b>51</b> from Column Purified Mixture <b>14</b></h4><div class="NLM_p last">An amount of 40.0 g of an approximately 1:1 mixture of <b>14</b> prepared in a similar manner was dissolved in dichloromethane (90 mL). Diisopropyl ether (70 mL) was added to the above solution to give a saturated solution. The solution was seeded with pure <b>51</b>, and the mixture was gently stirred with a stir bar at room temperature for 20 h.. The solid was filtered, washed with a mixture of diisopropyl ether/dichloromethane (40 mL, 1:1 v/v), and dried to give white solid (16.6 g, 89.35% pure <b>51</b> by <sup>31</sup>P NMR). This solid was suspended in dichloromethane (83 mL) and heated to reflux for 3 h. The suspension was cooled to ambient temperature and stirred overnight. The solid was filtered and washed with cold dichloromethane (10 mL). The solid was dried under vacuum to give <b>51</b> (13.1 g, 99.48% pure by HPLC). Then 11 g of this solid was redissolved in DCM (330 mL), and the mixture was heated to reflux. The solution was cooled to ambient temperature and left at this temperature overnight without stirring. The product was filtered and dried (25 °C, 0.2 mm, 24 h) to give 10.5 g of <b>51</b> (99.74% by HPLC) as large white needles in 53% recovered theoretical yield of the single isomer.</div></div><div id="sec4_2_2_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> Crystallization of <b>51</b> from Crude Mixture of <b>14</b></h4><div class="NLM_p last">To a stirred solution of <span class="smallcaps smallerCapital">l</span>-alanine isopropyl ester hydrochloride (10.5 g, 61.5 mmol, azeotropically dried, two times, with 50 mL of toluene each time) in dichloromethane (100 mL) was added phenyl dichlorophosphate (7.5 mL, 50 mmol) at ambient temperature. The mixture was cooled to −10 °C, and then a solution of NMI (30.5 mL, 384 mmol) in 30 mL of dichloromethane was added over a period of 30 min. After completion of the addition, the mixture was stirred between −10 and −15 °C for 1 h. To the above mixture was added 2′-deoxy-2′-fluoro-2′-<i>C</i>-methyluridine (<b>5</b>, 10 g, 38.4 mmol) in one lot, and the mixture was stirred below −10 °C for 3 h and then slowly allowed to warm to 20 °C (6 h). The mixture was stirred at this temperature overnight (15 h) and then quenched with 10 mL of methanol. The solvent was evaporated, and the residue was redissolved in EtOAc (200 mL). The EtOAc layer was washed with water (100 mL), 1 N HCl (3 × 75 mL), 2% aqueous NaHCO<sub>3</sub> solution (50 mL), and brine (50 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was dried under high vacuum for 2 h to give white foam (22 g). The above foam was dissolved in 33 mL of DCM, and then 65 mL of IPE (isopropyl ether) was added to give a saturated solution. The solution was filtered though a small pad of Celite, and the filtrate was stirred with <b>51</b> seeds for 72 h at ambient temperature. The white solid was filtered, washed with IPE (20 mL), and dried to give 4.58 g of a white powder which was determined by <sup>31</sup>P NMR to be an 85:15 mixture of <b>51</b>/<b>50</b>. The above solid was suspended in DCM (23 mL), and then the mixture was refluxed for 3 h. The mixture was cooled to room temperature and stirred for 15 h. The white solid was filtered, washed with cold DCM (4.5 mL), and dried under high vacuum at 45 °C to give 3.11 g of <b>51</b> (HPLC purity 99.74%, mp 93.9−104.7 °C) in 15.2% yield from <b>6</b>.</div></div><div id="sec4_2_2_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> X-ray Structure Determination of Compound <b>51</b></h4><div class="NLM_p">Compound <b>51</b>, C<sub>23</sub>H<sub>31</sub>N<sub>3</sub>PO<sub>9</sub>FCl<sub>2</sub>, crystallizes in the monoclinic space group <i>P</i>2<sub>1</sub> (systematic absences 0<i>k</i>0, <i>k</i> = odd) with <i>a</i> = 12.8822(14) Å, <i>b</i> = 6.1690(7) Å, <i>c</i> = 17.733(2) Å, β = 92.045(3)°, <i>V</i> = 1408.4(3) Å<sup>3</sup>, <i>Z</i> = 2, and <i>d</i><sub>calc</sub> = 1.449 g/cm<sup>3</sup>. X-ray intensity data were collected on a Rigaku mercury CCD area detector employing graphite-monochromated Mo Kα radiation (λ = 0.710 73 Å) at 143 K. Preliminary indexing was performed from a series of 12 0.5° rotation images with exposures of 30 s. A total of 648 rotation images were collected with a crystal to detector distance of 35 mm, a 2θ swing angle of −12°, rotation widths of 0.5°, and exposures of 30 s: scan no. 1 was a ϕ-scan from 315° to 525° at ω = 10° and χ = 20°; scan no. 2 was an ω-scan from −20° to 5° at χ = −90° and ϕ = 315°; scan no. 3 was an ω-scan from −20° to 4° at χ = −90° and ϕ = 135°; scan no. 4 was an ω-scan from −20° to 5° at χ = −90° and ϕ = 225°; scan no. 5 was an ω-scan from −20° to 20° at χ = −90° and ϕ = 45°. Rotation images were processed using CrystalClear (Rigaku Corp., 1999), producing a listing of unaveraged <i>F</i><sup>2</sup> and σ(<i>F</i><sup>2</sup>) values which were then passed to the CrystalStructure (Crystal Structure Analysis Package, Rigaku Corp., 2002) program package for further processing and structure solution on a Dell Pentium III computer. A total of 7707 reflections were measured over the ranges 5.48° ≤ 2θ ≤ 50.04°, −14 ≤ <i>h</i> ≤ 15, −7 ≤ <i>k</i> ≤ 6, −19 ≤ <i>l</i> ≤ 21, yielding 4253 unique reflections (<i>R</i><sub>int</sub> = 0.0180). The intensity data were corrected for Lorentz and polarization effects and for absorption using REQAB (minimum and maximum transmission of 0.824 and 1.000).</div><div class="NLM_p last">The structure was solved by direct methods (SIR97).<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Refinement was by full-matrix least squares based on <i>F</i><sup>2</sup> using SHELXL-97.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> All reflections were used during refinement. The weighting scheme used was <i>w</i> = 1/[σ<sup>2</sup>(<i>F</i><sub>o</sub><sup>2</sup>) + 0.0472<i>P</i><sup>2</sup> + 0.4960<i>P</i>] where <i>P</i> = (<i>F</i><sub>o</sub><sup>2</sup> + 2<i>F</i><sub>c</sub><sup>2</sup>)/3 . Non-hydrogen atoms were refined anisotropically, and hydrogen atoms were refined using a “riding” model. Refinement converged to R1 = 0.0328 and wR2 = 0.0817 for 4046 reflections for which <i>F</i> > 4σ(<i>F</i>) and R1 = 0.0348, wR2 = 0.0838, and GOF = 1.056 for all 4253 unique, nonzero reflections and 358 variables. The maximum Δ/σ in the final cycle of least squares was 0.000, and the two most prominent peaks in the final difference Fourier were +0.312 and −0.389 e/Å<sup>3</sup>. The Flack absolute structure parameter was refined to −0.06(6), thus corroborating the stereochemistry of the title compound.</div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> Biological Assays</h3><div id="sec5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> HCV Replicon Assay</h4><div class="NLM_p">HCV replicon assays using clone A cells and ET-lunet cells were performed as described previously .<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Briefly, clone A cells and ET-lunet cells were seeded at a density of 1500 and 3000 cells per well in a 96-well plate, respectively. Test compounds serially diluted in culture medium without G418 were added to cells. Plates were incubated at 37 °C in a 5% CO<sub>2</sub> atmosphere for 4 days. Inhibition of HCV RNA replication was determined by quantitative real time PCR.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></div><div class="NLM_p last">To express the antiviral effectiveness of a compound, the threshold RT-PCR cycle of the test compound was subtracted from the average threshold RT-PCR cycle of the no-drug control (ΔCt<sub>HCV</sub>). A ΔCt of 3.3 equals a 1 − log 10 reduction (equal to the 90% effective concentration [EC<sub>90</sub>]) in replicon RNA levels. The cytotoxicity of the test compound could also be expressed by calculating the ΔCt<sub>rRNA</sub> values. The ΔΔCt specificity parameter could then be introduced (ΔCt<sub>HCV</sub> − ΔCt<sub>rRNA</sub>), in which the levels of HCV RNA are normalized for the rRNA levels and calibrated against the no-drug control.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> Cell Cytotoxicity Assays</h4><div class="NLM_p last">Each compound (serially diluted from 100 μM) was added to Huh7 (2 × 10<sup>3</sup> cells/well), HepG2 (2 × 10<sup>3</sup> cells/well), BxPC3 (2 × 10<sup>3</sup> cells/well), or CEM (5 × 10<sup>3</sup> cells/well) cells and allowed to incubate for 8 days at 37 °C. A medium only control was used to determine the minimum absorbance value and an untreated cell. At the end of the growth period, MTS dye from the CellTiter 96 AQueous One Solution Cell Proliferation Assay kit (Promega) was added to each well, and the plate was incubated for an additional 2 h. The absorbance at 490 nm was read with a Victor3 plate reader (Perkin-Elmer) using the medium only control wells as blanks. The 50% inhibition value (CC<sub>50</sub>) was determined by comparing the absorbance in wells containing cells and test compound to untreated cell control wells.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> Mitochrondria Toxicity Assay</h4><div class="NLM_p last">Each compound or ddC was serially diluted from 100 μM in assay medium and was added to HepG2, BxPC3, or CEM cells seeded at 1 × 10<sup>4</sup> cells/well in a 24-well plate. Cells were incubated at 37 °C in a humidified 5% CO<sub>2</sub> atmosphere for 14 days. On days 7 and 11 medium was removed and replenished with fresh medium containing the appropriate concentration of compound. On day 14, cells were harvested and total cellular DNA was extracted as recommended by the manufacturer (Qiagen). The mitochondrial cytochrome C oxidase subunit II (COXII) gene and rDNA were amplified using a multiplex quantitative RT-PCR protocol. The ΔCt of mitochondrial COXII DNA (mtDNA) and ΔCt of rDNA (rDNA) for each sample were determined as described previously.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(43)</a> ΔCt was converted to log reduction of mtDNA or rDNA, and percent inhibition was determined relative to the untreated cell controls. Toxicity levels were expressed as the concentration inhibiting mtDNA and rDNA by 90%.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> Human Bone Marrow Cytotoxicity Assay</h4><div class="NLM_p last">The proliferation of human erythroid and myeloid hematopoietic progenitor cells derived from normal bone marrow (Lonza, Walkersville, MD) was assessed in a semisolid methylcellulose-based medium (R&D Systems, Minneapolis, MN) containing recombinant human (rh-) stem cell factor (50 ng/mL), rh-interleukin-3 (10 ng/mL), rh-granulocyte/monocyte-colony stimulating factor (10 ng/mL), and rh-erythropoietin (3 U/mL). Increasing concentrations of each compound (up to 50 μM) diluted in DMSO were added to progenitor cells seeded at 2 × 10<sup>4</sup> cells per culture in the methylcellulose-based medium. Each compound or the DMSO (0.1%) control were incubated with the progenitor cells for 14−16 days in culture, after which the proliferated colonies were assessed and scored based on size and morphology to determine 50% inhibition concentration as described previously.<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35, 36)</a></div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> Simulated Gastric Fluid (SGF) and Simulated Intestinal Fluid (SIF) Stability Assay</h4><div class="NLM_p last">Stock solutions of each compound (10 mg/mL) were prepared in DMSO and stored at −20 °C. An amount of 5 μL of the stock solution was added to 995 μL of simulated gastric fluid (SGF without pepsin, RICCA Chemical Co.) or simulated intestinal fluid (SIF without pancreatin, RICCA Chemical Co.) to give the working solution (50 μg/mL). The working solution was immediately analyzed by HPLC to obtain the initial (<i>T</i> = 0) absorbance value for the compound (peak area at 260 nm). The sample was repeatedly injected every 2 h over a 20 h time period with the autosampler set at 37 °C. Each compound was analyzed by reverse phase HPLC with an Eclipse XDB-C18 5 μm column (Agilent) using a Alliance system (Waters). The mobile phase consisted of solvent A (Water with 50 mM triethylammonium acetate) and solvent B (acetonitrile). Elution was performed using a linear gradient of solvent B from 20% to 98% for 5 min. The amount of parent compound was determined on the basis of the peak area at each time point, and the percentage remaining was calculated on the basis of the initial amount measured at 0 h.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> Compound Stability in Human Liver S9 Fraction</h4><div class="NLM_p last">Stock solutions of each compound (50 mM) were prepared in DMSO and stored at −20 °C. The reaction mixture was prepared in a total volume of 1 mL containing 5 mM of MgCl<sub>2</sub>, 50 mM of K<sub>2</sub>HPO<sub>4</sub> (pH 7.4), and 100 μM compound. The reaction was initiated by adding 4 mg/mL human liver S9 fraction (CellzDirect) to the reaction mixture and incubated at 37 °C. At the desired times (0, 0.5, 1, 2, 4, 6, 8, and 24 h), 100 μL aliquots were taken and the reaction was stopped by mixing the reaction mixture sample with 300 μL of acetonitrile. The samples were centrifuged at 14 000 rpm for 30 min at 4 °C. Then 100 μL of the supernatant was mixed with 100 μL of LC/MS solvent A (95% water, 5% acetonitrile, 10 mM ammonium acetate, and 0.01% formic acid) and frozen at −20 °C. The standard solutions of each compound was prepared from 10 mg/mL of stock solution and diluted to a final concentration of 1 μg/mL in methanol. The standard solutions were injected into the LC/MS to determine the daughter ion, cone voltage, and collision energy in order to develop the LC/MS/MS method. Each compound was separated by using a Phenomenex Luna 5 μm C18 column with a Waters Alliance system. The mobile phase consisted of solvent A (95% water, 5% acetonitrile, 10 mM ammonium acetate, and 0.01% formic acid) and solvent B (95% acetonitrile, 5% water, 10 mM ammonium acetate, and 0.01% formic acid). Elution was performed using a linear gradient of solvent B from 0% to 100% for 2.5 min. The MS/MS detection was performed by using Micromass Quattro Micro with cone voltage 35 and collision energy 20 eV. The samples collected at the desired time points were thawed, and 10 μL aliquots were used for LC/MS/MS analysis. The amount of parent compound was determined on the basis of the peak area for each time point, and the percentage remaining was calculated on the basis of the initial amount measured at 0 h. The half-life of each compound, which is a measure of the stability of the compound, was calculated by using the GraphPad Prism software.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> Compound Stability in Human Plasma</h4><div class="NLM_p last">Stock solutions of each compound were prepared in DMSO and stored at −20 °C. Then 1 mL of human plasma containing 5 mM MgCl<sub>2</sub> was used for the reaction. The reaction was started by adding 2 μL of a 50 mM stock solution of each compound to give a final concentration of 100 μM and incubated at 37 °C. At the desired times (0, 0.5, 1, 2, 4, 6, 8, and 24 h), 100 μL aliquots were taken and the reaction was stopped by mixing the reaction mixture sample with 200 μL of acetonitrile. The samples were centrifuged at 14 000 rpm for 30 min at 4 °C. Then 100 μL of the supernatant was mixed with 100 μL of LC/MS solvent A (95% water, 5% acetonitrile, 10 mM ammonium acetate, and 0.01% formic acid) and frozen at −20 °C. The standard solution of each compound was prepared from 10 mg/mL stock solution and diluted to a final concentration of 1 μg/mL in methanol. The standard solutions were injected into the LC/MS to determine the daughter ion, cone voltage, and collision energy in order to develop the LC/MS/MS method. Each compound was separated by using a Phenomenex Luna 5 μm C18 column (Phenomenex) with a Waters Alliance system (Waters). The mobile phase consisted of solvent A (95% water, 5% acetonitrile, 10 mM ammonium acetate, and 0.01% formic acid) and solvent B (95% acetonitrile, 5% water, 10 mM ammonium acetate, and 0.01% formic acid). Elution was performed using a linear gradient of solvent B from 0% to 100% for 2.5 min. The MS/MS detection was performed by using Micromass Quattro Micro (Waters) with cone voltage 35 and collision energy 20 eV. The samples collected at the desired time points were thawed, and 10 μL aliquots were used for LC/MS analysis. The amount of parent compound based on the peak area was determined for each time point and the percentage remaining was calculated on the basis of the initial amount measured at 0 h. The half-life of each compound was calculated by using the GraphPad Prism software.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> Parallel Artificial Membrane Permeability Assay (PAMPA)</h4><div class="NLM_p last">A 96-well filtration plate (PVDF membrane, pore size 0.45 μm, Millipore, Billerica, MA) coated with 5 μL of lecithin in dodecane (20 mg/mL) was used as donor plate. The donor plate was filled with 200 μL of PBS buffer (pH 7.4, Gibco) containing 200 μg/mL test compound and 2% of DMSO. The acceptor plate was filled with 300 μL of PBS buffer with 2% of DMSO. The donor filter plate was carefully put on the acceptor plate to form a sandwich, which was left undisturbed for 24 h. The concentration of compounds in the donor and acceptor wells after incubation was determined by LC/MS/MS, which consisted of a Waters Alliance HT 2795 separations module, a Waters Quattro Micro API triple quadrupole mass spectrometer (Milford, MA), and a Ascentis phenylhexyl column (4.6 mm × 30 mm, 2.7 μm partical, Supelco, Bellefonte, PA). The mass spectrometer was operated in MRM mode for quantitation. The permeability is determined using the following equations: <i>P</i><sub>e</sub> = [−ln(1 − <i>C</i><sub>A</sub>/<i>C</i><sub>eq</sub>)]/[<i>A</i>(1/<i>V</i><sub>D</sub> + 1/<i>V</i><sub>A</sub>)<i>t</i>], <i>C</i><sub>eq</sub> = (<i>C</i><sub>D</sub><i>V</i><sub>D</sub> + <i>C</i><sub>A</sub><i>V</i><sub>A</sub>)/(<i>V</i><sub>D</sub> + <i>V</i><sub>A</sub>), where <i>C</i><sub>D</sub> is the compound concentration in donor well, <i>C</i><sub>A</sub> is the compound concentration in acceptor well, <i>V</i><sub>D</sub> is the donor well volume, <i>V</i><sub>A</sub> is the acceptor well volume, <i>C</i><sub>eq</sub> is the concentration at equilibrium, <i>A</i> is the filter area, and <i>t</i> is the incubation time.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> In Vitro Determination of Triphosphate Levels in Primary Human, Rat, Dog, and Monkey Hepatocytes</h4><div class="NLM_p last">Clone A cells and primary hepatocytes were seeded (5 000 000 cells) into T75 flasks in DMEM containing 10% FBS and primary cell plating medium (CellzDirect, Inc.), respectively. After overnight incubation to allow the cells to attach, the cells were incubated for up to 24 h at 37 °C in a 5% CO<sub>2</sub> atmosphere in the fresh medium containing 100 μM test compound. At selected times, extracellular medium was removed and the cell layer was washed with cold PBS. After trypsinization, cells were counted and centrifuged at 1200 rpm for 5 min. The cell pellets were resuspended in 1 mL of cold 60% methanol and incubated overnight at −20 °C. The samples were centrifuged at 14 000 rpm for 5 min, and the supernatants were collected and dried using a SpeedVac concentrator, then stored at −20 °C until they were to be analyzed by HPLC. Residues were suspended in 100 μL of water, and 50 μL aliquots were injected into the HPLC instrument. HPLC analysis was performed as previously described.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> Rat in Vivo Liver Triphosphate Analysis</h4><div class="NLM_p last">Each compound was dosed orally by gavage with a single dose of compound at 50 mg/kg to rats in a volume of 5 mL/kg in 0.5% carboxymethylcellulose sodium. Liver samples were removed at time points 0.5, 1, 2, 4, 6, and 12 h postdose by first sacrificing the animal by CO<sub>2</sub> inhalation, perfusing the liver with ice cold saline and removing approximately 1 g of liver, which was then snap-frozen in liquid nitrogen and stored at −80 °C. Live samples were homogenized in 3 volumes of ice cold 70% methanol containing 20 mM EDTA/EGTA. Samples were centrifuged at 3000<i>g</i> for 15 min, and aliquots of the supernatant (100 μL) were evaporated to dryness. The resulting dried residue was reconstituted with 100 μL of mobile phase and analyzed for <b>6</b> by LC/MS/MS. LC conditions were as follows: Shiseido SI-2 3301 HPLC instrument; column, Agela venusil XBP C8 2.1 mm × 50 mm; 30 °C column temperature; mobile phase of (A) 0.1% formic acid in water, (B) 0.1% formic acid in acetonitrile; flow rate of 0.45 mL/min; gradient of 0−3 min; time, 0 min at 5% B and 95% A, 1.4 min at 100% A, 2 min at 5% A and 95% B, 3 min at 5% A and 95% B. Mass spectometer conditions were as follows: Thermo TSQ Quantum Ultra, electospray ionization, MRM negative mode, spray voltage 3500 V. Liver concentrations versus time data were analyzed by noncompartmental approaches using the WinNonlin software, version 5.0.1.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> Dog and Cynomolgus Monkey in Vivo Pharmacokinetic Analysis</h4><div class="NLM_p last">Compounds <b>12</b>, <b>14</b>, and <b>47</b> were each dosed orally by gavage (dog, gastric; monkey, nasogastric) at a dose of 50 mg/kg in hydroxypropyl-β-cyclodextrin in water (20% w/v) for 4 consecutive days. Dose volume was 2.5 mL/kg. Serial blood samples were collected at 1, 2, 4, 6, 12, and 24 postdose after dose administration on day 3. All blood samples were obtained by venipuncture into polypropylene tubes containing K<sub>2</sub>EDTA (10 mL, 0.5 M) and kept on ice for processing by centrifugation. Plasma samples were quick-frozen over dry ice and kept at −70 °C until LC/MS/MS analysis. At the 4 h time point postdose on day 4, the animals were anesthetized using pentobarbital. Ice cold saline was perfused into the liver via a portal cannula. Five samples from various liver lobes (10 g each) were harvested, weighed, and snap-frozen in liquid nitrogen. Frozen liver samples were homogenized in three volumes of ice cold 70% methanol containing 20 mM EDTA/EGTA. The amount of compound <b>6</b> was quantified by LC/MS/MS. LC conditions were as follows: Shiseido SI-2 3301 HPLC instrument; column, Agela venusil XBP C8 2.1 mm × 50 mm; 30 °C column temperature; mobile phase of (A) 0.1% formic acid in water, (B) 0.1% formic acid in acetonitrile; flow rate of 0.45 mL/min; gradient of 0−3 min; time, 0 min at 5% B and 95%A, 1.4 min at 100% A, 2 min at 5% A and 95% B, 3 min at 5% A and 95% B. Mass spectometer conditions were as follows: Thermo TSQ Quantum Ultra, electospray ionization, MRM negative mode, spray voltage 3500 V. Plasma and liver concentrations versus time data were analyzed by noncompartmental approaches using the WinNonlin software program, version 5.0.1.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> Single Dose in Vivo Rat Toxicology Assessment</h4><div class="NLM_p last">For each compound, 24 (12 per sex) rats (<i>Rattus norvegicus</i>; breed, CDIGS-Crl:CD(SD); source, Charles River Laboratories, Wilmington, MA; age, 4−5 weeks; body weight, 76−100 g) were dosed with compound or vehicle (30% PEG400/30% Tween 20/20% corn oil/20% water) as a single dose at a dose volume of 10 mg/mL. Doses administered were 50, 300, and 1800 mg/kg of body weight. All toxicology animals were euthanized for post-mortem examinations on study day 15, which was 14 days after dose was administered. A general physical exam was conducted on all animals prior to assignment to study. Subsequently, all animals were examined twice daily for morbidity, mortality, injury, and availability of food and water. Beginning on day 1 after administration and continuing through the day of scheduled euthanasia, examinations of general signs of toxicity, including fecal and urine quality, were conducted once daily. Beginning on day 1 of dosing, body weights were recorded daily until euthanasia. Post-mortem examinations were performed on all toxicology animals. At necropsy, the animals were examined visually for external abnormalities. The abdominal, thoracic, and cranial cavities and their contents were examined for abnormalities and the liver and kidneys removed and examined. Prenecropsy fasted body weights were examined as well as necropsy weights of the liver and paired kidneys.</div></div></div></div><div class="NLM_back"><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15326" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15326" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael J. Sofia</span> - <span class="hlFld-Affiliation affiliation">Pharmasset, Inc., 303A College Road East, Princeton, New Jersey 08540</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#620f0b010a03070e4c110d040b0322120a03100f03111107164c010d0f"><span class="__cf_email__" data-cfemail="44292d272c2521286a372b222d2504342c25362925373721306a272b29">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Donghui Bao</span> - <span class="hlFld-Affiliation affiliation">Pharmasset, Inc., 303A College Road East, Princeton, New Jersey 08540</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wonsuk Chang</span> - <span class="hlFld-Affiliation affiliation">Pharmasset, Inc., 303A College Road East, Princeton, New Jersey 08540</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jinfa Du</span> - <span class="hlFld-Affiliation affiliation">Pharmasset, Inc., 303A College Road East, Princeton, New Jersey 08540</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dhanapalan Nagarathnam</span> - <span class="hlFld-Affiliation affiliation">Pharmasset, Inc., 303A College Road East, Princeton, New Jersey 08540</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Suguna Rachakonda</span> - <span class="hlFld-Affiliation affiliation">Pharmasset, Inc., 303A College Road East, Princeton, New Jersey 08540</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">P. Ganapati Reddy</span> - <span class="hlFld-Affiliation affiliation">Pharmasset, Inc., 303A College Road East, Princeton, New Jersey 08540</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bruce S. Ross</span> - <span class="hlFld-Affiliation affiliation">Pharmasset, Inc., 303A College Road East, Princeton, New Jersey 08540</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peiyuan Wang</span> - <span class="hlFld-Affiliation affiliation">Pharmasset, Inc., 303A College Road East, Princeton, New Jersey 08540</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hai-Ren Zhang</span> - <span class="hlFld-Affiliation affiliation">Pharmasset, Inc., 303A College Road East, Princeton, New Jersey 08540</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shalini Bansal</span> - <span class="hlFld-Affiliation affiliation">Pharmasset, Inc., 303A College Road East, Princeton, New Jersey 08540</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christine Espiritu</span> - <span class="hlFld-Affiliation affiliation">Pharmasset, Inc., 303A College Road East, Princeton, New Jersey 08540</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Meg Keilman</span> - <span class="hlFld-Affiliation affiliation">Pharmasset, Inc., 303A College Road East, Princeton, New Jersey 08540</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Angela M. Lam</span> - <span class="hlFld-Affiliation affiliation">Pharmasset, Inc., 303A College Road East, Princeton, New Jersey 08540</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Holly M. Micolochick Steuer</span> - <span class="hlFld-Affiliation affiliation">Pharmasset, Inc., 303A College Road East, Princeton, New Jersey 08540</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Congrong Niu</span> - <span class="hlFld-Affiliation affiliation">Pharmasset, Inc., 303A College Road East, Princeton, New Jersey 08540</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael J. Otto</span> - <span class="hlFld-Affiliation affiliation">Pharmasset, Inc., 303A College Road East, Princeton, New Jersey 08540</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Phillip A. Furman</span> - <span class="hlFld-Affiliation affiliation">Pharmasset, Inc., 303A College Road East, Princeton, New Jersey 08540</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="testing" data-doi="10.1021/jm100863x" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i77">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64054" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64054" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We acknowledge the following individuals and organizations for their contributions to the work described in this manuscript: Wuxi AppTec; ReachBio LLC; BASi; and Dr. Patrick Carroll, University of Pennsylvania.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i78">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33062" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33062" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 43 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="ref1_1"><span> <span class="citation_source-book">Hepatitis C</span>; World Health Organization Fact Sheet No. 164; World Health Organization: Geneva, October<span class="NLM_x"> </span><span class="NLM_year">2000</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Hepatitis+C%3B+World+Health+Organization+Fact+Sheet+No.+164%3B+World+Health+Organization%3A+Geneva%2C+October+2000."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref1_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DHepatitis%2520C%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Lavanchy, D.</span><span> </span><span class="NLM_article-title">The Global Burden of Hepatitis C</span> <span class="citation_source-journal">Liver Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x"> (</span><span class="NLM_issue">S1</span><span class="NLM_x">) </span> <span class="NLM_fpage">74</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=74&issue=S1&author=D.+Lavanchy&title=The+Global+Burden+of+Hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLavanchy%26aufirst%3DD.%26atitle%3DThe%2520Global%2520Burden%2520of%2520Hepatitis%2520C%26jtitle%3DLiver%2520Int.%26date%3D2009%26volume%3D29%26issue%3DS1%26spage%3D74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Zeuzem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moeller, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinrichsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauss, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedemeyer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarrazin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hueppe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zehnter, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manns, M. P.</span><span> </span><span class="NLM_article-title">Expert Opinion on the Treatment of Patients with Chronic Hepatitis C</span> <span class="citation_source-journal">J. Viral Hepatitus</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">75</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm100863x&amp;key=10.1111%2Fj.1365-2893.2008.01012.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm100863x&amp;key=18761607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm100863x&amp;key=1%3ACAS%3A280%3ADC%252BD1M7ht1Crtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=75&author=S.+Zeuzemauthor=T.+Bergauthor=B.+Moellerauthor=H.+Hinrichsenauthor=S.+Maussauthor=H.+Wedemeyerauthor=C.+Sarrazinauthor=D.+Hueppeauthor=E.+Zehnterauthor=M.+P.+Manns&title=Expert+Opinion+on+the+Treatment+of+Patients+with+Chronic+Hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Expert opinion on the treatment of patients with chronic hepatitis C</span></div><div class="casAuthors">Zeuzem S; Berg T; Moeller B; Hinrichsen H; Mauss S; Wedemeyer H; Sarrazin C; Hueppe D; Zehnter E; Manns M P</div><div class="citationInfo"><span class="NLM_cas:title">Journal of viral hepatitis</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">75-90</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The current preferred treatment for patients with hepatitis C virus (HCV) is combination therapy consisting of pegylated interferon alfa and ribavirin (RBV) for 24-48 weeks.  Although this approach appears to be highly effective for patients with HCV genotypes 2 or 3, who have a sustained virological response (SVR) of approximately 80%, the treatment algorithm is less effective for patients with HCV genotype 1, as these patients have SVR rates of just 40-50%.  In order to improve treatment outcomes, this article explores potential approaches for the optimization of treatment for patients with HCV genotype 1: considering shorter treatment periods for patients with a rapid virological response (RVR), increasing treatment periods for slow responders, and increasing RBV dose are all suggestions.  Results from clinical trials suggest that approximately 20% of the HCV genotype 1-infected population are slow responders, and around 15% of all HCV genotype-1 infected patients could benefit from a shorter treatment duration without compromising the SVR rate.  Interest has also focused on whether treatment duration could be individualized in some patients with genotype 2 and 3 infection.  Here all the findings from recent studies are translated into practical advice, to help practitioners make evidence-based treatment decisions in everyday clinical practice.  Although there are areas where currently available data do not provide conclusive evidence to suggest amending treatment approaches, there is clearly potential for individualized treatment in all aspects of hepatitis treatment in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS6UQwwDsewsuQ4Pl9hzjQhfW6udTcc2eY0Ml8Mo0e5Qbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M7ht1Crtg%253D%253D&md5=6bb4b656592a11243b42540f5a090e9e</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2893.2008.01012.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2893.2008.01012.x%26sid%3Dliteratum%253Aachs%26aulast%3DZeuzem%26aufirst%3DS.%26aulast%3DBerg%26aufirst%3DT.%26aulast%3DMoeller%26aufirst%3DB.%26aulast%3DHinrichsen%26aufirst%3DH.%26aulast%3DMauss%26aufirst%3DS.%26aulast%3DWedemeyer%26aufirst%3DH.%26aulast%3DSarrazin%26aufirst%3DC.%26aulast%3DHueppe%26aufirst%3DD.%26aulast%3DZehnter%26aufirst%3DE.%26aulast%3DManns%26aufirst%3DM.%2BP.%26atitle%3DExpert%2520Opinion%2520on%2520the%2520Treatment%2520of%2520Patients%2520with%2520Chronic%2520Hepatitis%2520C%26jtitle%3DJ.%2520Viral%2520Hepatitus%26date%3D2009%26volume%3D16%26spage%3D75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Fried, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiffman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinos, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goncales, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haussinger, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diango, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carosi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhumeaux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craxi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J.</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">347</span><span class="NLM_x">, </span> <span class="NLM_fpage">975</span><span class="NLM_x">–</span> <span class="NLM_lpage">982</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm100863x&amp;key=10.1056%2FNEJMoa020047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm100863x&amp;key=12324553" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm100863x&amp;key=1%3ACAS%3A528%3ADC%252BD38Xnt12rtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Fried%2C+M.+W.%3B+Shiffman%2C+M.+L.%3B+Reddy%2C+K.+R.%3B+Smith%2C+C.%3B+Marinos%2C+G.%3B+Goncales%2C+F.+L.%3B+Haussinger%2C+D.%3B+Diango%2C+M.%3B+Carosi%2C+G.%3B+Dhumeaux%2C+D.%3B+Craxi%2C+A.%3B+Lin%2C+A.%3B+Hoffman%2C+J.%3B+Yu%2C+J.N.+Engl.+J.+Med.+2002%2C+347%2C+975%E2%80%93982"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection</span></div><div class="casAuthors">Fried, Michael W.; Shiffman, Mitchell L.; Reddy, K. Rajender; Smith, Coleman; Marinos, George; Goncales, Fernando L., Jr.; Haussinger, Dieter; Diago, Moises; Carosi, Giampiero; Dhumeaux, Daniel; Craxi, Antonio; Lin, Amy; Hoffman, Joseph; Yu, Jian</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">975-982</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Treatment with peginterferon alfa-2a alone produces significantly higher sustained virol. responses than treatment with interferon alfa-2a alone in patients with chronic hepatitis C virus (HCV) infection.  We compared the efficacy and safety of peginterferon alfa-2a plus ribavirin, interferon alfa-2b plus ribavirin, and peginterferon alfa-2a alone in the initial treatment of chronic hepatitis C.  Methods: A total of 1121 patients were randomly assigned to treatment and received at least one dose of study medication, consisting of 180 μg of peginterferon alfa-2a once weekly plus daily ribavirin (1000 or 1200 mg, depending on body wt.), weekly peginterferon alfa-2a plus daily placebo, or 3 million units of interferon alfa-2b thrice weekly plus daily ribavirin for 48 wk.  Results: A significantly higher proportion of patients who received peginterferon alfa-2a plus ribavirin had a sustained virol. response (defined as the absence of detectable HCV RNA 24 wk after cessation of therapy) than of patients who received interferon alfa-2b plus ribavirin (56 % vs. 44 %, P<0.001) or peginterferon alfa-2a alone (56 % vs. 29 %, P<0.001).  The proportions of patients with HCV genotype 1 who had sustained virol. responses were 46 %, 36 %, and 21 %, resp., for the three regimens.  Among patients with HCV genotype 1 and high base-line levels of HCV RNA, the proportions of those with sustained virol. responses were 41 %, 33 %, and 13 %, resp.  The overall safety profiles of the three treatment regimens were similar; the incidence of influenza-like symptoms and depression was lower in the groups receiving peginterferon alfa-2a than in the group receiving interferon alfa-2b plus ribavirin.  Conclusions: In patients with chronic hepatitis C, once-weekly peginterferon alfa-2a plus ribavirin was tolerated as well as interferon alfa-2b plus ribavirin and produced significant improvements in the rate of sustained virol. response, as compared with interferon alfa-2b plus ribavirin or peginterferon alfa-2a alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqblwkeNXWJzbVg90H21EOLACvtfcHk0lh-eA2lMLERVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xnt12rtb0%253D&md5=2fd959d790b9505384fbd26ef44b2963</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa020047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa020047%26sid%3Dliteratum%253Aachs%26aulast%3DFried%26aufirst%3DM.%2BW.%26aulast%3DShiffman%26aufirst%3DM.%2BL.%26aulast%3DReddy%26aufirst%3DK.%2BR.%26aulast%3DSmith%26aufirst%3DC.%26aulast%3DMarinos%26aufirst%3DG.%26aulast%3DGoncales%26aufirst%3DF.%2BL.%26aulast%3DHaussinger%26aufirst%3DD.%26aulast%3DDiango%26aufirst%3DM.%26aulast%3DCarosi%26aufirst%3DG.%26aulast%3DDhumeaux%26aufirst%3DD.%26aulast%3DCraxi%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DA.%26aulast%3DHoffman%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DJ.%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2002%26volume%3D347%26spage%3D975%26epage%3D982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Burton, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Everson, G. T.</span><span> </span><span class="NLM_article-title">HCV NS5B Polymerase Inhibitors</span> <span class="citation_source-journal">Clin. Liver Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">453</span><span class="NLM_x">–</span> <span class="NLM_lpage">465</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2009&pages=453-465&author=J.+R.+Burtonauthor=G.+T.+Everson&title=HCV+NS5B+Polymerase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurton%26aufirst%3DJ.%2BR.%26aulast%3DEverson%26aufirst%3DG.%2BT.%26atitle%3DHCV%2520NS5B%2520Polymerase%2520Inhibitors%26jtitle%3DClin.%2520Liver%2520Dis.%26date%3D2009%26volume%3D13%26spage%3D453%26epage%3D465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span> </span><span class="NLM_article-title">Recent Advances in the Development of NS5B Polymerase Inhibitors for the Treatment of Hepatitis C Virus Infection</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">164</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm100863x&amp;key=10.1517%2F13543770802672598" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm100863x&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVCks74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=145-164&author=P.+L.+Beaulieu&title=Recent+Advances+in+the+Development+of+NS5B+Polymerase+Inhibitors+for+the+Treatment+of+Hepatitis+C+Virus+Infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the development of NS5B polymerase inhibitors for the treatment of hepatitis C virus infection</span></div><div class="casAuthors">Beaulieu, Pierre L.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">145-164</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  170 To 200 million people worldwide are believed to suffer from chronic hepatitis C virus (HCV) infection, a blood-born disease that targets the liver and progresses to organ cirrhosis and primary cancer in a significant proportion of patients.  The currently available treatment has limited efficacy and suffers from restricting side effects.  HCV infection is the principal cause of liver transplant in industrialized nations and between 8000 and 10,000 deaths result annually from the disease in the United States alone.  Virus-specific, more efficacious, and better-tolerated anti-HCV therapies are thus required to address the unmet medical need.  Objective: To review progress achieved since 2005 in the development of HCV NS5B polymerase inhibitors as potential therapy for the treatment of HCV infection with a primary focus on available patent and medical literature.  Results/conclusion: Several classes of small-mol. inhibitors of HCV NS5B have progressed into clin. development and demonstrated efficacy in reducing viral load in infected patients.  The results so far provide an encouraging foundation for the development of novel, more tolerable therapies and addressing emergence of resistance through combination of antiviral agents with complementary mechanisms of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoo8VVFJs4oSbVg90H21EOLACvtfcHk0lh-eA2lMLERVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVCks74%253D&md5=64b78562e2b4e3e8a166fdabf14f7efe</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1517%2F13543770802672598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770802672598%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26atitle%3DRecent%2520Advances%2520in%2520the%2520Development%2520of%2520NS5B%2520Polymerase%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Hepatitis%2520C%2520Virus%2520Infection%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2009%26volume%3D19%26spage%3D145%26epage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Simmonds, P.</span><span> </span><span class="NLM_article-title">Genetic Diversity and Evolution of Hepatitis C Virus—15 Years On</span> <span class="citation_source-journal">J. Gen. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">3173</span><span class="NLM_x">–</span> <span class="NLM_lpage">3188</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm100863x&amp;key=10.1099%2Fvir.0.80401-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm100863x&amp;key=15483230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm100863x&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpsVSmsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2004&pages=3173-3188&author=P.+Simmonds&title=Genetic+Diversity+and+Evolution+of+Hepatitis+C+Virus%E2%80%9415+Years+On"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic diversity and evolution of hepatitis C virus - 15 years on</span></div><div class="casAuthors">Simmonds, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of General Virology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3173-3188</span>CODEN:
                <span class="NLM_cas:coden">JGVIAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-1317</span>.
    
            (<span class="NLM_cas:orgname">Society for General Microbiology</span>)
        </div><div class="casAbstract">A review.  In the 15 years since the discovery of hepatitis C virus (HCV), much has been learned about its role as a major causative agent of human liver disease and its ability to persist in the face of host-cell defenses and the immune system.  This review describes what is known about the diversity of HCV, the current classification of HCV genotypes within the family Flaviviridae and how this genetic diversity contributes to its pathogenesis.  On one hand, diversification of HCV was constrained by its intimate adaptation to its host.  Despite the >30% nucleotide sequence divergence between genotypes, HCV variants nevertheless remain remarkably similar in their transmission dynamics, persistence and disease development.  Nowhere is this more evident than in the evolutionary conservation of numerous evasion methods to counteract the cell's innate antiviral defense pathways; this series of highly complex virus-host interactions may represent key components in establishing its ecol. niche in the human liver.  On the other hand, the mutability and large population size of HCV enables it to respond very rapidly to new selection pressures, manifested by immune-driven changes in T- and B-cell epitopes that are encountered on transmission between individuals with different antigen-recognition repertoires.  If human immunodeficiency virus type 1 is a precedent, future therapies that target virus protease or polymerase enzymes may also select very rapidly for antiviral-resistant mutants.  These contrasting aspects of conservatism and adaptability provide a fascinating paradigm in which to explore the complex selection pressures that underlie the evolution of HCV and other persistent viruses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotwOpXQZprmrVg90H21EOLACvtfcHk0lh-eA2lMLERVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpsVSmsr0%253D&md5=a07b3411b6b18b5e7ab3cf9bc3b89026</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1099%2Fvir.0.80401-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1099%252Fvir.0.80401-0%26sid%3Dliteratum%253Aachs%26aulast%3DSimmonds%26aufirst%3DP.%26atitle%3DGenetic%2520Diversity%2520and%2520Evolution%2520of%2520Hepatitis%2520C%2520Virus%25E2%2580%259415%2520Years%2520On%26jtitle%3DJ.%2520Gen.%2520Virol.%26date%3D2004%26volume%3D85%26spage%3D3173%26epage%3D3188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Le Guillou-Guillemette, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vallet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaudy-Graffin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pivet, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goudeau, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunel-Fabiani, F.</span><span> </span><span class="NLM_article-title">Genetic Diversity of the Hepatitis C Virus: Impact and Issues in the Antiviral Therapy</span> <span class="citation_source-journal">World J. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2416</span><span class="NLM_x">–</span> <span class="NLM_lpage">2426</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm100863x&amp;key=10.3748%2Fwjg.v13.i17.2416" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm100863x&amp;key=17552024" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm100863x&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotl2ltL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=2416-2426&author=H.+Le+Guillou-Guillemetteauthor=S.+Valletauthor=C.+Gaudy-Graffinauthor=C.+Payanauthor=A.+Pivetauthor=A.+Goudeauauthor=F.+Lunel-Fabiani&title=Genetic+Diversity+of+the+Hepatitis+C+Virus%3A+Impact+and+Issues+in+the+Antiviral+Therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic diversity of the hepatitis C virus: impact and issues in the antiviral therapy</span></div><div class="casAuthors">Le Guillou-Guillemette, H.; Vallet, S.; Gaudy-Graffin, C.; Payan, C.; Pivert, A.; Goudeau, A.; Lunel-Fabiani, F.</div><div class="citationInfo"><span class="NLM_cas:title">World Journal of Gastroenterology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2416-2426</span>CODEN:
                <span class="NLM_cas:coden">WJGAF2</span>;
        ISSN:<span class="NLM_cas:issn">1007-9327</span>.
    
            (<span class="NLM_cas:orgname">World Journal of Gastroenterology</span>)
        </div><div class="casAbstract">A review.  The hepatitis C Virus (HCV) presents a high degree of genetic variability which is explained by the combination of a lack of proof reading by the RNA dependent RNA polymerase and a high level of viral replication.  The resulting genetic polymorphism defines a classification in clades, genotypes, subtypes, isolates and quasispecies.  This diversity is known to reflect the range of responses to Interferon therapy.  The genotype is one of the predictive parameters currently used to define the antiviral treatment strategy and the chance of therapeutic success.  Studies have also reported the potential impact of the viral genetic polymorphism in the outcome of antiviral therapy in patients infected by the same HCV genotype.  Both structural and non structural genomic regions of HCV have been suggested to be involved in the Interferon pathway and the resistance to antiviral therapy.  In this review, the authors first detail the viral basis of HCV diversity.  Then, the HCV genetic regions that may be implicated in resistance to therapy are described, with a focus on the structural region encoded by the E2 gene and the non-structural genes NS3, NS5A and NS5B.  Both mechanisms of the Interferon resistance and of the new antiviral drugs are described in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSpQ7xkfDdBrVg90H21EOLACvtfcHk0lhGQENnBcr6gQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotl2ltL0%253D&md5=457a642ea142dee4a7522e8a48c52b60</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.3748%2Fwjg.v13.i17.2416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3748%252Fwjg.v13.i17.2416%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BGuillou-Guillemette%26aufirst%3DH.%26aulast%3DVallet%26aufirst%3DS.%26aulast%3DGaudy-Graffin%26aufirst%3DC.%26aulast%3DPayan%26aufirst%3DC.%26aulast%3DPivet%26aufirst%3DA.%26aulast%3DGoudeau%26aufirst%3DA.%26aulast%3DLunel-Fabiani%26aufirst%3DF.%26atitle%3DGenetic%2520Diversity%2520of%2520the%2520Hepatitis%2520C%2520Virus%253A%2520Impact%2520and%2520Issues%2520in%2520the%2520Antiviral%2520Therapy%26jtitle%3DWorld%2520J.%2520Gastroenterol.%26date%3D2007%26volume%3D13%26spage%3D2416%26epage%3D2426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Pierra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amador, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benzaria, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cretton-Scott, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Amours, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moussa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Standring, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sammadossi, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosselin, G.</span><span> </span><span class="NLM_article-title">Synthesis and Pharmacokinetics of Valopicitabine (NM283), an Efficient Prodrug of the Potent Anti-HCV Agent 2′-<i>C</i>-Methylcytidine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6614</span><span class="NLM_x">–</span> <span class="NLM_lpage">6620</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0603623" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6614-6620&author=C.+Pierraauthor=A.+Amadorauthor=S.+Benzariaauthor=E.+Cretton-Scottauthor=M.+D%E2%80%99Amoursauthor=J.+Maoauthor=S.+Mathieuauthor=A.+Moussaauthor=E.+G.+Bridgesauthor=D.+M.+Standringauthor=J.-P.+Sammadossiauthor=R.+Storerauthor=G.+Gosselin&title=Synthesis+and+Pharmacokinetics+of+Valopicitabine+%28NM283%29%2C+an+Efficient+Prodrug+of+the+Potent+Anti-HCV+Agent+2%E2%80%B2-C-Methylcytidine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm0603623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0603623%26sid%3Dliteratum%253Aachs%26aulast%3DPierra%26aufirst%3DC.%26aulast%3DAmador%26aufirst%3DA.%26aulast%3DBenzaria%26aufirst%3DS.%26aulast%3DCretton-Scott%26aufirst%3DE.%26aulast%3DD%25E2%2580%2599Amours%26aufirst%3DM.%26aulast%3DMao%26aufirst%3DJ.%26aulast%3DMathieu%26aufirst%3DS.%26aulast%3DMoussa%26aufirst%3DA.%26aulast%3DBridges%26aufirst%3DE.%2BG.%26aulast%3DStandring%26aufirst%3DD.%2BM.%26aulast%3DSammadossi%26aufirst%3DJ.-P.%26aulast%3DStorer%26aufirst%3DR.%26aulast%3DGosselin%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520Pharmacokinetics%2520of%2520Valopicitabine%2520%2528NM283%2529%252C%2520an%2520Efficient%2520Prodrug%2520of%2520the%2520Potent%2520Anti-HCV%2520Agent%25202%25E2%2580%25B2-C-Methylcytidine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6614%26epage%3D6620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Smith, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalayanov, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sund, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winqvist, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maltseva, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leveque, V. J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajyagurr, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pogam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Najer, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benkestock, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maag, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammack, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swallow, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johannsson, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klumpp, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M.</span><span> </span><span class="NLM_article-title">The Design, Synthesis, and Antiviral Activity of Monofluoro and Difluoro Analogues of 4′-Axidocytidine against Hepatitis C Virus Replication: The Discovery of 4′-Azido-2′-deoxy-2′-fluorocytidine and 4′-Azido-2′-dideoxy-2′,2′-difuorocytidine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2971</span><span class="NLM_x">–</span> <span class="NLM_lpage">2978</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801595c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2971-2978&author=D.+B.+Smithauthor=G.+Kalayanovauthor=G.+Sundauthor=A.+Winqvistauthor=T.+Maltsevaauthor=V.+J.-P.+Levequeauthor=S.+Rajyagurrauthor=S.+Le+Pogamauthor=I.+Najerauthor=K.+Benkestockauthor=X.-X.+Zhouauthor=A.+C.+Kaiserauthor=H.+Maagauthor=N.+Cammackauthor=J.+A.+Martinauthor=S.+Swallowauthor=N.+G.+Johannssonauthor=K.+Klumppauthor=M.+Smith&title=The+Design%2C+Synthesis%2C+and+Antiviral+Activity+of+Monofluoro+and+Difluoro+Analogues+of+4%E2%80%B2-Axidocytidine+against+Hepatitis+C+Virus+Replication%3A+The+Discovery+of+4%E2%80%B2-Azido-2%E2%80%B2-deoxy-2%E2%80%B2-fluorocytidine+and+4%E2%80%B2-Azido-2%E2%80%B2-dideoxy-2%E2%80%B2%2C2%E2%80%B2-difuorocytidine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm801595c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801595c%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BB.%26aulast%3DKalayanov%26aufirst%3DG.%26aulast%3DSund%26aufirst%3DG.%26aulast%3DWinqvist%26aufirst%3DA.%26aulast%3DMaltseva%26aufirst%3DT.%26aulast%3DLeveque%26aufirst%3DV.%2BJ.-P.%26aulast%3DRajyagurr%26aufirst%3DS.%26aulast%3DLe%2BPogam%26aufirst%3DS.%26aulast%3DNajer%26aufirst%3DI.%26aulast%3DBenkestock%26aufirst%3DK.%26aulast%3DZhou%26aufirst%3DX.-X.%26aulast%3DKaiser%26aufirst%3DA.%2BC.%26aulast%3DMaag%26aufirst%3DH.%26aulast%3DCammack%26aufirst%3DN.%26aulast%3DMartin%26aufirst%3DJ.%2BA.%26aulast%3DSwallow%26aufirst%3DS.%26aulast%3DJohannsson%26aufirst%3DN.%2BG.%26aulast%3DKlumpp%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DM.%26atitle%3DThe%2520Design%252C%2520Synthesis%252C%2520and%2520Antiviral%2520Activity%2520of%2520Monofluoro%2520and%2520Difluoro%2520Analogues%2520of%25204%25E2%2580%25B2-Axidocytidine%2520against%2520Hepatitis%2520C%2520Virus%2520Replication%253A%2520The%2520Discovery%2520of%25204%25E2%2580%25B2-Azido-2%25E2%2580%25B2-deoxy-2%25E2%2580%25B2-fluorocytidine%2520and%25204%25E2%2580%25B2-Azido-2%25E2%2580%25B2-dideoxy-2%25E2%2580%25B2%252C2%25E2%2580%25B2-difuorocytidine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2971%26epage%3D2978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Clark, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollecker, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuyver, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tharnish, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lostia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBrayer, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schinazi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otto, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furman, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stec, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pankiewicz, K. W.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Antiviral Activity of 2′-Deoxy-2′-fluoro-2′-<i>C</i>-methylcytidine, a Potent Inhibitor of Hepatitis C Virus Replication</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">5504</span><span class="NLM_x">–</span> <span class="NLM_lpage">5508</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0502788" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5504-5508&author=J.+L.+Clarkauthor=L.+Holleckerauthor=J.+C.+Masonauthor=L.+J.+Stuyverauthor=P.+M.+Tharnishauthor=S.+Lostiaauthor=T.+R.+McBrayerauthor=R.+Schinaziauthor=K.+A.+Watanabeauthor=M.+J.+Ottoauthor=P.+A.+Furmanauthor=W.+J.+Stecauthor=S.+E.+Pattersonauthor=K.+W.+Pankiewicz&title=Design%2C+Synthesis%2C+and+Antiviral+Activity+of+2%E2%80%B2-Deoxy-2%E2%80%B2-fluoro-2%E2%80%B2-C-methylcytidine%2C+a+Potent+Inhibitor+of+Hepatitis+C+Virus+Replication"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm0502788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0502788%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DJ.%2BL.%26aulast%3DHollecker%26aufirst%3DL.%26aulast%3DMason%26aufirst%3DJ.%2BC.%26aulast%3DStuyver%26aufirst%3DL.%2BJ.%26aulast%3DTharnish%26aufirst%3DP.%2BM.%26aulast%3DLostia%26aufirst%3DS.%26aulast%3DMcBrayer%26aufirst%3DT.%2BR.%26aulast%3DSchinazi%26aufirst%3DR.%26aulast%3DWatanabe%26aufirst%3DK.%2BA.%26aulast%3DOtto%26aufirst%3DM.%2BJ.%26aulast%3DFurman%26aufirst%3DP.%2BA.%26aulast%3DStec%26aufirst%3DW.%2BJ.%26aulast%3DPatterson%26aufirst%3DS.%2BE.%26aulast%3DPankiewicz%26aufirst%3DK.%2BW.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Antiviral%2520Activity%2520of%25202%25E2%2580%25B2-Deoxy-2%25E2%2580%25B2-fluoro-2%25E2%2580%25B2-C-methylcytidine%252C%2520a%2520Potent%2520Inhibitor%2520of%2520Hepatitis%2520C%2520Virus%2520Replication%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5504%26epage%3D5508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Stuyver, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBrayer, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tharnish, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollecher, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lostia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nachman</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, M.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schinazi, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrey, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Julander, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furman, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otto, M. J.</span><span> </span><span class="NLM_article-title">Inhibition of Hepatitis C Replicon RNA Synthesis by β-<span class="smallcaps smallerCapital">d</span>-2′-Deoxy-2′-fluoro-2′-<i>C</i>-methylcytidine: A Specific Inhibitor of Hepatitis C Virus Replication</span> <span class="citation_source-journal">Antiviral Chem. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">87</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2006&pages=79-87&author=L.+J.+Stuyverauthor=T.+R.+McBrayerauthor=P.+M.+Tharnishauthor=J.+L.+Clarkauthor=L.+Hollecherauthor=S.+Lostiaauthor=+Nachmanauthor=J.+Grierauthor=M.+A.+Bennettauthor=M.-Y.+Xieauthor=R.+F.+Schinaziauthor=J.+D.+Morreyauthor=J.+L.+Julanderauthor=P.+A.+Furmanauthor=M.+J.+Otto&title=Inhibition+of+Hepatitis+C+Replicon+RNA+Synthesis+by+%CE%B2-d-2%E2%80%B2-Deoxy-2%E2%80%B2-fluoro-2%E2%80%B2-C-methylcytidine%3A+A+Specific+Inhibitor+of+Hepatitis+C+Virus+Replication"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStuyver%26aufirst%3DL.%2BJ.%26aulast%3DMcBrayer%26aufirst%3DT.%2BR.%26aulast%3DTharnish%26aufirst%3DP.%2BM.%26aulast%3DClark%26aufirst%3DJ.%2BL.%26aulast%3DHollecher%26aufirst%3DL.%26aulast%3DLostia%26aufirst%3DS.%26aulast%3DNachman%26aulast%3DGrier%26aufirst%3DJ.%26aulast%3DBennett%26aufirst%3DM.%2BA.%26aulast%3DXie%26aufirst%3DM.-Y.%26aulast%3DSchinazi%26aufirst%3DR.%2BF.%26aulast%3DMorrey%26aufirst%3DJ.%2BD.%26aulast%3DJulander%26aufirst%3DJ.%2BL.%26aulast%3DFurman%26aufirst%3DP.%2BA.%26aulast%3DOtto%26aufirst%3DM.%2BJ.%26atitle%3DInhibition%2520of%2520Hepatitis%2520C%2520Replicon%2520RNA%2520Synthesis%2520by%2520%25CE%25B2-d-2%25E2%2580%25B2-Deoxy-2%25E2%2580%25B2-fluoro-2%25E2%2580%25B2-C-methylcytidine%253A%2520A%2520Specific%2520Inhibitor%2520of%2520Hepatitis%2520C%2520Virus%2520Replication%26jtitle%3DAntiviral%2520Chem.%2520Chemother.%26date%3D2006%26volume%3D17%26spage%3D79%26epage%3D87" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Stuyver, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBrayer, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitaker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tharnish, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramesh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lostia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cartee, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobbs, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schinazi, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, K. A</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otto, M. J.</span><span> </span><span class="NLM_article-title">Inhibition of the Subgenomic Hepatitis C Virus Replicon in Huh-7 Cells by 2′-Deoxy-2′-fluoro Cytidine</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">651</span><span class="NLM_x">–</span> <span class="NLM_lpage">654</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2004&pages=651-654&author=L.+J.+Stuyverauthor=T.+R.+McBrayerauthor=T.+Whitakerauthor=P.+M.+Tharnishauthor=M.+Rameshauthor=S.+Lostiaauthor=L.+Carteeauthor=J.+Shiauthor=A.+Hobbsauthor=R.+F.+Schinaziauthor=K.+A+Watanabeauthor=M.+J.+Otto&title=Inhibition+of+the+Subgenomic+Hepatitis+C+Virus+Replicon+in+Huh-7+Cells+by+2%E2%80%B2-Deoxy-2%E2%80%B2-fluoro+Cytidine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStuyver%26aufirst%3DL.%2BJ.%26aulast%3DMcBrayer%26aufirst%3DT.%2BR.%26aulast%3DWhitaker%26aufirst%3DT.%26aulast%3DTharnish%26aufirst%3DP.%2BM.%26aulast%3DRamesh%26aufirst%3DM.%26aulast%3DLostia%26aufirst%3DS.%26aulast%3DCartee%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DHobbs%26aufirst%3DA.%26aulast%3DSchinazi%26aufirst%3DR.%2BF.%26aulast%3DWatanabe%26aufirst%3DK.%2BA%26aulast%3DOtto%26aufirst%3DM.%2BJ.%26atitle%3DInhibition%2520of%2520the%2520Subgenomic%2520Hepatitis%2520C%2520Virus%2520Replicon%2520in%2520Huh-7%2520Cells%2520by%25202%25E2%2580%25B2-Deoxy-2%25E2%2580%25B2-fluoro%2520Cytidine%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2004%26volume%3D48%26spage%3D651%26epage%3D654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Reddy, R.; Rodriguez-Torres, M.; Gane, E.; Robson, R.; Lalezari, J.; Everson, G.; DeJesus, E.; McHutchinson, J.; Vargas, H.</span> Presented at the 58th Annual Meeting of the American Association of the Study of Liver Disease, Boston, November<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">; </span>Abstract LB9; unpublished results.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Reddy%2C+R.%3B+Rodriguez-Torres%2C+M.%3B+Gane%2C+E.%3B+Robson%2C+R.%3B+Lalezari%2C+J.%3B+Everson%2C+G.%3B+DeJesus%2C+E.%3B+McHutchinson%2C+J.%3B+Vargas%2C+H.+Presented+at+the+58th+Annual+Meeting+of+the+American+Association+of+the+Study+of+Liver+Disease%2C+Boston%2C+November+2007%3B+Abstract+LB9%3B+unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DReddy%26aufirst%3DR.%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Lalezari, J.; Gane, E.; Rodriguez,-Torres, M.; DeJesus, E.; Nelson, D.; Everson, G.; Jacobson, I.; Reddy, R.; Hill, G. Z.; Beard, A.; Symonds, W. T.; Berrey, M. M.; McHutchison, J. G.</span> Potent Antiviral Activity of the HCV Nucleoside Polymerase Inhibitor R7128 with PEG-INF and Ribavirin: Interim Results of R7128 500 mg BID for 28-Days. Presented at the 43rd Annual Meeting of the European Association for the Study of the Liver, Milan, Italy, April<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>unpublished results.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Lalezari%2C+J.%3B+Gane%2C+E.%3B+Rodriguez%2C-Torres%2C+M.%3B+DeJesus%2C+E.%3B+Nelson%2C+D.%3B+Everson%2C+G.%3B+Jacobson%2C+I.%3B+Reddy%2C+R.%3B+Hill%2C+G.+Z.%3B+Beard%2C+A.%3B+Symonds%2C+W.+T.%3B+Berrey%2C+M.+M.%3B+McHutchison%2C+J.+G.+Potent+Antiviral+Activity+of+the+HCV+Nucleoside+Polymerase+Inhibitor+R7128+with+PEG-INF+and+Ribavirin%3A+Interim+Results+of+R7128+500+mg+BID+for+28-Days.+Presented+at+the+43rd+Annual+Meeting+of+the+European+Association+for+the+Study+of+the+Liver%2C+Milan%2C+Italy%2C+April+2008%3B+unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DLalezari%26aufirst%3DJ.%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Rodriguez-Torres, M.; Lalezari, J; Gane, E.; DeJesus, E.; Nelson, D.; Everson, G.; Jacobsen, I.; Reddy, R.; McHutchinson, J.; Beard, A.; Walker, S.; Symonds, B.; Berrey, M.</span> Potent Antiviral Response to the HCV Nucleoside Polymerase Inhibitor R7128 for 28 Days with PEG-INF and Ribavirin: Subanalysis by Race/Ethnicity, Weight and HCV Genotype. Presented at the 59th Annual Meeting of the American Association for the Study of Liver Disease, San Francisco, CA, November<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>Abstract No. 1899; unpublished results.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Rodriguez-Torres%2C+M.%3B+Lalezari%2C+J%3B+Gane%2C+E.%3B+DeJesus%2C+E.%3B+Nelson%2C+D.%3B+Everson%2C+G.%3B+Jacobsen%2C+I.%3B+Reddy%2C+R.%3B+McHutchinson%2C+J.%3B+Beard%2C+A.%3B+Walker%2C+S.%3B+Symonds%2C+B.%3B+Berrey%2C+M.+Potent+Antiviral+Response+to+the+HCV+Nucleoside+Polymerase+Inhibitor+R7128+for+28+Days+with+PEG-INF+and+Ribavirin%3A+Subanalysis+by+Race%2FEthnicity%2C+Weight+and+HCV+Genotype.+Presented+at+the+59th+Annual+Meeting+of+the+American+Association+for+the+Study+of+Liver+Disease%2C+San+Francisco%2C+CA%2C+November+2008%3B+Abstract+No.+1899%3B+unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez-Torres%26aufirst%3DM.%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Ma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roblendo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leveque, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lara-Jaime, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masjedizdeh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammack, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klumpp, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symons, J.</span><span> </span><span class="NLM_article-title">Characterization of the Metabolic Activation of Hepatitis C Virus Nucleoside Iinhibitor beta-<span class="smallcaps smallerCapital">d</span>-2′-Deoxy-2′-fluoro-2′-<i>C</i>-methylcytidine (PSI-6130) and Identification of a Novel active 5′-Triphosphate Species</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">29812</span><span class="NLM_x">–</span> <span class="NLM_lpage">29820</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=29812-29820&author=H.+Maauthor=W.+R.+Jiangauthor=N.+Roblendoauthor=V.+Levequeauthor=S.+Aliauthor=T.+Lara-Jaimeauthor=M.+Masjedizdehauthor=D.+B.+Smithauthor=N.+Cammackauthor=K.+Klumppauthor=J.+Symons&title=Characterization+of+the+Metabolic+Activation+of+Hepatitis+C+Virus+Nucleoside+Iinhibitor+beta-d-2%E2%80%B2-Deoxy-2%E2%80%B2-fluoro-2%E2%80%B2-C-methylcytidine+%28PSI-6130%29+and+Identification+of+a+Novel+active+5%E2%80%B2-Triphosphate+Species"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DW.%2BR.%26aulast%3DRoblendo%26aufirst%3DN.%26aulast%3DLeveque%26aufirst%3DV.%26aulast%3DAli%26aufirst%3DS.%26aulast%3DLara-Jaime%26aufirst%3DT.%26aulast%3DMasjedizdeh%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DD.%2BB.%26aulast%3DCammack%26aufirst%3DN.%26aulast%3DKlumpp%26aufirst%3DK.%26aulast%3DSymons%26aufirst%3DJ.%26atitle%3DCharacterization%2520of%2520the%2520Metabolic%2520Activation%2520of%2520Hepatitis%2520C%2520Virus%2520Nucleoside%2520Iinhibitor%2520beta-d-2%25E2%2580%25B2-Deoxy-2%25E2%2580%25B2-fluoro-2%25E2%2580%25B2-C-methylcytidine%2520%2528PSI-6130%2529%2520and%2520Identification%2520of%2520a%2520Novel%2520active%25205%25E2%2580%25B2-Triphosphate%2520Species%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D29812%26epage%3D29820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Murakami, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramesh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGrayer, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitaker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Micolochick Steuer, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schinazi, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuyver, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obikhod, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otto, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furman, P. A.</span><span> </span><span class="NLM_article-title">Mechanism of Activation of beta-<span class="smallcaps smallerCapital">d</span>-2′-Deoxy-2′-fluoro-2′-<i>C</i>-methylcytidine and Inhibition of Hepatitis C Virus NS5B RNA Polymerase</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">503</span><span class="NLM_x">–</span> <span class="NLM_lpage">509</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2007&pages=503-509&author=E.+Murakamiauthor=H.+Baoauthor=M.+Rameshauthor=T.+R.+McGrayerauthor=T.+Whitakerauthor=H.+M.+Micolochick+Steuerauthor=R.+F.+Schinaziauthor=L.+J.+Stuyverauthor=A.+Obikhodauthor=M.+J.+Ottoauthor=P.+A.+Furman&title=Mechanism+of+Activation+of+beta-d-2%E2%80%B2-Deoxy-2%E2%80%B2-fluoro-2%E2%80%B2-C-methylcytidine+and+Inhibition+of+Hepatitis+C+Virus+NS5B+RNA+Polymerase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMurakami%26aufirst%3DE.%26aulast%3DBao%26aufirst%3DH.%26aulast%3DRamesh%26aufirst%3DM.%26aulast%3DMcGrayer%26aufirst%3DT.%2BR.%26aulast%3DWhitaker%26aufirst%3DT.%26aulast%3DMicolochick%2BSteuer%26aufirst%3DH.%2BM.%26aulast%3DSchinazi%26aufirst%3DR.%2BF.%26aulast%3DStuyver%26aufirst%3DL.%2BJ.%26aulast%3DObikhod%26aufirst%3DA.%26aulast%3DOtto%26aufirst%3DM.%2BJ.%26aulast%3DFurman%26aufirst%3DP.%2BA.%26atitle%3DMechanism%2520of%2520Activation%2520of%2520beta-d-2%25E2%2580%25B2-Deoxy-2%25E2%2580%25B2-fluoro-2%25E2%2580%25B2-C-methylcytidine%2520and%2520Inhibition%2520of%2520Hepatitis%2520C%2520Virus%2520NS5B%2520RNA%2520Polymerase%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2007%26volume%3D51%26spage%3D503%26epage%3D509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Murakami, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Micolochick Steuer, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitaker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nachman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sofia, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otto, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furman, P. A.</span><span> </span><span class="NLM_article-title">The Mechanism of Action of beta-<span class="smallcaps smallerCapital">d</span>-2′-Deoxy-2′-fluoro-2′-<i>C</i>-methylcytidine Involves a Second Metabolic Pathway Leading to beta-<span class="smallcaps smallerCapital">d</span>-2′-Deoxy-2′-fluoro-2′-<i>C</i>-methyluridine 5′-Triphosphate, a Potent Inhibitor of the Hepatitis C Virus RNA-Dependent RNA Polymerase</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">458</span><span class="NLM_x">–</span> <span class="NLM_lpage">464</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=458-464&author=E.+Murakamiauthor=C.+Niuauthor=H.+Baoauthor=H.+M.+Micolochick+Steuerauthor=T.+Whitakerauthor=T.+Nachmanauthor=M.+J.+Sofiaauthor=P.+Wangauthor=M.+J.+Ottoauthor=P.+A.+Furman&title=The+Mechanism+of+Action+of+beta-d-2%E2%80%B2-Deoxy-2%E2%80%B2-fluoro-2%E2%80%B2-C-methylcytidine+Involves+a+Second+Metabolic+Pathway+Leading+to+beta-d-2%E2%80%B2-Deoxy-2%E2%80%B2-fluoro-2%E2%80%B2-C-methyluridine+5%E2%80%B2-Triphosphate%2C+a+Potent+Inhibitor+of+the+Hepatitis+C+Virus+RNA-Dependent+RNA+Polymerase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMurakami%26aufirst%3DE.%26aulast%3DNiu%26aufirst%3DC.%26aulast%3DBao%26aufirst%3DH.%26aulast%3DMicolochick%2BSteuer%26aufirst%3DH.%2BM.%26aulast%3DWhitaker%26aufirst%3DT.%26aulast%3DNachman%26aufirst%3DT.%26aulast%3DSofia%26aufirst%3DM.%2BJ.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DOtto%26aufirst%3DM.%2BJ.%26aulast%3DFurman%26aufirst%3DP.%2BA.%26atitle%3DThe%2520Mechanism%2520of%2520Action%2520of%2520beta-d-2%25E2%2580%25B2-Deoxy-2%25E2%2580%25B2-fluoro-2%25E2%2580%25B2-C-methylcytidine%2520Involves%2520a%2520Second%2520Metabolic%2520Pathway%2520Leading%2520to%2520beta-d-2%25E2%2580%25B2-Deoxy-2%25E2%2580%25B2-fluoro-2%25E2%2580%25B2-C-methyluridine%25205%25E2%2580%25B2-Triphosphate%252C%2520a%2520Potent%2520Inhibitor%2520of%2520the%2520Hepatitis%2520C%2520Virus%2520RNA-Dependent%2520RNA%2520Polymerase%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D458%26epage%3D464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">McGuigan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cahard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheeka, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balzarini, J.</span><span> </span><span class="NLM_article-title">Aryl Phosphoramidate Derivatives of d4T Have Improved Anti-HIV Efficacy in Tissue Culture and May Act by the Generation of a Novel Intracellular Metabolite</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1748</span><span class="NLM_x">–</span> <span class="NLM_lpage">1753</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm950605j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm100863x&amp;key=1%3ACAS%3A528%3ADyaK28XhslGmu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=1748-1753&author=C.+McGuiganauthor=D.+Cahardauthor=H.+M.+Sheekaauthor=E.+De+Clercqauthor=J.+Balzarini&title=Aryl+Phosphoramidate+Derivatives+of+d4T+Have+Improved+Anti-HIV+Efficacy+in+Tissue+Culture+and+May+Act+by+the+Generation+of+a+Novel+Intracellular+Metabolite"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Aryl Phosphoramidate Derivatives of d4T Have Improved Anti-HIV Efficacy in Tissue Culture and May Act by an Entirely New Mechanism of Reverse Transcriptase Inhibition</span></div><div class="casAuthors">McGuigan, Christopher; Cahard, Dominique; Sheeka, Hendrika M.; De Clercq, Erik; Balzarini, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1748-53</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">New phosphate derivs. of the anti-HIV nucleoside analog d4T were prepd. as potential membrane-sol. prodrugs of the bioactive free nucleotide.  The enhanced antiviral potency and/or reduced cytotoxicity of the derivs. leads to an increase in selectivity relative to the parent nucleoside analog.  Moreover, the derivs. appear to bypass the dependence of the nucleoside on thymidine kinase-mediated activation, retaining full activity in thymidine kinase-deficient cells.  This strongly suggests the successful intracellular delivery of free nucleotides by the masked phosphate triester prodrugs.  This is further confirmed by studies using radiolabeled compd. which clearly demonstrate the generation of d4T mono-, di- and triphosphates from the prodrug, even in thymidine kinase-deficient cells.  However, the major discovery herein reported is the generation of a new metabolite, a partially hydrolyzed phosphate diester, alaninyl d4T monophosphate, which is itself a competitive inhibitor of HIV1 reverse transcriptase without the need for further phosphorylation.  The authors suggest that at least part of the antiviral action of the prodrugs derives from the intracellular generation of such novel diesters and that this novel mode of action may add considerable wt. to the suggested further preclin. development of the phosphate prodrugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWbf_f_hqABrVg90H21EOLACvtfcHk0lhgXbKfvqKOow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhslGmu7g%253D&md5=21cb9e163880e1426cdd3df3bf052956</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm950605j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm950605j%26sid%3Dliteratum%253Aachs%26aulast%3DMcGuigan%26aufirst%3DC.%26aulast%3DCahard%26aufirst%3DD.%26aulast%3DSheeka%26aufirst%3DH.%2BM.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DBalzarini%26aufirst%3DJ.%26atitle%3DAryl%2520Phosphoramidate%2520Derivatives%2520of%2520d4T%2520Have%2520Improved%2520Anti-HIV%2520Efficacy%2520in%2520Tissue%2520Culture%2520and%2520May%2520Act%2520by%2520the%2520Generation%2520of%2520a%2520Novel%2520Intracellular%2520Metabolite%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D1748%26epage%3D1753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">McGuigan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cahard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Leary, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gumbleton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balzarini, J.</span><span> </span><span class="NLM_article-title">Synthesis, Anti-Human Immunodeficiency Virus Activity and Esterase Lability of Some Novel Carboxylic Ester-Modified Phosphoramidate Derivatives of Stavudine (d4T)</span> <span class="citation_source-journal">Antiviral Chem. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">473</span><span class="NLM_x">–</span> <span class="NLM_lpage">479</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1998&pages=473-479&author=C.+McGuiganauthor=P.+W.+Suttonauthor=D.+Cahardauthor=K.+Turnerauthor=G.+O%E2%80%99Learyauthor=Y.+Wangauthor=M.+Gumbletonauthor=E.+De+Clercqauthor=J.+Balzarini&title=Synthesis%2C+Anti-Human+Immunodeficiency+Virus+Activity+and+Esterase+Lability+of+Some+Novel+Carboxylic+Ester-Modified+Phosphoramidate+Derivatives+of+Stavudine+%28d4T%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcGuigan%26aufirst%3DC.%26aulast%3DSutton%26aufirst%3DP.%2BW.%26aulast%3DCahard%26aufirst%3DD.%26aulast%3DTurner%26aufirst%3DK.%26aulast%3DO%25E2%2580%2599Leary%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DGumbleton%26aufirst%3DM.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DBalzarini%26aufirst%3DJ.%26atitle%3DSynthesis%252C%2520Anti-Human%2520Immunodeficiency%2520Virus%2520Activity%2520and%2520Esterase%2520Lability%2520of%2520Some%2520Novel%2520Carboxylic%2520Ester-Modified%2520Phosphoramidate%2520Derivatives%2520of%2520Stavudine%2520%2528d4T%2529%26jtitle%3DAntiviral%2520Chem.%2520Chemother.%26date%3D1998%26volume%3D9%26spage%3D473%26epage%3D479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Saboulard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naesens, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cahard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salgado, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pathirana, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velazquez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuigan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balzarini, J.</span><span> </span><span class="NLM_article-title">Characterization of the Activation Pathway of Phosphoramidate Triester Prodrugs of Stavudine and Zidovudine</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">693</span><span class="NLM_x">–</span> <span class="NLM_lpage">704</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm100863x&amp;key=10496951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm100863x&amp;key=1%3ACAS%3A528%3ADyaK1MXmsVCmtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1999&pages=693-704&author=D.+Saboulardauthor=L.+Naesensauthor=D.+Cahardauthor=A.+Salgadoauthor=R.+Pathiranaauthor=S.+Velazquezauthor=C.+McGuiganauthor=E.+De+Clercqauthor=J.+Balzarini&title=Characterization+of+the+Activation+Pathway+of+Phosphoramidate+Triester+Prodrugs+of+Stavudine+and+Zidovudine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the activation pathway of phosphoramidate triester prodrugs of stavudine and zidovudine</span></div><div class="casAuthors">Saboulard, Didier; Naesens, Lieve; Cahard, Dominique; Salgado, Antonio; Pathirana, Ranjith; Velazquez, Sonsoles; Mcguigan, Christopher; De Clercq, Erik; Balzarini, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">693-704</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The phosphoramidate triester prodrugs of anti-human HIV 2',3'-dideoxynucleoside analogs (ddN) represent a convenient approach to bypass the first phosphorylation to ddN 5'-mono-phosphate (ddNMP), resulting in an improved formation of ddN 5'-triphosphate and, hence, higher antiviral efficacy.  Although phosphoramidate derivatization markedly increases the anti-HIV activity of 2',3'-didehydro-2',3'-dideoxythymidine (d4T) in both wild-type and thymidine kinase-deficient CEM cells, the concept is far less successful for the 3'-azido-2',3'-dideoxythymidine (AZT) triesters.  We now investigated the metab. of triester prodrugs of d4T and AZT using pure enzymes or different biol. media.  The efficiency of the first activation step, mediated by carboxylesterases, consists of the formation of the amino acyl ddNMP metabolite.  The efficiency of this step was shown to be dependent on the amino acid, alkyl ester, and ddN moiety.  Triesters that showed no conversion to the amino acyl ddNMP accumulated as the phenyl-contg. intermediate and had poor, if any, anti-HIV activity.  In contrast to the relative stability of the triesters in human serum, carboxylesterase-mediated cleavage of the prodrugs was found to be remarkably high in mouse serum.  The subsequent conversion of the amino acyl ddNMP metabolite to ddNMP or ddN was highest in rat liver cytosolic enzyme prepns.  Although L-alaninyl-d4TMP was efficiently converted to d4TMP, the main metabolite formed from L-alaninyl-AZTMP was the free nucleoside (AZT), thus explaining why d4T prodrugs, but not AZT prodrugs, retain anti-HIV activity in HIV-infected thymidine kinase-deficient cell cultures.  The rat liver phosphoramidase responsible for the formation of ddNMP was shown to be distinct from creatine kinase, alk. phosphatase, and phosphodiesterase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkU4eud7u1AbVg90H21EOLACvtfcHk0lhgXbKfvqKOow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmsVCmtLk%253D&md5=7d88e50f782fb3acdf934ac8a75bcee6</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSaboulard%26aufirst%3DD.%26aulast%3DNaesens%26aufirst%3DL.%26aulast%3DCahard%26aufirst%3DD.%26aulast%3DSalgado%26aufirst%3DA.%26aulast%3DPathirana%26aufirst%3DR.%26aulast%3DVelazquez%26aufirst%3DS.%26aulast%3DMcGuigan%26aufirst%3DC.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DBalzarini%26aufirst%3DJ.%26atitle%3DCharacterization%2520of%2520the%2520Activation%2520Pathway%2520of%2520Phosphoramidate%2520Triester%2520Prodrugs%2520of%2520Stavudine%2520and%2520Zidovudine%26jtitle%3DMol.%2520Pharmacol.%26date%3D1999%26volume%3D56%26spage%3D693%26epage%3D704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Perrone, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daverio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valente, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajyaguru, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lévêque, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pogam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Najera, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klumpp, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGruigan, C.</span><span> </span><span class="NLM_article-title">First Example of Phosphoramidate Approach Applied to a 4′-Substituted Purine Nucleotide (4′-Azidoadenosine): Conversion of an Inactive Nucleotide to a Submicromolar Compound versus Hepatitis C Virus</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">55463</span><span class="NLM_x">–</span> <span class="NLM_lpage">5470</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=55463-5470&author=P.+Perroneauthor=F.+Daverioauthor=R.+Valenteauthor=S.+Rajyaguruauthor=J.+A.+Martinauthor=V.+L%C3%A9v%C3%AAqueauthor=S.+Le+Pogamauthor=I.+Najeraauthor=K.+Klumppauthor=D.+B.+Smithauthor=C.+McGruigan&title=First+Example+of+Phosphoramidate+Approach+Applied+to+a+4%E2%80%B2-Substituted+Purine+Nucleotide+%284%E2%80%B2-Azidoadenosine%29%3A+Conversion+of+an+Inactive+Nucleotide+to+a+Submicromolar+Compound+versus+Hepatitis+C+Virus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerrone%26aufirst%3DP.%26aulast%3DDaverio%26aufirst%3DF.%26aulast%3DValente%26aufirst%3DR.%26aulast%3DRajyaguru%26aufirst%3DS.%26aulast%3DMartin%26aufirst%3DJ.%2BA.%26aulast%3DL%25C3%25A9v%25C3%25AAque%26aufirst%3DV.%26aulast%3DLe%2BPogam%26aufirst%3DS.%26aulast%3DNajera%26aufirst%3DI.%26aulast%3DKlumpp%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DD.%2BB.%26aulast%3DMcGruigan%26aufirst%3DC.%26atitle%3DFirst%2520Example%2520of%2520Phosphoramidate%2520Approach%2520Applied%2520to%2520a%25204%25E2%2580%25B2-Substituted%2520Purine%2520Nucleotide%2520%25284%25E2%2580%25B2-Azidoadenosine%2529%253A%2520Conversion%2520of%2520an%2520Inactive%2520Nucleotide%2520to%2520a%2520Submicromolar%2520Compound%2520versus%2520Hepatitis%2520C%2520Virus%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D55463%26epage%3D5470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">McGuigan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelleher, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulready, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luoni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daverio., F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajyaguru, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pogam., S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Najer, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klumpp, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. B.</span><span> </span><span class="NLM_article-title">The Application of Phosphoramidate ProTide Technology to the Potent Anti-HCV Compound 4′-Azidocytidine (R1479)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4250</span><span class="NLM_x">–</span> <span class="NLM_lpage">4254</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4250-4254&author=C.+McGuiganauthor=M.+R.+Kelleherauthor=P.+Perroneauthor=S.+Mulreadyauthor=G.+Luoniauthor=F.+Daverio.author=S.+Rajyaguruauthor=S.+Le+Pogam.author=I.+Najerauthor=J.+A.+Martinauthor=K.+Klumppauthor=D.+B.+Smith&title=The+Application+of+Phosphoramidate+ProTide+Technology+to+the+Potent+Anti-HCV+Compound+4%E2%80%B2-Azidocytidine+%28R1479%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcGuigan%26aufirst%3DC.%26aulast%3DKelleher%26aufirst%3DM.%2BR.%26aulast%3DPerrone%26aufirst%3DP.%26aulast%3DMulready%26aufirst%3DS.%26aulast%3DLuoni%26aufirst%3DG.%26aulast%3DDaverio.%26aufirst%3DF.%26aulast%3DRajyaguru%26aufirst%3DS.%26aulast%3DLe%2BPogam.%26aufirst%3DS.%26aulast%3DNajer%26aufirst%3DI.%26aulast%3DMartin%26aufirst%3DJ.%2BA.%26aulast%3DKlumpp%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DD.%2BB.%26atitle%3DThe%2520Application%2520of%2520Phosphoramidate%2520ProTide%2520Technology%2520to%2520the%2520Potent%2520Anti-HCV%2520Compound%25204%25E2%2580%25B2-Azidocytidine%2520%2528R1479%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4250%26epage%3D4254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Gardelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attenni, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donghi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meppen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harper, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiori, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuliano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pucci, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gennari, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcucci, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leone, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacCoss, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, F.</span><span> </span><span class="NLM_article-title">Phosphoramidate Prodrugs of 2′-<i>C</i>-Methylcytidine for the Therapy of Hepatitis C Virus Infection</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">5394</span><span class="NLM_x">–</span> <span class="NLM_lpage">5407</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900447q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5394-5407&author=C.+Gardelliauthor=B.+Attenniauthor=M.+Donghiauthor=M.+Meppenauthor=B.+Paciniauthor=S.+Harperauthor=A.+Di+Marcoauthor=F.+Fioriauthor=C.+Giulianoauthor=V.+Pucciauthor=R.+Lauferauthor=N.+Gennariauthor=I.+Marcucciauthor=J.+F.+Leoneauthor=D.+B.+Olsenauthor=M.+MacCossauthor=M.+Rowleyauthor=F.+Narjes&title=Phosphoramidate+Prodrugs+of+2%E2%80%B2-C-Methylcytidine+for+the+Therapy+of+Hepatitis+C+Virus+Infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm900447q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900447q%26sid%3Dliteratum%253Aachs%26aulast%3DGardelli%26aufirst%3DC.%26aulast%3DAttenni%26aufirst%3DB.%26aulast%3DDonghi%26aufirst%3DM.%26aulast%3DMeppen%26aufirst%3DM.%26aulast%3DPacini%26aufirst%3DB.%26aulast%3DHarper%26aufirst%3DS.%26aulast%3DDi%2BMarco%26aufirst%3DA.%26aulast%3DFiori%26aufirst%3DF.%26aulast%3DGiuliano%26aufirst%3DC.%26aulast%3DPucci%26aufirst%3DV.%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DGennari%26aufirst%3DN.%26aulast%3DMarcucci%26aufirst%3DI.%26aulast%3DLeone%26aufirst%3DJ.%2BF.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DMacCoss%26aufirst%3DM.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DNarjes%26aufirst%3DF.%26atitle%3DPhosphoramidate%2520Prodrugs%2520of%25202%25E2%2580%25B2-C-Methylcytidine%2520for%2520the%2520Therapy%2520of%2520Hepatitis%2520C%2520Virus%2520Infection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5394%26epage%3D5407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Wang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, B.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rachakonda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stec, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleary, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sofia, M. J.</span><span> </span><span class="NLM_article-title">An Efficient and Diastereoselective Synthesis of PSI-6130: A Clinically Efficacious Inhibitor of HCV NS5B Polymerase</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">6819</span><span class="NLM_x">–</span> <span class="NLM_lpage">6824</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo901345j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2009&pages=6819-6824&author=P.+Wangauthor=B.-K.+Chinauthor=S.+Rachakondaauthor=J.+Duauthor=N.+Khanauthor=J.+Shiauthor=W.+Stecauthor=D.+Clearyauthor=B.+S.+Rossauthor=M.+J.+Sofia&title=An+Efficient+and+Diastereoselective+Synthesis+of+PSI-6130%3A+A+Clinically+Efficacious+Inhibitor+of+HCV+NS5B+Polymerase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjo901345j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo901345j%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DP.%26aulast%3DChin%26aufirst%3DB.-K.%26aulast%3DRachakonda%26aufirst%3DS.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DKhan%26aufirst%3DN.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DStec%26aufirst%3DW.%26aulast%3DCleary%26aufirst%3DD.%26aulast%3DRoss%26aufirst%3DB.%2BS.%26aulast%3DSofia%26aufirst%3DM.%2BJ.%26atitle%3DAn%2520Efficient%2520and%2520Diastereoselective%2520Synthesis%2520of%2520PSI-6130%253A%2520A%2520Clinically%2520Efficacious%2520Inhibitor%2520of%2520HCV%2520NS5B%2520Polymerase%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2009%26volume%3D74%26spage%3D6819%26epage%3D6824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span> </span><span class="NLM_article-title">Cytotoxic Effects of Environmentally Relevant Chlorophenols on L929 Cells and Their Mechanism</span> <span class="citation_source-journal">Cell Biol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">183</span><span class="NLM_x">–</span> <span class="NLM_lpage">196</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm100863x&amp;key=10.1023%2FB%3ACBTO.0000029468.89746.64" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm100863x&amp;key=15250542" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm100863x&amp;key=1%3ACAS%3A528%3ADC%252BD2cXktlyksbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2004&pages=183-196&author=J.+Chenauthor=J.+Jianauthor=F.+Zhangauthor=H.+Yuauthor=J.+Zhang&title=Cytotoxic+Effects+of+Environmentally+Relevant+Chlorophenols+on+L929+Cells+and+Their+Mechanism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic effects of environmentally relevant chlorophenols on L929 cells and their mechanisms</span></div><div class="casAuthors">Chen, J.; Jiang, J.; Zhang, F.; Yu, H.; Zhang, J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Biology and Toxicology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">183-196</span>CODEN:
                <span class="NLM_cas:coden">CBTOE2</span>;
        ISSN:<span class="NLM_cas:issn">0742-2091</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">The chlorophenol chems. (CPs) are a major class of widely distributed and frequently occurring persistent environmental pollutants.  Pentachlorophenol (PCP) has been proposed to be procarcinogen in rodents and in possibly human beings.  Human beings are also easily exposed to other chlorophenol chems., including 4-chlorophenol (CP), 2,4-dichlorophenol (DCP), 2,3,4-trichlorophenol (TCP), prompting this investigation of their comparative cytotoxic effects and cell death mechanisms, assayed in fibroblast L929 cells.  The effective concn. for half-maximal response (EC50) values at 24 h for CP, DCP, TCP, and PCP are 2.18, 0.83, 0.46, and 0.11 mmol/L resp. and the EC50 values at 48 h are 1.18, 0.13, 0.08, and 0.06 mmol/L resp. by using 3-(4,5-dimethylthiazd-2-yl)-2,5-diphenyltentrazolium bromide (MTT) redn. assay.  A clear structure-activity relationship was obsd. between toxicity of CPs and their octanol-water partition coeffs.  The further studies indicate that CP, DCP, and TCP induce apoptosis in L929 cells in a concn. or time-dependent manner, but PCP mediates cell death more characteristic of necrosis than apoptosis.  These results not only demonstrate that L929 cell growth inhibition bioassay may be useful to provide the comparative evaluation of toxicity of CPs in vitro, but also implicate that CP, DCP, TCP, in comparison with PCP, can induce L929 cell death by apoptosis, resulting in lower procarcinogensis, which may help to elucidate the mol. basis for the adverse health effects assocd. with CPs exposure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQQXKmsbKYYLVg90H21EOLACvtfcHk0lgWF2X1b3Tv1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXktlyksbY%253D&md5=b0b9c2f1abe74c5bc1b0c26716f4db1d</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1023%2FB%3ACBTO.0000029468.89746.64&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FB%253ACBTO.0000029468.89746.64%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DJian%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3DCytotoxic%2520Effects%2520of%2520Environmentally%2520Relevant%2520Chlorophenols%2520on%2520L929%2520Cells%2520and%2520Their%2520Mechanism%26jtitle%3DCell%2520Biol.%2520Toxicol.%26date%3D2004%26volume%3D20%26spage%3D183%26epage%3D196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Phornchirasilp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Victor DeSouza, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feller, D. R.</span><span> </span><span class="NLM_article-title">Vivo and In Vitro Studies of the Hepatotoxic Effects of 4-Chlorophenol in Mice</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">961</span><span class="NLM_x">–</span> <span class="NLM_lpage">972</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1989&pages=961-972&author=S.+Phornchirasilpauthor=J.+J.+Victor+DeSouzaauthor=D.+R.+Feller&title=Vivo+and+In+Vitro+Studies+of+the+Hepatotoxic+Effects+of+4-Chlorophenol+in+Mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPhornchirasilp%26aufirst%3DS.%26aulast%3DVictor%2BDeSouza%26aufirst%3DJ.%2BJ.%26aulast%3DFeller%26aufirst%3DD.%2BR.%26atitle%3DVivo%2520and%2520In%2520Vitro%2520Studies%2520of%2520the%2520Hepatotoxic%2520Effects%2520of%25204-Chlorophenol%2520in%2520Mice%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1989%26volume%3D38%26spage%3D961%26epage%3D972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Zhao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burghardt, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, T. D.</span><span> </span><span class="NLM_article-title">Developmental Toxicity and Structure−Activity Relationships of Chlorophenols Using Human Embryonic Palatal Mesenchymal Cells</span> <span class="citation_source-journal">Toxicol. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm100863x&amp;key=10.1016%2F0378-4274%2895%2999684-A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm100863x&amp;key=7604397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm100863x&amp;key=1%3ACAS%3A528%3ADyaK2MXmt1yntbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=1995&pages=35-42&author=F.+Zhaoauthor=K.+Mayuraauthor=R.+W.+Hutchinsonauthor=R.+P.+Lewisauthor=R.+C.+Burghardtauthor=T.+D.+Phillips&title=Developmental+Toxicity+and+Structure%E2%88%92Activity+Relationships+of+Chlorophenols+Using+Human+Embryonic+Palatal+Mesenchymal+Cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Developmental toxicity and structure-activity relationships of chlorophenols using human embryonic palatal mesenchymal cells</span></div><div class="casAuthors">Zhao, Feng; Mayura, Kittane; Hutchinson, Richard W.; Lewis, Richard P.; Burghardt, Robert C.; Phillips, Timothy D.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology Letters</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">35-42</span>CODEN:
                <span class="NLM_cas:coden">TOLED5</span>;
        ISSN:<span class="NLM_cas:issn">0378-4274</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The chlorophenols (CPs) comprise a major class of widely distributed and frequently occurring environmental contaminants.  Previous studies have demonstrated the adverse effects of CPs on embryonic and fetal development.  HEPM (human embryonic palatal mesenchymal) and MOT (mouse ovarian tumor) cell lines have been utilized in complementary bioassays for the detection of teratogens, but not the CPs.  In this study, the objectives were 2-fold: (1) to det. if the HEPM assay could be used to complement other bioassay systems of nonhuman origin, i.e., Hydra attenuata (HA) and rat whole embryo culture (WEC), in the evaluation of the developmental toxicity of CPs, and (2) to delineate the ability of the HEPM assay to evaluate structure-activity relationships of pentachlorophenol (C5P), 2,3,4,5- tetrachlorophenol (C4P), 2,3,5-trichlorophenol (C3P), 3,5-dichlorophenol (C2P), 4-monochlorophenol (CP), phenol, and CP derivs. (i.e., acetates, sodium phenates and anisoles).  HEPM cells were seeded into each well of a 24-well plate and cultivated for 24 h.  The medium was replaced with fresh medium contg. various concns. of test chems. dissolved in DMSO (0.1%).  After culturing for 72 h, the medium was removed, cells were trypsinized, and cell no. detd.  The HEPM cell growth inhibition assay demonstrated a linear relation between the IC50 values of the CPs and degree of chlorine substitution.  The IC50 values of C5P, C4P, C3P, C2P, CP, and phenol were 18.8, 21.5, 27.5, 63.0, 150.0 and 470.0 μM, resp.  A clear structure-activity relation was obsd. between toxicity of CPs and the degree of chlorine substitution.  The rank order of CP toxicity from the HEPM assay (i.e., C5P > C4P > C3P > C2P > CP > phenol) is in excellent agreement with previous in vitro and in vivo studies.  However, contrary to published reports, the HEPM assay predicted that all CPs were teratogenic (false positives).  These findings suggest that the HEPM cell growth inhibition bioassay may be useful to discriminate between subtle differences in structure-activity and, in combination with other bioassays, might facilitate the rapid detection and prioritization of diverse cytotoxins, including various developmental toxicants.  Importantly, conclusions about the teratogenicity of a test chem. (via HEPM testing) should be approached with caution and confirmed with other teratogen-sensitive systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgr_IoCS5aHLVg90H21EOLACvtfcHk0lgWF2X1b3Tv1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmt1yntbk%253D&md5=ce723494deb3fe1c43f719a4dfe088aa</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2F0378-4274%2895%2999684-A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0378-4274%252895%252999684-A%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DMayura%26aufirst%3DK.%26aulast%3DHutchinson%26aufirst%3DR.%2BW.%26aulast%3DLewis%26aufirst%3DR.%2BP.%26aulast%3DBurghardt%26aufirst%3DR.%2BC.%26aulast%3DPhillips%26aufirst%3DT.%2BD.%26atitle%3DDevelopmental%2520Toxicity%2520and%2520Structure%25E2%2588%2592Activity%2520Relationships%2520of%2520Chlorophenols%2520Using%2520Human%2520Embryonic%2520Palatal%2520Mesenchymal%2520Cells%26jtitle%3DToxicol.%2520Lett.%26date%3D1995%26volume%3D78%26spage%3D35%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Niu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furman, P. A.</span><span> </span><span class="NLM_article-title">Clevudine Is Efficiently Phosphorylated to the Active Triphosphate Form in Primary Human Hepatocytes</span> <span class="citation_source-journal">Antiviral Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">263</span><span class="NLM_x">–</span> <span class="NLM_lpage">269</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=263-269&author=C.+Niuauthor=E.+Murakamiauthor=P.+A.+Furman&title=Clevudine+Is+Efficiently+Phosphorylated+to+the+Active+Triphosphate+Form+in+Primary+Human+Hepatocytes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNiu%26aufirst%3DC.%26aulast%3DMurakami%26aufirst%3DE.%26aulast%3DFurman%26aufirst%3DP.%2BA.%26atitle%3DClevudine%2520Is%2520Efficiently%2520Phosphorylated%2520to%2520the%2520Active%2520Triphosphate%2520Form%2520in%2520Primary%2520Human%2520Hepatocytes%26jtitle%3DAntiviral%2520Ther.%26date%3D2008%26volume%3D13%26spage%3D263%26epage%3D269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Ghose, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viswanadhan, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wendoloski, J. J.</span><span> </span><span class="NLM_article-title">Prediction of Hydrohobic Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and ClogP Methods</span> <span class="citation_source-journal">J. Phys. Chem. A</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">3762</span><span class="NLM_x">–</span> <span class="NLM_lpage">3772</span></span><div class="citationLinks">[<a href="/doi/10.1021/jp980230o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=1998&pages=3762-3772&author=A.+K.+Ghoseauthor=V.+N.+Viswanadhanauthor=J.+J.+Wendoloski&title=Prediction+of+Hydrohobic+Properties+of+Small+Organic+Molecules+Using+Fragment+Methods%3A+An+Analysis+of+AlogP+and+ClogP+Methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjp980230o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp980230o%26sid%3Dliteratum%253Aachs%26aulast%3DGhose%26aufirst%3DA.%2BK.%26aulast%3DViswanadhan%26aufirst%3DV.%2BN.%26aulast%3DWendoloski%26aufirst%3DJ.%2BJ.%26atitle%3DPrediction%2520of%2520Hydrohobic%2520Properties%2520of%2520Small%2520Organic%2520Molecules%2520Using%2520Fragment%2520Methods%253A%2520An%2520Analysis%2520of%2520AlogP%2520and%2520ClogP%2520Methods%26jtitle%3DJ.%2520Phys.%2520Chem.%2520A%26date%3D1998%26volume%3D102%26spage%3D3762%26epage%3D3772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Faller, B.</span><span> </span><span class="NLM_article-title">Artificial Membrane Assays To Assess Permeability</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">886</span><span class="NLM_x">–</span> <span class="NLM_lpage">892</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm100863x&amp;key=10.2174%2F138920008786485227" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm100863x&amp;key=18991585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm100863x&amp;key=1%3ACAS%3A528%3ADC%252BD1MXivF2nsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=886-892&author=B.+Faller&title=Artificial+Membrane+Assays+To+Assess+Permeability"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Artificial membrane assays to assess permeability</span></div><div class="casAuthors">Faller, Bernard</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">886-892</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  This paper reviews the development of artificial membrane assays in the last decade.  Reasons why parallel artificial membrane assays (PAMPA) became widely used are discussed and the various PAMPA assays targeting gastrointestinal absorption, blood brain barrier and skin penetration are presented.  Improvements in the assay technol. like the introduction of a paracellular component and the crit. factors to get quality data are reviewed.  The question how does PAMPA compare with Caco-2 monolayer permeability is being addressed.  New dimensions in artificial membrane assays like octanol/water logP measurement, influence of excipients on soly./permeability and binding consts. measurements are introduced.  Finally, similarity and differences between partition coeffs. and permeability values are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTpkeB5ssWpbVg90H21EOLACvtfcHk0lgdwrA3GuNzkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXivF2nsbw%253D&md5=7199c7fdea61f640773ce3453b273e81</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.2174%2F138920008786485227&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920008786485227%26sid%3Dliteratum%253Aachs%26aulast%3DFaller%26aufirst%3DB.%26atitle%3DArtificial%2520Membrane%2520Assays%2520To%2520Assess%2520Permeability%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2008%26volume%3D9%26spage%3D886%26epage%3D892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Fleischer, R. l.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lok, A. S.</span><span> </span><span class="NLM_article-title">Myopathy and Neuropathy Associated with Nucleos(t)ide Analog Therapy for Hepatitis B</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">787</span><span class="NLM_x">–</span> <span class="NLM_lpage">791</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm100863x&amp;key=10.1016%2Fj.jhep.2009.06.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm100863x&amp;key=19665816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm100863x&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFagt7%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2009&pages=787-791&author=R.+l.+Fleischerauthor=A.+S.+Lok&title=Myopathy+and+Neuropathy+Associated+with+Nucleos%28t%29ide+Analog+Therapy+for+Hepatitis+B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Myopathy and neuropathy associated with nucleos(t)ide analog therapy for hepatitis B</span></div><div class="casAuthors">Fleischer, Russell D.; Lok, Anna S. F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hepatology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">787-791</span>CODEN:
                <span class="NLM_cas:coden">JOHEEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-8278</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The development of clevudine as a treatment for hepatitis B was terminated recently because of case reports of myopathy.  In each case, the onset of symptoms occurred between 8 and 13 mo after the initiation of treatment.  Electromyog. and muscle biopsy confirmed the presence of myonecrosis.  One report also found evidence of mitochondrial toxicity.  The delayed onset and the finding of mitochondrial damage are reminiscent of fialuridine toxicity.  Telbivudine has also been reported to be assocd. with myopathy and neuropathy, particularly when used in combination with pegylated interferon.  These findings serve as a sober reminder of the lack of data on long-term safety of nucleos(t)ide analogs for hepatitis B, the importance of balancing benefits vs. risks before initiating treatment, and the need for more stringent post-marketing surveillance for drug toxicities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoavyhIHa1biLVg90H21EOLACvtfcHk0lgdwrA3GuNzkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFagt7%252FJ&md5=e09f459a5cc5018bd0f60fa81523563a</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.jhep.2009.06.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhep.2009.06.011%26sid%3Dliteratum%253Aachs%26aulast%3DFleischer%26aufirst%3DR.%2Bl.%26aulast%3DLok%26aufirst%3DA.%2BS.%26atitle%3DMyopathy%2520and%2520Neuropathy%2520Associated%2520with%2520Nucleos%2528t%2529ide%2520Analog%2520Therapy%2520for%2520Hepatitis%2520B%26jtitle%3DJ.%2520Hepatol.%26date%3D2009%26volume%3D51%26spage%3D787%26epage%3D791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Lewis, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copeland, W. C.</span><span> </span><span class="NLM_article-title">Mitochondrial Toxicity of NRTI Antiviral Drugs: An Integrated Cellular Perspective</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">812</span><span class="NLM_x">–</span> <span class="NLM_lpage">822</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm100863x&amp;key=10.1038%2Fnrd1201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm100863x&amp;key=14526384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm100863x&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnslarsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=812-822&author=W.+Lewisauthor=B.+J.+Dayauthor=W.+C.+Copeland&title=Mitochondrial+Toxicity+of+NRTI+Antiviral+Drugs%3A+An+Integrated+Cellular+Perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial toxicity of NRTI antiviral drugs: an integrated cellular perspective</span></div><div class="casAuthors">Lewis, William; Day, Brian J.; Copeland, William C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">812-822</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Highly active antiretroviral therapy (HAART) regimes based on nucleoside reverse transcriptase inhibitors (NRTIs) have revolutionized the treatment of AIDS in recent years.  Although HAART can successfully suppress viral replication in the long term, it is not without significant toxicity, which can seriously compromise treatment effectiveness.  A major toxicity that has been recognized for more than a decade is NRTI-related mitochondrial toxicity, which manifests as serious side effects such as hepatic failure and lactic acidosis.  However, a lack of understanding of the mechanisms underlying mitochondrial toxicity has hampered efforts to develop novel drugs with better side-effect profiles.  This review characterizes the pharmacol. mechanisms and pathways that are involved in mitochondrial dysfunction caused by NRTIs, and suggests opportunities for future pharmacol. research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSLd33wOAwYLVg90H21EOLACvtfcHk0lgdwrA3GuNzkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnslarsbo%253D&md5=e027a725c00f135731b9dbb041ae986f</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fnrd1201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1201%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DW.%26aulast%3DDay%26aufirst%3DB.%2BJ.%26aulast%3DCopeland%26aufirst%3DW.%2BC.%26atitle%3DMitochondrial%2520Toxicity%2520of%2520NRTI%2520Antiviral%2520Drugs%253A%2520An%2520Integrated%2520Cellular%2520Perspective%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2003%26volume%3D2%26spage%3D812%26epage%3D822" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Sammadossi, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlisle, R.</span><span> </span><span class="NLM_article-title">Toxicity of 3′-Azido-3′-deoxythymidine and 9-(1,3-Dihydroxy-2-propoxymethyl)guanine for Normal Human Hematopoietic Cells in Vitro</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">452</span><span class="NLM_x">–</span> <span class="NLM_lpage">454</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1987&pages=452-454&author=J.+P.+Sammadossiauthor=R.+Carlisle&title=Toxicity+of+3%E2%80%B2-Azido-3%E2%80%B2-deoxythymidine+and+9-%281%2C3-Dihydroxy-2-propoxymethyl%29guanine+for+Normal+Human+Hematopoietic+Cells+in+Vitro"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSammadossi%26aufirst%3DJ.%2BP.%26aulast%3DCarlisle%26aufirst%3DR.%26atitle%3DToxicity%2520of%25203%25E2%2580%25B2-Azido-3%25E2%2580%25B2-deoxythymidine%2520and%25209-%25281%252C3-Dihydroxy-2-propoxymethyl%2529guanine%2520for%2520Normal%2520Human%2520Hematopoietic%2520Cells%2520in%2520Vitro%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1987%26volume%3D31%26spage%3D452%26epage%3D454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Sammadossi, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schinazi, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, M. Y.</span><span> </span><span class="NLM_article-title">Comparison of Cytotoxicity of the (−)- and (+)-Enantiomer of 2′,3′-Dideoxy-3′-thiacytidine in Normal Human Bone Marrow Progenitor Cells</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1921</span><span class="NLM_x">–</span> <span class="NLM_lpage">1925</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1992&pages=1921-1925&author=J.+P.+Sammadossiauthor=R.+F.+Schinaziauthor=C.+K.+Chuauthor=M.+Y.+Xie&title=Comparison+of+Cytotoxicity+of+the+%28%E2%88%92%29-+and+%28%2B%29-Enantiomer+of+2%E2%80%B2%2C3%E2%80%B2-Dideoxy-3%E2%80%B2-thiacytidine+in+Normal+Human+Bone+Marrow+Progenitor+Cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSammadossi%26aufirst%3DJ.%2BP.%26aulast%3DSchinazi%26aufirst%3DR.%2BF.%26aulast%3DChu%26aufirst%3DC.%2BK.%26aulast%3DXie%26aufirst%3DM.%2BY.%26atitle%3DComparison%2520of%2520Cytotoxicity%2520of%2520the%2520%2528%25E2%2588%2592%2529-%2520and%2520%2528%252B%2529-Enantiomer%2520of%25202%25E2%2580%25B2%252C3%25E2%2580%25B2-Dideoxy-3%25E2%2580%25B2-thiacytidine%2520in%2520Normal%2520Human%2520Bone%2520Marrow%2520Progenitor%2520Cells%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1992%26volume%3D44%26spage%3D1921%26epage%3D1925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sofia, M. J.; Du, J.; Wang, P.; Nagarathnam, D.</span><span> </span><span class="NLM_article-title">Nucleoside Phosphoramidate Prodrugs</span>. WO2008121634,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=M.+J.+Sofia&author=J.+&author=P.+&author=D.+&title=Nucleoside+Phosphoramidate+Prodrugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSofia%26aufirst%3DM.%2BJ.%26atitle%3DNucleoside%2520Phosphoramidate%2520Prodrugs%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Migliaccio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomassini, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhat, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartholomew, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosserman, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceccacci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colwell, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortese, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eldrup, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Getty, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFemina, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludmerer, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacCoss, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMasters, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flores, O. A.</span><span> </span><span class="NLM_article-title">Characterization of Resistance to Non-Obligate Chain-Terminating Ribonucleoside Analogs That Inhibit Hepatitis C Virus Replication in Vitro</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">49164</span><span class="NLM_x">–</span> <span class="NLM_lpage">49170</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm100863x&amp;key=10.1074%2Fjbc.M305041200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm100863x&amp;key=12966103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm100863x&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptlGrsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=49164-49170&author=G.+Migliaccioauthor=J.+E.+Tomassiniauthor=S.+S.+Carrollauthor=L.+Tomeiauthor=S.+Altamuraauthor=B.+Bhatauthor=L.+Bartholomewauthor=M.+R.+Gossermanauthor=A.+Ceccacciauthor=L.+F.+Colwellauthor=R.+Corteseauthor=A.+B.+Eldrupauthor=K.+L.+Gettyauthor=X.+S.+Houauthor=R.+L.+LaFeminaauthor=S.+W.+Ludmererauthor=M.+MacCossauthor=D.+R.+McMastersauthor=M.+W.+Stahlhutauthor=D.+B.+Olsenauthor=D.+J.+Hazudaauthor=O.+A.+Flores&title=Characterization+of+Resistance+to+Non-Obligate+Chain-Terminating+Ribonucleoside+Analogs+That+Inhibit+Hepatitis+C+Virus+Replication+in+Vitro"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of Resistance to Non-obligate Chain-terminating Ribonucleoside Analogs That Inhibit Hepatitis C Virus Replication in Vitro</span></div><div class="casAuthors">Migliaccio, Giovanni; Tomassini, Joanne E.; Carroll, Steven S.; Tomei, Licia; Altamura, Sergio; Bhat, Balkrishen; Bartholomew, Linda; Bosserman, Michele R.; Ceccacci, Alessandra; Colwell, Lawrence F.; Cortese, Riccardo; De Francesco, Raffaele; Eldrup, Anne B.; Getty, Krista L.; Hou, Xiaoli S.; LaFemina, Robert L.; Ludmerer, Steven W.; MacCoss, Malcolm; McMasters, Daniel R.; Stahlhut, Mark W.; Olsen, David B.; Hazuda, Daria J.; Flores, Osvaldo A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">49164-49170</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The urgent need for efficacious drugs to treat chronic hepatitis C virus (HCV) infection requires a concerted effort to develop inhibitors specific for virally encoded enzymes.  We demonstrate that 2'-C-Me ribonucleosides are efficient chain-terminating inhibitors of HCV genome replication.  Characterization of drug-resistant HCV replicons defined a single S282T mutation within the active site of the viral polymerase that conferred loss of sensitivity to structurally related compds. in both replicon and isolated polymerase assays.  Biochem. analyses demonstrated that resistance at the level of the enzyme results from a combination of reduced affinity of the mutant polymerase for the drug and an increased ability to extend the incorporated nucleoside analog.  Importantly, the combination of these agents with interferon-α results in synergistic inhibition of HCV genome replication in cell culture.  Furthermore, 2'-C-methyl-substituted ribonucleosides also inhibited replication of genetically related viruses such as bovine diarrhea virus, yellow fever, and West African Nile viruses.  These observations, together with the finding that 2'-C-methyl-guanosine in particular has a favorable pharmacol. profile, suggest that this class of compds. may have broad utility in the treatment of HCV and other flavivirus infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7Zeuc5zFmbbVg90H21EOLACvtfcHk0lgrVQ6MjtyQbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptlGrsL4%253D&md5=a7183ce208fe008e48c7a1a83ef66e85</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M305041200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M305041200%26sid%3Dliteratum%253Aachs%26aulast%3DMigliaccio%26aufirst%3DG.%26aulast%3DTomassini%26aufirst%3DJ.%2BE.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DTomei%26aufirst%3DL.%26aulast%3DAltamura%26aufirst%3DS.%26aulast%3DBhat%26aufirst%3DB.%26aulast%3DBartholomew%26aufirst%3DL.%26aulast%3DGosserman%26aufirst%3DM.%2BR.%26aulast%3DCeccacci%26aufirst%3DA.%26aulast%3DColwell%26aufirst%3DL.%2BF.%26aulast%3DCortese%26aufirst%3DR.%26aulast%3DEldrup%26aufirst%3DA.%2BB.%26aulast%3DGetty%26aufirst%3DK.%2BL.%26aulast%3DHou%26aufirst%3DX.%2BS.%26aulast%3DLaFemina%26aufirst%3DR.%2BL.%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26aulast%3DMacCoss%26aufirst%3DM.%26aulast%3DMcMasters%26aufirst%3DD.%2BR.%26aulast%3DStahlhut%26aufirst%3DM.%2BW.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DFlores%26aufirst%3DO.%2BA.%26atitle%3DCharacterization%2520of%2520Resistance%2520to%2520Non-Obligate%2520Chain-Terminating%2520Ribonucleoside%2520Analogs%2520That%2520Inhibit%2520Hepatitis%2520C%2520Virus%2520Replication%2520in%2520Vitro%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D49164%26epage%3D49170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Le Pagam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, W.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leveque, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajyaguru, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klumpp, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symons, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammack, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Najera, I.</span><span> </span><span class="NLM_article-title">In Vitro Selected Con1 Subgenomic Replicons Resistant to 2′-<i>C</i>-Methyl-cytidine or to R1479 Show Lack of Cross Resistance</span> <span class="citation_source-journal">Virology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">351</span><span class="NLM_x">, </span> <span class="NLM_fpage">349</span><span class="NLM_x">–</span> <span class="NLM_lpage">359</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=2006&pages=349-359&author=S.+Le+Pagamauthor=W.-R.+Jiangauthor=V.+Levequeauthor=S.+Rajyaguruauthor=H.+Maauthor=H.+Kangauthor=S.+Jiangauthor=M.+Singerauthor=S.+Aliauthor=K.+Klumppauthor=D.+Smithauthor=J.+Symonsauthor=N.+Cammackauthor=I.+Najera&title=In+Vitro+Selected+Con1+Subgenomic+Replicons+Resistant+to+2%E2%80%B2-C-Methyl-cytidine+or+to+R1479+Show+Lack+of+Cross+Resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BPagam%26aufirst%3DS.%26aulast%3DJiang%26aufirst%3DW.-R.%26aulast%3DLeveque%26aufirst%3DV.%26aulast%3DRajyaguru%26aufirst%3DS.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DKang%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DSinger%26aufirst%3DM.%26aulast%3DAli%26aufirst%3DS.%26aulast%3DKlumpp%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DSymons%26aufirst%3DJ.%26aulast%3DCammack%26aufirst%3DN.%26aulast%3DNajera%26aufirst%3DI.%26atitle%3DIn%2520Vitro%2520Selected%2520Con1%2520Subgenomic%2520Replicons%2520Resistant%2520to%25202%25E2%2580%25B2-C-Methyl-cytidine%2520or%2520to%2520R1479%2520Show%2520Lack%2520of%2520Cross%2520Resistance%26jtitle%3DVirology%26date%3D2006%26volume%3D351%26spage%3D349%26epage%3D359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Ali, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leveque, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pogam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philipp, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inocencio, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Najera, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klumpp, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symons, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammack, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, W. R.</span><span> </span><span class="NLM_article-title">Selected Replicon Variants with Low-Level in Vitro Resistance to the Hepatitis C Virus NS5B Polymerase Inhibitor PSI-6130 Lack Cross-Resistance with R1479</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4356</span><span class="NLM_x">–</span> <span class="NLM_lpage">4369</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=4356-4369&author=S.+Aliauthor=V.+Levequeauthor=S.+Le+Pogamauthor=+Ma.author=F.+Philippauthor=N.+Inocencioauthor=M.+Smithauthor=A.+Alkerauthor=H.+Kangauthor=I.+Najeraauthor=K.+Klumppauthor=J.+Symonsauthor=N.+Cammackauthor=W.+R.+Jiang&title=Selected+Replicon+Variants+with+Low-Level+in+Vitro+Resistance+to+the+Hepatitis+C+Virus+NS5B+Polymerase+Inhibitor+PSI-6130+Lack+Cross-Resistance+with+R1479"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAli%26aufirst%3DS.%26aulast%3DLeveque%26aufirst%3DV.%26aulast%3DLe%2BPogam%26aufirst%3DS.%26aulast%3DMa.%26aulast%3DPhilipp%26aufirst%3DF.%26aulast%3DInocencio%26aufirst%3DN.%26aulast%3DSmith%26aufirst%3DM.%26aulast%3DAlker%26aufirst%3DA.%26aulast%3DKang%26aufirst%3DH.%26aulast%3DNajera%26aufirst%3DI.%26aulast%3DKlumpp%26aufirst%3DK.%26aulast%3DSymons%26aufirst%3DJ.%26aulast%3DCammack%26aufirst%3DN.%26aulast%3DJiang%26aufirst%3DW.%2BR.%26atitle%3DSelected%2520Replicon%2520Variants%2520with%2520Low-Level%2520in%2520Vitro%2520Resistance%2520to%2520the%2520Hepatitis%2520C%2520Virus%2520NS5B%2520Polymerase%2520Inhibitor%2520PSI-6130%2520Lack%2520Cross-Resistance%2520with%2520R1479%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D4356%26epage%3D4369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Altomare, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burla, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camalli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cascarano, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giacovazzo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guagliardi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moliterni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polidori, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spagna, R.</span><span> </span><span class="NLM_article-title">SIR97: A New Tool for Crystal Structure Determination and Refinement</span> <span class="citation_source-journal">J. Appl. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">115</span><span class="NLM_x">–</span> <span class="NLM_lpage">116</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm100863x&amp;key=10.1107%2FS0021889898007717" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm100863x&amp;key=1%3ACAS%3A528%3ADyaK1MXhsFOrsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1999&pages=115-116&author=A.+Altomareauthor=M.+Burlaauthor=G.+Camalliauthor=G.+Cascaranoauthor=C.+Giacovazzoauthor=A.+Guagliardiauthor=A.+Moliterniauthor=G.+Polidoriauthor=R.+Spagna&title=SIR97%3A+A+New+Tool+for+Crystal+Structure+Determination+and+Refinement"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">SIR97: a new tool for crystal structure determination and refinement</span></div><div class="casAuthors">Altomare, Angela; Burla, Maria Cristina; Camalli, Mercedes; Cascarano, Giovanni Luca; Giacovazzo, Carmelo; Guagliardi, Antonietra; Moliterni, Anna Grazia Giuseppina; Polidori, Giampiero; Spagna, Riccardo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">115-119</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard International Publishers Ltd.</span>)
        </div><div class="casAbstract">SIR97 is the integration of two programs, SIR92 and CAOS, the 1st devoted to the soln. of crystal structures by direct methods, the 2nd to refinement via least-squares-Fourier procedures.  Several new features were introduced in SIR97 with respect to the previous version, SIR92: greater automatization, increased efficiency of the direct methods section, and a powerful graphics interface.  The program also provides publication tables and CIF files.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooMiXqY8IckrVg90H21EOLACvtfcHk0lgrVQ6MjtyQbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhsFOrsbo%253D&md5=45ee00c9eedb9f7c188ec112dc45546e</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1107%2FS0021889898007717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889898007717%26sid%3Dliteratum%253Aachs%26aulast%3DAltomare%26aufirst%3DA.%26aulast%3DBurla%26aufirst%3DM.%26aulast%3DCamalli%26aufirst%3DG.%26aulast%3DCascarano%26aufirst%3DG.%26aulast%3DGiacovazzo%26aufirst%3DC.%26aulast%3DGuagliardi%26aufirst%3DA.%26aulast%3DMoliterni%26aufirst%3DA.%26aulast%3DPolidori%26aufirst%3DG.%26aulast%3DSpagna%26aufirst%3DR.%26atitle%3DSIR97%253A%2520A%2520New%2520Tool%2520for%2520Crystal%2520Structure%2520Determination%2520and%2520Refinement%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D1999%26volume%3D32%26spage%3D115%26epage%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Sheldrick, G. M.</span><span> </span><span class="NLM_article-title">A Short History of SHELX</span> <span class="citation_source-journal">Acta Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">A64</span><span class="NLM_x">, </span> <span class="NLM_fpage">112</span><span class="NLM_x">–</span> <span class="NLM_lpage">122</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm100863x&amp;key=10.1107%2FS0108767307043930" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm100863x&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVGhurzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=A64&publication_year=2008&pages=112-122&author=G.+M.+Sheldrick&title=A+Short+History+of+SHELX"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">A short history of SHELX</span></div><div class="casAuthors">Sheldrick, George M.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section A: Foundations of Crystallography</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">112-122</span>CODEN:
                <span class="NLM_cas:coden">ACACEQ</span>;
        ISSN:<span class="NLM_cas:issn">0108-7673</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">An account is given of the development of the SHELX system of computer programs from SHELX-76 to the present day.  In addn. to identifying useful innovations that have come into general use through their implementation in SHELX, a crit. anal. is presented of the less-successful features, missed opportunities and desirable improvements for future releases of the software.  An attempt is made to understand how a program originally designed for photog. intensity data, punched cards and computers over 10000 times slower than an av. modern personal computer has managed to survive for so long.  SHELXL is the most widely used program for small-mol. refinement and SHELXS and SHELXD are often employed for structure soln. despite the availability of objectively superior programs.  SHELXL also finds a niche for the refinement of macromols. against high-resoln. or twinned data; SHELXPRO acts as an interface for macromol. applications.  SHELXC, SHELXD and SHELXE are proving useful for the exptl. phasing of macromols., esp. because they are fast and robust and so are often employed in pipelines for high-throughput phasing.  This paper could serve as a general literature citation when one or more of the open-source SHELX programs (and the Bruker AXS version SHELXTL) are employed in the course of a crystal-structure detn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfLPYyJyJ2RbVg90H21EOLACvtfcHk0lgrHuAZif3JTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVGhurzO&md5=8f91f10be4a9df74b2a9dad522c71e6e</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1107%2FS0108767307043930&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0108767307043930%26sid%3Dliteratum%253Aachs%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26atitle%3DA%2520Short%2520History%2520of%2520SHELX%26jtitle%3DActa%2520Crystallogr.%26date%3D2008%26volume%3DA64%26spage%3D112%26epage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group">Stuyver, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lostia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathew, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pai, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tharnish, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otto, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schinazi, R. F.</span><span> </span><span class="NLM_article-title">Antiviral Activities and Cellular Toxicities of Modified 2′,3′-Dideoxy-2′,3′-didehydrocytidine Analogues</span> <span class="citation_source-journal">Antimicrob Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3854</span><span class="NLM_x">–</span> <span class="NLM_lpage">3860</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2002&pages=3854-3860&author=L.+J.+Stuyverauthor=S.+Lostiaauthor=M.+Adamsauthor=J.+S.+Mathewauthor=B.+S.+Paiauthor=J.+Grierauthor=P.+M.+Tharnishauthor=Y.+Choiauthor=Y.+Chongauthor=H.+Chooauthor=C.+K.+Chuauthor=M.+J.+Ottoauthor=R.+F.+Schinazi&title=Antiviral+Activities+and+Cellular+Toxicities+of+Modified+2%E2%80%B2%2C3%E2%80%B2-Dideoxy-2%E2%80%B2%2C3%E2%80%B2-didehydrocytidine+Analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStuyver%26aufirst%3DL.%2BJ.%26aulast%3DLostia%26aufirst%3DS.%26aulast%3DAdams%26aufirst%3DM.%26aulast%3DMathew%26aufirst%3DJ.%2BS.%26aulast%3DPai%26aufirst%3DB.%2BS.%26aulast%3DGrier%26aufirst%3DJ.%26aulast%3DTharnish%26aufirst%3DP.%2BM.%26aulast%3DChoi%26aufirst%3DY.%26aulast%3DChong%26aufirst%3DY.%26aulast%3DChoo%26aufirst%3DH.%26aulast%3DChu%26aufirst%3DC.%2BK.%26aulast%3DOtto%26aufirst%3DM.%2BJ.%26aulast%3DSchinazi%26aufirst%3DR.%2BF.%26atitle%3DAntiviral%2520Activities%2520and%2520Cellular%2520Toxicities%2520of%2520Modified%25202%25E2%2580%25B2%252C3%25E2%2580%25B2-Dideoxy-2%25E2%2580%25B2%252C3%25E2%2580%25B2-didehydrocytidine%2520Analogues%26jtitle%3DAntimicrob%2520Agents%2520Chemother.%26date%3D2002%26volume%3D46%26spage%3D3854%26epage%3D3860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['ref1_1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref100':['cit100']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 414 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Yong-Jin Wu, <span class="NLM_string-name hlFld-ContribAuthor">Nicholas A. Meanwell</span>. </span><span class="cited-content_cbyCitation_article-title">Geminal Diheteroatomic Motifs: Some Applications of Acetals, Ketals, and Their Sulfur and Nitrogen Homologues in Medicinal Chemistry and Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (14)
                                     , 9786-9874. <a href="https://doi.org/10.1021/acs.jmedchem.1c00790" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00790</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00790&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00790%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DGeminal%252BDiheteroatomic%252BMotifs%25253A%252BSome%252BApplications%252Bof%252BAcetals%25252C%252BKetals%25252C%252Band%252BTheir%252BSulfur%252Band%252BNitrogen%252BHomologues%252Bin%252BMedicinal%252BChemistry%252Band%252BDrug%252BDesign%26aulast%3DWu%26aufirst%3DYong-Jin%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D30042021%26date%3D02072021%26volume%3D64%26issue%3D14%26spage%3D9786%26epage%3D9874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Magdalena Slusarczyk, Michaela Serpi, Essam Ghazaly, Benson M. Kariuki, Christopher McGuigan, <span class="NLM_string-name hlFld-ContribAuthor">Chris Pepper</span>. </span><span class="cited-content_cbyCitation_article-title">Single Diastereomers of the Clinical Anticancer ProTide Agents NUC-1031 and NUC-3373 Preferentially Target Cancer Stem Cells In Vitro. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (12)
                                     , 8179-8193. <a href="https://doi.org/10.1021/acs.jmedchem.0c02194" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02194</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02194%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSingle%252BDiastereomers%252Bof%252Bthe%252BClinical%252BAnticancer%252BProTide%252BAgents%252BNUC-1031%252Band%252BNUC-3373%252BPreferentially%252BTarget%252BCancer%252BStem%252BCells%252BIn%252BVitro%26aulast%3DSlusarczyk%26aufirst%3DMagdalena%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D19122020%26date%3D04062021%26volume%3D64%26issue%3D12%26spage%3D8179%26epage%3D8193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Markéta Pimková Polidarová, Petra Břehová, Martin Maxmilian Kaiser, Miroslav Smola, Martin Dračínský, Joshua Smith, Aleš Marek, Milan Dejmek, Michal Šála, Ondrej Gutten, Lubomír Rulíšek, Barbora Novotná, Andrea Brázdová, Zlatko Janeba, Radim Nencka, Evzen Boura, Ondřej Páv, <span class="NLM_string-name hlFld-ContribAuthor">Gabriel Birkuš</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of Phosphoester and Phosphorothioate Prodrugs of STING Agonist 3′,3′-c-Di(2′F,2′dAMP). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (11)
                                     , 7596-7616. <a href="https://doi.org/10.1021/acs.jmedchem.1c00301" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00301</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00301&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00301%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BPhosphoester%252Band%252BPhosphorothioate%252BProdrugs%252Bof%252BSTING%252BAgonist%252B3%2525E2%252580%2525B2%25252C3%2525E2%252580%2525B2-c-Di%2525282%2525E2%252580%2525B2F%25252C2%2525E2%252580%2525B2dAMP%252529%26aulast%3DPimkov%25C3%25A1%2BPolidarov%25C3%25A1%26aufirst%3DMark%25C3%25A9ta%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D16022021%26date%3D21052021%26volume%3D64%26issue%3D11%26spage%3D7596%26epage%3D7616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Andrea Ambrosi, Dustin A. Bringley, Selcuk Calimsiz, Jeffrey A. O. Garber, Huy Huynh, Sankar Mohan, Keshab Sarma, Jinyu Shen, Jonah Curl, Bernard Kwong, Olga Lapina, Edmund Leung, Lennie Lin, Andrew Martins, Teague McGinitie, Jaspal Phull, Ben Roberts, Mary Rosario, Bing Shi, Eric A. Standley, Li Wang, Xueqing Wang, <span class="NLM_string-name hlFld-ContribAuthor">Guojun Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Rovafovir Etalafenamide (Part III): Evolution of the Synthetic Process to the Phosphonamidate Fragment. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2021,</strong> <em>25 </em>
                                    (5)
                                     , 1247-1262. <a href="https://doi.org/10.1021/acs.oprd.0c00428" title="DOI URL">https://doi.org/10.1021/acs.oprd.0c00428</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.0c00428&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.0c00428%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DSynthesis%252Bof%252BRovafovir%252BEtalafenamide%252B%252528Part%252BIII%252529%25253A%252BEvolution%252Bof%252Bthe%252BSynthetic%252BProcess%252Bto%252Bthe%252BPhosphonamidate%252BFragment%26aulast%3DAmbrosi%26aufirst%3DAndrea%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D25092020%26date%3D05052021%26volume%3D25%26issue%3D5%26spage%3D1247%26epage%3D1262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Carolyn E. Suh, Hayden M. Carder, <span class="NLM_string-name hlFld-ContribAuthor">Alison E. Wendlandt</span>. </span><span class="cited-content_cbyCitation_article-title">Selective Transformations of Carbohydrates Inspired by Radical-Based Enzymatic Mechanisms. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2021</strong>, Article ASAP.</span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.1c00190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.1c00190%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DSelective%252BTransformations%252Bof%252BCarbohydrates%252BInspired%252Bby%252BRadical-Based%252BEnzymatic%252BMechanisms%26aulast%3DSuh%26aufirst%3DCarolyn%2BE.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D15032021%26date%3D03052021%26volume%3D0%26issue%3D0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Richard L. Mackman, Hon C. Hui, Michel Perron, Eisuke Murakami, Christopher Palmiotti, Gary Lee, Kirsten Stray, Lijun Zhang, Bindu Goyal, Kwon Chun, Daniel Byun, Dustin Siegel, Scott Simonovich, Venice Du Pont, Jared Pitts, Darius Babusis, Arya Vijjapurapu, Xianghan Lu, Cynthia Kim, Xiaofeng Zhao, Julie Chan, Bin Ma, Diane Lye, Adelle Vandersteen, Sarah Wortman, Kimberly T. Barrett, Maria Toteva, Robert Jordan, Raju Subramanian, John P. Bilello, <span class="NLM_string-name hlFld-ContribAuthor">Tomas Cihlar</span>. </span><span class="cited-content_cbyCitation_article-title">Prodrugs of a 1′-CN-4-Aza-7,9-dideazaadenosine C-Nucleoside Leading to the Discovery of Remdesivir (GS-5734) as a Potent Inhibitor of Respiratory Syncytial Virus with Efficacy in the African Green Monkey Model of RSV. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (8)
                                     , 5001-5017. <a href="https://doi.org/10.1021/acs.jmedchem.1c00071" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00071</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00071%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DProdrugs%252Bof%252Ba%252B1%2525E2%252580%2525B2-CN-4-Aza-7%25252C9-dideazaadenosine%252BC-Nucleoside%252BLeading%252Bto%252Bthe%252BDiscovery%252Bof%252BRemdesivir%252B%252528GS-5734%252529%252Bas%252Ba%252BPotent%252BInhibitor%252Bof%252BRespiratory%252BSyncytial%252BVirus%252Bwith%252BEfficacy%252Bin%252Bthe%252BAfrican%252BGreen%252BMonkey%252BModel%252Bof%252BRSV%26aulast%3DMackman%26aufirst%3DRichard%2BL.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D15012021%26date%3D09042021%26volume%3D64%26issue%3D8%26spage%3D5001%26epage%3D5017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jiapeng Li, Shuhan Liu, Jian Shi, Xinwen Wang, Yanling Xue, <span class="NLM_string-name hlFld-ContribAuthor">Hao-Jie Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Tissue-Specific Proteomics Analysis of Anti-COVID-19 Nucleoside and Nucleotide Prodrug-Activating Enzymes Provides Insights into the Optimization of Prodrug Design and Pharmacotherapy Strategy. </span><span class="cited-content_cbyCitation_journal-name">ACS Pharmacology & Translational Science</span><span> <strong>2021,</strong> <em>4 </em>
                                    (2)
                                     , 870-887. <a href="https://doi.org/10.1021/acsptsci.1c00016" title="DOI URL">https://doi.org/10.1021/acsptsci.1c00016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsptsci.1c00016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsptsci.1c00016%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Pharmacology%2520%2526%2520Translational%2520Science%26atitle%3DTissue-Specific%252BProteomics%252BAnalysis%252Bof%252BAnti-COVID-19%252BNucleoside%252Band%252BNucleotide%252BProdrug-Activating%252BEnzymes%252BProvides%252BInsights%252Binto%252Bthe%252BOptimization%252Bof%252BProdrug%252BDesign%252Band%252BPharmacotherapy%252BStrategy%26aulast%3DLi%26aufirst%3DJiapeng%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D08012021%26date%3D01042021%26volume%3D4%26issue%3D2%26spage%3D870%26epage%3D887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ashley N. Matthew, Florian Leidner, Gordon J. Lockbaum, Mina Henes, Jacqueto Zephyr, Shurong Hou, Desaboini Nageswara Rao, Jennifer Timm, Linah N. Rusere, Debra A. Ragland, Janet L. Paulsen, Kristina Prachanronarong, Djade I. Soumana, Ellen A. Nalivaika, Nese Kurt Yilmaz, Akbar Ali, <span class="NLM_string-name hlFld-ContribAuthor">Celia A. Schiffer</span>. </span><span class="cited-content_cbyCitation_article-title">Drug Design Strategies to Avoid Resistance in Direct-Acting Antivirals and Beyond. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2021,</strong> <em>121 </em>
                                    (6)
                                     , 3238-3270. <a href="https://doi.org/10.1021/acs.chemrev.0c00648" title="DOI URL">https://doi.org/10.1021/acs.chemrev.0c00648</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.0c00648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.0c00648%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DDrug%252BDesign%252BStrategies%252Bto%252BAvoid%252BResistance%252Bin%252BDirect-Acting%252BAntivirals%252Band%252BBeyond%26aulast%3DMatthew%26aufirst%3DAshley%2BN.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D22062020%26date%3D07012021%26volume%3D121%26issue%3D6%26spage%3D3238%26epage%3D3270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Nemanja Milisavljevic, Eva Konkolová, Jaroslav Kozák, Jan Hodek, Lucia Veselovská, Veronika Sýkorová, Karel Čížek, Radek Pohl, Luděk Eyer, Pavel Svoboda, Daniel Růžek, Jan Weber, Radim Nencka, Evžen Bouřa, <span class="NLM_string-name hlFld-ContribAuthor">Michal Hocek</span>. </span><span class="cited-content_cbyCitation_article-title">Antiviral Activity of 7-Substituted 7-Deazapurine Ribonucleosides, Monophosphate Prodrugs, and Triphoshates against Emerging RNA Viruses. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2021,</strong> <em>7 </em>
                                    (2)
                                     , 471-478. <a href="https://doi.org/10.1021/acsinfecdis.0c00829" title="DOI URL">https://doi.org/10.1021/acsinfecdis.0c00829</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.0c00829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.0c00829%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DAntiviral%252BActivity%252Bof%252B7-Substituted%252B7-Deazapurine%252BRibonucleosides%25252C%252BMonophosphate%252BProdrugs%25252C%252Band%252BTriphoshates%252Bagainst%252BEmerging%252BRNA%252BViruses%26aulast%3DMilisavljevic%26aufirst%3DNemanja%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D25112020%26date%3D04012021%26volume%3D7%26issue%3D2%26spage%3D471%26epage%3D478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor "> Sara S.    Rocks    </span><span class="hlFld-ContribAuthor "> Robert A.    Stockland    ,    Jr. </span>. </span><span class="cited-content_cbyCitation_article-title">Heteronuclear NMR Spectroscopy in the Undergraduate Curriculum: Direct and Indirect Effects. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 191-208. <a href="https://doi.org/10.1021/bk-2021-1376.ch013" title="DOI URL">https://doi.org/10.1021/bk-2021-1376.ch013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/bk-2021-1376.ch013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fbk-2021-1376.ch013%26sid%3Dliteratum%253Aachs%26atitle%3DHeteronuclear%252BNMR%252BSpectroscopy%252Bin%252Bthe%252BUndergraduate%252BCurriculum%25253A%252BDirect%252Band%252BIndirect%252BEffects%26aulast%3DRocks%26aufirst%3DSara%2BS.%26date%3D2021%26date%3D2021%26spage%3D191%26epage%3D208%26atitle%3DNMR%252BSpectroscopy%252Bin%252Bthe%252BUndergraduate%252BCurriculum%25252C%252BVolume%252B4%25253A%252BIn-Person%252Band%252BDistance%252BLearning%252BApproaches%26aulast%3DSoulsby%26aufirst%3DDavid%26date%3D2021%26date%3D2021%26volume%3D1376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Tanaji T. Talele</span>. </span><span class="cited-content_cbyCitation_article-title">Opportunities for Tapping into Three-Dimensional Chemical Space through a Quaternary Carbon. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (22)
                                     , 13291-13315. <a href="https://doi.org/10.1021/acs.jmedchem.0c00829" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00829</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00829%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOpportunities%252Bfor%252BTapping%252Binto%252BThree-Dimensional%252BChemical%252BSpace%252Bthrough%252Ba%252BQuaternary%252BCarbon%26aulast%3DTalele%26aufirst%3DTanaji%2BT.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D15052020%26date%3D31082020%26date%3D17082020%26volume%3D63%26issue%3D22%26spage%3D13291%26epage%3D13315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Nicholas A. Meanwell, Gunda I. Georg, <span class="NLM_string-name hlFld-ContribAuthor">Shaomeng Wang</span>. </span><span class="cited-content_cbyCitation_article-title">The 2020 Nobel Prize in Physiology or Medicine. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (22)
                                     , 13197-13204. <a href="https://doi.org/10.1021/acs.jmedchem.0c01877" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01877</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01877&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01877%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252B2020%252BNobel%252BPrize%252Bin%252BPhysiology%252Bor%252BMedicine%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2020%26date%3D2020%26date%3D05112020%26volume%3D63%26issue%3D22%26spage%3D13197%26epage%3D13204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Marwa O. Mikati, Justin J. Miller, Damon M. Osbourn, Yasaman Barekatain, Naomi Ghebremichael, Ishaan T. Shah, Carey-Ann D. Burnham, Kenneth M. Heidel, Victoria C. Yan, Florian L. Muller, Cynthia S. Dowd, Rachel L. Edwards, <span class="NLM_string-name hlFld-ContribAuthor">Audrey R. Odom John</span>. </span><span class="cited-content_cbyCitation_article-title">Antimicrobial Prodrug Activation by the Staphylococcal Glyoxalase GloB. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2020,</strong> <em>6 </em>
                                    (11)
                                     , 3064-3075. <a href="https://doi.org/10.1021/acsinfecdis.0c00582" title="DOI URL">https://doi.org/10.1021/acsinfecdis.0c00582</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.0c00582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.0c00582%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DAntimicrobial%252BProdrug%252BActivation%252Bby%252Bthe%252BStaphylococcal%252BGlyoxalase%252BGloB%26aulast%3DMikati%26aufirst%3DMarwa%2BO.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D14082020%26date%3D29102020%26volume%3D6%26issue%3D11%26spage%3D3064%26epage%3D3075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Guangyi Wang, Natalia Dyatkina, Marija Prhavc, Caroline Williams, Vladimir Serebryany, Yujian Hu, Yongfei Huang, Xiangyang Wu, Tongqian Chen, Wensheng Huang, Vivek K. Rajwanshi, Jerome Deval, Amy Fung, Zhinan Jin, Antitsa Stoycheva, Kenneth Shaw, Kusum Gupta, Yuen Tam, Andreas Jekle, David B. Smith, <span class="NLM_string-name hlFld-ContribAuthor">Leonid Beigelman</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Anti-HCV Activity of Sugar-Modified Guanosine Analogues: Discovery of AL-611 as an HCV NS5B Polymerase Inhibitor for the Treatment of Chronic Hepatitis C. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (18)
                                     , 10380-10395. <a href="https://doi.org/10.1021/acs.jmedchem.0c00935" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00935</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00935%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BAnti-HCV%252BActivity%252Bof%252BSugar-Modified%252BGuanosine%252BAnalogues%25253A%252BDiscovery%252Bof%252BAL-611%252Bas%252Ban%252BHCV%252BNS5B%252BPolymerase%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BChronic%252BHepatitis%252BC%26aulast%3DWang%26aufirst%3DGuangyi%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D01062020%26date%3D03092020%26date%3D20082020%26volume%3D63%26issue%3D18%26spage%3D10380%26epage%3D10395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Daniel M. C. Schwarz, Sarah K. Williams, Maxwell Dillenburg, Carston R. Wagner, <span class="NLM_string-name hlFld-ContribAuthor">Jason E. Gestwicki</span>. </span><span class="cited-content_cbyCitation_article-title">A Phosphoramidate Strategy Enables Membrane Permeability of a Non-nucleotide Inhibitor of the Prolyl Isomerase Pin1. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (9)
                                     , 1704-1710. <a href="https://doi.org/10.1021/acsmedchemlett.0c00170" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00170</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00170%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DA%252BPhosphoramidate%252BStrategy%252BEnables%252BMembrane%252BPermeability%252Bof%252Ba%252BNon-nucleotide%252BInhibitor%252Bof%252Bthe%252BProlyl%252BIsomerase%252BPin1%26aulast%3DSchwarz%26aufirst%3DDaniel%2BM.%2BC.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D05042020%26date%3D30072020%26date%3D10082020%26volume%3D11%26issue%3D9%26spage%3D1704%26epage%3D1710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Andrew J. Wiemer</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolic Efficacy of Phosphate Prodrugs and the Remdesivir Paradigm. </span><span class="cited-content_cbyCitation_journal-name">ACS Pharmacology & Translational Science</span><span> <strong>2020,</strong> <em>3 </em>
                                    (4)
                                     , 613-626. <a href="https://doi.org/10.1021/acsptsci.0c00076" title="DOI URL">https://doi.org/10.1021/acsptsci.0c00076</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsptsci.0c00076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsptsci.0c00076%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Pharmacology%2520%2526%2520Translational%2520Science%26atitle%3DMetabolic%252BEfficacy%252Bof%252BPhosphate%252BProdrugs%252Band%252Bthe%252BRemdesivir%252BParadigm%26aulast%3DWiemer%26aufirst%3DAndrew%2BJ.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D29062020%26date%3D05082020%26date%3D24072020%26volume%3D3%26issue%3D4%26spage%3D613%26epage%3D626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yanan Wu, Ken Chen, Xia Ge, Panpan Ma, Zhiyuan Xu, Hongjian Lu, <span class="NLM_string-name hlFld-ContribAuthor">Guigen Li</span>. </span><span class="cited-content_cbyCitation_article-title">Redox-Neutral P(O)–N Coupling between P(O)–H Compounds and Azides via Dual Copper and Photoredox Catalysis. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (15)
                                     , 6143-6149. <a href="https://doi.org/10.1021/acs.orglett.0c02207" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c02207</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c02207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c02207%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DRedox-Neutral%252BP%252528O%252529%2525E2%252580%252593N%252BCoupling%252Bbetween%252BP%252528O%252529%2525E2%252580%252593H%252BCompounds%252Band%252BAzides%252Bvia%252BDual%252BCopper%252Band%252BPhotoredox%252BCatalysis%26aulast%3DWu%26aufirst%3DYanan%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D03072020%26date%3D10072020%26volume%3D22%26issue%3D15%26spage%3D6143%26epage%3D6149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xinbei Jiang, Jiali Tan, Yixuan Wang, Jinhua Chen, Jianrui Li, Zhi Jiang, Yanni Quan, Jie Jin, Yuhuan Li, Shan Cen, Yanping Li, Zonggen Peng, <span class="NLM_string-name hlFld-ContribAuthor">Zhuorong Li</span>. </span><span class="cited-content_cbyCitation_article-title">2-((4-Arylpiperazin-1-yl)methyl)benzonitrile Derivatives as Orally Available Inhibitors of Hepatitis C Virus with a Novel Mechanism of Action. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (11)
                                     , 5972-5989. <a href="https://doi.org/10.1021/acs.jmedchem.0c00232" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00232</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00232%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D2-%252528%2525284-Arylpiperazin-1-yl%252529methyl%252529benzonitrile%252BDerivatives%252Bas%252BOrally%252BAvailable%252BInhibitors%252Bof%252BHepatitis%252BC%252BVirus%252Bwith%252Ba%252BNovel%252BMechanism%252Bof%252BAction%26aulast%3DJiang%26aufirst%3DXinbei%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D09022020%26date%3D20052020%26date%3D07052020%26volume%3D63%26issue%3D11%26spage%3D5972%26epage%3D5989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hyejin Lee, Dnyandev B. Jarhad, Jinha Yu, Choongho Lee, <span class="NLM_string-name hlFld-ContribAuthor">Lak Shin Jeong</span>. </span><span class="cited-content_cbyCitation_article-title">Asymmetric Synthesis of 2′-C-Methyl-4′-selenonucleosides as Anti-Hepatitis C Virus Agents. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>
                                    (22)
                                     , 14414-14426. <a href="https://doi.org/10.1021/acs.joc.9b01462" title="DOI URL">https://doi.org/10.1021/acs.joc.9b01462</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b01462&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b01462%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DAsymmetric%252BSynthesis%252Bof%252B2%2525E2%252580%2525B2-C-Methyl-4%2525E2%252580%2525B2-selenonucleosides%252Bas%252BAnti-Hepatitis%252BC%252BVirus%252BAgents%26aulast%3DLee%26aufirst%3DHyejin%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D04062019%26date%3D29102019%26date%3D14102019%26volume%3D84%26issue%3D22%26spage%3D14414%26epage%3D14426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Nicholas
A. Lentini, Chia-Hung Christine Hsiao, George B. Crull, Andrew J. Wiemer, <span class="NLM_string-name hlFld-ContribAuthor">David F. Wiemer</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Bioactivity of the Alanyl Phosphonamidate Stereoisomers Derived from a Butyrophilin Ligand. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>10 </em>
                                    (9)
                                     , 1284-1289. <a href="https://doi.org/10.1021/acsmedchemlett.9b00153" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00153</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00153%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252BBioactivity%252Bof%252Bthe%252BAlanyl%252BPhosphonamidate%252BStereoisomers%252BDerived%252Bfrom%252Ba%252BButyrophilin%252BLigand%26aulast%3DLentini%26aufirst%3DNicholas%2BA.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D03042019%26date%3D06082019%26date%3D13082019%26date%3D06082019%26volume%3D10%26issue%3D9%26spage%3D1284%26epage%3D1289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dao Feng Xiang, Andrew N. Bigley, Emily Desormeaux, Tamari Narindoshvili, <span class="NLM_string-name hlFld-ContribAuthor">Frank M. Raushel</span>. </span><span class="cited-content_cbyCitation_article-title">Enzyme-Catalyzed Kinetic Resolution of Chiral Precursors to Antiviral Prodrugs. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry</span><span> <strong>2019,</strong> <em>58 </em>
                                    (29)
                                     , 3204-3211. <a href="https://doi.org/10.1021/acs.biochem.9b00530" title="DOI URL">https://doi.org/10.1021/acs.biochem.9b00530</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.biochem.9b00530&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.biochem.9b00530%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%26atitle%3DEnzyme-Catalyzed%252BKinetic%252BResolution%252Bof%252BChiral%252BPrecursors%252Bto%252BAntiviral%252BProdrugs%26aulast%3DXiang%26aufirst%3DDao%2BFeng%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D19062019%26date%3D03072019%26date%3D10072019%26date%3D03072019%26volume%3D58%26issue%3D29%26spage%3D3204%26epage%3D3211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ji-seong Yoon, Gyudong Kim, Dnyandev B. Jarhad, Hong-Rae Kim, Young-Sup Shin, Shuhao Qu, Pramod K. Sahu, Hea Ok Kim, Hyuk Woo Lee, Su Bin Wang, Yun Jeong Kong, Tong-Shin Chang, Natacha S. Ogando, Kristina Kovacikova, Eric J. Snijder, Clara C. Posthuma, Martijn J. van Hemert, <span class="NLM_string-name hlFld-ContribAuthor">Lak Shin Jeong</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Anti-RNA Virus Activity of 6′-Fluorinated-Aristeromycin Analogues. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (13)
                                     , 6346-6362. <a href="https://doi.org/10.1021/acs.jmedchem.9b00781" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00781</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00781&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00781%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BAnti-RNA%252BVirus%252BActivity%252Bof%252B6%2525E2%252580%2525B2-Fluorinated-Aristeromycin%252BAnalogues%26aulast%3DYoon%26aufirst%3DJi-seong%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D13052019%26date%3D20062019%26date%3D07062019%26volume%3D62%26issue%3D13%26spage%3D6346%26epage%3D6362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Guangyi Wang, Natalia Dyatkina, Marija Prhavc, Caroline Williams, Vladimir Serebryany, Yujian Hu, Yongfei Huang, Jinqiao Wan, Xiangyang Wu, Jerome Deval, Amy Fung, Zhinan Jin, Hua Tan, Kenneth Shaw, Hyunsoon Kang, Qingling Zhang, Yuen Tam, Antitsa Stoycheva, Andreas Jekle, David B. Smith, <span class="NLM_string-name hlFld-ContribAuthor">Leonid Beigelman</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Anti-HCV Activities of 4′-Fluoro-2′-Substituted Uridine Triphosphates and Nucleotide Prodrugs: Discovery of 4′-Fluoro-2′-C-methyluridine 5′-Phosphoramidate Prodrug (AL-335) for the Treatment of Hepatitis C Infection. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (9)
                                     , 4555-4570. <a href="https://doi.org/10.1021/acs.jmedchem.9b00143" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00143</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00143%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BAnti-HCV%252BActivities%252Bof%252B4%2525E2%252580%2525B2-Fluoro-2%2525E2%252580%2525B2-Substituted%252BUridine%252BTriphosphates%252Band%252BNucleotide%252BProdrugs%25253A%252BDiscovery%252Bof%252B4%2525E2%252580%2525B2-Fluoro-2%2525E2%252580%2525B2-C-methyluridine%252B5%2525E2%252580%2525B2-Phosphoramidate%252BProdrug%252B%252528AL-335%252529%252Bfor%252Bthe%252BTreatment%252Bof%252BHepatitis%252BC%252BInfection%26aulast%3DWang%26aufirst%3DGuangyi%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D23012019%26date%3D19042019%26date%3D05042019%26volume%3D62%26issue%3D9%26spage%3D4555%26epage%3D4570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Changxia Yuan, Ke Chen, <span class="NLM_string-name hlFld-ContribAuthor">Martin Eastgate</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 2′-Methyl-6-methoxyguanosine from the Parent Ribonucleoside Guanosine. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>
                                    (8)
                                     , 4646-4652. <a href="https://doi.org/10.1021/acs.joc.8b02194" title="DOI URL">https://doi.org/10.1021/acs.joc.8b02194</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.8b02194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.8b02194%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252B2%2525E2%252580%2525B2-Methyl-6-methoxyguanosine%252Bfrom%252Bthe%252BParent%252BRibonucleoside%252BGuanosine%26aulast%3DYuan%26aufirst%3DChangxia%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D24082018%26date%3D11102018%26date%3D25092018%26volume%3D84%26issue%3D8%26spage%3D4646%26epage%3D4652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kenneth Arrington, Gregg A. Barcan, Nicholas A. Calandra, Greg A. Erickson, Ling Li, Li Liu, Mark G. Nilson, Iulia I. Strambeanu, Kelsey F. VanGelder, John L. Woodard, Shiping Xie, C. Liana Allen, John A. Kowalski, <span class="NLM_string-name hlFld-ContribAuthor">David C. Leitch</span>. </span><span class="cited-content_cbyCitation_article-title">Convergent Synthesis of the NS5B Inhibitor GSK8175 Enabled by Transition Metal Catalysis. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>
                                    (8)
                                     , 4680-4694. <a href="https://doi.org/10.1021/acs.joc.8b02269" title="DOI URL">https://doi.org/10.1021/acs.joc.8b02269</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.8b02269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.8b02269%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DConvergent%252BSynthesis%252Bof%252Bthe%252BNS5B%252BInhibitor%252BGSK8175%252BEnabled%252Bby%252BTransition%252BMetal%252BCatalysis%26aulast%3DArrington%26aufirst%3DKenneth%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D01092018%26date%3D29102018%26date%3D19102018%26volume%3D84%26issue%3D8%26spage%3D4680%26epage%3D4694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Eric A. Voight, Brian S. Brown, Stephen N. Greszler, Geoff T. Halvorsen, Gang Zhao, Albert W. Kruger, John Hartung, Kirill A. Lukin, Steven R. Martinez, Eric G. Moschetta, Michael T. Tudesco, <span class="NLM_string-name hlFld-ContribAuthor">Nathan D. Ide</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of ABBV-168, a 2′-Bromouridine for the Treatment of Hepatitis C. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>
                                    (8)
                                     , 4723-4734. <a href="https://doi.org/10.1021/acs.joc.8b02341" title="DOI URL">https://doi.org/10.1021/acs.joc.8b02341</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.8b02341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.8b02341%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252BABBV-168%25252C%252Ba%252B2%2525E2%252580%2525B2-Bromouridine%252Bfor%252Bthe%252BTreatment%252Bof%252BHepatitis%252BC%26aulast%3DVoight%26aufirst%3DEric%2BA.%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D10092018%26date%3D19112018%26date%3D09112018%26volume%3D84%26issue%3D8%26spage%3D4723%26epage%3D4734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Seema Mengshetti, Longhu Zhou, Ozkan Sari, Coralie De Schutter, Hongwang Zhang, Jong Hyun Cho, Sijia Tao, Leda C. Bassit, Kiran Verma, Robert A. Domaoal, Maryam Ehteshami, Yong Jiang, Reuben Ovadia, Mahesh Kasthuri, Olivia Ollinger Russell, Tamara McBrayer, Tony Whitaker, Judy Pattassery, Maria Luz Pascual, Lothar Uher, Biing Y. Lin, Sam Lee, Franck Amblard, Steven J. Coats, <span class="NLM_string-name hlFld-ContribAuthor">Raymond F. Schinazi</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Series of 2′-α-Fluoro,2′-β-bromo-ribonucleosides and Their Phosphoramidate Prodrugs as Potent Pan-Genotypic Inhibitors of Hepatitis C Virus. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (4)
                                     , 1859-1874. <a href="https://doi.org/10.1021/acs.jmedchem.8b01300" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01300</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01300%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BSeries%252Bof%252B2%2525E2%252580%2525B2-%2525CE%2525B1-Fluoro%25252C2%2525E2%252580%2525B2-%2525CE%2525B2-bromo-ribonucleosides%252Band%252BTheir%252BPhosphoramidate%252BProdrugs%252Bas%252BPotent%252BPan-Genotypic%252BInhibitors%252Bof%252BHepatitis%252BC%252BVirus%26aulast%3DMengshetti%26aufirst%3DSeema%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D16082018%26date%3D07022019%26date%3D17012019%26volume%3D62%26issue%3D4%26spage%3D1859%26epage%3D1874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Gabriele Pupo, Anna Chiara Vicini, David M. H. Ascough, Francesco Ibba, Kirsten E. Christensen, Amber L. Thompson, John M. Brown, Robert S. Paton, <span class="NLM_string-name hlFld-ContribAuthor">Véronique Gouverneur</span>. </span><span class="cited-content_cbyCitation_article-title">Hydrogen Bonding Phase-Transfer Catalysis with Potassium Fluoride: Enantioselective Synthesis of β-Fluoroamines. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2019,</strong> <em>141 </em>
                                    (7)
                                     , 2878-2883. <a href="https://doi.org/10.1021/jacs.8b12568" title="DOI URL">https://doi.org/10.1021/jacs.8b12568</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.8b12568&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.8b12568%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DHydrogen%252BBonding%252BPhase-Transfer%252BCatalysis%252Bwith%252BPotassium%252BFluoride%25253A%252BEnantioselective%252BSynthesis%252Bof%252B%2525CE%2525B2-Fluoroamines%26aulast%3DPupo%26aufirst%3DGabriele%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D30112018%26date%3D04022019%26date%3D28012019%26volume%3D141%26issue%3D7%26spage%3D2878%26epage%3D2883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Nicholas
A. Lentini, Benjamin J. Foust, Chia-Hung Christine Hsiao, Andrew J. Wiemer, <span class="NLM_string-name hlFld-ContribAuthor">David F. Wiemer</span>. </span><span class="cited-content_cbyCitation_article-title">Phosphonamidate Prodrugs of a Butyrophilin Ligand Display Plasma Stability and Potent Vγ9 Vδ2 T Cell Stimulation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (19)
                                     , 8658-8669. <a href="https://doi.org/10.1021/acs.jmedchem.8b00655" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00655</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00655%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPhosphonamidate%252BProdrugs%252Bof%252Ba%252BButyrophilin%252BLigand%252BDisplay%252BPlasma%252BStability%252Band%252BPotent%252BV%2525CE%2525B39%252BV%2525CE%2525B42%252BT%252BCell%252BStimulation%26aulast%3DLentini%26aufirst%3DNicholas%2BA.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D25042018%26date%3D26092018%26date%3D10092018%26volume%3D61%26issue%3D19%26spage%3D8658%26epage%3D8669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Nicholas A. Meanwell</span>. </span><span class="cited-content_cbyCitation_article-title">Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (14)
                                     , 5822-5880. <a href="https://doi.org/10.1021/acs.jmedchem.7b01788" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01788</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01788%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFluorine%252Band%252BFluorinated%252BMotifs%252Bin%252Bthe%252BDesign%252Band%252BApplication%252Bof%252BBioisosteres%252Bfor%252BDrug%252BDesign%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D05122017%26date%3D05022018%26volume%3D61%26issue%3D14%26spage%3D5822%26epage%3D5880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yi Zhu, Jianlin Han, Jiandong Wang, Norio Shibata, Mikiko Sodeoka, Vadim A. Soloshonok, Jaime A. S. Coelho, <span class="NLM_string-name hlFld-ContribAuthor">F. Dean Toste</span>. </span><span class="cited-content_cbyCitation_article-title">Modern Approaches for Asymmetric Construction of Carbon–Fluorine Quaternary Stereogenic Centers: Synthetic Challenges and Pharmaceutical Needs. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2018,</strong> <em>118 </em>
                                    (7)
                                     , 3887-3964. <a href="https://doi.org/10.1021/acs.chemrev.7b00778" title="DOI URL">https://doi.org/10.1021/acs.chemrev.7b00778</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.7b00778&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.7b00778%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DModern%252BApproaches%252Bfor%252BAsymmetric%252BConstruction%252Bof%252BCarbon%2525E2%252580%252593Fluorine%252BQuaternary%252BStereogenic%252BCenters%25253A%252BSynthetic%252BChallenges%252Band%252BPharmaceutical%252BNeeds%26aulast%3DZhu%26aufirst%3DYi%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D31122017%26date%3D02042018%26volume%3D118%26issue%3D7%26spage%3D3887%26epage%3D3964" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Youcef Mehellou, Hardeep S. Rattan, <span class="NLM_string-name hlFld-ContribAuthor">Jan Balzarini</span>. </span><span class="cited-content_cbyCitation_article-title">The ProTide Prodrug Technology: From the Concept to the Clinic. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (6)
                                     , 2211-2226. <a href="https://doi.org/10.1021/acs.jmedchem.7b00734" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00734</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00734&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00734%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BProTide%252BProdrug%252BTechnology%25253A%252BFrom%252Bthe%252BConcept%252Bto%252Bthe%252BClinic%26aulast%3DMehellou%26aufirst%3DYoucef%26date%3D2018%26date%3D2017%26date%3D2017%26date%3D18052017%26date%3D24082017%26date%3D09082017%26volume%3D61%26issue%3D6%26spage%3D2211%26epage%3D2226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aniekan  Okon</span>, <span class="hlFld-ContribAuthor ">JingJing  Han</span>, <span class="hlFld-ContribAuthor ">Surendra  Dawadi</span>, <span class="hlFld-ContribAuthor ">Christos  Demosthenous</span>, <span class="hlFld-ContribAuthor ">Courtney C.  Aldrich</span>, <span class="hlFld-ContribAuthor ">Mamta  Gupta</span>, and <span class="hlFld-ContribAuthor ">Carston R.  Wagner</span>  . </span><span class="cited-content_cbyCitation_article-title">Anchimerically Activated ProTides as Inhibitors of Cap-Dependent Translation and Inducers of Chemosensitization in Mantle Cell Lymphoma. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (19)
                                     , 8131-8144. <a href="https://doi.org/10.1021/acs.jmedchem.7b00916" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00916</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00916&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00916%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAnchimerically%252BActivated%252BProTides%252Bas%252BInhibitors%252Bof%252BCap-Dependent%252BTranslation%252Band%252BInducers%252Bof%252BChemosensitization%252Bin%252BMantle%252BCell%252BLymphoma%26aulast%3DOkon%26aufirst%3DAniekan%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D21062017%26date%3D20092017%26date%3D12102017%26date%3D31082017%26volume%3D60%26issue%3D19%26spage%3D8131%26epage%3D8144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benjamin J.  Foust</span>, <span class="hlFld-ContribAuthor ">Michael M.  Poe</span>, <span class="hlFld-ContribAuthor ">Nicholas A.  Lentini</span>, <span class="hlFld-ContribAuthor ">Chia-Hung Christine  Hsiao</span>, <span class="hlFld-ContribAuthor ">Andrew J.  Wiemer</span>, and <span class="hlFld-ContribAuthor ">David F.  Wiemer</span>  . </span><span class="cited-content_cbyCitation_article-title">Mixed Aryl Phosphonate Prodrugs of a Butyrophilin Ligand. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (9)
                                     , 914-918. <a href="https://doi.org/10.1021/acsmedchemlett.7b00245" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.7b00245</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.7b00245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.7b00245%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DMixed%252BAryl%252BPhosphonate%252BProdrugs%252Bof%252Ba%252BButyrophilin%252BLigand%26aulast%3DFoust%26aufirst%3DBenjamin%2BJ.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D20062017%26date%3D09082017%26date%3D16082017%26date%3D14092017%26date%3D09082017%26volume%3D8%26issue%3D9%26spage%3D914%26epage%3D918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Le  Zhen</span>, <span class="hlFld-ContribAuthor ">Liang  Dai</span>, <span class="hlFld-ContribAuthor ">Xiaoan  Wen</span>, <span class="hlFld-ContribAuthor ">Lan  Yao</span>, <span class="hlFld-ContribAuthor ">Xiaoliang  Jin</span>, <span class="hlFld-ContribAuthor ">Xiao-Wen  Yang</span>, <span class="hlFld-ContribAuthor ">Wenfeng  Zhao</span>, <span class="hlFld-ContribAuthor ">Sheng-Qi  Yu</span>, <span class="hlFld-ContribAuthor ">Haoliang  Yuan</span>, <span class="hlFld-ContribAuthor ">Guangji  Wang</span>, and <span class="hlFld-ContribAuthor ">Hongbin  Sun</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Nucleotide Prodrugs with Improved Potency Against HCV Variants Carrying NS5B S282T Mutation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (14)
                                     , 6077-6088. <a href="https://doi.org/10.1021/acs.jmedchem.7b00262" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00262</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00262%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNovel%252BNucleotide%252BProdrugs%252Bwith%252BImproved%252BPotency%252BAgainst%252BHCV%252BVariants%252BCarrying%252BNS5B%252BS282T%252BMutation%26aulast%3DZhen%26aufirst%3DLe%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D22022017%26date%3D10072017%26date%3D27072017%26date%3D26062017%26volume%3D60%26issue%3D14%26spage%3D6077%26epage%3D6088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shaoman  Zhou</span>, <span class="hlFld-ContribAuthor ">Sawsan  Mahmoud</span>, <span class="hlFld-ContribAuthor ">Peng  Liu</span>, <span class="hlFld-ContribAuthor ">Longhu  Zhou</span>, <span class="hlFld-ContribAuthor ">Maryam  Ehteshami</span>, <span class="hlFld-ContribAuthor ">Leda  Bassit</span>, <span class="hlFld-ContribAuthor ">Sijia  Tao</span>, <span class="hlFld-ContribAuthor ">Robert A.  Domaoal</span>, <span class="hlFld-ContribAuthor ">Ozkan  Sari</span>, <span class="hlFld-ContribAuthor ">Coralie De  Schutter</span>, <span class="hlFld-ContribAuthor ">Sheida  Amiralaei</span>, <span class="hlFld-ContribAuthor ">Ahmed  Khalil</span>, <span class="hlFld-ContribAuthor ">Olivia  Ollinger Russell</span>, <span class="hlFld-ContribAuthor ">Tamara  McBrayer</span>, <span class="hlFld-ContribAuthor ">Tony  Whitaker</span>, <span class="hlFld-ContribAuthor ">Nageh  Abou-Taleb</span>, <span class="hlFld-ContribAuthor ">Franck  Amblard</span>, <span class="hlFld-ContribAuthor ">Steven J.  Coats</span>, and <span class="hlFld-ContribAuthor ">Raymond F.  Schinazi</span>  . </span><span class="cited-content_cbyCitation_article-title">2′-Chloro,2′-fluoro Ribonucleotide Prodrugs with Potent Pan-genotypic Activity against Hepatitis C Virus Replication in Culture. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (13)
                                     , 5424-5437. <a href="https://doi.org/10.1021/acs.jmedchem.7b00067" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00067</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00067%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D2%2525E2%252580%2525B2-Chloro%25252C2%2525E2%252580%2525B2-fluoro%252BRibonucleotide%252BProdrugs%252Bwith%252BPotent%252BPan-genotypic%252BActivity%252Bagainst%252BHepatitis%252BC%252BVirus%252BReplication%252Bin%252BCulture%26aulast%3DZhou%26aufirst%3DShaoman%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D13012017%26date%3D26062017%26date%3D13072017%26date%3D08062017%26volume%3D60%26issue%3D13%26spage%3D5424%26epage%3D5437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenquan  Yu</span>, <span class="hlFld-ContribAuthor ">Ertong  Li</span>, <span class="hlFld-ContribAuthor ">Zhigang  Lv</span>, <span class="hlFld-ContribAuthor ">Ke  Liu</span>, <span class="hlFld-ContribAuthor ">Xiaohe  Guo</span>, <span class="hlFld-ContribAuthor ">Yuan  Liu</span>, and <span class="hlFld-ContribAuthor ">Junbiao  Chang</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Anti-HCV Activity of a Novel 2′,3′-Dideoxy-2′-α-fluoro-2′-β-C-methyl Guanosine Phosphoramidate Prodrug. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (6)
                                     , 682-684. <a href="https://doi.org/10.1021/acsmedchemlett.7b00174" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.7b00174</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.7b00174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.7b00174%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252BAnti-HCV%252BActivity%252Bof%252Ba%252BNovel%252B2%2525E2%252580%2525B2%25252C3%2525E2%252580%2525B2-Dideoxy-2%2525E2%252580%2525B2-%2525CE%2525B1-fluoro-2%2525E2%252580%2525B2-%2525CE%2525B2-C-methyl%252BGuanosine%252BPhosphoramidate%252BProdrug%26aulast%3DYu%26aufirst%3DWenquan%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D22042017%26date%3D01052017%26date%3D03052017%26date%3D08062017%26date%3D01052017%26volume%3D8%26issue%3D6%26spage%3D682%26epage%3D684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bryon  Simmons</span>, <span class="hlFld-ContribAuthor ">Zhuqing  Liu</span>, <span class="hlFld-ContribAuthor ">Artis  Klapars</span>, <span class="hlFld-ContribAuthor ">Ana  Bellomo</span>, and <span class="hlFld-ContribAuthor ">Steven M.  Silverman</span>  . </span><span class="cited-content_cbyCitation_article-title">Mechanism-Based Solution to the ProTide Synthesis Problem: Selective Access to Sofosbuvir, Acelarin, and INX-08189. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2017,</strong> <em>19 </em>
                                    (9)
                                     , 2218-2221. <a href="https://doi.org/10.1021/acs.orglett.7b00469" title="DOI URL">https://doi.org/10.1021/acs.orglett.7b00469</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.7b00469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.7b00469%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DMechanism-Based%252BSolution%252Bto%252Bthe%252BProTide%252BSynthesis%252BProblem%25253A%252BSelective%252BAccess%252Bto%252BSofosbuvir%25252C%252BAcelarin%25252C%252Band%252BINX-08189%26aulast%3DSimmons%26aufirst%3DBryon%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D06032017%26date%3D18042017%26date%3D05052017%26volume%3D19%26issue%3D9%26spage%3D2218%26epage%3D2221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dustin Siegel, Hon C. Hui, Edward Doerffler, Michael O. Clarke, Kwon Chun, Lijun Zhang, Sean Neville, Ernest Carra, Willard Lew, Bruce Ross, Queenie Wang, Lydia Wolfe, Robert Jordan, Veronica Soloveva, John Knox, Jason Perry, Michel Perron, Kirsten M. Stray, Ona Barauskas, Joy Y. Feng, Yili Xu, Gary Lee, Arnold L. Rheingold, Adrian S. Ray, Roy Bannister, Robert Strickley, Swami Swaminathan, William A. Lee, Sina Bavari, Tomas Cihlar, Michael K. Lo, Travis K. Warren, <span class="NLM_string-name hlFld-ContribAuthor">Richard L. Mackman</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (5)
                                     , 1648-1661. <a href="https://doi.org/10.1021/acs.jmedchem.6b01594" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01594</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01594%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%26date%3D2016%26volume%3D531%26spage%3D381%26epage%3D385%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BSynthesis%252Bof%252Ba%252BPhosphoramidate%252BProdrug%252Bof%252Ba%252BPyrrolo%25255B2%25252C1-f%25255D%25255Btriazin-4-amino%25255D%252BAdenine%252BC-Nucleoside%252B%252528GS-5734%252529%252Bfor%252Bthe%252BTreatment%252Bof%252BEbola%252Band%252BEmerging%252BViruses%26aulast%3DSiegel%26aufirst%3DDustin%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D27102016%26date%3D14022017%26date%3D26012017%26volume%3D60%26issue%3D5%26spage%3D1648%26epage%3D1661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julia  Ma</span>, <span class="hlFld-ContribAuthor ">Shuo  Wu</span>, <span class="hlFld-ContribAuthor ">Xuexiang  Zhang</span>, <span class="hlFld-ContribAuthor ">Fang  Guo</span>, <span class="hlFld-ContribAuthor ">Katherine  Yang</span>, <span class="hlFld-ContribAuthor ">Jia  Guo</span>, <span class="hlFld-ContribAuthor ">Qing  Su</span>, <span class="hlFld-ContribAuthor ">Huagang  Lu</span>, <span class="hlFld-ContribAuthor ">Patrick  Lam</span>, <span class="hlFld-ContribAuthor ">Yuhuan  Li</span>, <span class="hlFld-ContribAuthor ">Zhengyin  Yan</span>, <span class="hlFld-ContribAuthor ">William  Kinney</span>, <span class="hlFld-ContribAuthor ">Ju-Tao  Guo</span>, <span class="hlFld-ContribAuthor ">Timothy M.  Block</span>, <span class="hlFld-ContribAuthor ">Jinhong  Chang</span>, and <span class="hlFld-ContribAuthor ">Yanming  Du</span>  . </span><span class="cited-content_cbyCitation_article-title">Ester Prodrugs of IHVR-19029 with Enhanced Oral Exposure and Prevention of Gastrointestinal Glucosidase Interaction. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (2)
                                     , 157-162. <a href="https://doi.org/10.1021/acsmedchemlett.6b00332" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.6b00332</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.6b00332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.6b00332%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DEster%252BProdrugs%252Bof%252BIHVR-19029%252Bwith%252BEnhanced%252BOral%252BExposure%252Band%252BPrevention%252Bof%252BGastrointestinal%252BGlucosidase%252BInteraction%26aulast%3DMa%26aufirst%3DJulia%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D30082016%26date%3D17012017%26date%3D18012017%26date%3D09022017%26date%3D17012017%26volume%3D8%26issue%3D2%26spage%3D157%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter J.  Thornton</span>, <span class="hlFld-ContribAuthor ">Hachemi  Kadri</span>, <span class="hlFld-ContribAuthor ">Ageo  Miccoli</span>, and <span class="hlFld-ContribAuthor ">Youcef  Mehellou</span>  . </span><span class="cited-content_cbyCitation_article-title">Nucleoside Phosphate and Phosphonate Prodrug Clinical Candidates. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (23)
                                     , 10400-10410. <a href="https://doi.org/10.1021/acs.jmedchem.6b00523" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00523</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00523&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00523%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNucleoside%252BPhosphate%252Band%252BPhosphonate%252BProdrug%252BClinical%252BCandidates%26aulast%3DThornton%26aufirst%3DPeter%2BJ.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D08042016%26date%3D08092016%26date%3D08122016%26date%3D25082016%26volume%3D59%26issue%3D23%26spage%3D10400%26epage%3D10410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Debin  Zeng</span>, <span class="hlFld-ContribAuthor ">Rui  Zhang</span>, <span class="hlFld-ContribAuthor ">Quandeng  Nie</span>, <span class="hlFld-ContribAuthor ">Lin  Cao</span>, <span class="hlFld-ContribAuthor ">Luqing  Shang</span>, and <span class="hlFld-ContribAuthor ">Zheng  Yin</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of 2′-α-C-Methyl-2′-β-C-fluorouridine Phosphoramidate Prodrugs as Inhibitors of Hepatitis C Virus. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>7 </em>
                                    (12)
                                     , 1197-1201. <a href="https://doi.org/10.1021/acsmedchemlett.6b00270" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.6b00270</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.6b00270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.6b00270%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B2%2525E2%252580%2525B2-%2525CE%2525B1-C-Methyl-2%2525E2%252580%2525B2-%2525CE%2525B2-C-fluorouridine%252BPhosphoramidate%252BProdrugs%252Bas%252BInhibitors%252Bof%252BHepatitis%252BC%252BVirus%26aulast%3DZeng%26aufirst%3DDebin%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D11072016%26date%3D19102016%26date%3D24102016%26date%3D08122016%26date%3D19102016%26volume%3D7%26issue%3D12%26spage%3D1197%26epage%3D1201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ling-Jie  Gao</span>, <span class="hlFld-ContribAuthor ">Steven De  Jonghe</span>, and <span class="hlFld-ContribAuthor ">Piet  Herdewijn</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis of a Nucleobase-Modified ProTide Library. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2016,</strong> <em>18 </em>
                                    (22)
                                     , 5816-5819. <a href="https://doi.org/10.1021/acs.orglett.6b02764" title="DOI URL">https://doi.org/10.1021/acs.orglett.6b02764</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.6b02764&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.6b02764%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DSynthesis%252Bof%252Ba%252BNucleobase-Modified%252BProTide%252BLibrary%26aulast%3DGao%26aufirst%3DLing-Jie%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D13092016%26date%3D28102016%26date%3D18112016%26volume%3D18%26issue%3D22%26spage%3D5816%26epage%3D5819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James A.  Bull</span>, <span class="hlFld-ContribAuthor ">Rosemary A.  Croft</span>, <span class="hlFld-ContribAuthor ">Owen A.  Davis</span>, <span class="hlFld-ContribAuthor ">Robert  Doran</span>, and <span class="hlFld-ContribAuthor ">Kate F.  Morgan</span>  . </span><span class="cited-content_cbyCitation_article-title">Oxetanes: Recent Advances in Synthesis, Reactivity, and Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2016,</strong> <em>116 </em>
                                    (19)
                                     , 12150-12233. <a href="https://doi.org/10.1021/acs.chemrev.6b00274" title="DOI URL">https://doi.org/10.1021/acs.chemrev.6b00274</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.6b00274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.6b00274%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DOxetanes%25253A%252BRecent%252BAdvances%252Bin%252BSynthesis%25252C%252BReactivity%25252C%252Band%252BMedicinal%252BChemistry%26aulast%3DBull%26aufirst%3DJames%2BA.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D28042016%26date%3D15092016%26date%3D12102016%26volume%3D116%26issue%3D19%26spage%3D12150%26epage%3D12233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John J.  Court</span>, <span class="hlFld-ContribAuthor ">Carl  Poisson</span>, <span class="hlFld-ContribAuthor ">Andrzej  Ardzinski</span>, <span class="hlFld-ContribAuthor ">Darius  Bilimoria</span>, <span class="hlFld-ContribAuthor ">Laval  Chan</span>, <span class="hlFld-ContribAuthor ">Kishan  Chandupatla</span>, <span class="hlFld-ContribAuthor ">Nathalie  Chauret</span>, <span class="hlFld-ContribAuthor ">Philip N.  Collier</span>, <span class="hlFld-ContribAuthor ">Sanjoy Kumar  Das</span>, <span class="hlFld-ContribAuthor ">Francois  Denis</span>, <span class="hlFld-ContribAuthor ">Warren  Dorsch</span>, <span class="hlFld-ContribAuthor ">Ganesh  Iyer</span>, <span class="hlFld-ContribAuthor ">David  Lauffer</span>, <span class="hlFld-ContribAuthor ">Lucille  L’Heureux</span>, <span class="hlFld-ContribAuthor ">Pan  Li</span>, <span class="hlFld-ContribAuthor ">Brian S.  Luisi</span>, <span class="hlFld-ContribAuthor ">Nagraj  Mani</span>, <span class="hlFld-ContribAuthor ">Suganthi  Nanthakumar</span>, <span class="hlFld-ContribAuthor ">Olivier  Nicolas</span>, <span class="hlFld-ContribAuthor ">B. Govinda  Rao</span>, <span class="hlFld-ContribAuthor ">Steven  Ronkin</span>, <span class="hlFld-ContribAuthor ">Subajini  Selliah</span>, <span class="hlFld-ContribAuthor ">Rebecca S.  Shawgo</span>, <span class="hlFld-ContribAuthor ">Qing  Tang</span>, <span class="hlFld-ContribAuthor ">Nathan D.  Waal</span>, <span class="hlFld-ContribAuthor ">Constantin G.  Yannopoulos</span>, and <span class="hlFld-ContribAuthor ">Jeremy  Green</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Thiophene-Based, Thumb Pocket 2 Allosteric Inhibitors of the Hepatitis C NS5B Polymerase with Improved Potency and Physicochemical Profiles. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (13)
                                     , 6293-6302. <a href="https://doi.org/10.1021/acs.jmedchem.6b00541" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00541</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00541%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNovel%252BThiophene-Based%25252C%252BThumb%252BPocket%252B2%252BAllosteric%252BInhibitors%252Bof%252Bthe%252BHepatitis%252BC%252BNS5B%252BPolymerase%252Bwith%252BImproved%252BPotency%252Band%252BPhysicochemical%252BProfiles%26aulast%3DCourt%26aufirst%3DJohn%2BJ.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D09042016%26date%3D01072016%26date%3D14072016%26volume%3D59%26issue%3D13%26spage%3D6293%26epage%3D6302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tim H. M.  Jonckers</span>, <span class="hlFld-ContribAuthor ">Abdellah  Tahri</span>, <span class="hlFld-ContribAuthor ">Leen  Vijgen</span>, <span class="hlFld-ContribAuthor ">Jan Martin  Berke</span>, <span class="hlFld-ContribAuthor ">Sophie  Lachau-Durand</span>, <span class="hlFld-ContribAuthor ">Bart  Stoops</span>, <span class="hlFld-ContribAuthor ">Jan  Snoeys</span>, <span class="hlFld-ContribAuthor ">Laurent  Leclercq</span>, <span class="hlFld-ContribAuthor ">Lotke  Tambuyzer</span>, <span class="hlFld-ContribAuthor ">Tse-I  Lin</span>, <span class="hlFld-ContribAuthor ">Kenny  Simmen</span>, and <span class="hlFld-ContribAuthor ">Pierre  Raboisson</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of 1-((2R,4aR,6R,7R,7aR)-2-Isopropoxy-2-oxidodihydro-4H,6H-spiro[furo[3,2-d][1,3,2]dioxaphosphinine-7,2′-oxetan]-6-yl)pyrimidine-2,4(1H,3H)-dione (JNJ-54257099), a 3′-5′-Cyclic Phosphate Ester Prodrug of 2′-Deoxy-2′-Spirooxetane Uridine Triphosphate Useful for HCV Inhibition. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (12)
                                     , 5790-5798. <a href="https://doi.org/10.1021/acs.jmedchem.6b00382" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00382</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00382&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00382%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B1-%252528%2525282R%25252C4aR%25252C6R%25252C7R%25252C7aR%252529-2-Isopropoxy-2-oxidodihydro-4H%25252C6H-spiro%25255Bfuro%25255B3%25252C2-d%25255D%25255B1%25252C3%25252C2%25255Ddioxaphosphinine-7%25252C2%2525E2%252580%2525B2-oxetan%25255D-6-yl%252529pyrimidine-2%25252C4%2525281H%25252C3H%252529-dione%252B%252528JNJ-54257099%252529%25252C%252Ba%252B3%2525E2%252580%2525B2-5%2525E2%252580%2525B2-Cyclic%252BPhosphate%252BEster%252BProdrug%252Bof%252B2%2525E2%252580%2525B2-Deoxy-2%2525E2%252580%2525B2-Spirooxetane%252BUridine%252BTriphosphate%252BUseful%252Bfor%252BHCV%252BInhibition%26aulast%3DJonckers%26aufirst%3DTim%2BH.%2BM.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D14032016%26date%3D03062016%26date%3D23062016%26date%3D14052016%26volume%3D59%26issue%3D12%26spage%3D5790%26epage%3D5798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shanshan  He</span>, <span class="hlFld-ContribAuthor ">Jingbo  Xiao</span>, <span class="hlFld-ContribAuthor ">Andrés E.  Dulcey</span>, <span class="hlFld-ContribAuthor ">Billy  Lin</span>, <span class="hlFld-ContribAuthor ">Adam  Rolt</span>, <span class="hlFld-ContribAuthor ">Zongyi  Hu</span>, <span class="hlFld-ContribAuthor ">Xin  Hu</span>, <span class="hlFld-ContribAuthor ">Amy Q.  Wang</span>, <span class="hlFld-ContribAuthor ">Xin  Xu</span>, <span class="hlFld-ContribAuthor ">Noel  Southall</span>, <span class="hlFld-ContribAuthor ">Marc  Ferrer</span>, <span class="hlFld-ContribAuthor ">Wei  Zheng</span>, <span class="hlFld-ContribAuthor ">T. Jake  Liang</span>, and <span class="hlFld-ContribAuthor ">Juan J.  Marugan</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery, Optimization, and Characterization of Novel Chlorcyclizine Derivatives for the Treatment of Hepatitis C Virus Infection. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (3)
                                     , 841-853. <a href="https://doi.org/10.1021/acs.jmedchem.5b00752" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00752</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00752&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00752%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%25252C%252BOptimization%25252C%252Band%252BCharacterization%252Bof%252BNovel%252BChlorcyclizine%252BDerivatives%252Bfor%252Bthe%252BTreatment%252Bof%252BHepatitis%252BC%252BVirus%252BInfection%26aulast%3DHe%26aufirst%3DShanshan%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D18052015%26date%3D01022016%26date%3D11022016%26date%3D24112015%26volume%3D59%26issue%3D3%26spage%3D841%26epage%3D853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Zhou</span>, <span class="hlFld-ContribAuthor ">Jiang  Wang</span>, <span class="hlFld-ContribAuthor ">Zhanni  Gu</span>, <span class="hlFld-ContribAuthor ">Shuni  Wang</span>, <span class="hlFld-ContribAuthor ">Wei  Zhu</span>, <span class="hlFld-ContribAuthor ">José Luis  Aceña</span>, <span class="hlFld-ContribAuthor ">Vadim A.  Soloshonok</span>, <span class="hlFld-ContribAuthor ">Kunisuke  Izawa</span>, and <span class="hlFld-ContribAuthor ">Hong  Liu</span>  . </span><span class="cited-content_cbyCitation_article-title">Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2016,</strong> <em>116 </em>
                                    (2)
                                     , 422-518. <a href="https://doi.org/10.1021/acs.chemrev.5b00392" title="DOI URL">https://doi.org/10.1021/acs.chemrev.5b00392</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.5b00392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.5b00392%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DNext%252BGeneration%252Bof%252BFluorine-Containing%252BPharmaceuticals%25252C%252BCompounds%252BCurrently%252Bin%252BPhase%252BII%2525E2%252580%252593III%252BClinical%252BTrials%252Bof%252BMajor%252BPharmaceutical%252BCompanies%25253A%252BNew%252BStructural%252BTrends%252Band%252BTherapeutic%252BAreas%26aulast%3DZhou%26aufirst%3DYu%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D06072015%26date%3D12012016%26date%3D27012016%26volume%3D116%26issue%3D2%26spage%3D422%26epage%3D518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rolando  Cannalire</span>, <span class="hlFld-ContribAuthor ">Maria Letizia  Barreca</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Manfroni</span>, and <span class="hlFld-ContribAuthor ">Violetta  Cecchetti</span>  . </span><span class="cited-content_cbyCitation_article-title">A Journey around the Medicinal Chemistry of Hepatitis C Virus Inhibitors Targeting NS4B: From Target to Preclinical Drug Candidates. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (1)
                                     , 16-41. <a href="https://doi.org/10.1021/acs.jmedchem.5b00825" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00825</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00825%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252BJourney%252Baround%252Bthe%252BMedicinal%252BChemistry%252Bof%252BHepatitis%252BC%252BVirus%252BInhibitors%252BTargeting%252BNS4B%25253A%252BFrom%252BTarget%252Bto%252BPreclinical%252BDrug%252BCandidates%26aulast%3DCannalire%26aufirst%3DRolando%26date%3D2016%26date%3D2015%26date%3D2015%26date%3D29052015%26date%3D31082015%26date%3D14012016%26date%3D04082015%26volume%3D59%26issue%3D1%26spage%3D16%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Longhu  Zhou</span>, <span class="hlFld-ContribAuthor ">Hongwang  Zhang</span>, <span class="hlFld-ContribAuthor ">Sijia  Tao</span>, <span class="hlFld-ContribAuthor ">Maryam  Ehteshami</span>, <span class="hlFld-ContribAuthor ">Jong Hyun  Cho</span>, <span class="hlFld-ContribAuthor ">Tamara R.  McBrayer</span>, <span class="hlFld-ContribAuthor ">Philip  Tharnish</span>, <span class="hlFld-ContribAuthor ">Tony  Whitaker</span>, <span class="hlFld-ContribAuthor ">Franck  Amblard</span>, <span class="hlFld-ContribAuthor ">Steven J.  Coats</span>, and <span class="hlFld-ContribAuthor ">Raymond F.  Schinazi</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Evaluation of 2,6-Modified Purine 2′-C-Methyl Ribonucleosides as Inhibitors of HCV Replication. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>7 </em>
                                    (1)
                                     , 17-22. <a href="https://doi.org/10.1021/acsmedchemlett.5b00402" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.5b00402</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.5b00402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.5b00402%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252BEvaluation%252Bof%252B2%25252C6-Modified%252BPurine%252B2%2525E2%252580%2525B2-C-Methyl%252BRibonucleosides%252Bas%252BInhibitors%252Bof%252BHCV%252BReplication%26aulast%3DZhou%26aufirst%3DLonghu%26date%3D2016%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D03042015%26date%3D23112015%26date%3D04122015%26date%3D14012016%26date%3D23112015%26volume%3D7%26issue%3D1%26spage%3D17%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhe  Chen</span>, <span class="hlFld-ContribAuthor ">Dirk  Jochmans</span>, <span class="hlFld-ContribAuthor ">Therese  Ku</span>, <span class="hlFld-ContribAuthor ">Jan  Paeshuyse</span>, <span class="hlFld-ContribAuthor ">Johan  Neyts</span>, and <span class="hlFld-ContribAuthor ">Katherine L.  Seley-Radtke</span>  . </span><span class="cited-content_cbyCitation_article-title">Bicyclic and Tricyclic “Expanded” Nucleobase Analogues of Sofosbuvir: New Scaffolds for Hepatitis C Therapies. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2015,</strong> <em>1 </em>
                                    (8)
                                     , 357-366. <a href="https://doi.org/10.1021/acsinfecdis.5b00029" title="DOI URL">https://doi.org/10.1021/acsinfecdis.5b00029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.5b00029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.5b00029%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DBicyclic%252Band%252BTricyclic%252B%2525E2%252580%25259CExpanded%2525E2%252580%25259D%252BNucleobase%252BAnalogues%252Bof%252BSofosbuvir%25253A%252BNew%252BScaffolds%252Bfor%252BHepatitis%252BC%252BTherapies%26aulast%3DChen%26aufirst%3DZhe%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D06032015%26date%3D09062015%26date%3D14082015%26date%3D02062015%26volume%3D1%26issue%3D8%26spage%3D357%26epage%3D366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kristy  Tran</span>, <span class="hlFld-ContribAuthor ">Gregory L.  Beutner</span>, <span class="hlFld-ContribAuthor ">Michael  Schmidt</span>, <span class="hlFld-ContribAuthor ">Jacob  Janey</span>, <span class="hlFld-ContribAuthor ">Ke  Chen</span>, <span class="hlFld-ContribAuthor ">Victor  Rosso</span>, and <span class="hlFld-ContribAuthor ">Martin D.  Eastgate</span>  . </span><span class="cited-content_cbyCitation_article-title">Development of a Diastereoselective Phosphorylation of a Complex Nucleoside via Dynamic Kinetic Resolution. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2015,</strong> <em>80 </em>
                                    (10)
                                     , 4994-5003. <a href="https://doi.org/10.1021/acs.joc.5b00392" title="DOI URL">https://doi.org/10.1021/acs.joc.5b00392</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.5b00392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.5b00392%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DDevelopment%252Bof%252Ba%252BDiastereoselective%252BPhosphorylation%252Bof%252Ba%252BComplex%252BNucleoside%252Bvia%252BDynamic%252BKinetic%252BResolution%26aulast%3DTran%26aufirst%3DKristy%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D18022015%26date%3D30042015%26date%3D15052015%26date%3D03042015%26volume%3D80%26issue%3D10%26spage%3D4994%26epage%3D5003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ugo  Pradere</span>, <span class="hlFld-ContribAuthor ">Ethel C.  Garnier-Amblard</span>, <span class="hlFld-ContribAuthor ">Steven J.  Coats</span>, <span class="hlFld-ContribAuthor ">Franck  Amblard</span>, and <span class="hlFld-ContribAuthor ">Raymond F.  Schinazi</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis of Nucleoside Phosphate and Phosphonate Prodrugs. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2014,</strong> <em>114 </em>
                                    (18)
                                     , 9154-9218. <a href="https://doi.org/10.1021/cr5002035" title="DOI URL">https://doi.org/10.1021/cr5002035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cr5002035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcr5002035%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DSynthesis%252Bof%252BNucleoside%252BPhosphate%252Band%252BPhosphonate%252BProdrugs%26aulast%3DPradere%26aufirst%3DUgo%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D11042014%26date%3D21082014%26date%3D24092014%26volume%3D114%26issue%3D18%26spage%3D9154%26epage%3D9218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Makonen  Belema</span> and <span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Daclatasvir, a Pan-Genotypic Hepatitis C Virus NS5A Replication Complex Inhibitor with Potent Clinical Effect. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (12)
                                     , 5057-5071. <a href="https://doi.org/10.1021/jm500335h" title="DOI URL">https://doi.org/10.1021/jm500335h</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500335h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500335h%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BDaclatasvir%25252C%252Ba%252BPan-Genotypic%252BHepatitis%252BC%252BVirus%252BNS5A%252BReplication%252BComplex%252BInhibitor%252Bwith%252BPotent%252BClinical%252BEffect%26aulast%3DBelema%26aufirst%3DMakonen%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D03032014%26date%3D21042014%26date%3D26062014%26volume%3D57%26issue%3D12%26spage%3D5057%26epage%3D5071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manuel  Peifer</span>, <span class="hlFld-ContribAuthor ">Raphaëlle  Berger</span>, <span class="hlFld-ContribAuthor ">Valerie W.  Shurtleff</span>, <span class="hlFld-ContribAuthor ">Jay C.  Conrad</span>, and <span class="hlFld-ContribAuthor ">David W. C.  MacMillan</span>  . </span><span class="cited-content_cbyCitation_article-title">A General and Enantioselective Approach to Pentoses: A Rapid Synthesis of PSI-6130, the Nucleoside Core of Sofosbuvir. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2014,</strong> <em>136 </em>
                                    (16)
                                     , 5900-5903. <a href="https://doi.org/10.1021/ja502205q" title="DOI URL">https://doi.org/10.1021/ja502205q</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ja502205q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fja502205q%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DA%252BGeneral%252Band%252BEnantioselective%252BApproach%252Bto%252BPentoses%25253A%252BA%252BRapid%252BSynthesis%252Bof%252BPSI-6130%25252C%252Bthe%252BNucleoside%252BCore%252Bof%252BSofosbuvir%26aulast%3DPeifer%26aufirst%3DManuel%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D03032014%26date%3D09042014%26date%3D23042014%26date%3D26032014%26volume%3D136%26issue%3D16%26spage%3D5900%26epage%3D5903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aesop  Cho</span>, <span class="hlFld-ContribAuthor ">Lijun  Zhang</span>, <span class="hlFld-ContribAuthor ">Jie  Xu</span>, <span class="hlFld-ContribAuthor ">Rick  Lee</span>, <span class="hlFld-ContribAuthor ">Thomas  Butler</span>, <span class="hlFld-ContribAuthor ">Sammy  Metobo</span>, <span class="hlFld-ContribAuthor ">Vangelis  Aktoudianakis</span>, <span class="hlFld-ContribAuthor ">Willard  Lew</span>, <span class="hlFld-ContribAuthor ">Hong  Ye</span>, <span class="hlFld-ContribAuthor ">Michael  Clarke</span>, <span class="hlFld-ContribAuthor ">Edward  Doerffler</span>, <span class="hlFld-ContribAuthor ">Daniel  Byun</span>, <span class="hlFld-ContribAuthor ">Ting  Wang</span>, <span class="hlFld-ContribAuthor ">Darius  Babusis</span>, <span class="hlFld-ContribAuthor ">Anne C.  Carey</span>, <span class="hlFld-ContribAuthor ">Polina  German</span>, <span class="hlFld-ContribAuthor ">Dorothea  Sauer</span>, <span class="hlFld-ContribAuthor ">Weidong  Zhong</span>, <span class="hlFld-ContribAuthor ">Stephen  Rossi</span>, <span class="hlFld-ContribAuthor ">Martijn  Fenaux</span>, <span class="hlFld-ContribAuthor ">John G.  McHutchison</span>, <span class="hlFld-ContribAuthor ">Jason  Perry</span>, <span class="hlFld-ContribAuthor ">Joy  Feng</span>, <span class="hlFld-ContribAuthor ">Adrian S.  Ray</span>, and <span class="hlFld-ContribAuthor ">Choung U.  Kim</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of the First C-Nucleoside HCV Polymerase Inhibitor (GS-6620) with Demonstrated Antiviral Response in HCV Infected Patients. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (5)
                                     , 1812-1825. <a href="https://doi.org/10.1021/jm400201a" title="DOI URL">https://doi.org/10.1021/jm400201a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400201a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400201a%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bthe%252BFirst%252BC-Nucleoside%252BHCV%252BPolymerase%252BInhibitor%252B%252528GS-6620%252529%252Bwith%252BDemonstrated%252BAntiviral%252BResponse%252Bin%252BHCV%252BInfected%252BPatients%26aulast%3DCho%26aufirst%3DAesop%26date%3D2014%26date%3D2013%26date%3D2013%26date%3D07022013%26date%3D01052013%26date%3D13032014%26date%3D02042013%26volume%3D57%26issue%3D5%26spage%3D1812%26epage%3D1825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinfa  Du</span>, <span class="hlFld-ContribAuthor ">Byoung-Kwon  Chun</span>, <span class="hlFld-ContribAuthor ">Ralph T.  Mosley</span>, <span class="hlFld-ContribAuthor ">Shalini  Bansal</span>, <span class="hlFld-ContribAuthor ">Haiying  Bao</span>, <span class="hlFld-ContribAuthor ">Christine  Espiritu</span>, <span class="hlFld-ContribAuthor ">Angela M.  Lam</span>, <span class="hlFld-ContribAuthor ">Eisuke  Murakami</span>, <span class="hlFld-ContribAuthor ">Congrong  Niu</span>, <span class="hlFld-ContribAuthor ">Holly M.   Micolochick Steuer</span>, <span class="hlFld-ContribAuthor ">Phillip A.  Furman</span>, and <span class="hlFld-ContribAuthor ">Michael J.  Sofia</span>  . </span><span class="cited-content_cbyCitation_article-title">Use of 2′-Spirocyclic Ethers in HCV Nucleoside Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (5)
                                     , 1826-1835. <a href="https://doi.org/10.1021/jm401224y" title="DOI URL">https://doi.org/10.1021/jm401224y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401224y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401224y%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DUse%252Bof%252B2%2525E2%252580%2525B2-Spirocyclic%252BEthers%252Bin%252BHCV%252BNucleoside%252BDesign%26aulast%3DDu%26aufirst%3DJinfa%26date%3D2014%26date%3D2013%26date%3D2013%26date%3D07082013%26date%3D18102013%26date%3D13032014%26date%3D30092013%26volume%3D57%26issue%3D5%26spage%3D1826%26epage%3D1835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ramesh  Kakarla</span>, <span class="hlFld-ContribAuthor ">Jian  Liu</span>, <span class="hlFld-ContribAuthor ">Devan  Naduthambi</span>, <span class="hlFld-ContribAuthor ">Wonsuk  Chang</span>, <span class="hlFld-ContribAuthor ">Ralph T.  Mosley</span>, <span class="hlFld-ContribAuthor ">Donghui  Bao</span>, <span class="hlFld-ContribAuthor ">Holly M. Micolochick  Steuer</span>, <span class="hlFld-ContribAuthor ">Meg  Keilman</span>, <span class="hlFld-ContribAuthor ">Shalini  Bansal</span>, <span class="hlFld-ContribAuthor ">Angela M.  Lam</span>, <span class="hlFld-ContribAuthor ">William  Seibel</span>, <span class="hlFld-ContribAuthor ">Sandra  Neilson</span>, <span class="hlFld-ContribAuthor ">Phillip A.  Furman</span>, and <span class="hlFld-ContribAuthor ">Michael J.  Sofia</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Novel Class of Potent HCV NS4B Inhibitors: SAR Studies on Piperazinone Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (5)
                                     , 2136-2160. <a href="https://doi.org/10.1021/jm4012643" title="DOI URL">https://doi.org/10.1021/jm4012643</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4012643&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4012643%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BNovel%252BClass%252Bof%252BPotent%252BHCV%252BNS4B%252BInhibitors%25253A%252BSAR%252BStudies%252Bon%252BPiperazinone%252BDerivatives%26aulast%3DKakarla%26aufirst%3DRamesh%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D15082013%26date%3D29012014%26date%3D13032014%26volume%3D57%26issue%3D5%26spage%3D2136%26epage%3D2160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John O.  Link</span>, <span class="hlFld-ContribAuthor ">James G.  Taylor</span>, <span class="hlFld-ContribAuthor ">Lianhong  Xu</span>, <span class="hlFld-ContribAuthor ">Michael  Mitchell</span>, <span class="hlFld-ContribAuthor ">Hongyan  Guo</span>, <span class="hlFld-ContribAuthor ">Hongtao  Liu</span>, <span class="hlFld-ContribAuthor ">Darryl  Kato</span>, <span class="hlFld-ContribAuthor ">Thorsten  Kirschberg</span>, <span class="hlFld-ContribAuthor ">Jianyu  Sun</span>, <span class="hlFld-ContribAuthor ">Neil  Squires</span>, <span class="hlFld-ContribAuthor ">Jay  Parrish</span>, <span class="hlFld-ContribAuthor ">Terry  Keller</span>, <span class="hlFld-ContribAuthor ">Zheng-Yu  Yang</span>, <span class="hlFld-ContribAuthor ">Chris  Yang</span>, <span class="hlFld-ContribAuthor ">Mike  Matles</span>, <span class="hlFld-ContribAuthor ">Yujin  Wang</span>, <span class="hlFld-ContribAuthor ">Kelly  Wang</span>, <span class="hlFld-ContribAuthor ">Guofeng  Cheng</span>, <span class="hlFld-ContribAuthor ">Yang  Tian</span>, <span class="hlFld-ContribAuthor ">Erik  Mogalian</span>, <span class="hlFld-ContribAuthor ">Elsa  Mondou</span>, <span class="hlFld-ContribAuthor ">Melanie  Cornpropst</span>, <span class="hlFld-ContribAuthor ">Jason  Perry</span>, and <span class="hlFld-ContribAuthor ">Manoj C.  Desai</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Ledipasvir (GS-5885): A Potent, Once-Daily Oral NS5A Inhibitor for the Treatment of Hepatitis C Virus Infection. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (5)
                                     , 2033-2046. <a href="https://doi.org/10.1021/jm401499g" title="DOI URL">https://doi.org/10.1021/jm401499g</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401499g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401499g%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BLedipasvir%252B%252528GS-5885%252529%25253A%252BA%252BPotent%25252C%252BOnce-Daily%252BOral%252BNS5A%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BHepatitis%252BC%252BVirus%252BInfection%26aulast%3DLink%26aufirst%3DJohn%2BO.%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D26092013%26date%3D10012014%26date%3D13032014%26date%3D09122013%26volume%3D57%26issue%3D5%26spage%3D2033%26epage%3D2046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tim H. M.  Jonckers</span>, <span class="hlFld-ContribAuthor ">Koen  Vandyck</span>, <span class="hlFld-ContribAuthor ">Leen  Vandekerckhove</span>, <span class="hlFld-ContribAuthor ">Lili  Hu</span>, <span class="hlFld-ContribAuthor ">Abdellah  Tahri</span>, <span class="hlFld-ContribAuthor ">Steven  Van Hoof</span>, <span class="hlFld-ContribAuthor ">Tse-I  Lin</span>, <span class="hlFld-ContribAuthor ">Leen  Vijgen</span>, <span class="hlFld-ContribAuthor ">Jan Martin  Berke</span>, <span class="hlFld-ContribAuthor ">Sophie  Lachau-Durand</span>, <span class="hlFld-ContribAuthor ">Bart  Stoops</span>, <span class="hlFld-ContribAuthor ">Laurent  Leclercq</span>, <span class="hlFld-ContribAuthor ">Gregory  Fanning</span>, <span class="hlFld-ContribAuthor ">Bertil  Samuelsson</span>, <span class="hlFld-ContribAuthor ">Magnus  Nilsson</span>, <span class="hlFld-ContribAuthor ">Åsa  Rosenquist</span>, <span class="hlFld-ContribAuthor ">Kenny  Simmen</span>, and <span class="hlFld-ContribAuthor ">Pierre  Raboisson</span>  . </span><span class="cited-content_cbyCitation_article-title">Nucleotide Prodrugs of 2′-Deoxy-2′-spirooxetane Ribonucleosides as Novel Inhibitors of the HCV NS5B Polymerase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (5)
                                     , 1836-1844. <a href="https://doi.org/10.1021/jm4015422" title="DOI URL">https://doi.org/10.1021/jm4015422</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4015422&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4015422%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNucleotide%252BProdrugs%252Bof%252B2%2525E2%252580%2525B2-Deoxy-2%2525E2%252580%2525B2-spirooxetane%252BRibonucleosides%252Bas%252BNovel%252BInhibitors%252Bof%252Bthe%252BHCV%252BNS5B%252BPolymerase%26aulast%3DJonckers%26aufirst%3DTim%2BH.%2BM.%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D03102013%26date%3D06012014%26date%3D13032014%26date%3D17122013%26volume%3D57%26issue%3D5%26spage%3D1836%26epage%3D1844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span> (<span class="NLM_role">Guest Editor</span>) and <span class="hlFld-ContribAuthor ">William J.  Watkins</span> (<span class="NLM_role">Guest Editor</span>). </span><span class="cited-content_cbyCitation_article-title">Introduction to Hepatitis C Virus (HCV) Therapies Special Thematic Issue. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (5)
                                     , 1625-1626. <a href="https://doi.org/10.1021/jm5000936" title="DOI URL">https://doi.org/10.1021/jm5000936</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5000936&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5000936%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIntroduction%252Bto%252BHepatitis%252BC%252BVirus%252B%252528HCV%252529%252BTherapies%252BSpecial%252BThematic%252BIssue%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2014%26date%3D2014%26date%3D28012014%26date%3D31012014%26date%3D13032014%26volume%3D57%26issue%3D5%26spage%3D1625%26epage%3D1626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pierre L.  Beaulieu</span>, <span class="hlFld-ContribAuthor ">Michael  Bös</span>, <span class="hlFld-ContribAuthor ">Michael G.  Cordingley</span>, <span class="hlFld-ContribAuthor ">Catherine  Chabot</span>, <span class="hlFld-ContribAuthor ">Gulrez  Fazal</span>, <span class="hlFld-ContribAuthor ">Michel  Garneau</span>, <span class="hlFld-ContribAuthor ">James R.  Gillard</span>, <span class="hlFld-ContribAuthor ">Eric  Jolicoeur</span>, <span class="hlFld-ContribAuthor ">Steven  LaPlante</span>, <span class="hlFld-ContribAuthor ">Ginette  McKercher</span>, <span class="hlFld-ContribAuthor ">Martin  Poirier</span>, <span class="hlFld-ContribAuthor ">Marc-André  Poupart</span>, <span class="hlFld-ContribAuthor ">Youla S.  Tsantrizos</span>, <span class="hlFld-ContribAuthor ">Jianmin  Duan</span>, and <span class="hlFld-ContribAuthor ">George  Kukolj</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of the First Thumb Pocket 1 NS5B Polymerase Inhibitor (BILB 1941) with Demonstrated Antiviral Activity in Patients Chronically Infected with Genotype 1 Hepatitis C Virus (HCV). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (17)
                                     , 7650-7666. <a href="https://doi.org/10.1021/jm3006788" title="DOI URL">https://doi.org/10.1021/jm3006788</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm3006788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm3006788%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bthe%252BFirst%252BThumb%252BPocket%252B1%252BNS5B%252BPolymerase%252BInhibitor%252B%252528BILB%252B1941%252529%252Bwith%252BDemonstrated%252BAntiviral%252BActivity%252Bin%252BPatients%252BChronically%252BInfected%252Bwith%252BGenotype%252B1%252BHepatitis%252BC%252BVirus%252B%252528HCV%252529%26aulast%3DBeaulieu%26aufirst%3DPierre%2BL.%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D15052012%26date%3D16082012%26date%3D13092012%26date%3D31072012%26volume%3D55%26issue%3D17%26spage%3D7650%26epage%3D7666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ugo  Pradere</span>, <span class="hlFld-ContribAuthor ">Franck  Amblard</span>, <span class="hlFld-ContribAuthor ">Steven J.  Coats</span>, and <span class="hlFld-ContribAuthor ">Raymond F.  Schinazi</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis of 5′-Methylene-Phosphonate Furanonucleoside Prodrugs: Application to D-2′-Deoxy-2′-α-fluoro-2′-β-C-methyl Nucleosides. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2012,</strong> <em>14 </em>
                                    (17)
                                     , 4426-4429. <a href="https://doi.org/10.1021/ol301937v" title="DOI URL">https://doi.org/10.1021/ol301937v</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol301937v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol301937v%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DSynthesis%252Bof%252B5%2525E2%252580%2525B2-Methylene-Phosphonate%252BFuranonucleoside%252BProdrugs%25253A%252BApplication%252Bto%252BD-2%2525E2%252580%2525B2-Deoxy-2%2525E2%252580%2525B2-%2525CE%2525B1-fluoro-2%2525E2%252580%2525B2-%2525CE%2525B2-C-methyl%252BNucleosides%26aulast%3DPradere%26aufirst%3DUgo%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D12072012%26date%3D23082012%26date%3D07092012%26volume%3D14%26issue%3D17%26spage%3D4426%26epage%3D4429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Edwuin H.  Rios Morales</span>, <span class="hlFld-ContribAuthor ">Jan  Balzarini</span>, and <span class="hlFld-ContribAuthor ">Chris  Meier</span>  . </span><span class="cited-content_cbyCitation_article-title">Stereoselective Synthesis and Antiviral Activity of Methyl-Substituted cycloSal-Pronucleotides. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (16)
                                     , 7245-7252. <a href="https://doi.org/10.1021/jm3008085" title="DOI URL">https://doi.org/10.1021/jm3008085</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm3008085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm3008085%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStereoselective%252BSynthesis%252Band%252BAntiviral%252BActivity%252Bof%252BMethyl-Substituted%252BcycloSal-Pronucleotides%26aulast%3DRios%2BMorales%26aufirst%3DEdwuin%2BH.%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D08062012%26date%3D03082012%26date%3D23082012%26date%3D24072012%26volume%3D55%26issue%3D16%26spage%3D7245%26epage%3D7252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jong Hyun  Cho</span>, <span class="hlFld-ContribAuthor ">Steven J.  Coats</span>, and <span class="hlFld-ContribAuthor ">Raymond F.  Schinazi</span>  . </span><span class="cited-content_cbyCitation_article-title">Efficient Synthesis of Exo-N-carbamoyl Nucleosides: Application to the Synthesis of Phosphoramidate Prodrugs. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2012,</strong> <em>14 </em>
                                    (10)
                                     , 2488-2491. <a href="https://doi.org/10.1021/ol300777p" title="DOI URL">https://doi.org/10.1021/ol300777p</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol300777p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol300777p%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DEfficient%252BSynthesis%252Bof%252BExo-N-carbamoyl%252BNucleosides%25253A%252BApplication%252Bto%252Bthe%252BSynthesis%252Bof%252BPhosphoramidate%252BProdrugs%26aulast%3DCho%26aufirst%3DJong%2BHyun%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D26032012%26date%3D03052012%26date%3D18052012%26volume%3D14%26issue%3D10%26spage%3D2488%26epage%3D2491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael J.  Sofia</span>, <span class="hlFld-ContribAuthor ">Wonsuk  Chang</span>, <span class="hlFld-ContribAuthor ">Phillip A.  Furman</span>, <span class="hlFld-ContribAuthor ">Ralph T.  Mosley</span>, and <span class="hlFld-ContribAuthor ">Bruce S.  Ross</span>  . </span><span class="cited-content_cbyCitation_article-title">Nucleoside, Nucleotide, and Non-Nucleoside Inhibitors of Hepatitis C Virus NS5B RNA-Dependent RNA-Polymerase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (6)
                                     , 2481-2531. <a href="https://doi.org/10.1021/jm201384j" title="DOI URL">https://doi.org/10.1021/jm201384j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm201384j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm201384j%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNucleoside%25252C%252BNucleotide%25252C%252Band%252BNon-Nucleoside%252BInhibitors%252Bof%252BHepatitis%252BC%252BVirus%252BNS5B%252BRNA-Dependent%252BRNA-Polymerase%26aulast%3DSofia%26aufirst%3DMichael%2BJ.%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D13102011%26date%3D23012012%26date%3D22032012%26date%3D16122011%26volume%3D55%26issue%3D6%26spage%3D2481%26epage%3D2531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kevin X.  Chen</span>, <span class="hlFld-ContribAuthor ">Charles A.  Lesburg</span>, <span class="hlFld-ContribAuthor ">Bancha  Vibulbhan</span>, <span class="hlFld-ContribAuthor ">Weiying  Yang</span>, <span class="hlFld-ContribAuthor ">Tin-Yau  Chan</span>, <span class="hlFld-ContribAuthor ">Srikanth  Venkatraman</span>, <span class="hlFld-ContribAuthor ">Francisco  Velazquez</span>, <span class="hlFld-ContribAuthor ">Qingbei  Zeng</span>, <span class="hlFld-ContribAuthor ">Frank  Bennett</span>, <span class="hlFld-ContribAuthor ">Gopinadhan N.  Anilkumar</span>, <span class="hlFld-ContribAuthor ">Jose  Duca</span>, <span class="hlFld-ContribAuthor ">Yueheng  Jiang</span>, <span class="hlFld-ContribAuthor ">Patrick  Pinto</span>, <span class="hlFld-ContribAuthor ">Li  Wang</span>, <span class="hlFld-ContribAuthor ">Yuhua  Huang</span>, <span class="hlFld-ContribAuthor ">Oleg  Selyutin</span>, <span class="hlFld-ContribAuthor ">Stephen  Gavalas</span>, <span class="hlFld-ContribAuthor ">Haiyan  Pu</span>, <span class="hlFld-ContribAuthor ">Sony  Agrawal</span>, <span class="hlFld-ContribAuthor ">Boris  Feld</span>, <span class="hlFld-ContribAuthor ">Hsueh-Cheng  Huang</span>, <span class="hlFld-ContribAuthor ">Cheng  Li</span>, <span class="hlFld-ContribAuthor ">Kuo-Chi  Cheng</span>, <span class="hlFld-ContribAuthor ">Neng-Yang  Shih</span>, <span class="hlFld-ContribAuthor ">Joseph A.  Kozlowski</span>, <span class="hlFld-ContribAuthor ">Stuart B.  Rosenblum</span>, and <span class="hlFld-ContribAuthor ">F. George  Njoroge</span>  . </span><span class="cited-content_cbyCitation_article-title">A Novel Class of Highly Potent Irreversible Hepatitis C Virus NS5B Polymerase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (5)
                                     , 2089-2101. <a href="https://doi.org/10.1021/jm201322r" title="DOI URL">https://doi.org/10.1021/jm201322r</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm201322r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm201322r%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252BNovel%252BClass%252Bof%252BHighly%252BPotent%252BIrreversible%252BHepatitis%252BC%252BVirus%252BNS5B%252BPolymerase%252BInhibitors%26aulast%3DChen%26aufirst%3DKevin%2BX.%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D03102011%26date%3D22022012%26date%3D08032012%26date%3D16012012%26volume%3D55%26issue%3D5%26spage%3D2089%26epage%3D2101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kevin X.  Chen</span>, <span class="hlFld-ContribAuthor ">Bancha  Vibulbhan</span>, <span class="hlFld-ContribAuthor ">Weiying  Yang</span>, <span class="hlFld-ContribAuthor ">Mousumi  Sannigrahi</span>, <span class="hlFld-ContribAuthor ">Francisco  Velazquez</span>, <span class="hlFld-ContribAuthor ">Tin-Yau  Chan</span>, <span class="hlFld-ContribAuthor ">Srikanth  Venkatraman</span>, <span class="hlFld-ContribAuthor ">Gopinadhan N.  Anilkumar</span>, <span class="hlFld-ContribAuthor ">Qingbei  Zeng</span>, <span class="hlFld-ContribAuthor ">Frank  Bennet</span>, <span class="hlFld-ContribAuthor ">Yueheng  Jiang</span>, <span class="hlFld-ContribAuthor ">Charles A.  Lesburg</span>, <span class="hlFld-ContribAuthor ">Jose  Duca</span>, <span class="hlFld-ContribAuthor ">Patrick  Pinto</span>, <span class="hlFld-ContribAuthor ">Stephen  Gavalas</span>, <span class="hlFld-ContribAuthor ">Yuhua  Huang</span>, <span class="hlFld-ContribAuthor ">Wanli  Wu</span>, <span class="hlFld-ContribAuthor ">Oleg  Selyutin</span>, <span class="hlFld-ContribAuthor ">Sony  Agrawal</span>, <span class="hlFld-ContribAuthor ">Boris  Feld</span>, <span class="hlFld-ContribAuthor ">Hsueh-Cheng  Huang</span>, <span class="hlFld-ContribAuthor ">Cheng  Li</span>, <span class="hlFld-ContribAuthor ">Kuo-Chi  Cheng</span>, <span class="hlFld-ContribAuthor ">Neng-Yang  Shih</span>, <span class="hlFld-ContribAuthor ">Joseph A.  Kozlowski</span>, <span class="hlFld-ContribAuthor ">Stuart B.  Rosenblum</span>, and <span class="hlFld-ContribAuthor ">F. George  Njoroge</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure–Activity Relationship (SAR) Development and Discovery of Potent Indole-Based Inhibitors of the Hepatitis C Virus (HCV) NS5B Polymerase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (2)
                                     , 754-765. <a href="https://doi.org/10.1021/jm201258k" title="DOI URL">https://doi.org/10.1021/jm201258k</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm201258k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm201258k%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure%2525E2%252580%252593Activity%252BRelationship%252B%252528SAR%252529%252BDevelopment%252Band%252BDiscovery%252Bof%252BPotent%252BIndole-Based%252BInhibitors%252Bof%252Bthe%252BHepatitis%252BC%252BVirus%252B%252528HCV%252529%252BNS5B%252BPolymerase%26aulast%3DChen%26aufirst%3DKevin%2BX.%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D20092011%26date%3D06012012%26date%3D26012012%26date%3D13122011%26volume%3D55%26issue%3D2%26spage%3D754%26epage%3D765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bruce S.  Ross</span>, <span class="hlFld-ContribAuthor ">P.  Ganapati Reddy</span>, <span class="hlFld-ContribAuthor ">Hai-Ren  Zhang</span>, <span class="hlFld-ContribAuthor ">Suguna  Rachakonda</span>, and <span class="hlFld-ContribAuthor ">Michael J.  Sofia</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis of Diastereomerically Pure Nucleotide Phosphoramidates. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2011,</strong> <em>76 </em>
                                    (20)
                                     , 8311-8319. <a href="https://doi.org/10.1021/jo201492m" title="DOI URL">https://doi.org/10.1021/jo201492m</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo201492m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo201492m%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252BDiastereomerically%252BPure%252BNucleotide%252BPhosphoramidates%26aulast%3DRoss%26aufirst%3DBruce%2BS.%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D18072011%26date%3D26092011%26date%3D21102011%26date%3D14092011%26volume%3D76%26issue%3D20%26spage%3D8311%26epage%3D8319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">P. Ganapati  Reddy</span>, <span class="hlFld-ContribAuthor ">Byoung-Kwon  Chun</span>, <span class="hlFld-ContribAuthor ">Hai-Ren  Zhang</span>, <span class="hlFld-ContribAuthor ">Suguna  Rachakonda</span>, <span class="hlFld-ContribAuthor ">Bruce S.  Ross</span>, and <span class="hlFld-ContribAuthor ">Michael J.  Sofia</span>  . </span><span class="cited-content_cbyCitation_article-title">Stereoselective Synthesis of PSI-352938: A β-d-2′-Deoxy-2′-α-fluoro-2′-β-C-methyl-3′,5′-cyclic Phosphate Nucleotide Prodrug for the Treatment of HCV. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2011,</strong> <em>76 </em>
                                    (10)
                                     , 3782-3790. <a href="https://doi.org/10.1021/jo200060f" title="DOI URL">https://doi.org/10.1021/jo200060f</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo200060f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo200060f%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DStereoselective%252BSynthesis%252Bof%252BPSI-352938%25253A%252BA%252B%2525CE%2525B2-d-2%2525E2%252580%2525B2-Deoxy-2%2525E2%252580%2525B2-%2525CE%2525B1-fluoro-2%2525E2%252580%2525B2-%2525CE%2525B2-C-methyl-3%2525E2%252580%2525B2%25252C5%2525E2%252580%2525B2-cyclic%252BPhosphate%252BNucleotide%252BProdrug%252Bfor%252Bthe%252BTreatment%252Bof%252BHCV%26aulast%3DReddy%26aufirst%3DP.%2BGanapati%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D13012011%26date%3D19042011%26date%3D20052011%26date%3D06042011%26volume%3D76%26issue%3D10%26spage%3D3782%26epage%3D3790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wonsuk  Chang</span>, <span class="hlFld-ContribAuthor ">Donghui  Bao</span>, <span class="hlFld-ContribAuthor ">Byoung-Kwon  Chun</span>, <span class="hlFld-ContribAuthor ">Devan  Naduthambi</span>, <span class="hlFld-ContribAuthor ">Dhanapalan  Nagarathnam</span>, <span class="hlFld-ContribAuthor ">Suguna  Rachakonda</span>, <span class="hlFld-ContribAuthor ">P. Ganapati  Reddy</span>, <span class="hlFld-ContribAuthor ">Bruce S.  Ross</span>, <span class="hlFld-ContribAuthor ">Hai-Ren  Zhang</span>, <span class="hlFld-ContribAuthor ">Shalini  Bansal</span>, <span class="hlFld-ContribAuthor ">Christine L.  Espiritu</span>, <span class="hlFld-ContribAuthor ">Meg  Keilman</span>, <span class="hlFld-ContribAuthor ">Angela M.  Lam</span>, <span class="hlFld-ContribAuthor ">Congrong  Niu</span>, <span class="hlFld-ContribAuthor ">Holly Micolochick  Steuer</span>, <span class="hlFld-ContribAuthor ">Phillip A.  Furman</span>, <span class="hlFld-ContribAuthor ">Michael J.  Otto</span>, and <span class="hlFld-ContribAuthor ">Michael J.  Sofia</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of PSI-353661, a Novel Purine Nucleotide Prodrug for the Treatment of HCV Infection. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>2 </em>
                                    (2)
                                     , 130-135. <a href="https://doi.org/10.1021/ml100209f" title="DOI URL">https://doi.org/10.1021/ml100209f</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml100209f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml100209f%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BPSI-353661%25252C%252Ba%252BNovel%252BPurine%252BNucleotide%252BProdrug%252Bfor%252Bthe%252BTreatment%252Bof%252BHCV%252BInfection%26aulast%3DChang%26aufirst%3DWonsuk%26date%3D2011%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D10092010%26date%3D08122010%26date%3D17122010%26date%3D10022011%26volume%3D2%26issue%3D2%26spage%3D130%26epage%3D135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ilaria  Vicenti</span>, <span class="hlFld-ContribAuthor ">Maria Grazia  Martina</span>, <span class="hlFld-ContribAuthor ">Adele  Boccuto</span>, <span class="hlFld-ContribAuthor ">Marta  De Angelis</span>, <span class="hlFld-ContribAuthor ">Giorgia  Giavarini</span>, <span class="hlFld-ContribAuthor ">Filippo  Dragoni</span>, <span class="hlFld-ContribAuthor ">Serena  Marchi</span>, <span class="hlFld-ContribAuthor ">Claudia Maria  Trombetta</span>, <span class="hlFld-ContribAuthor ">Emmanuele  Crespan</span>, <span class="hlFld-ContribAuthor ">Giovanni  Maga</span>, <span class="hlFld-ContribAuthor ">Cecilia  Eydoux</span>, <span class="hlFld-ContribAuthor ">Etienne  Decroly</span>, <span class="hlFld-ContribAuthor ">Emanuele  Montomoli</span>, <span class="hlFld-ContribAuthor ">Lucia  Nencioni</span>, <span class="hlFld-ContribAuthor ">Maurizio  Zazzi</span>, <span class="hlFld-ContribAuthor ">Marco  Radi</span>. </span><span class="cited-content_cbyCitation_article-title">System-oriented optimization of multi-target 2,6-diaminopurine derivatives: Easily accessible broad-spectrum antivirals active against flaviviruses, influenza virus and SARS-CoV-2. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>224 </em>, 113683. <a href="https://doi.org/10.1016/j.ejmech.2021.113683" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113683</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113683&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113683%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSystem-oriented%252Boptimization%252Bof%252Bmulti-target%252B2%25252C6-diaminopurine%252Bderivatives%25253A%252BEasily%252Baccessible%252Bbroad-spectrum%252Bantivirals%252Bactive%252Bagainst%252Bflaviviruses%25252C%252Binfluenza%252Bvirus%252Band%252BSARS-CoV-2%26aulast%3DVicenti%26aufirst%3DIlaria%26date%3D2021%26volume%3D224%26spage%3D113683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kuan-Ju  Chen</span>, <span class="hlFld-ContribAuthor ">Adam J.  Plaunt</span>, <span class="hlFld-ContribAuthor ">Franziska G.  Leifer</span>, <span class="hlFld-ContribAuthor ">Jeong Yeon  Kang</span>, <span class="hlFld-ContribAuthor ">David  Cipolla</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in prodrug-based nanoparticle therapeutics. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutics and Biopharmaceutics</span><span> <strong>2021,</strong> <em>165 </em>, 219-243. <a href="https://doi.org/10.1016/j.ejpb.2021.04.025" title="DOI URL">https://doi.org/10.1016/j.ejpb.2021.04.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejpb.2021.04.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejpb.2021.04.025%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutics%2520and%2520Biopharmaceutics%26atitle%3DRecent%252Badvances%252Bin%252Bprodrug-based%252Bnanoparticle%252Btherapeutics%26aulast%3DChen%26aufirst%3DKuan-Ju%26date%3D2021%26volume%3D165%26spage%3D219%26epage%3D243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert M  Cox</span>, <span class="hlFld-ContribAuthor ">Richard K  Plemper</span>. </span><span class="cited-content_cbyCitation_article-title">The impact of high-resolution structural data on stemming the COVID-19 pandemic. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Virology</span><span> <strong>2021,</strong> <em>49 </em>, 127-138. <a href="https://doi.org/10.1016/j.coviro.2021.05.005" title="DOI URL">https://doi.org/10.1016/j.coviro.2021.05.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.coviro.2021.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.coviro.2021.05.005%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Virology%26atitle%3DThe%252Bimpact%252Bof%252Bhigh-resolution%252Bstructural%252Bdata%252Bon%252Bstemming%252Bthe%252BCOVID-19%252Bpandemic%26aulast%3DCox%26aufirst%3DRobert%2BM%26date%3D2021%26volume%3D49%26spage%3D127%26epage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">José J.  García-Trejo</span>, <span class="hlFld-ContribAuthor ">Raquel  Ortega</span>, <span class="hlFld-ContribAuthor ">Mariel  Zarco-Zavala</span>. </span><span class="cited-content_cbyCitation_article-title">Putative Repurposing of Lamivudine, a Nucleoside/Nucleotide Analogue and Antiretroviral to Improve the Outcome of Cancer and COVID-19 Patients. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Oncology</span><span> <strong>2021,</strong> <em>11 </em><a href="https://doi.org/10.3389/fonc.2021.664794" title="DOI URL">https://doi.org/10.3389/fonc.2021.664794</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fonc.2021.664794&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffonc.2021.664794%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Oncology%26atitle%3DPutative%252BRepurposing%252Bof%252BLamivudine%25252C%252Ba%252BNucleoside%25252FNucleotide%252BAnalogue%252Band%252BAntiretroviral%252Bto%252BImprove%252Bthe%252BOutcome%252Bof%252BCancer%252Band%252BCOVID-19%252BPatients%26aulast%3DGarc%25C3%25ADa-Trejo%26aufirst%3DJos%25C3%25A9%2BJ.%26date%3D2021%26date%3D2021%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pearson  Balatow</span>, <span class="hlFld-ContribAuthor ">Amber  Sandlin</span>, <span class="hlFld-ContribAuthor ">Theodore James  Cory</span>. </span><span class="cited-content_cbyCitation_article-title">An evaluation of ledipasvir + sofosbuvir for the treatment of chronic Hepatitis C infection. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Pharmacotherapy</span><span> <strong>2021,</strong> <em> </em><a href="https://doi.org/10.1080/14656566.2021.1943359" title="DOI URL">https://doi.org/10.1080/14656566.2021.1943359</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14656566.2021.1943359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14656566.2021.1943359%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Pharmacotherapy%26atitle%3DAn%252Bevaluation%252Bof%252Bledipasvir%252B%25252B%252Bsofosbuvir%252Bfor%252Bthe%252Btreatment%252Bof%252Bchronic%252BHepatitis%252BC%252Binfection%26aulast%3DBalatow%26aufirst%3DPearson%26date%3D2021%26date%3D2021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiashu  Xie</span>, <span class="hlFld-ContribAuthor ">Zhengqiang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Can remdesivir and its parent nucleoside GS-441524 be potential oral drugs? An in vitro and in vivo DMPK assessment. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2021,</strong> <em>11 </em>
                                    (6)
                                     , 1607-1616. <a href="https://doi.org/10.1016/j.apsb.2021.03.028" title="DOI URL">https://doi.org/10.1016/j.apsb.2021.03.028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2021.03.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2021.03.028%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DCan%252Bremdesivir%252Band%252Bits%252Bparent%252Bnucleoside%252BGS-441524%252Bbe%252Bpotential%252Boral%252Bdrugs%25253F%252BAn%252Bin%2525C2%2525A0vitro%252Band%252Bin%2525C2%2525A0vivo%252BDMPK%252Bassessment%26aulast%3DXie%26aufirst%3DJiashu%26date%3D2021%26volume%3D11%26issue%3D6%26spage%3D1607%26epage%3D1616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yawen  Yu</span>, <span class="hlFld-ContribAuthor ">Liangxiao  Wang</span>, <span class="hlFld-ContribAuthor ">Junping  Han</span>, <span class="hlFld-ContribAuthor ">Aiping  Wang</span>, <span class="hlFld-ContribAuthor ">Liuxiang  Chu</span>, <span class="hlFld-ContribAuthor ">Xinran  Xi</span>, <span class="hlFld-ContribAuthor ">Ronglin  Kan</span>, <span class="hlFld-ContribAuthor ">Chunjie  Sha</span>, <span class="hlFld-ContribAuthor ">Kaoxiang  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Characterization of a Series of Temozolomide Esters and Its Anti-glioma Study. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmaceutical Sciences</span><span> <strong>2021,</strong> <em>19 </em><a href="https://doi.org/10.1016/j.xphs.2021.06.025" title="DOI URL">https://doi.org/10.1016/j.xphs.2021.06.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.xphs.2021.06.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.xphs.2021.06.025%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DSynthesis%252Band%252BCharacterization%252Bof%252Ba%252BSeries%252Bof%252BTemozolomide%252BEsters%252Band%252BIts%252BAnti-glioma%252BStudy%26aulast%3DYu%26aufirst%3DYawen%26date%3D2021%26volume%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michaela  Serpi</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Pertusati</span>. </span><span class="cited-content_cbyCitation_article-title">An overview of ProTide technology and its implications to drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2021,</strong> <em>87 </em>, 1-13. <a href="https://doi.org/10.1080/17460441.2021.1922385" title="DOI URL">https://doi.org/10.1080/17460441.2021.1922385</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2021.1922385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2021.1922385%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DAn%252Boverview%252Bof%252BProTide%252Btechnology%252Band%252Bits%252Bimplications%252Bto%252Bdrug%252Bdiscovery%26aulast%3DSerpi%26aufirst%3DMichaela%26date%3D2021%26date%3D2021%26volume%3D87%26spage%3D1%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alsu Z.  Malikova</span>, <span class="hlFld-ContribAuthor ">Anastasia S.  Shcherbakova</span>, <span class="hlFld-ContribAuthor ">Konstantin A.  Konduktorov</span>, <span class="hlFld-ContribAuthor ">Anastasia S.  Zemskaya</span>, <span class="hlFld-ContribAuthor ">Alexandra A.  Dalina</span>, <span class="hlFld-ContribAuthor ">Vladimir I.  Popenko</span>, <span class="hlFld-ContribAuthor ">Olga G.  Leonova</span>, <span class="hlFld-ContribAuthor ">Alexei V.  Morozov</span>, <span class="hlFld-ContribAuthor ">Nikolay N.  Kurochkin</span>, <span class="hlFld-ContribAuthor ">Olga A.  Smirnova</span>, <span class="hlFld-ContribAuthor ">Sergey N.  Kochetkov</span>, <span class="hlFld-ContribAuthor ">Maxim V.  Kozlov</span>. </span><span class="cited-content_cbyCitation_article-title">Pre-Senescence Induction in Hepatoma Cells Favors Hepatitis C Virus Replication and Can Be Used in Exploring Antiviral Potential of Histone Deacetylase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (9)
                                     , 4559. <a href="https://doi.org/10.3390/ijms22094559" title="DOI URL">https://doi.org/10.3390/ijms22094559</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22094559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22094559%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DPre-Senescence%252BInduction%252Bin%252BHepatoma%252BCells%252BFavors%252BHepatitis%252BC%252BVirus%252BReplication%252Band%252BCan%252BBe%252BUsed%252Bin%252BExploring%252BAntiviral%252BPotential%252Bof%252BHistone%252BDeacetylase%252BInhibitors%26aulast%3DMalikova%26aufirst%3DAlsu%2BZ.%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D9%26spage%3D4559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Evelyn J.  Franco</span>, <span class="hlFld-ContribAuthor ">Camilly P.  Pires de Mello</span>, <span class="hlFld-ContribAuthor ">Ashley N.  Brown</span>. </span><span class="cited-content_cbyCitation_article-title">Antiviral Evaluation of UV-4B and Interferon-Alpha Combination Regimens against Dengue Virus. </span><span class="cited-content_cbyCitation_journal-name">Viruses</span><span> <strong>2021,</strong> <em>13 </em>
                                    (5)
                                     , 771. <a href="https://doi.org/10.3390/v13050771" title="DOI URL">https://doi.org/10.3390/v13050771</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/v13050771&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fv13050771%26sid%3Dliteratum%253Aachs%26jtitle%3DViruses%26atitle%3DAntiviral%252BEvaluation%252Bof%252BUV-4B%252Band%252BInterferon-Alpha%252BCombination%252BRegimens%252Bagainst%252BDengue%252BVirus%26aulast%3DFranco%26aufirst%3DEvelyn%2BJ.%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D5%26spage%3D771" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leonardo L.G.  Ferreira</span>, <span class="hlFld-ContribAuthor ">Adriano D.  Andricopulo</span>. </span><span class="cited-content_cbyCitation_article-title">Structure‐Based Drug Design. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-54. <a href="https://doi.org/10.1002/0471266949.bmc141.pub2" title="DOI URL">https://doi.org/10.1002/0471266949.bmc141.pub2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc141.pub2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc141.pub2%26sid%3Dliteratum%253Aachs%26atitle%3DStructure%2525E2%252580%252590Based%252BDrug%252BDesign%26aulast%3DFerreira%26aufirst%3DLeonardo%2BL.G.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D54%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rahul  Kumar</span>, <span class="hlFld-ContribAuthor ">Sahil  Mishra</span>, <span class="hlFld-ContribAuthor ">Shreya</span>, <span class="hlFld-ContribAuthor ">Sushil K.  Maurya</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the discovery of potent RNA-dependent RNA-polymerase (RdRp) inhibitors targeting viruses. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2021,</strong> <em>12 </em>
                                    (3)
                                     , 306-320. <a href="https://doi.org/10.1039/D0MD00318B" title="DOI URL">https://doi.org/10.1039/D0MD00318B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0MD00318B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0MD00318B%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bdiscovery%252Bof%252Bpotent%252BRNA-dependent%252BRNA-polymerase%252B%252528RdRp%252529%252Binhibitors%252Btargeting%252Bviruses%26aulast%3DKumar%26aufirst%3DRahul%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D3%26spage%3D306%26epage%3D320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert J.  Geraghty</span>, <span class="hlFld-ContribAuthor ">Matthew T.  Aliota</span>, <span class="hlFld-ContribAuthor ">Laurent F.  Bonnac</span>. </span><span class="cited-content_cbyCitation_article-title">Broad-Spectrum Antiviral Strategies and Nucleoside Analogues. </span><span class="cited-content_cbyCitation_journal-name">Viruses</span><span> <strong>2021,</strong> <em>13 </em>
                                    (4)
                                     , 667. <a href="https://doi.org/10.3390/v13040667" title="DOI URL">https://doi.org/10.3390/v13040667</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/v13040667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fv13040667%26sid%3Dliteratum%253Aachs%26jtitle%3DViruses%26atitle%3DBroad-Spectrum%252BAntiviral%252BStrategies%252Band%252BNucleoside%252BAnalogues%26aulast%3DGeraghty%26aufirst%3DRobert%2BJ.%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D4%26spage%3D667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vladimir E.  Kataev</span>, <span class="hlFld-ContribAuthor ">Bulat F.  Garifullin</span>. </span><span class="cited-content_cbyCitation_article-title">Antiviral nucleoside analogs. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2021,</strong> <em>57 </em>
                                    (4)
                                     , 326-341. <a href="https://doi.org/10.1007/s10593-021-02912-8" title="DOI URL">https://doi.org/10.1007/s10593-021-02912-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-021-02912-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-021-02912-8%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DAntiviral%252Bnucleoside%252Banalogs%26aulast%3DKataev%26aufirst%3DVladimir%2BE.%26date%3D2021%26date%3D2021%26volume%3D57%26issue%3D4%26spage%3D326%26epage%3D341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Tian</span>, <span class="hlFld-ContribAuthor ">Taotao  Qiang</span>, <span class="hlFld-ContribAuthor ">Chengyuan  Liang</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Ren</span>, <span class="hlFld-ContribAuthor ">Minyi  Jia</span>, <span class="hlFld-ContribAuthor ">Jiayun  Zhang</span>, <span class="hlFld-ContribAuthor ">Jingyi  Li</span>, <span class="hlFld-ContribAuthor ">Minge  Wan</span>, <span class="hlFld-ContribAuthor ">Xin  YuWen</span>, <span class="hlFld-ContribAuthor ">Han  Li</span>, <span class="hlFld-ContribAuthor ">Wenqiang  Cao</span>, <span class="hlFld-ContribAuthor ">Hong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">RNA-dependent RNA polymerase (RdRp) inhibitors: The current landscape and repurposing for the COVID-19 pandemic. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>213 </em>, 113201. <a href="https://doi.org/10.1016/j.ejmech.2021.113201" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113201</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113201%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRNA-dependent%252BRNA%252Bpolymerase%252B%252528RdRp%252529%252Binhibitors%25253A%252BThe%252Bcurrent%252Blandscape%252Band%252Brepurposing%252Bfor%252Bthe%252BCOVID-19%252Bpandemic%26aulast%3DTian%26aufirst%3DLei%26date%3D2021%26volume%3D213%26spage%3D113201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark A.  Vanden Avond</span>, <span class="hlFld-ContribAuthor ">Hui  Meng</span>, <span class="hlFld-ContribAuthor ">Margaret J.  Beatka</span>, <span class="hlFld-ContribAuthor ">Daniel C.  Helbling</span>, <span class="hlFld-ContribAuthor ">Mariah J.  Prom</span>, <span class="hlFld-ContribAuthor ">Jessica L.  Sutton</span>, <span class="hlFld-ContribAuthor ">Rebecca A.  Slick</span>, <span class="hlFld-ContribAuthor ">David P.  Dimmock</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Pertusati</span>, <span class="hlFld-ContribAuthor ">Michaela  Serpi</span>, <span class="hlFld-ContribAuthor ">Elisa  Pileggi</span>, <span class="hlFld-ContribAuthor ">Patrick  Crutcher</span>, <span class="hlFld-ContribAuthor ">Stephen  Thomas</span>, <span class="hlFld-ContribAuthor ">Michael W.  Lawlor</span>. </span><span class="cited-content_cbyCitation_article-title">The nucleotide prodrug
              CERC
              ‐913 improves
              mtDNA
              content in primary hepatocytes from
              DGUOK‐deficient
              rats. </span><span class="cited-content_cbyCitation_journal-name">Journal of Inherited Metabolic Disease</span><span> <strong>2021,</strong> <em>44 </em>
                                    (2)
                                     , 492-501. <a href="https://doi.org/10.1002/jimd.12354" title="DOI URL">https://doi.org/10.1002/jimd.12354</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jimd.12354&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjimd.12354%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Inherited%2520Metabolic%2520Disease%26atitle%3DThe%252Bnucleotide%252Bprodrug%252BCERC%252B%2525E2%252580%252590913%252Bimproves%252BmtDNA%252Bcontent%252Bin%252Bprimary%252Bhepatocytes%252Bfrom%252BDGUOK%2525E2%252580%252590deficient%252Brats%26aulast%3DVanden%2BAvond%26aufirst%3DMark%2BA.%26date%3D2021%26date%3D2021%26volume%3D44%26issue%3D2%26spage%3D492%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Debarshi  Chakraborty</span>, <span class="hlFld-ContribAuthor ">Hadi  Gholami</span>, <span class="hlFld-ContribAuthor ">Aritra  Sarkar</span>, <span class="hlFld-ContribAuthor ">Leo A.  Joyce</span>, <span class="hlFld-ContribAuthor ">James E.  Jackson</span>, <span class="hlFld-ContribAuthor ">Babak  Borhan</span>. </span><span class="cited-content_cbyCitation_article-title">A chiroptical approach for the absolute stereochemical determination of
              P
              -stereogenic centers. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2021,</strong> <em>12 </em>
                                    (5)
                                     , 1750-1755. <a href="https://doi.org/10.1039/D0SC02940H" title="DOI URL">https://doi.org/10.1039/D0SC02940H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0SC02940H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0SC02940H%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DA%252Bchiroptical%252Bapproach%252Bfor%252Bthe%252Babsolute%252Bstereochemical%252Bdetermination%252Bof%252BP%252B-stereogenic%252Bcenters%26aulast%3DChakraborty%26aufirst%3DDebarshi%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D5%26spage%3D1750%26epage%3D1755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yang  Xi</span>, <span class="hlFld-ContribAuthor ">Chenchen  Wang</span>, <span class="hlFld-ContribAuthor ">Qian  Zhang</span>, <span class="hlFld-ContribAuthor ">Jingping  Qu</span>, <span class="hlFld-ContribAuthor ">Yifeng  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium‐Catalyzed Regio‐, Diastereo‐, and Enantioselective 1,2‐Arylfluorination of Internal Enamides. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2021,</strong> <em>133 </em>
                                    (5)
                                     , 2731-2735. <a href="https://doi.org/10.1002/ange.202012882" title="DOI URL">https://doi.org/10.1002/ange.202012882</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.202012882&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.202012882%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DPalladium%2525E2%252580%252590Catalyzed%252BRegio%2525E2%252580%252590%25252C%252BDiastereo%2525E2%252580%252590%25252C%252Band%252BEnantioselective%252B1%25252C2%2525E2%252580%252590Arylfluorination%252Bof%252BInternal%252BEnamides%26aulast%3DXi%26aufirst%3DYang%26date%3D2021%26date%3D2020%26volume%3D133%26issue%3D5%26spage%3D2731%26epage%3D2735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yang  Xi</span>, <span class="hlFld-ContribAuthor ">Chenchen  Wang</span>, <span class="hlFld-ContribAuthor ">Qian  Zhang</span>, <span class="hlFld-ContribAuthor ">Jingping  Qu</span>, <span class="hlFld-ContribAuthor ">Yifeng  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium‐Catalyzed Regio‐, Diastereo‐, and Enantioselective 1,2‐Arylfluorination of Internal Enamides. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2021,</strong> <em>60 </em>
                                    (5)
                                     , 2699-2703. <a href="https://doi.org/10.1002/anie.202012882" title="DOI URL">https://doi.org/10.1002/anie.202012882</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.202012882&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.202012882%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DPalladium%2525E2%252580%252590Catalyzed%252BRegio%2525E2%252580%252590%25252C%252BDiastereo%2525E2%252580%252590%25252C%252Band%252BEnantioselective%252B1%25252C2%2525E2%252580%252590Arylfluorination%252Bof%252BInternal%252BEnamides%26aulast%3DXi%26aufirst%3DYang%26date%3D2021%26date%3D2020%26volume%3D60%26issue%3D5%26spage%3D2699%26epage%3D2703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pooneh  Rahimi</span>, <span class="hlFld-ContribAuthor ">Heidar  Sharafi</span>, <span class="hlFld-ContribAuthor ">Golnaz  Bahramali</span>, <span class="hlFld-ContribAuthor ">FaridehSadat  SajadianFard</span>, <span class="hlFld-ContribAuthor ">Nafiseh Sadat  Asadi</span>, <span class="hlFld-ContribAuthor ">Seyed Moayed  Alavian</span>, <span class="hlFld-ContribAuthor ">Vahid  Iranpur Mobarakeh</span>, <span class="hlFld-ContribAuthor ">Seyedeh Zahra  Moravej</span>. </span><span class="cited-content_cbyCitation_article-title">Prevalence of Naturally-Occurring NS5A and NS5B Resistance-Associated Substitutions in Iranian Patients With Chronic Hepatitis C Infection. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Microbiology</span><span> <strong>2021,</strong> <em>11 </em><a href="https://doi.org/10.3389/fmicb.2020.617375" title="DOI URL">https://doi.org/10.3389/fmicb.2020.617375</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fmicb.2020.617375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffmicb.2020.617375%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Microbiology%26atitle%3DPrevalence%252Bof%252BNaturally-Occurring%252BNS5A%252Band%252BNS5B%252BResistance-Associated%252BSubstitutions%252Bin%252BIranian%252BPatients%252BWith%252BChronic%252BHepatitis%252BC%252BInfection%26aulast%3DRahimi%26aufirst%3DPooneh%26date%3D2021%26date%3D2021%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luděk  Eyer</span>, <span class="hlFld-ContribAuthor ">Pavel  Svoboda</span>, <span class="hlFld-ContribAuthor ">Jan  Balvan</span>, <span class="hlFld-ContribAuthor ">Tomáš  Vičar</span>, <span class="hlFld-ContribAuthor ">Matina  Raudenská</span>, <span class="hlFld-ContribAuthor ">Michal  Štefánik</span>, <span class="hlFld-ContribAuthor ">Jan  Haviernik</span>, <span class="hlFld-ContribAuthor ">Ivana  Huvarová</span>, <span class="hlFld-ContribAuthor ">Petra  Straková</span>, <span class="hlFld-ContribAuthor ">Ivo  Rudolf</span>, <span class="hlFld-ContribAuthor ">Zdeněk  Hubálek</span>, <span class="hlFld-ContribAuthor ">Katherine  Seley-Radtke</span>, <span class="hlFld-ContribAuthor ">Erik  de Clercq</span>, <span class="hlFld-ContribAuthor ">Daniel  Růžek</span>. </span><span class="cited-content_cbyCitation_article-title">Broad-Spectrum Antiviral Activity of 3′-Deoxy-3′-Fluoroadenosine against Emerging Flaviviruses. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2021,</strong> <em>65 </em>
                                    (2)
                                     <a href="https://doi.org/10.1128/AAC.01522-20" title="DOI URL">https://doi.org/10.1128/AAC.01522-20</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.01522-20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.01522-20%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DBroad-Spectrum%252BAntiviral%252BActivity%252Bof%252B3%2525E2%252580%2525B2-Deoxy-3%2525E2%252580%2525B2-Fluoroadenosine%252Bagainst%252BEmerging%252BFlaviviruses%26aulast%3DEyer%26aufirst%3DLud%25C4%259Bk%26date%3D2021%26volume%3D65%26issue%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianyang  Han</span>, <span class="hlFld-ContribAuthor ">Christina  Funk</span>, <span class="hlFld-ContribAuthor ">Juri  Eyberg</span>, <span class="hlFld-ContribAuthor ">Susanne  Bailer</span>, <span class="hlFld-ContribAuthor ">Clemens  Richert</span>. </span><span class="cited-content_cbyCitation_article-title">An AZT Analog with Strongly Pairing Ethynylpyridone Nucleobase and Its Antiviral Activity against HSV1. </span><span class="cited-content_cbyCitation_journal-name">Chemistry & Biodiversity</span><span> <strong>2021,</strong> <em>18 </em>
                                    (1)
                                     <a href="https://doi.org/10.1002/cbdv.202000937" title="DOI URL">https://doi.org/10.1002/cbdv.202000937</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbdv.202000937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbdv.202000937%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%2526%2520Biodiversity%26atitle%3DAn%252BAZT%252BAnalog%252Bwith%252BStrongly%252BPairing%252BEthynylpyridone%252BNucleobase%252Band%252BIts%252BAntiviral%252BActivity%252Bagainst%252BHSV1%26aulast%3DHan%26aufirst%3DJianyang%26date%3D2021%26date%3D2020%26volume%3D18%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">E. J.  Lim</span>, <span class="hlFld-ContribAuthor ">J.  Torresi</span>. </span><span class="cited-content_cbyCitation_article-title">Prevention of Hepatitis C Virus Infection and Liver Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 107-140. <a href="https://doi.org/10.1007/978-3-030-57362-1_6" title="DOI URL">https://doi.org/10.1007/978-3-030-57362-1_6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-57362-1_6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-57362-1_6%26sid%3Dliteratum%253Aachs%26atitle%3DPrevention%252Bof%252BHepatitis%252BC%252BVirus%252BInfection%252Band%252BLiver%252BCancer%26aulast%3DLim%26aufirst%3DE.%2BJ.%26date%3D2021%26date%3D2020%26spage%3D107%26epage%3D140%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DViruses%252Band%252BHuman%252BCancer%26aulast%3DWu%26aufirst%3DT.-C.%26date%3D2021%26volume%3D217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao-huan  Liu</span>, <span class="hlFld-ContribAuthor ">Xiao  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhen-hua  Lu</span>, <span class="hlFld-ContribAuthor ">You-shuang  Zhu</span>, <span class="hlFld-ContribAuthor ">Tao  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Potential molecular targets of nonstructural proteins for the development of antiviral drugs against SARS-CoV-2 infection. </span><span class="cited-content_cbyCitation_journal-name">Biomedicine & Pharmacotherapy</span><span> <strong>2021,</strong> <em>133 </em>, 111035. <a href="https://doi.org/10.1016/j.biopha.2020.111035" title="DOI URL">https://doi.org/10.1016/j.biopha.2020.111035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biopha.2020.111035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biopha.2020.111035%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicine%2520%2526%2520Pharmacotherapy%26atitle%3DPotential%252Bmolecular%252Btargets%252Bof%252Bnonstructural%252Bproteins%252Bfor%252Bthe%252Bdevelopment%252Bof%252Bantiviral%252Bdrugs%252Bagainst%252BSARS-CoV-2%252Binfection%26aulast%3DLiu%26aufirst%3DXiao-huan%26date%3D2021%26volume%3D133%26spage%3D111035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rachel E.  Barenie</span>, <span class="hlFld-ContribAuthor ">Jerry  Avorn</span>, <span class="hlFld-ContribAuthor ">Frazer A.  Tessema</span>, <span class="hlFld-ContribAuthor ">Aaron S.  Kesselheim</span>. </span><span class="cited-content_cbyCitation_article-title">Public funding for transformative drugs: the case of sofosbuvir. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2021,</strong> <em>26 </em>
                                    (1)
                                     , 273-281. <a href="https://doi.org/10.1016/j.drudis.2020.09.024" title="DOI URL">https://doi.org/10.1016/j.drudis.2020.09.024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2020.09.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2020.09.024%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DPublic%252Bfunding%252Bfor%252Btransformative%252Bdrugs%25253A%252Bthe%252Bcase%252Bof%252Bsofosbuvir%26aulast%3DBarenie%26aufirst%3DRachel%2BE.%26date%3D2021%26volume%3D26%26issue%3D1%26spage%3D273%26epage%3D281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jingyue  Ju</span>, <span class="hlFld-ContribAuthor ">Xiaoxu  Li</span>, <span class="hlFld-ContribAuthor ">Shiv  Kumar</span>, <span class="hlFld-ContribAuthor ">Steffen  Jockusch</span>, <span class="hlFld-ContribAuthor ">Minchen  Chien</span>, <span class="hlFld-ContribAuthor ">Chuanjuan  Tao</span>, <span class="hlFld-ContribAuthor ">Irina  Morozova</span>, <span class="hlFld-ContribAuthor ">Sergey  Kalachikov</span>, <span class="hlFld-ContribAuthor ">Robert N.  Kirchdoerfer</span>, <span class="hlFld-ContribAuthor ">James J.  Russo</span>. </span><span class="cited-content_cbyCitation_article-title">Nucleotide analogues as inhibitors of SARS‐CoV Polymerase. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology Research & Perspectives</span><span> <strong>2020,</strong> <em>8 </em>
                                    (6)
                                     <a href="https://doi.org/10.1002/prp2.674" title="DOI URL">https://doi.org/10.1002/prp2.674</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/prp2.674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fprp2.674%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520Research%2520%2526%2520Perspectives%26atitle%3DNucleotide%252Banalogues%252Bas%252Binhibitors%252Bof%252BSARS%2525E2%252580%252590CoV%252BPolymerase%26aulast%3DJu%26aufirst%3DJingyue%26date%3D2020%26date%3D2020%26volume%3D8%26issue%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicky  Hwang</span>, <span class="hlFld-ContribAuthor ">Yonggang  Pei</span>, <span class="hlFld-ContribAuthor ">Jason  Clement</span>, <span class="hlFld-ContribAuthor ">Erle S.  Robertson</span>, <span class="hlFld-ContribAuthor ">Yanming  Du</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of a 3-β-homoalanine conjugate of brusatol with reduced toxicity in mice. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (23)
                                     , 127553. <a href="https://doi.org/10.1016/j.bmcl.2020.127553" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127553</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127553%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252Ba%252B3-%2525CE%2525B2-homoalanine%252Bconjugate%252Bof%252Bbrusatol%252Bwith%252Breduced%252Btoxicity%252Bin%252Bmice%26aulast%3DHwang%26aufirst%3DNicky%26date%3D2020%26volume%3D30%26issue%3D23%26spage%3D127553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Victoria C.  Yan</span>, <span class="hlFld-ContribAuthor ">Cong-Dat  Pham</span>, <span class="hlFld-ContribAuthor ">Kenisha  Arthur</span>, <span class="hlFld-ContribAuthor ">Kristine L.  Yang</span>, <span class="hlFld-ContribAuthor ">Florian L.  Muller</span>. </span><span class="cited-content_cbyCitation_article-title">Aliphatic amines are viable pro-drug moieties in phosphonoamidate drugs. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (24)
                                     , 127656. <a href="https://doi.org/10.1016/j.bmcl.2020.127656" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127656</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127656%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAliphatic%252Bamines%252Bare%252Bviable%252Bpro-drug%252Bmoieties%252Bin%252Bphosphonoamidate%252Bdrugs%26aulast%3DYan%26aufirst%3DVictoria%2BC.%26date%3D2020%26volume%3D30%26issue%3D24%26spage%3D127656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amany A.  Sakr</span>, <span class="hlFld-ContribAuthor ">Amr E.  Ahmed</span>, <span class="hlFld-ContribAuthor ">Mohamed D.E.  Abd El-Maksoud</span>, <span class="hlFld-ContribAuthor ">Amany  Gamal</span>, <span class="hlFld-ContribAuthor ">Hasan  El-garem</span>, <span class="hlFld-ContribAuthor ">Osama M.  Ahmed</span>. </span><span class="cited-content_cbyCitation_article-title">Interferon lambda 4 gene polymorphisms as a predicting tool of response to hepatitis C virus genotype 4 patients treated with Sofosbuvir and Ribavirin. </span><span class="cited-content_cbyCitation_journal-name">Infection, Genetics and Evolution</span><span> <strong>2020,</strong> <em>86 </em>, 104606. <a href="https://doi.org/10.1016/j.meegid.2020.104606" title="DOI URL">https://doi.org/10.1016/j.meegid.2020.104606</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.meegid.2020.104606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.meegid.2020.104606%26sid%3Dliteratum%253Aachs%26jtitle%3DInfection%252C%2520Genetics%2520and%2520Evolution%26atitle%3DInterferon%252Blambda%252B4%252Bgene%252Bpolymorphisms%252Bas%252Ba%252Bpredicting%252Btool%252Bof%252Bresponse%252Bto%252Bhepatitis%252BC%252Bvirus%252Bgenotype%252B4%252Bpatients%252Btreated%252Bwith%252BSofosbuvir%252Band%252BRibavirin%26aulast%3DSakr%26aufirst%3DAmany%2BA.%26date%3D2020%26volume%3D86%26spage%3D104606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div><a href="#" data-source="/pb/widgets/cited-by?doi=10.1021%2Fjm100863x&amp;widgetId=9cf770f4-a9a2-46e0-bd29-3da15bcf4ae0&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-19%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm100863x%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text&amp;citedByCount=414&amp;pagesCount=5&amp;pageNumber=2" title="Load more citations" class="button_primary float-right cited-by__see-more mb-5"><i aria-hidden="”true”" class="icon-angle-double-down"></i><span>Load more citations</span></a></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/medium/jm-2010-00863x_0001.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/large/jm-2010-00863x_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100863x&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/medium/jm-2010-00863x_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/large/jm-2010-00863x_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of HCV nucleoside inhibitors <b>1</b>, <b>2</b>, <b>3</b>, and <b>4</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/large/jm-2010-00863x_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100863x&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/medium/jm-2010-00863x_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/large/jm-2010-00863x_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Metabolism of <b>4</b> leads to both the active triphosphate and the inactive nucleoside <b>5</b>. The monophosphate metabolite of <b>4</b> is also metabolized to the uridine monophosphate derivative which is then further phosphorylated to the active uridine triphosphate <b>6</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/large/jm-2010-00863x_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100863x&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/medium/jm-2010-00863x_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/large/jm-2010-00863x_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. First pass metabolism of the phosphoramidate prodrug derivative of the monophosphate of <b>5</b> releases the monophosphate in the liver at the desired site of action.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/large/jm-2010-00863x_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100863x&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/medium/jm-2010-00863x_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/large/jm-2010-00863x_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/large/jm-2010-00863x_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100863x&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) 70% aqueous acetic acid, 100 °C; (b) 25% methanolic ammonia, 0−15 °C.</p></p></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/medium/jm-2010-00863x_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/large/jm-2010-00863x_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/large/jm-2010-00863x_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100863x&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>NMI, DCM, −5 to 5 °C; (b) NMI, DCM, 5−25 °C.</p></p></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/medium/jm-2010-00863x_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/large/jm-2010-00863x_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Uridine triphosphate (<b>6</b>) levels in human, rat, dog, and monkey primary hepatocytes when treated with <b>4</b> and uridine phosphoramidates <b>12</b>, <b>14</b>, and <b>47</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/large/jm-2010-00863x_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100863x&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/medium/jm-2010-00863x_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/large/jm-2010-00863x_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. X-ray crystal structure of <b>51</b> crystallized from CH<sub>2</sub>Cl<sub>2</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/large/jm-2010-00863x_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100863x&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/medium/jm-2010-00863x_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/large/jm-2010-00863x_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Structures of diastereomers <b>50</b> and <b>51</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100863x/production/images/large/jm-2010-00863x_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100863x&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i78">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03270" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03270" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 43 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-ref1_1"><span> <span class="citation_source-book">Hepatitis C</span>; World Health Organization Fact Sheet No. 164; World Health Organization: Geneva, October<span class="NLM_x"> </span><span class="NLM_year">2000</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Hepatitis+C%3B+World+Health+Organization+Fact+Sheet+No.+164%3B+World+Health+Organization%3A+Geneva%2C+October+2000."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref1_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DHepatitis%2520C%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Lavanchy, D.</span><span> </span><span class="NLM_article-title">The Global Burden of Hepatitis C</span> <span class="citation_source-journal">Liver Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x"> (</span><span class="NLM_issue">S1</span><span class="NLM_x">) </span> <span class="NLM_fpage">74</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=74&issue=S1&author=D.+Lavanchy&title=The+Global+Burden+of+Hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLavanchy%26aufirst%3DD.%26atitle%3DThe%2520Global%2520Burden%2520of%2520Hepatitis%2520C%26jtitle%3DLiver%2520Int.%26date%3D2009%26volume%3D29%26issue%3DS1%26spage%3D74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Zeuzem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moeller, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinrichsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauss, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedemeyer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarrazin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hueppe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zehnter, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manns, M. P.</span><span> </span><span class="NLM_article-title">Expert Opinion on the Treatment of Patients with Chronic Hepatitis C</span> <span class="citation_source-journal">J. Viral Hepatitus</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">75</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm100863x&amp;key=10.1111%2Fj.1365-2893.2008.01012.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm100863x&amp;key=18761607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm100863x&amp;key=1%3ACAS%3A280%3ADC%252BD1M7ht1Crtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=75&author=S.+Zeuzemauthor=T.+Bergauthor=B.+Moellerauthor=H.+Hinrichsenauthor=S.+Maussauthor=H.+Wedemeyerauthor=C.+Sarrazinauthor=D.+Hueppeauthor=E.+Zehnterauthor=M.+P.+Manns&title=Expert+Opinion+on+the+Treatment+of+Patients+with+Chronic+Hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Expert opinion on the treatment of patients with chronic hepatitis C</span></div><div class="casAuthors">Zeuzem S; Berg T; Moeller B; Hinrichsen H; Mauss S; Wedemeyer H; Sarrazin C; Hueppe D; Zehnter E; Manns M P</div><div class="citationInfo"><span class="NLM_cas:title">Journal of viral hepatitis</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">75-90</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The current preferred treatment for patients with hepatitis C virus (HCV) is combination therapy consisting of pegylated interferon alfa and ribavirin (RBV) for 24-48 weeks.  Although this approach appears to be highly effective for patients with HCV genotypes 2 or 3, who have a sustained virological response (SVR) of approximately 80%, the treatment algorithm is less effective for patients with HCV genotype 1, as these patients have SVR rates of just 40-50%.  In order to improve treatment outcomes, this article explores potential approaches for the optimization of treatment for patients with HCV genotype 1: considering shorter treatment periods for patients with a rapid virological response (RVR), increasing treatment periods for slow responders, and increasing RBV dose are all suggestions.  Results from clinical trials suggest that approximately 20% of the HCV genotype 1-infected population are slow responders, and around 15% of all HCV genotype-1 infected patients could benefit from a shorter treatment duration without compromising the SVR rate.  Interest has also focused on whether treatment duration could be individualized in some patients with genotype 2 and 3 infection.  Here all the findings from recent studies are translated into practical advice, to help practitioners make evidence-based treatment decisions in everyday clinical practice.  Although there are areas where currently available data do not provide conclusive evidence to suggest amending treatment approaches, there is clearly potential for individualized treatment in all aspects of hepatitis treatment in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS6UQwwDsewsuQ4Pl9hzjQhfW6udTcc2eY7hBd5WB6OZrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M7ht1Crtg%253D%253D&md5=6bb4b656592a11243b42540f5a090e9e</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2893.2008.01012.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2893.2008.01012.x%26sid%3Dliteratum%253Aachs%26aulast%3DZeuzem%26aufirst%3DS.%26aulast%3DBerg%26aufirst%3DT.%26aulast%3DMoeller%26aufirst%3DB.%26aulast%3DHinrichsen%26aufirst%3DH.%26aulast%3DMauss%26aufirst%3DS.%26aulast%3DWedemeyer%26aufirst%3DH.%26aulast%3DSarrazin%26aufirst%3DC.%26aulast%3DHueppe%26aufirst%3DD.%26aulast%3DZehnter%26aufirst%3DE.%26aulast%3DManns%26aufirst%3DM.%2BP.%26atitle%3DExpert%2520Opinion%2520on%2520the%2520Treatment%2520of%2520Patients%2520with%2520Chronic%2520Hepatitis%2520C%26jtitle%3DJ.%2520Viral%2520Hepatitus%26date%3D2009%26volume%3D16%26spage%3D75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Fried, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiffman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinos, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goncales, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haussinger, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diango, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carosi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhumeaux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craxi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J.</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">347</span><span class="NLM_x">, </span> <span class="NLM_fpage">975</span><span class="NLM_x">–</span> <span class="NLM_lpage">982</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm100863x&amp;key=10.1056%2FNEJMoa020047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm100863x&amp;key=12324553" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm100863x&amp;key=1%3ACAS%3A528%3ADC%252BD38Xnt12rtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Fried%2C+M.+W.%3B+Shiffman%2C+M.+L.%3B+Reddy%2C+K.+R.%3B+Smith%2C+C.%3B+Marinos%2C+G.%3B+Goncales%2C+F.+L.%3B+Haussinger%2C+D.%3B+Diango%2C+M.%3B+Carosi%2C+G.%3B+Dhumeaux%2C+D.%3B+Craxi%2C+A.%3B+Lin%2C+A.%3B+Hoffman%2C+J.%3B+Yu%2C+J.N.+Engl.+J.+Med.+2002%2C+347%2C+975%E2%80%93982"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection</span></div><div class="casAuthors">Fried, Michael W.; Shiffman, Mitchell L.; Reddy, K. Rajender; Smith, Coleman; Marinos, George; Goncales, Fernando L., Jr.; Haussinger, Dieter; Diago, Moises; Carosi, Giampiero; Dhumeaux, Daniel; Craxi, Antonio; Lin, Amy; Hoffman, Joseph; Yu, Jian</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">975-982</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Treatment with peginterferon alfa-2a alone produces significantly higher sustained virol. responses than treatment with interferon alfa-2a alone in patients with chronic hepatitis C virus (HCV) infection.  We compared the efficacy and safety of peginterferon alfa-2a plus ribavirin, interferon alfa-2b plus ribavirin, and peginterferon alfa-2a alone in the initial treatment of chronic hepatitis C.  Methods: A total of 1121 patients were randomly assigned to treatment and received at least one dose of study medication, consisting of 180 μg of peginterferon alfa-2a once weekly plus daily ribavirin (1000 or 1200 mg, depending on body wt.), weekly peginterferon alfa-2a plus daily placebo, or 3 million units of interferon alfa-2b thrice weekly plus daily ribavirin for 48 wk.  Results: A significantly higher proportion of patients who received peginterferon alfa-2a plus ribavirin had a sustained virol. response (defined as the absence of detectable HCV RNA 24 wk after cessation of therapy) than of patients who received interferon alfa-2b plus ribavirin (56 % vs. 44 %, P<0.001) or peginterferon alfa-2a alone (56 % vs. 29 %, P<0.001).  The proportions of patients with HCV genotype 1 who had sustained virol. responses were 46 %, 36 %, and 21 %, resp., for the three regimens.  Among patients with HCV genotype 1 and high base-line levels of HCV RNA, the proportions of those with sustained virol. responses were 41 %, 33 %, and 13 %, resp.  The overall safety profiles of the three treatment regimens were similar; the incidence of influenza-like symptoms and depression was lower in the groups receiving peginterferon alfa-2a than in the group receiving interferon alfa-2b plus ribavirin.  Conclusions: In patients with chronic hepatitis C, once-weekly peginterferon alfa-2a plus ribavirin was tolerated as well as interferon alfa-2b plus ribavirin and produced significant improvements in the rate of sustained virol. response, as compared with interferon alfa-2b plus ribavirin or peginterferon alfa-2a alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqblwkeNXWJzbVg90H21EOLACvtfcHk0lgO5opjQKjmoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xnt12rtb0%253D&md5=2fd959d790b9505384fbd26ef44b2963</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa020047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa020047%26sid%3Dliteratum%253Aachs%26aulast%3DFried%26aufirst%3DM.%2BW.%26aulast%3DShiffman%26aufirst%3DM.%2BL.%26aulast%3DReddy%26aufirst%3DK.%2BR.%26aulast%3DSmith%26aufirst%3DC.%26aulast%3DMarinos%26aufirst%3DG.%26aulast%3DGoncales%26aufirst%3DF.%2BL.%26aulast%3DHaussinger%26aufirst%3DD.%26aulast%3DDiango%26aufirst%3DM.%26aulast%3DCarosi%26aufirst%3DG.%26aulast%3DDhumeaux%26aufirst%3DD.%26aulast%3DCraxi%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DA.%26aulast%3DHoffman%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DJ.%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2002%26volume%3D347%26spage%3D975%26epage%3D982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Burton, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Everson, G. T.</span><span> </span><span class="NLM_article-title">HCV NS5B Polymerase Inhibitors</span> <span class="citation_source-journal">Clin. Liver Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">453</span><span class="NLM_x">–</span> <span class="NLM_lpage">465</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2009&pages=453-465&author=J.+R.+Burtonauthor=G.+T.+Everson&title=HCV+NS5B+Polymerase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurton%26aufirst%3DJ.%2BR.%26aulast%3DEverson%26aufirst%3DG.%2BT.%26atitle%3DHCV%2520NS5B%2520Polymerase%2520Inhibitors%26jtitle%3DClin.%2520Liver%2520Dis.%26date%3D2009%26volume%3D13%26spage%3D453%26epage%3D465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span> </span><span class="NLM_article-title">Recent Advances in the Development of NS5B Polymerase Inhibitors for the Treatment of Hepatitis C Virus Infection</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">164</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm100863x&amp;key=10.1517%2F13543770802672598" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm100863x&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVCks74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=145-164&author=P.+L.+Beaulieu&title=Recent+Advances+in+the+Development+of+NS5B+Polymerase+Inhibitors+for+the+Treatment+of+Hepatitis+C+Virus+Infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the development of NS5B polymerase inhibitors for the treatment of hepatitis C virus infection</span></div><div class="casAuthors">Beaulieu, Pierre L.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">145-164</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  170 To 200 million people worldwide are believed to suffer from chronic hepatitis C virus (HCV) infection, a blood-born disease that targets the liver and progresses to organ cirrhosis and primary cancer in a significant proportion of patients.  The currently available treatment has limited efficacy and suffers from restricting side effects.  HCV infection is the principal cause of liver transplant in industrialized nations and between 8000 and 10,000 deaths result annually from the disease in the United States alone.  Virus-specific, more efficacious, and better-tolerated anti-HCV therapies are thus required to address the unmet medical need.  Objective: To review progress achieved since 2005 in the development of HCV NS5B polymerase inhibitors as potential therapy for the treatment of HCV infection with a primary focus on available patent and medical literature.  Results/conclusion: Several classes of small-mol. inhibitors of HCV NS5B have progressed into clin. development and demonstrated efficacy in reducing viral load in infected patients.  The results so far provide an encouraging foundation for the development of novel, more tolerable therapies and addressing emergence of resistance through combination of antiviral agents with complementary mechanisms of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoo8VVFJs4oSbVg90H21EOLACvtfcHk0lgO5opjQKjmoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVCks74%253D&md5=64b78562e2b4e3e8a166fdabf14f7efe</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1517%2F13543770802672598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770802672598%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26atitle%3DRecent%2520Advances%2520in%2520the%2520Development%2520of%2520NS5B%2520Polymerase%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Hepatitis%2520C%2520Virus%2520Infection%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2009%26volume%3D19%26spage%3D145%26epage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Simmonds, P.</span><span> </span><span class="NLM_article-title">Genetic Diversity and Evolution of Hepatitis C Virus—15 Years On</span> <span class="citation_source-journal">J. Gen. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">3173</span><span class="NLM_x">–</span> <span class="NLM_lpage">3188</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm100863x&amp;key=10.1099%2Fvir.0.80401-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm100863x&amp;key=15483230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm100863x&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpsVSmsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2004&pages=3173-3188&author=P.+Simmonds&title=Genetic+Diversity+and+Evolution+of+Hepatitis+C+Virus%E2%80%9415+Years+On"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic diversity and evolution of hepatitis C virus - 15 years on</span></div><div class="casAuthors">Simmonds, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of General Virology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3173-3188</span>CODEN:
                <span class="NLM_cas:coden">JGVIAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-1317</span>.
    
            (<span class="NLM_cas:orgname">Society for General Microbiology</span>)
        </div><div class="casAbstract">A review.  In the 15 years since the discovery of hepatitis C virus (HCV), much has been learned about its role as a major causative agent of human liver disease and its ability to persist in the face of host-cell defenses and the immune system.  This review describes what is known about the diversity of HCV, the current classification of HCV genotypes within the family Flaviviridae and how this genetic diversity contributes to its pathogenesis.  On one hand, diversification of HCV was constrained by its intimate adaptation to its host.  Despite the >30% nucleotide sequence divergence between genotypes, HCV variants nevertheless remain remarkably similar in their transmission dynamics, persistence and disease development.  Nowhere is this more evident than in the evolutionary conservation of numerous evasion methods to counteract the cell's innate antiviral defense pathways; this series of highly complex virus-host interactions may represent key components in establishing its ecol. niche in the human liver.  On the other hand, the mutability and large population size of HCV enables it to respond very rapidly to new selection pressures, manifested by immune-driven changes in T- and B-cell epitopes that are encountered on transmission between individuals with different antigen-recognition repertoires.  If human immunodeficiency virus type 1 is a precedent, future therapies that target virus protease or polymerase enzymes may also select very rapidly for antiviral-resistant mutants.  These contrasting aspects of conservatism and adaptability provide a fascinating paradigm in which to explore the complex selection pressures that underlie the evolution of HCV and other persistent viruses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotwOpXQZprmrVg90H21EOLACvtfcHk0lgO5opjQKjmoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpsVSmsr0%253D&md5=a07b3411b6b18b5e7ab3cf9bc3b89026</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1099%2Fvir.0.80401-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1099%252Fvir.0.80401-0%26sid%3Dliteratum%253Aachs%26aulast%3DSimmonds%26aufirst%3DP.%26atitle%3DGenetic%2520Diversity%2520and%2520Evolution%2520of%2520Hepatitis%2520C%2520Virus%25E2%2580%259415%2520Years%2520On%26jtitle%3DJ.%2520Gen.%2520Virol.%26date%3D2004%26volume%3D85%26spage%3D3173%26epage%3D3188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Le Guillou-Guillemette, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vallet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaudy-Graffin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pivet, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goudeau, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunel-Fabiani, F.</span><span> </span><span class="NLM_article-title">Genetic Diversity of the Hepatitis C Virus: Impact and Issues in the Antiviral Therapy</span> <span class="citation_source-journal">World J. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2416</span><span class="NLM_x">–</span> <span class="NLM_lpage">2426</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm100863x&amp;key=10.3748%2Fwjg.v13.i17.2416" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm100863x&amp;key=17552024" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm100863x&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotl2ltL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=2416-2426&author=H.+Le+Guillou-Guillemetteauthor=S.+Valletauthor=C.+Gaudy-Graffinauthor=C.+Payanauthor=A.+Pivetauthor=A.+Goudeauauthor=F.+Lunel-Fabiani&title=Genetic+Diversity+of+the+Hepatitis+C+Virus%3A+Impact+and+Issues+in+the+Antiviral+Therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic diversity of the hepatitis C virus: impact and issues in the antiviral therapy</span></div><div class="casAuthors">Le Guillou-Guillemette, H.; Vallet, S.; Gaudy-Graffin, C.; Payan, C.; Pivert, A.; Goudeau, A.; Lunel-Fabiani, F.</div><div class="citationInfo"><span class="NLM_cas:title">World Journal of Gastroenterology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2416-2426</span>CODEN:
                <span class="NLM_cas:coden">WJGAF2</span>;
        ISSN:<span class="NLM_cas:issn">1007-9327</span>.
    
            (<span class="NLM_cas:orgname">World Journal of Gastroenterology</span>)
        </div><div class="casAbstract">A review.  The hepatitis C Virus (HCV) presents a high degree of genetic variability which is explained by the combination of a lack of proof reading by the RNA dependent RNA polymerase and a high level of viral replication.  The resulting genetic polymorphism defines a classification in clades, genotypes, subtypes, isolates and quasispecies.  This diversity is known to reflect the range of responses to Interferon therapy.  The genotype is one of the predictive parameters currently used to define the antiviral treatment strategy and the chance of therapeutic success.  Studies have also reported the potential impact of the viral genetic polymorphism in the outcome of antiviral therapy in patients infected by the same HCV genotype.  Both structural and non structural genomic regions of HCV have been suggested to be involved in the Interferon pathway and the resistance to antiviral therapy.  In this review, the authors first detail the viral basis of HCV diversity.  Then, the HCV genetic regions that may be implicated in resistance to therapy are described, with a focus on the structural region encoded by the E2 gene and the non-structural genes NS3, NS5A and NS5B.  Both mechanisms of the Interferon resistance and of the new antiviral drugs are described in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSpQ7xkfDdBrVg90H21EOLACvtfcHk0linZzvDkEwlDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotl2ltL0%253D&md5=457a642ea142dee4a7522e8a48c52b60</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.3748%2Fwjg.v13.i17.2416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3748%252Fwjg.v13.i17.2416%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BGuillou-Guillemette%26aufirst%3DH.%26aulast%3DVallet%26aufirst%3DS.%26aulast%3DGaudy-Graffin%26aufirst%3DC.%26aulast%3DPayan%26aufirst%3DC.%26aulast%3DPivet%26aufirst%3DA.%26aulast%3DGoudeau%26aufirst%3DA.%26aulast%3DLunel-Fabiani%26aufirst%3DF.%26atitle%3DGenetic%2520Diversity%2520of%2520the%2520Hepatitis%2520C%2520Virus%253A%2520Impact%2520and%2520Issues%2520in%2520the%2520Antiviral%2520Therapy%26jtitle%3DWorld%2520J.%2520Gastroenterol.%26date%3D2007%26volume%3D13%26spage%3D2416%26epage%3D2426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Pierra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amador, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benzaria, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cretton-Scott, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Amours, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moussa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Standring, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sammadossi, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosselin, G.</span><span> </span><span class="NLM_article-title">Synthesis and Pharmacokinetics of Valopicitabine (NM283), an Efficient Prodrug of the Potent Anti-HCV Agent 2′-<i>C</i>-Methylcytidine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6614</span><span class="NLM_x">–</span> <span class="NLM_lpage">6620</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0603623" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6614-6620&author=C.+Pierraauthor=A.+Amadorauthor=S.+Benzariaauthor=E.+Cretton-Scottauthor=M.+D%E2%80%99Amoursauthor=J.+Maoauthor=S.+Mathieuauthor=A.+Moussaauthor=E.+G.+Bridgesauthor=D.+M.+Standringauthor=J.-P.+Sammadossiauthor=R.+Storerauthor=G.+Gosselin&title=Synthesis+and+Pharmacokinetics+of+Valopicitabine+%28NM283%29%2C+an+Efficient+Prodrug+of+the+Potent+Anti-HCV+Agent+2%E2%80%B2-C-Methylcytidine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm0603623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0603623%26sid%3Dliteratum%253Aachs%26aulast%3DPierra%26aufirst%3DC.%26aulast%3DAmador%26aufirst%3DA.%26aulast%3DBenzaria%26aufirst%3DS.%26aulast%3DCretton-Scott%26aufirst%3DE.%26aulast%3DD%25E2%2580%2599Amours%26aufirst%3DM.%26aulast%3DMao%26aufirst%3DJ.%26aulast%3DMathieu%26aufirst%3DS.%26aulast%3DMoussa%26aufirst%3DA.%26aulast%3DBridges%26aufirst%3DE.%2BG.%26aulast%3DStandring%26aufirst%3DD.%2BM.%26aulast%3DSammadossi%26aufirst%3DJ.-P.%26aulast%3DStorer%26aufirst%3DR.%26aulast%3DGosselin%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520Pharmacokinetics%2520of%2520Valopicitabine%2520%2528NM283%2529%252C%2520an%2520Efficient%2520Prodrug%2520of%2520the%2520Potent%2520Anti-HCV%2520Agent%25202%25E2%2580%25B2-C-Methylcytidine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6614%26epage%3D6620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Smith, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalayanov, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sund, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winqvist, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maltseva, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leveque, V. J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajyagurr, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pogam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Najer, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benkestock, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maag, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammack, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swallow, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johannsson, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klumpp, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M.</span><span> </span><span class="NLM_article-title">The Design, Synthesis, and Antiviral Activity of Monofluoro and Difluoro Analogues of 4′-Axidocytidine against Hepatitis C Virus Replication: The Discovery of 4′-Azido-2′-deoxy-2′-fluorocytidine and 4′-Azido-2′-dideoxy-2′,2′-difuorocytidine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2971</span><span class="NLM_x">–</span> <span class="NLM_lpage">2978</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801595c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2971-2978&author=D.+B.+Smithauthor=G.+Kalayanovauthor=G.+Sundauthor=A.+Winqvistauthor=T.+Maltsevaauthor=V.+J.-P.+Levequeauthor=S.+Rajyagurrauthor=S.+Le+Pogamauthor=I.+Najerauthor=K.+Benkestockauthor=X.-X.+Zhouauthor=A.+C.+Kaiserauthor=H.+Maagauthor=N.+Cammackauthor=J.+A.+Martinauthor=S.+Swallowauthor=N.+G.+Johannssonauthor=K.+Klumppauthor=M.+Smith&title=The+Design%2C+Synthesis%2C+and+Antiviral+Activity+of+Monofluoro+and+Difluoro+Analogues+of+4%E2%80%B2-Axidocytidine+against+Hepatitis+C+Virus+Replication%3A+The+Discovery+of+4%E2%80%B2-Azido-2%E2%80%B2-deoxy-2%E2%80%B2-fluorocytidine+and+4%E2%80%B2-Azido-2%E2%80%B2-dideoxy-2%E2%80%B2%2C2%E2%80%B2-difuorocytidine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm801595c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801595c%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BB.%26aulast%3DKalayanov%26aufirst%3DG.%26aulast%3DSund%26aufirst%3DG.%26aulast%3DWinqvist%26aufirst%3DA.%26aulast%3DMaltseva%26aufirst%3DT.%26aulast%3DLeveque%26aufirst%3DV.%2BJ.-P.%26aulast%3DRajyagurr%26aufirst%3DS.%26aulast%3DLe%2BPogam%26aufirst%3DS.%26aulast%3DNajer%26aufirst%3DI.%26aulast%3DBenkestock%26aufirst%3DK.%26aulast%3DZhou%26aufirst%3DX.-X.%26aulast%3DKaiser%26aufirst%3DA.%2BC.%26aulast%3DMaag%26aufirst%3DH.%26aulast%3DCammack%26aufirst%3DN.%26aulast%3DMartin%26aufirst%3DJ.%2BA.%26aulast%3DSwallow%26aufirst%3DS.%26aulast%3DJohannsson%26aufirst%3DN.%2BG.%26aulast%3DKlumpp%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DM.%26atitle%3DThe%2520Design%252C%2520Synthesis%252C%2520and%2520Antiviral%2520Activity%2520of%2520Monofluoro%2520and%2520Difluoro%2520Analogues%2520of%25204%25E2%2580%25B2-Axidocytidine%2520against%2520Hepatitis%2520C%2520Virus%2520Replication%253A%2520The%2520Discovery%2520of%25204%25E2%2580%25B2-Azido-2%25E2%2580%25B2-deoxy-2%25E2%2580%25B2-fluorocytidine%2520and%25204%25E2%2580%25B2-Azido-2%25E2%2580%25B2-dideoxy-2%25E2%2580%25B2%252C2%25E2%2580%25B2-difuorocytidine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2971%26epage%3D2978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Clark, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollecker, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuyver, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tharnish, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lostia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBrayer, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schinazi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otto, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furman, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stec, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pankiewicz, K. W.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Antiviral Activity of 2′-Deoxy-2′-fluoro-2′-<i>C</i>-methylcytidine, a Potent Inhibitor of Hepatitis C Virus Replication</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">5504</span><span class="NLM_x">–</span> <span class="NLM_lpage">5508</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0502788" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5504-5508&author=J.+L.+Clarkauthor=L.+Holleckerauthor=J.+C.+Masonauthor=L.+J.+Stuyverauthor=P.+M.+Tharnishauthor=S.+Lostiaauthor=T.+R.+McBrayerauthor=R.+Schinaziauthor=K.+A.+Watanabeauthor=M.+J.+Ottoauthor=P.+A.+Furmanauthor=W.+J.+Stecauthor=S.+E.+Pattersonauthor=K.+W.+Pankiewicz&title=Design%2C+Synthesis%2C+and+Antiviral+Activity+of+2%E2%80%B2-Deoxy-2%E2%80%B2-fluoro-2%E2%80%B2-C-methylcytidine%2C+a+Potent+Inhibitor+of+Hepatitis+C+Virus+Replication"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm0502788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0502788%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DJ.%2BL.%26aulast%3DHollecker%26aufirst%3DL.%26aulast%3DMason%26aufirst%3DJ.%2BC.%26aulast%3DStuyver%26aufirst%3DL.%2BJ.%26aulast%3DTharnish%26aufirst%3DP.%2BM.%26aulast%3DLostia%26aufirst%3DS.%26aulast%3DMcBrayer%26aufirst%3DT.%2BR.%26aulast%3DSchinazi%26aufirst%3DR.%26aulast%3DWatanabe%26aufirst%3DK.%2BA.%26aulast%3DOtto%26aufirst%3DM.%2BJ.%26aulast%3DFurman%26aufirst%3DP.%2BA.%26aulast%3DStec%26aufirst%3DW.%2BJ.%26aulast%3DPatterson%26aufirst%3DS.%2BE.%26aulast%3DPankiewicz%26aufirst%3DK.%2BW.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Antiviral%2520Activity%2520of%25202%25E2%2580%25B2-Deoxy-2%25E2%2580%25B2-fluoro-2%25E2%2580%25B2-C-methylcytidine%252C%2520a%2520Potent%2520Inhibitor%2520of%2520Hepatitis%2520C%2520Virus%2520Replication%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5504%26epage%3D5508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Stuyver, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBrayer, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tharnish, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollecher, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lostia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nachman</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, M.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schinazi, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrey, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Julander, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furman, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otto, M. J.</span><span> </span><span class="NLM_article-title">Inhibition of Hepatitis C Replicon RNA Synthesis by β-<span class="smallcaps smallerCapital">d</span>-2′-Deoxy-2′-fluoro-2′-<i>C</i>-methylcytidine: A Specific Inhibitor of Hepatitis C Virus Replication</span> <span class="citation_source-journal">Antiviral Chem. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">87</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2006&pages=79-87&author=L.+J.+Stuyverauthor=T.+R.+McBrayerauthor=P.+M.+Tharnishauthor=J.+L.+Clarkauthor=L.+Hollecherauthor=S.+Lostiaauthor=+Nachmanauthor=J.+Grierauthor=M.+A.+Bennettauthor=M.-Y.+Xieauthor=R.+F.+Schinaziauthor=J.+D.+Morreyauthor=J.+L.+Julanderauthor=P.+A.+Furmanauthor=M.+J.+Otto&title=Inhibition+of+Hepatitis+C+Replicon+RNA+Synthesis+by+%CE%B2-d-2%E2%80%B2-Deoxy-2%E2%80%B2-fluoro-2%E2%80%B2-C-methylcytidine%3A+A+Specific+Inhibitor+of+Hepatitis+C+Virus+Replication"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStuyver%26aufirst%3DL.%2BJ.%26aulast%3DMcBrayer%26aufirst%3DT.%2BR.%26aulast%3DTharnish%26aufirst%3DP.%2BM.%26aulast%3DClark%26aufirst%3DJ.%2BL.%26aulast%3DHollecher%26aufirst%3DL.%26aulast%3DLostia%26aufirst%3DS.%26aulast%3DNachman%26aulast%3DGrier%26aufirst%3DJ.%26aulast%3DBennett%26aufirst%3DM.%2BA.%26aulast%3DXie%26aufirst%3DM.-Y.%26aulast%3DSchinazi%26aufirst%3DR.%2BF.%26aulast%3DMorrey%26aufirst%3DJ.%2BD.%26aulast%3DJulander%26aufirst%3DJ.%2BL.%26aulast%3DFurman%26aufirst%3DP.%2BA.%26aulast%3DOtto%26aufirst%3DM.%2BJ.%26atitle%3DInhibition%2520of%2520Hepatitis%2520C%2520Replicon%2520RNA%2520Synthesis%2520by%2520%25CE%25B2-d-2%25E2%2580%25B2-Deoxy-2%25E2%2580%25B2-fluoro-2%25E2%2580%25B2-C-methylcytidine%253A%2520A%2520Specific%2520Inhibitor%2520of%2520Hepatitis%2520C%2520Virus%2520Replication%26jtitle%3DAntiviral%2520Chem.%2520Chemother.%26date%3D2006%26volume%3D17%26spage%3D79%26epage%3D87" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Stuyver, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBrayer, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitaker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tharnish, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramesh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lostia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cartee, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobbs, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schinazi, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, K. A</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otto, M. J.</span><span> </span><span class="NLM_article-title">Inhibition of the Subgenomic Hepatitis C Virus Replicon in Huh-7 Cells by 2′-Deoxy-2′-fluoro Cytidine</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">651</span><span class="NLM_x">–</span> <span class="NLM_lpage">654</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2004&pages=651-654&author=L.+J.+Stuyverauthor=T.+R.+McBrayerauthor=T.+Whitakerauthor=P.+M.+Tharnishauthor=M.+Rameshauthor=S.+Lostiaauthor=L.+Carteeauthor=J.+Shiauthor=A.+Hobbsauthor=R.+F.+Schinaziauthor=K.+A+Watanabeauthor=M.+J.+Otto&title=Inhibition+of+the+Subgenomic+Hepatitis+C+Virus+Replicon+in+Huh-7+Cells+by+2%E2%80%B2-Deoxy-2%E2%80%B2-fluoro+Cytidine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStuyver%26aufirst%3DL.%2BJ.%26aulast%3DMcBrayer%26aufirst%3DT.%2BR.%26aulast%3DWhitaker%26aufirst%3DT.%26aulast%3DTharnish%26aufirst%3DP.%2BM.%26aulast%3DRamesh%26aufirst%3DM.%26aulast%3DLostia%26aufirst%3DS.%26aulast%3DCartee%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DHobbs%26aufirst%3DA.%26aulast%3DSchinazi%26aufirst%3DR.%2BF.%26aulast%3DWatanabe%26aufirst%3DK.%2BA%26aulast%3DOtto%26aufirst%3DM.%2BJ.%26atitle%3DInhibition%2520of%2520the%2520Subgenomic%2520Hepatitis%2520C%2520Virus%2520Replicon%2520in%2520Huh-7%2520Cells%2520by%25202%25E2%2580%25B2-Deoxy-2%25E2%2580%25B2-fluoro%2520Cytidine%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2004%26volume%3D48%26spage%3D651%26epage%3D654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Reddy, R.; Rodriguez-Torres, M.; Gane, E.; Robson, R.; Lalezari, J.; Everson, G.; DeJesus, E.; McHutchinson, J.; Vargas, H.</span> Presented at the 58th Annual Meeting of the American Association of the Study of Liver Disease, Boston, November<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">; </span>Abstract LB9; unpublished results.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Reddy%2C+R.%3B+Rodriguez-Torres%2C+M.%3B+Gane%2C+E.%3B+Robson%2C+R.%3B+Lalezari%2C+J.%3B+Everson%2C+G.%3B+DeJesus%2C+E.%3B+McHutchinson%2C+J.%3B+Vargas%2C+H.+Presented+at+the+58th+Annual+Meeting+of+the+American+Association+of+the+Study+of+Liver+Disease%2C+Boston%2C+November+2007%3B+Abstract+LB9%3B+unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DReddy%26aufirst%3DR.%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Lalezari, J.; Gane, E.; Rodriguez,-Torres, M.; DeJesus, E.; Nelson, D.; Everson, G.; Jacobson, I.; Reddy, R.; Hill, G. Z.; Beard, A.; Symonds, W. T.; Berrey, M. M.; McHutchison, J. G.</span> Potent Antiviral Activity of the HCV Nucleoside Polymerase Inhibitor R7128 with PEG-INF and Ribavirin: Interim Results of R7128 500 mg BID for 28-Days. Presented at the 43rd Annual Meeting of the European Association for the Study of the Liver, Milan, Italy, April<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>unpublished results.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Lalezari%2C+J.%3B+Gane%2C+E.%3B+Rodriguez%2C-Torres%2C+M.%3B+DeJesus%2C+E.%3B+Nelson%2C+D.%3B+Everson%2C+G.%3B+Jacobson%2C+I.%3B+Reddy%2C+R.%3B+Hill%2C+G.+Z.%3B+Beard%2C+A.%3B+Symonds%2C+W.+T.%3B+Berrey%2C+M.+M.%3B+McHutchison%2C+J.+G.+Potent+Antiviral+Activity+of+the+HCV+Nucleoside+Polymerase+Inhibitor+R7128+with+PEG-INF+and+Ribavirin%3A+Interim+Results+of+R7128+500+mg+BID+for+28-Days.+Presented+at+the+43rd+Annual+Meeting+of+the+European+Association+for+the+Study+of+the+Liver%2C+Milan%2C+Italy%2C+April+2008%3B+unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DLalezari%26aufirst%3DJ.%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Rodriguez-Torres, M.; Lalezari, J; Gane, E.; DeJesus, E.; Nelson, D.; Everson, G.; Jacobsen, I.; Reddy, R.; McHutchinson, J.; Beard, A.; Walker, S.; Symonds, B.; Berrey, M.</span> Potent Antiviral Response to the HCV Nucleoside Polymerase Inhibitor R7128 for 28 Days with PEG-INF and Ribavirin: Subanalysis by Race/Ethnicity, Weight and HCV Genotype. Presented at the 59th Annual Meeting of the American Association for the Study of Liver Disease, San Francisco, CA, November<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>Abstract No. 1899; unpublished results.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Rodriguez-Torres%2C+M.%3B+Lalezari%2C+J%3B+Gane%2C+E.%3B+DeJesus%2C+E.%3B+Nelson%2C+D.%3B+Everson%2C+G.%3B+Jacobsen%2C+I.%3B+Reddy%2C+R.%3B+McHutchinson%2C+J.%3B+Beard%2C+A.%3B+Walker%2C+S.%3B+Symonds%2C+B.%3B+Berrey%2C+M.+Potent+Antiviral+Response+to+the+HCV+Nucleoside+Polymerase+Inhibitor+R7128+for+28+Days+with+PEG-INF+and+Ribavirin%3A+Subanalysis+by+Race%2FEthnicity%2C+Weight+and+HCV+Genotype.+Presented+at+the+59th+Annual+Meeting+of+the+American+Association+for+the+Study+of+Liver+Disease%2C+San+Francisco%2C+CA%2C+November+2008%3B+Abstract+No.+1899%3B+unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez-Torres%26aufirst%3DM.%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Ma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roblendo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leveque, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lara-Jaime, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masjedizdeh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammack, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klumpp, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symons, J.</span><span> </span><span class="NLM_article-title">Characterization of the Metabolic Activation of Hepatitis C Virus Nucleoside Iinhibitor beta-<span class="smallcaps smallerCapital">d</span>-2′-Deoxy-2′-fluoro-2′-<i>C</i>-methylcytidine (PSI-6130) and Identification of a Novel active 5′-Triphosphate Species</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">29812</span><span class="NLM_x">–</span> <span class="NLM_lpage">29820</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=29812-29820&author=H.+Maauthor=W.+R.+Jiangauthor=N.+Roblendoauthor=V.+Levequeauthor=S.+Aliauthor=T.+Lara-Jaimeauthor=M.+Masjedizdehauthor=D.+B.+Smithauthor=N.+Cammackauthor=K.+Klumppauthor=J.+Symons&title=Characterization+of+the+Metabolic+Activation+of+Hepatitis+C+Virus+Nucleoside+Iinhibitor+beta-d-2%E2%80%B2-Deoxy-2%E2%80%B2-fluoro-2%E2%80%B2-C-methylcytidine+%28PSI-6130%29+and+Identification+of+a+Novel+active+5%E2%80%B2-Triphosphate+Species"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DW.%2BR.%26aulast%3DRoblendo%26aufirst%3DN.%26aulast%3DLeveque%26aufirst%3DV.%26aulast%3DAli%26aufirst%3DS.%26aulast%3DLara-Jaime%26aufirst%3DT.%26aulast%3DMasjedizdeh%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DD.%2BB.%26aulast%3DCammack%26aufirst%3DN.%26aulast%3DKlumpp%26aufirst%3DK.%26aulast%3DSymons%26aufirst%3DJ.%26atitle%3DCharacterization%2520of%2520the%2520Metabolic%2520Activation%2520of%2520Hepatitis%2520C%2520Virus%2520Nucleoside%2520Iinhibitor%2520beta-d-2%25E2%2580%25B2-Deoxy-2%25E2%2580%25B2-fluoro-2%25E2%2580%25B2-C-methylcytidine%2520%2528PSI-6130%2529%2520and%2520Identification%2520of%2520a%2520Novel%2520active%25205%25E2%2580%25B2-Triphosphate%2520Species%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D29812%26epage%3D29820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Murakami, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramesh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGrayer, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitaker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Micolochick Steuer, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schinazi, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuyver, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obikhod, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otto, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furman, P. A.</span><span> </span><span class="NLM_article-title">Mechanism of Activation of beta-<span class="smallcaps smallerCapital">d</span>-2′-Deoxy-2′-fluoro-2′-<i>C</i>-methylcytidine and Inhibition of Hepatitis C Virus NS5B RNA Polymerase</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">503</span><span class="NLM_x">–</span> <span class="NLM_lpage">509</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2007&pages=503-509&author=E.+Murakamiauthor=H.+Baoauthor=M.+Rameshauthor=T.+R.+McGrayerauthor=T.+Whitakerauthor=H.+M.+Micolochick+Steuerauthor=R.+F.+Schinaziauthor=L.+J.+Stuyverauthor=A.+Obikhodauthor=M.+J.+Ottoauthor=P.+A.+Furman&title=Mechanism+of+Activation+of+beta-d-2%E2%80%B2-Deoxy-2%E2%80%B2-fluoro-2%E2%80%B2-C-methylcytidine+and+Inhibition+of+Hepatitis+C+Virus+NS5B+RNA+Polymerase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMurakami%26aufirst%3DE.%26aulast%3DBao%26aufirst%3DH.%26aulast%3DRamesh%26aufirst%3DM.%26aulast%3DMcGrayer%26aufirst%3DT.%2BR.%26aulast%3DWhitaker%26aufirst%3DT.%26aulast%3DMicolochick%2BSteuer%26aufirst%3DH.%2BM.%26aulast%3DSchinazi%26aufirst%3DR.%2BF.%26aulast%3DStuyver%26aufirst%3DL.%2BJ.%26aulast%3DObikhod%26aufirst%3DA.%26aulast%3DOtto%26aufirst%3DM.%2BJ.%26aulast%3DFurman%26aufirst%3DP.%2BA.%26atitle%3DMechanism%2520of%2520Activation%2520of%2520beta-d-2%25E2%2580%25B2-Deoxy-2%25E2%2580%25B2-fluoro-2%25E2%2580%25B2-C-methylcytidine%2520and%2520Inhibition%2520of%2520Hepatitis%2520C%2520Virus%2520NS5B%2520RNA%2520Polymerase%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2007%26volume%3D51%26spage%3D503%26epage%3D509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Murakami, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Micolochick Steuer, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitaker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nachman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sofia, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otto, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furman, P. A.</span><span> </span><span class="NLM_article-title">The Mechanism of Action of beta-<span class="smallcaps smallerCapital">d</span>-2′-Deoxy-2′-fluoro-2′-<i>C</i>-methylcytidine Involves a Second Metabolic Pathway Leading to beta-<span class="smallcaps smallerCapital">d</span>-2′-Deoxy-2′-fluoro-2′-<i>C</i>-methyluridine 5′-Triphosphate, a Potent Inhibitor of the Hepatitis C Virus RNA-Dependent RNA Polymerase</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">458</span><span class="NLM_x">–</span> <span class="NLM_lpage">464</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=458-464&author=E.+Murakamiauthor=C.+Niuauthor=H.+Baoauthor=H.+M.+Micolochick+Steuerauthor=T.+Whitakerauthor=T.+Nachmanauthor=M.+J.+Sofiaauthor=P.+Wangauthor=M.+J.+Ottoauthor=P.+A.+Furman&title=The+Mechanism+of+Action+of+beta-d-2%E2%80%B2-Deoxy-2%E2%80%B2-fluoro-2%E2%80%B2-C-methylcytidine+Involves+a+Second+Metabolic+Pathway+Leading+to+beta-d-2%E2%80%B2-Deoxy-2%E2%80%B2-fluoro-2%E2%80%B2-C-methyluridine+5%E2%80%B2-Triphosphate%2C+a+Potent+Inhibitor+of+the+Hepatitis+C+Virus+RNA-Dependent+RNA+Polymerase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMurakami%26aufirst%3DE.%26aulast%3DNiu%26aufirst%3DC.%26aulast%3DBao%26aufirst%3DH.%26aulast%3DMicolochick%2BSteuer%26aufirst%3DH.%2BM.%26aulast%3DWhitaker%26aufirst%3DT.%26aulast%3DNachman%26aufirst%3DT.%26aulast%3DSofia%26aufirst%3DM.%2BJ.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DOtto%26aufirst%3DM.%2BJ.%26aulast%3DFurman%26aufirst%3DP.%2BA.%26atitle%3DThe%2520Mechanism%2520of%2520Action%2520of%2520beta-d-2%25E2%2580%25B2-Deoxy-2%25E2%2580%25B2-fluoro-2%25E2%2580%25B2-C-methylcytidine%2520Involves%2520a%2520Second%2520Metabolic%2520Pathway%2520Leading%2520to%2520beta-d-2%25E2%2580%25B2-Deoxy-2%25E2%2580%25B2-fluoro-2%25E2%2580%25B2-C-methyluridine%25205%25E2%2580%25B2-Triphosphate%252C%2520a%2520Potent%2520Inhibitor%2520of%2520the%2520Hepatitis%2520C%2520Virus%2520RNA-Dependent%2520RNA%2520Polymerase%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D458%26epage%3D464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">McGuigan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cahard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheeka, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balzarini, J.</span><span> </span><span class="NLM_article-title">Aryl Phosphoramidate Derivatives of d4T Have Improved Anti-HIV Efficacy in Tissue Culture and May Act by the Generation of a Novel Intracellular Metabolite</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1748</span><span class="NLM_x">–</span> <span class="NLM_lpage">1753</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm950605j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm100863x&amp;key=1%3ACAS%3A528%3ADyaK28XhslGmu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=1748-1753&author=C.+McGuiganauthor=D.+Cahardauthor=H.+M.+Sheekaauthor=E.+De+Clercqauthor=J.+Balzarini&title=Aryl+Phosphoramidate+Derivatives+of+d4T+Have+Improved+Anti-HIV+Efficacy+in+Tissue+Culture+and+May+Act+by+the+Generation+of+a+Novel+Intracellular+Metabolite"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Aryl Phosphoramidate Derivatives of d4T Have Improved Anti-HIV Efficacy in Tissue Culture and May Act by an Entirely New Mechanism of Reverse Transcriptase Inhibition</span></div><div class="casAuthors">McGuigan, Christopher; Cahard, Dominique; Sheeka, Hendrika M.; De Clercq, Erik; Balzarini, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1748-53</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">New phosphate derivs. of the anti-HIV nucleoside analog d4T were prepd. as potential membrane-sol. prodrugs of the bioactive free nucleotide.  The enhanced antiviral potency and/or reduced cytotoxicity of the derivs. leads to an increase in selectivity relative to the parent nucleoside analog.  Moreover, the derivs. appear to bypass the dependence of the nucleoside on thymidine kinase-mediated activation, retaining full activity in thymidine kinase-deficient cells.  This strongly suggests the successful intracellular delivery of free nucleotides by the masked phosphate triester prodrugs.  This is further confirmed by studies using radiolabeled compd. which clearly demonstrate the generation of d4T mono-, di- and triphosphates from the prodrug, even in thymidine kinase-deficient cells.  However, the major discovery herein reported is the generation of a new metabolite, a partially hydrolyzed phosphate diester, alaninyl d4T monophosphate, which is itself a competitive inhibitor of HIV1 reverse transcriptase without the need for further phosphorylation.  The authors suggest that at least part of the antiviral action of the prodrugs derives from the intracellular generation of such novel diesters and that this novel mode of action may add considerable wt. to the suggested further preclin. development of the phosphate prodrugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWbf_f_hqABrVg90H21EOLACvtfcHk0lh9NalPtPhfPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhslGmu7g%253D&md5=21cb9e163880e1426cdd3df3bf052956</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm950605j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm950605j%26sid%3Dliteratum%253Aachs%26aulast%3DMcGuigan%26aufirst%3DC.%26aulast%3DCahard%26aufirst%3DD.%26aulast%3DSheeka%26aufirst%3DH.%2BM.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DBalzarini%26aufirst%3DJ.%26atitle%3DAryl%2520Phosphoramidate%2520Derivatives%2520of%2520d4T%2520Have%2520Improved%2520Anti-HIV%2520Efficacy%2520in%2520Tissue%2520Culture%2520and%2520May%2520Act%2520by%2520the%2520Generation%2520of%2520a%2520Novel%2520Intracellular%2520Metabolite%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D1748%26epage%3D1753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">McGuigan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cahard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Leary, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gumbleton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balzarini, J.</span><span> </span><span class="NLM_article-title">Synthesis, Anti-Human Immunodeficiency Virus Activity and Esterase Lability of Some Novel Carboxylic Ester-Modified Phosphoramidate Derivatives of Stavudine (d4T)</span> <span class="citation_source-journal">Antiviral Chem. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">473</span><span class="NLM_x">–</span> <span class="NLM_lpage">479</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1998&pages=473-479&author=C.+McGuiganauthor=P.+W.+Suttonauthor=D.+Cahardauthor=K.+Turnerauthor=G.+O%E2%80%99Learyauthor=Y.+Wangauthor=M.+Gumbletonauthor=E.+De+Clercqauthor=J.+Balzarini&title=Synthesis%2C+Anti-Human+Immunodeficiency+Virus+Activity+and+Esterase+Lability+of+Some+Novel+Carboxylic+Ester-Modified+Phosphoramidate+Derivatives+of+Stavudine+%28d4T%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcGuigan%26aufirst%3DC.%26aulast%3DSutton%26aufirst%3DP.%2BW.%26aulast%3DCahard%26aufirst%3DD.%26aulast%3DTurner%26aufirst%3DK.%26aulast%3DO%25E2%2580%2599Leary%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DGumbleton%26aufirst%3DM.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DBalzarini%26aufirst%3DJ.%26atitle%3DSynthesis%252C%2520Anti-Human%2520Immunodeficiency%2520Virus%2520Activity%2520and%2520Esterase%2520Lability%2520of%2520Some%2520Novel%2520Carboxylic%2520Ester-Modified%2520Phosphoramidate%2520Derivatives%2520of%2520Stavudine%2520%2528d4T%2529%26jtitle%3DAntiviral%2520Chem.%2520Chemother.%26date%3D1998%26volume%3D9%26spage%3D473%26epage%3D479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Saboulard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naesens, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cahard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salgado, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pathirana, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velazquez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuigan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balzarini, J.</span><span> </span><span class="NLM_article-title">Characterization of the Activation Pathway of Phosphoramidate Triester Prodrugs of Stavudine and Zidovudine</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">693</span><span class="NLM_x">–</span> <span class="NLM_lpage">704</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm100863x&amp;key=10496951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm100863x&amp;key=1%3ACAS%3A528%3ADyaK1MXmsVCmtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1999&pages=693-704&author=D.+Saboulardauthor=L.+Naesensauthor=D.+Cahardauthor=A.+Salgadoauthor=R.+Pathiranaauthor=S.+Velazquezauthor=C.+McGuiganauthor=E.+De+Clercqauthor=J.+Balzarini&title=Characterization+of+the+Activation+Pathway+of+Phosphoramidate+Triester+Prodrugs+of+Stavudine+and+Zidovudine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the activation pathway of phosphoramidate triester prodrugs of stavudine and zidovudine</span></div><div class="casAuthors">Saboulard, Didier; Naesens, Lieve; Cahard, Dominique; Salgado, Antonio; Pathirana, Ranjith; Velazquez, Sonsoles; Mcguigan, Christopher; De Clercq, Erik; Balzarini, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">693-704</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The phosphoramidate triester prodrugs of anti-human HIV 2',3'-dideoxynucleoside analogs (ddN) represent a convenient approach to bypass the first phosphorylation to ddN 5'-mono-phosphate (ddNMP), resulting in an improved formation of ddN 5'-triphosphate and, hence, higher antiviral efficacy.  Although phosphoramidate derivatization markedly increases the anti-HIV activity of 2',3'-didehydro-2',3'-dideoxythymidine (d4T) in both wild-type and thymidine kinase-deficient CEM cells, the concept is far less successful for the 3'-azido-2',3'-dideoxythymidine (AZT) triesters.  We now investigated the metab. of triester prodrugs of d4T and AZT using pure enzymes or different biol. media.  The efficiency of the first activation step, mediated by carboxylesterases, consists of the formation of the amino acyl ddNMP metabolite.  The efficiency of this step was shown to be dependent on the amino acid, alkyl ester, and ddN moiety.  Triesters that showed no conversion to the amino acyl ddNMP accumulated as the phenyl-contg. intermediate and had poor, if any, anti-HIV activity.  In contrast to the relative stability of the triesters in human serum, carboxylesterase-mediated cleavage of the prodrugs was found to be remarkably high in mouse serum.  The subsequent conversion of the amino acyl ddNMP metabolite to ddNMP or ddN was highest in rat liver cytosolic enzyme prepns.  Although L-alaninyl-d4TMP was efficiently converted to d4TMP, the main metabolite formed from L-alaninyl-AZTMP was the free nucleoside (AZT), thus explaining why d4T prodrugs, but not AZT prodrugs, retain anti-HIV activity in HIV-infected thymidine kinase-deficient cell cultures.  The rat liver phosphoramidase responsible for the formation of ddNMP was shown to be distinct from creatine kinase, alk. phosphatase, and phosphodiesterase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkU4eud7u1AbVg90H21EOLACvtfcHk0ljO-MfNiseBGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmsVCmtLk%253D&md5=7d88e50f782fb3acdf934ac8a75bcee6</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSaboulard%26aufirst%3DD.%26aulast%3DNaesens%26aufirst%3DL.%26aulast%3DCahard%26aufirst%3DD.%26aulast%3DSalgado%26aufirst%3DA.%26aulast%3DPathirana%26aufirst%3DR.%26aulast%3DVelazquez%26aufirst%3DS.%26aulast%3DMcGuigan%26aufirst%3DC.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DBalzarini%26aufirst%3DJ.%26atitle%3DCharacterization%2520of%2520the%2520Activation%2520Pathway%2520of%2520Phosphoramidate%2520Triester%2520Prodrugs%2520of%2520Stavudine%2520and%2520Zidovudine%26jtitle%3DMol.%2520Pharmacol.%26date%3D1999%26volume%3D56%26spage%3D693%26epage%3D704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Perrone, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daverio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valente, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajyaguru, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lévêque, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pogam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Najera, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klumpp, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGruigan, C.</span><span> </span><span class="NLM_article-title">First Example of Phosphoramidate Approach Applied to a 4′-Substituted Purine Nucleotide (4′-Azidoadenosine): Conversion of an Inactive Nucleotide to a Submicromolar Compound versus Hepatitis C Virus</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">55463</span><span class="NLM_x">–</span> <span class="NLM_lpage">5470</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=55463-5470&author=P.+Perroneauthor=F.+Daverioauthor=R.+Valenteauthor=S.+Rajyaguruauthor=J.+A.+Martinauthor=V.+L%C3%A9v%C3%AAqueauthor=S.+Le+Pogamauthor=I.+Najeraauthor=K.+Klumppauthor=D.+B.+Smithauthor=C.+McGruigan&title=First+Example+of+Phosphoramidate+Approach+Applied+to+a+4%E2%80%B2-Substituted+Purine+Nucleotide+%284%E2%80%B2-Azidoadenosine%29%3A+Conversion+of+an+Inactive+Nucleotide+to+a+Submicromolar+Compound+versus+Hepatitis+C+Virus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerrone%26aufirst%3DP.%26aulast%3DDaverio%26aufirst%3DF.%26aulast%3DValente%26aufirst%3DR.%26aulast%3DRajyaguru%26aufirst%3DS.%26aulast%3DMartin%26aufirst%3DJ.%2BA.%26aulast%3DL%25C3%25A9v%25C3%25AAque%26aufirst%3DV.%26aulast%3DLe%2BPogam%26aufirst%3DS.%26aulast%3DNajera%26aufirst%3DI.%26aulast%3DKlumpp%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DD.%2BB.%26aulast%3DMcGruigan%26aufirst%3DC.%26atitle%3DFirst%2520Example%2520of%2520Phosphoramidate%2520Approach%2520Applied%2520to%2520a%25204%25E2%2580%25B2-Substituted%2520Purine%2520Nucleotide%2520%25284%25E2%2580%25B2-Azidoadenosine%2529%253A%2520Conversion%2520of%2520an%2520Inactive%2520Nucleotide%2520to%2520a%2520Submicromolar%2520Compound%2520versus%2520Hepatitis%2520C%2520Virus%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D55463%26epage%3D5470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">McGuigan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelleher, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulready, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luoni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daverio., F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajyaguru, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pogam., S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Najer, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klumpp, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. B.</span><span> </span><span class="NLM_article-title">The Application of Phosphoramidate ProTide Technology to the Potent Anti-HCV Compound 4′-Azidocytidine (R1479)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4250</span><span class="NLM_x">–</span> <span class="NLM_lpage">4254</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4250-4254&author=C.+McGuiganauthor=M.+R.+Kelleherauthor=P.+Perroneauthor=S.+Mulreadyauthor=G.+Luoniauthor=F.+Daverio.author=S.+Rajyaguruauthor=S.+Le+Pogam.author=I.+Najerauthor=J.+A.+Martinauthor=K.+Klumppauthor=D.+B.+Smith&title=The+Application+of+Phosphoramidate+ProTide+Technology+to+the+Potent+Anti-HCV+Compound+4%E2%80%B2-Azidocytidine+%28R1479%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcGuigan%26aufirst%3DC.%26aulast%3DKelleher%26aufirst%3DM.%2BR.%26aulast%3DPerrone%26aufirst%3DP.%26aulast%3DMulready%26aufirst%3DS.%26aulast%3DLuoni%26aufirst%3DG.%26aulast%3DDaverio.%26aufirst%3DF.%26aulast%3DRajyaguru%26aufirst%3DS.%26aulast%3DLe%2BPogam.%26aufirst%3DS.%26aulast%3DNajer%26aufirst%3DI.%26aulast%3DMartin%26aufirst%3DJ.%2BA.%26aulast%3DKlumpp%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DD.%2BB.%26atitle%3DThe%2520Application%2520of%2520Phosphoramidate%2520ProTide%2520Technology%2520to%2520the%2520Potent%2520Anti-HCV%2520Compound%25204%25E2%2580%25B2-Azidocytidine%2520%2528R1479%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4250%26epage%3D4254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Gardelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attenni, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donghi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meppen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harper, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiori, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuliano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pucci, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gennari, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcucci, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leone, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacCoss, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, F.</span><span> </span><span class="NLM_article-title">Phosphoramidate Prodrugs of 2′-<i>C</i>-Methylcytidine for the Therapy of Hepatitis C Virus Infection</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">5394</span><span class="NLM_x">–</span> <span class="NLM_lpage">5407</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900447q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5394-5407&author=C.+Gardelliauthor=B.+Attenniauthor=M.+Donghiauthor=M.+Meppenauthor=B.+Paciniauthor=S.+Harperauthor=A.+Di+Marcoauthor=F.+Fioriauthor=C.+Giulianoauthor=V.+Pucciauthor=R.+Lauferauthor=N.+Gennariauthor=I.+Marcucciauthor=J.+F.+Leoneauthor=D.+B.+Olsenauthor=M.+MacCossauthor=M.+Rowleyauthor=F.+Narjes&title=Phosphoramidate+Prodrugs+of+2%E2%80%B2-C-Methylcytidine+for+the+Therapy+of+Hepatitis+C+Virus+Infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm900447q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900447q%26sid%3Dliteratum%253Aachs%26aulast%3DGardelli%26aufirst%3DC.%26aulast%3DAttenni%26aufirst%3DB.%26aulast%3DDonghi%26aufirst%3DM.%26aulast%3DMeppen%26aufirst%3DM.%26aulast%3DPacini%26aufirst%3DB.%26aulast%3DHarper%26aufirst%3DS.%26aulast%3DDi%2BMarco%26aufirst%3DA.%26aulast%3DFiori%26aufirst%3DF.%26aulast%3DGiuliano%26aufirst%3DC.%26aulast%3DPucci%26aufirst%3DV.%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DGennari%26aufirst%3DN.%26aulast%3DMarcucci%26aufirst%3DI.%26aulast%3DLeone%26aufirst%3DJ.%2BF.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DMacCoss%26aufirst%3DM.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DNarjes%26aufirst%3DF.%26atitle%3DPhosphoramidate%2520Prodrugs%2520of%25202%25E2%2580%25B2-C-Methylcytidine%2520for%2520the%2520Therapy%2520of%2520Hepatitis%2520C%2520Virus%2520Infection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5394%26epage%3D5407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Wang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, B.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rachakonda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stec, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleary, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sofia, M. J.</span><span> </span><span class="NLM_article-title">An Efficient and Diastereoselective Synthesis of PSI-6130: A Clinically Efficacious Inhibitor of HCV NS5B Polymerase</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">6819</span><span class="NLM_x">–</span> <span class="NLM_lpage">6824</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo901345j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2009&pages=6819-6824&author=P.+Wangauthor=B.-K.+Chinauthor=S.+Rachakondaauthor=J.+Duauthor=N.+Khanauthor=J.+Shiauthor=W.+Stecauthor=D.+Clearyauthor=B.+S.+Rossauthor=M.+J.+Sofia&title=An+Efficient+and+Diastereoselective+Synthesis+of+PSI-6130%3A+A+Clinically+Efficacious+Inhibitor+of+HCV+NS5B+Polymerase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjo901345j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo901345j%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DP.%26aulast%3DChin%26aufirst%3DB.-K.%26aulast%3DRachakonda%26aufirst%3DS.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DKhan%26aufirst%3DN.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DStec%26aufirst%3DW.%26aulast%3DCleary%26aufirst%3DD.%26aulast%3DRoss%26aufirst%3DB.%2BS.%26aulast%3DSofia%26aufirst%3DM.%2BJ.%26atitle%3DAn%2520Efficient%2520and%2520Diastereoselective%2520Synthesis%2520of%2520PSI-6130%253A%2520A%2520Clinically%2520Efficacious%2520Inhibitor%2520of%2520HCV%2520NS5B%2520Polymerase%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2009%26volume%3D74%26spage%3D6819%26epage%3D6824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span> </span><span class="NLM_article-title">Cytotoxic Effects of Environmentally Relevant Chlorophenols on L929 Cells and Their Mechanism</span> <span class="citation_source-journal">Cell Biol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">183</span><span class="NLM_x">–</span> <span class="NLM_lpage">196</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm100863x&amp;key=10.1023%2FB%3ACBTO.0000029468.89746.64" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm100863x&amp;key=15250542" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm100863x&amp;key=1%3ACAS%3A528%3ADC%252BD2cXktlyksbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2004&pages=183-196&author=J.+Chenauthor=J.+Jianauthor=F.+Zhangauthor=H.+Yuauthor=J.+Zhang&title=Cytotoxic+Effects+of+Environmentally+Relevant+Chlorophenols+on+L929+Cells+and+Their+Mechanism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic effects of environmentally relevant chlorophenols on L929 cells and their mechanisms</span></div><div class="casAuthors">Chen, J.; Jiang, J.; Zhang, F.; Yu, H.; Zhang, J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Biology and Toxicology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">183-196</span>CODEN:
                <span class="NLM_cas:coden">CBTOE2</span>;
        ISSN:<span class="NLM_cas:issn">0742-2091</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">The chlorophenol chems. (CPs) are a major class of widely distributed and frequently occurring persistent environmental pollutants.  Pentachlorophenol (PCP) has been proposed to be procarcinogen in rodents and in possibly human beings.  Human beings are also easily exposed to other chlorophenol chems., including 4-chlorophenol (CP), 2,4-dichlorophenol (DCP), 2,3,4-trichlorophenol (TCP), prompting this investigation of their comparative cytotoxic effects and cell death mechanisms, assayed in fibroblast L929 cells.  The effective concn. for half-maximal response (EC50) values at 24 h for CP, DCP, TCP, and PCP are 2.18, 0.83, 0.46, and 0.11 mmol/L resp. and the EC50 values at 48 h are 1.18, 0.13, 0.08, and 0.06 mmol/L resp. by using 3-(4,5-dimethylthiazd-2-yl)-2,5-diphenyltentrazolium bromide (MTT) redn. assay.  A clear structure-activity relationship was obsd. between toxicity of CPs and their octanol-water partition coeffs.  The further studies indicate that CP, DCP, and TCP induce apoptosis in L929 cells in a concn. or time-dependent manner, but PCP mediates cell death more characteristic of necrosis than apoptosis.  These results not only demonstrate that L929 cell growth inhibition bioassay may be useful to provide the comparative evaluation of toxicity of CPs in vitro, but also implicate that CP, DCP, TCP, in comparison with PCP, can induce L929 cell death by apoptosis, resulting in lower procarcinogensis, which may help to elucidate the mol. basis for the adverse health effects assocd. with CPs exposure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQQXKmsbKYYLVg90H21EOLACvtfcHk0liPyigYKZcdwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXktlyksbY%253D&md5=b0b9c2f1abe74c5bc1b0c26716f4db1d</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1023%2FB%3ACBTO.0000029468.89746.64&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FB%253ACBTO.0000029468.89746.64%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DJian%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3DCytotoxic%2520Effects%2520of%2520Environmentally%2520Relevant%2520Chlorophenols%2520on%2520L929%2520Cells%2520and%2520Their%2520Mechanism%26jtitle%3DCell%2520Biol.%2520Toxicol.%26date%3D2004%26volume%3D20%26spage%3D183%26epage%3D196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Phornchirasilp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Victor DeSouza, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feller, D. R.</span><span> </span><span class="NLM_article-title">Vivo and In Vitro Studies of the Hepatotoxic Effects of 4-Chlorophenol in Mice</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">961</span><span class="NLM_x">–</span> <span class="NLM_lpage">972</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1989&pages=961-972&author=S.+Phornchirasilpauthor=J.+J.+Victor+DeSouzaauthor=D.+R.+Feller&title=Vivo+and+In+Vitro+Studies+of+the+Hepatotoxic+Effects+of+4-Chlorophenol+in+Mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPhornchirasilp%26aufirst%3DS.%26aulast%3DVictor%2BDeSouza%26aufirst%3DJ.%2BJ.%26aulast%3DFeller%26aufirst%3DD.%2BR.%26atitle%3DVivo%2520and%2520In%2520Vitro%2520Studies%2520of%2520the%2520Hepatotoxic%2520Effects%2520of%25204-Chlorophenol%2520in%2520Mice%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1989%26volume%3D38%26spage%3D961%26epage%3D972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Zhao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burghardt, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, T. D.</span><span> </span><span class="NLM_article-title">Developmental Toxicity and Structure−Activity Relationships of Chlorophenols Using Human Embryonic Palatal Mesenchymal Cells</span> <span class="citation_source-journal">Toxicol. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm100863x&amp;key=10.1016%2F0378-4274%2895%2999684-A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm100863x&amp;key=7604397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm100863x&amp;key=1%3ACAS%3A528%3ADyaK2MXmt1yntbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=1995&pages=35-42&author=F.+Zhaoauthor=K.+Mayuraauthor=R.+W.+Hutchinsonauthor=R.+P.+Lewisauthor=R.+C.+Burghardtauthor=T.+D.+Phillips&title=Developmental+Toxicity+and+Structure%E2%88%92Activity+Relationships+of+Chlorophenols+Using+Human+Embryonic+Palatal+Mesenchymal+Cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Developmental toxicity and structure-activity relationships of chlorophenols using human embryonic palatal mesenchymal cells</span></div><div class="casAuthors">Zhao, Feng; Mayura, Kittane; Hutchinson, Richard W.; Lewis, Richard P.; Burghardt, Robert C.; Phillips, Timothy D.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology Letters</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">35-42</span>CODEN:
                <span class="NLM_cas:coden">TOLED5</span>;
        ISSN:<span class="NLM_cas:issn">0378-4274</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The chlorophenols (CPs) comprise a major class of widely distributed and frequently occurring environmental contaminants.  Previous studies have demonstrated the adverse effects of CPs on embryonic and fetal development.  HEPM (human embryonic palatal mesenchymal) and MOT (mouse ovarian tumor) cell lines have been utilized in complementary bioassays for the detection of teratogens, but not the CPs.  In this study, the objectives were 2-fold: (1) to det. if the HEPM assay could be used to complement other bioassay systems of nonhuman origin, i.e., Hydra attenuata (HA) and rat whole embryo culture (WEC), in the evaluation of the developmental toxicity of CPs, and (2) to delineate the ability of the HEPM assay to evaluate structure-activity relationships of pentachlorophenol (C5P), 2,3,4,5- tetrachlorophenol (C4P), 2,3,5-trichlorophenol (C3P), 3,5-dichlorophenol (C2P), 4-monochlorophenol (CP), phenol, and CP derivs. (i.e., acetates, sodium phenates and anisoles).  HEPM cells were seeded into each well of a 24-well plate and cultivated for 24 h.  The medium was replaced with fresh medium contg. various concns. of test chems. dissolved in DMSO (0.1%).  After culturing for 72 h, the medium was removed, cells were trypsinized, and cell no. detd.  The HEPM cell growth inhibition assay demonstrated a linear relation between the IC50 values of the CPs and degree of chlorine substitution.  The IC50 values of C5P, C4P, C3P, C2P, CP, and phenol were 18.8, 21.5, 27.5, 63.0, 150.0 and 470.0 μM, resp.  A clear structure-activity relation was obsd. between toxicity of CPs and the degree of chlorine substitution.  The rank order of CP toxicity from the HEPM assay (i.e., C5P > C4P > C3P > C2P > CP > phenol) is in excellent agreement with previous in vitro and in vivo studies.  However, contrary to published reports, the HEPM assay predicted that all CPs were teratogenic (false positives).  These findings suggest that the HEPM cell growth inhibition bioassay may be useful to discriminate between subtle differences in structure-activity and, in combination with other bioassays, might facilitate the rapid detection and prioritization of diverse cytotoxins, including various developmental toxicants.  Importantly, conclusions about the teratogenicity of a test chem. (via HEPM testing) should be approached with caution and confirmed with other teratogen-sensitive systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgr_IoCS5aHLVg90H21EOLACvtfcHk0liPyigYKZcdwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmt1yntbk%253D&md5=ce723494deb3fe1c43f719a4dfe088aa</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2F0378-4274%2895%2999684-A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0378-4274%252895%252999684-A%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DMayura%26aufirst%3DK.%26aulast%3DHutchinson%26aufirst%3DR.%2BW.%26aulast%3DLewis%26aufirst%3DR.%2BP.%26aulast%3DBurghardt%26aufirst%3DR.%2BC.%26aulast%3DPhillips%26aufirst%3DT.%2BD.%26atitle%3DDevelopmental%2520Toxicity%2520and%2520Structure%25E2%2588%2592Activity%2520Relationships%2520of%2520Chlorophenols%2520Using%2520Human%2520Embryonic%2520Palatal%2520Mesenchymal%2520Cells%26jtitle%3DToxicol.%2520Lett.%26date%3D1995%26volume%3D78%26spage%3D35%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Niu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furman, P. A.</span><span> </span><span class="NLM_article-title">Clevudine Is Efficiently Phosphorylated to the Active Triphosphate Form in Primary Human Hepatocytes</span> <span class="citation_source-journal">Antiviral Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">263</span><span class="NLM_x">–</span> <span class="NLM_lpage">269</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=263-269&author=C.+Niuauthor=E.+Murakamiauthor=P.+A.+Furman&title=Clevudine+Is+Efficiently+Phosphorylated+to+the+Active+Triphosphate+Form+in+Primary+Human+Hepatocytes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNiu%26aufirst%3DC.%26aulast%3DMurakami%26aufirst%3DE.%26aulast%3DFurman%26aufirst%3DP.%2BA.%26atitle%3DClevudine%2520Is%2520Efficiently%2520Phosphorylated%2520to%2520the%2520Active%2520Triphosphate%2520Form%2520in%2520Primary%2520Human%2520Hepatocytes%26jtitle%3DAntiviral%2520Ther.%26date%3D2008%26volume%3D13%26spage%3D263%26epage%3D269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Ghose, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viswanadhan, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wendoloski, J. J.</span><span> </span><span class="NLM_article-title">Prediction of Hydrohobic Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and ClogP Methods</span> <span class="citation_source-journal">J. Phys. Chem. A</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">3762</span><span class="NLM_x">–</span> <span class="NLM_lpage">3772</span></span><div class="citationLinks">[<a href="/doi/10.1021/jp980230o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=1998&pages=3762-3772&author=A.+K.+Ghoseauthor=V.+N.+Viswanadhanauthor=J.+J.+Wendoloski&title=Prediction+of+Hydrohobic+Properties+of+Small+Organic+Molecules+Using+Fragment+Methods%3A+An+Analysis+of+AlogP+and+ClogP+Methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjp980230o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp980230o%26sid%3Dliteratum%253Aachs%26aulast%3DGhose%26aufirst%3DA.%2BK.%26aulast%3DViswanadhan%26aufirst%3DV.%2BN.%26aulast%3DWendoloski%26aufirst%3DJ.%2BJ.%26atitle%3DPrediction%2520of%2520Hydrohobic%2520Properties%2520of%2520Small%2520Organic%2520Molecules%2520Using%2520Fragment%2520Methods%253A%2520An%2520Analysis%2520of%2520AlogP%2520and%2520ClogP%2520Methods%26jtitle%3DJ.%2520Phys.%2520Chem.%2520A%26date%3D1998%26volume%3D102%26spage%3D3762%26epage%3D3772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Faller, B.</span><span> </span><span class="NLM_article-title">Artificial Membrane Assays To Assess Permeability</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">886</span><span class="NLM_x">–</span> <span class="NLM_lpage">892</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm100863x&amp;key=10.2174%2F138920008786485227" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm100863x&amp;key=18991585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm100863x&amp;key=1%3ACAS%3A528%3ADC%252BD1MXivF2nsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=886-892&author=B.+Faller&title=Artificial+Membrane+Assays+To+Assess+Permeability"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Artificial membrane assays to assess permeability</span></div><div class="casAuthors">Faller, Bernard</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">886-892</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  This paper reviews the development of artificial membrane assays in the last decade.  Reasons why parallel artificial membrane assays (PAMPA) became widely used are discussed and the various PAMPA assays targeting gastrointestinal absorption, blood brain barrier and skin penetration are presented.  Improvements in the assay technol. like the introduction of a paracellular component and the crit. factors to get quality data are reviewed.  The question how does PAMPA compare with Caco-2 monolayer permeability is being addressed.  New dimensions in artificial membrane assays like octanol/water logP measurement, influence of excipients on soly./permeability and binding consts. measurements are introduced.  Finally, similarity and differences between partition coeffs. and permeability values are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTpkeB5ssWpbVg90H21EOLACvtfcHk0ljk9yjaGAE22g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXivF2nsbw%253D&md5=7199c7fdea61f640773ce3453b273e81</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.2174%2F138920008786485227&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920008786485227%26sid%3Dliteratum%253Aachs%26aulast%3DFaller%26aufirst%3DB.%26atitle%3DArtificial%2520Membrane%2520Assays%2520To%2520Assess%2520Permeability%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2008%26volume%3D9%26spage%3D886%26epage%3D892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Fleischer, R. l.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lok, A. S.</span><span> </span><span class="NLM_article-title">Myopathy and Neuropathy Associated with Nucleos(t)ide Analog Therapy for Hepatitis B</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">787</span><span class="NLM_x">–</span> <span class="NLM_lpage">791</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm100863x&amp;key=10.1016%2Fj.jhep.2009.06.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm100863x&amp;key=19665816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm100863x&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFagt7%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2009&pages=787-791&author=R.+l.+Fleischerauthor=A.+S.+Lok&title=Myopathy+and+Neuropathy+Associated+with+Nucleos%28t%29ide+Analog+Therapy+for+Hepatitis+B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Myopathy and neuropathy associated with nucleos(t)ide analog therapy for hepatitis B</span></div><div class="casAuthors">Fleischer, Russell D.; Lok, Anna S. F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hepatology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">787-791</span>CODEN:
                <span class="NLM_cas:coden">JOHEEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-8278</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The development of clevudine as a treatment for hepatitis B was terminated recently because of case reports of myopathy.  In each case, the onset of symptoms occurred between 8 and 13 mo after the initiation of treatment.  Electromyog. and muscle biopsy confirmed the presence of myonecrosis.  One report also found evidence of mitochondrial toxicity.  The delayed onset and the finding of mitochondrial damage are reminiscent of fialuridine toxicity.  Telbivudine has also been reported to be assocd. with myopathy and neuropathy, particularly when used in combination with pegylated interferon.  These findings serve as a sober reminder of the lack of data on long-term safety of nucleos(t)ide analogs for hepatitis B, the importance of balancing benefits vs. risks before initiating treatment, and the need for more stringent post-marketing surveillance for drug toxicities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoavyhIHa1biLVg90H21EOLACvtfcHk0ljk9yjaGAE22g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFagt7%252FJ&md5=e09f459a5cc5018bd0f60fa81523563a</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.jhep.2009.06.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhep.2009.06.011%26sid%3Dliteratum%253Aachs%26aulast%3DFleischer%26aufirst%3DR.%2Bl.%26aulast%3DLok%26aufirst%3DA.%2BS.%26atitle%3DMyopathy%2520and%2520Neuropathy%2520Associated%2520with%2520Nucleos%2528t%2529ide%2520Analog%2520Therapy%2520for%2520Hepatitis%2520B%26jtitle%3DJ.%2520Hepatol.%26date%3D2009%26volume%3D51%26spage%3D787%26epage%3D791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Lewis, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copeland, W. C.</span><span> </span><span class="NLM_article-title">Mitochondrial Toxicity of NRTI Antiviral Drugs: An Integrated Cellular Perspective</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">812</span><span class="NLM_x">–</span> <span class="NLM_lpage">822</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm100863x&amp;key=10.1038%2Fnrd1201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm100863x&amp;key=14526384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm100863x&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnslarsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=812-822&author=W.+Lewisauthor=B.+J.+Dayauthor=W.+C.+Copeland&title=Mitochondrial+Toxicity+of+NRTI+Antiviral+Drugs%3A+An+Integrated+Cellular+Perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial toxicity of NRTI antiviral drugs: an integrated cellular perspective</span></div><div class="casAuthors">Lewis, William; Day, Brian J.; Copeland, William C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">812-822</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Highly active antiretroviral therapy (HAART) regimes based on nucleoside reverse transcriptase inhibitors (NRTIs) have revolutionized the treatment of AIDS in recent years.  Although HAART can successfully suppress viral replication in the long term, it is not without significant toxicity, which can seriously compromise treatment effectiveness.  A major toxicity that has been recognized for more than a decade is NRTI-related mitochondrial toxicity, which manifests as serious side effects such as hepatic failure and lactic acidosis.  However, a lack of understanding of the mechanisms underlying mitochondrial toxicity has hampered efforts to develop novel drugs with better side-effect profiles.  This review characterizes the pharmacol. mechanisms and pathways that are involved in mitochondrial dysfunction caused by NRTIs, and suggests opportunities for future pharmacol. research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSLd33wOAwYLVg90H21EOLACvtfcHk0ljk9yjaGAE22g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnslarsbo%253D&md5=e027a725c00f135731b9dbb041ae986f</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fnrd1201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1201%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DW.%26aulast%3DDay%26aufirst%3DB.%2BJ.%26aulast%3DCopeland%26aufirst%3DW.%2BC.%26atitle%3DMitochondrial%2520Toxicity%2520of%2520NRTI%2520Antiviral%2520Drugs%253A%2520An%2520Integrated%2520Cellular%2520Perspective%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2003%26volume%3D2%26spage%3D812%26epage%3D822" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Sammadossi, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlisle, R.</span><span> </span><span class="NLM_article-title">Toxicity of 3′-Azido-3′-deoxythymidine and 9-(1,3-Dihydroxy-2-propoxymethyl)guanine for Normal Human Hematopoietic Cells in Vitro</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">452</span><span class="NLM_x">–</span> <span class="NLM_lpage">454</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1987&pages=452-454&author=J.+P.+Sammadossiauthor=R.+Carlisle&title=Toxicity+of+3%E2%80%B2-Azido-3%E2%80%B2-deoxythymidine+and+9-%281%2C3-Dihydroxy-2-propoxymethyl%29guanine+for+Normal+Human+Hematopoietic+Cells+in+Vitro"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSammadossi%26aufirst%3DJ.%2BP.%26aulast%3DCarlisle%26aufirst%3DR.%26atitle%3DToxicity%2520of%25203%25E2%2580%25B2-Azido-3%25E2%2580%25B2-deoxythymidine%2520and%25209-%25281%252C3-Dihydroxy-2-propoxymethyl%2529guanine%2520for%2520Normal%2520Human%2520Hematopoietic%2520Cells%2520in%2520Vitro%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1987%26volume%3D31%26spage%3D452%26epage%3D454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Sammadossi, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schinazi, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, M. Y.</span><span> </span><span class="NLM_article-title">Comparison of Cytotoxicity of the (−)- and (+)-Enantiomer of 2′,3′-Dideoxy-3′-thiacytidine in Normal Human Bone Marrow Progenitor Cells</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1921</span><span class="NLM_x">–</span> <span class="NLM_lpage">1925</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1992&pages=1921-1925&author=J.+P.+Sammadossiauthor=R.+F.+Schinaziauthor=C.+K.+Chuauthor=M.+Y.+Xie&title=Comparison+of+Cytotoxicity+of+the+%28%E2%88%92%29-+and+%28%2B%29-Enantiomer+of+2%E2%80%B2%2C3%E2%80%B2-Dideoxy-3%E2%80%B2-thiacytidine+in+Normal+Human+Bone+Marrow+Progenitor+Cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSammadossi%26aufirst%3DJ.%2BP.%26aulast%3DSchinazi%26aufirst%3DR.%2BF.%26aulast%3DChu%26aufirst%3DC.%2BK.%26aulast%3DXie%26aufirst%3DM.%2BY.%26atitle%3DComparison%2520of%2520Cytotoxicity%2520of%2520the%2520%2528%25E2%2588%2592%2529-%2520and%2520%2528%252B%2529-Enantiomer%2520of%25202%25E2%2580%25B2%252C3%25E2%2580%25B2-Dideoxy-3%25E2%2580%25B2-thiacytidine%2520in%2520Normal%2520Human%2520Bone%2520Marrow%2520Progenitor%2520Cells%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1992%26volume%3D44%26spage%3D1921%26epage%3D1925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sofia, M. J.; Du, J.; Wang, P.; Nagarathnam, D.</span><span> </span><span class="NLM_article-title">Nucleoside Phosphoramidate Prodrugs</span>. WO2008121634,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=M.+J.+Sofia&author=J.+&author=P.+&author=D.+&title=Nucleoside+Phosphoramidate+Prodrugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSofia%26aufirst%3DM.%2BJ.%26atitle%3DNucleoside%2520Phosphoramidate%2520Prodrugs%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Migliaccio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomassini, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhat, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartholomew, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosserman, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceccacci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colwell, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortese, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eldrup, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Getty, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFemina, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludmerer, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacCoss, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMasters, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flores, O. A.</span><span> </span><span class="NLM_article-title">Characterization of Resistance to Non-Obligate Chain-Terminating Ribonucleoside Analogs That Inhibit Hepatitis C Virus Replication in Vitro</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">49164</span><span class="NLM_x">–</span> <span class="NLM_lpage">49170</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm100863x&amp;key=10.1074%2Fjbc.M305041200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm100863x&amp;key=12966103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm100863x&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptlGrsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=49164-49170&author=G.+Migliaccioauthor=J.+E.+Tomassiniauthor=S.+S.+Carrollauthor=L.+Tomeiauthor=S.+Altamuraauthor=B.+Bhatauthor=L.+Bartholomewauthor=M.+R.+Gossermanauthor=A.+Ceccacciauthor=L.+F.+Colwellauthor=R.+Corteseauthor=A.+B.+Eldrupauthor=K.+L.+Gettyauthor=X.+S.+Houauthor=R.+L.+LaFeminaauthor=S.+W.+Ludmererauthor=M.+MacCossauthor=D.+R.+McMastersauthor=M.+W.+Stahlhutauthor=D.+B.+Olsenauthor=D.+J.+Hazudaauthor=O.+A.+Flores&title=Characterization+of+Resistance+to+Non-Obligate+Chain-Terminating+Ribonucleoside+Analogs+That+Inhibit+Hepatitis+C+Virus+Replication+in+Vitro"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of Resistance to Non-obligate Chain-terminating Ribonucleoside Analogs That Inhibit Hepatitis C Virus Replication in Vitro</span></div><div class="casAuthors">Migliaccio, Giovanni; Tomassini, Joanne E.; Carroll, Steven S.; Tomei, Licia; Altamura, Sergio; Bhat, Balkrishen; Bartholomew, Linda; Bosserman, Michele R.; Ceccacci, Alessandra; Colwell, Lawrence F.; Cortese, Riccardo; De Francesco, Raffaele; Eldrup, Anne B.; Getty, Krista L.; Hou, Xiaoli S.; LaFemina, Robert L.; Ludmerer, Steven W.; MacCoss, Malcolm; McMasters, Daniel R.; Stahlhut, Mark W.; Olsen, David B.; Hazuda, Daria J.; Flores, Osvaldo A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">49164-49170</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The urgent need for efficacious drugs to treat chronic hepatitis C virus (HCV) infection requires a concerted effort to develop inhibitors specific for virally encoded enzymes.  We demonstrate that 2'-C-Me ribonucleosides are efficient chain-terminating inhibitors of HCV genome replication.  Characterization of drug-resistant HCV replicons defined a single S282T mutation within the active site of the viral polymerase that conferred loss of sensitivity to structurally related compds. in both replicon and isolated polymerase assays.  Biochem. analyses demonstrated that resistance at the level of the enzyme results from a combination of reduced affinity of the mutant polymerase for the drug and an increased ability to extend the incorporated nucleoside analog.  Importantly, the combination of these agents with interferon-α results in synergistic inhibition of HCV genome replication in cell culture.  Furthermore, 2'-C-methyl-substituted ribonucleosides also inhibited replication of genetically related viruses such as bovine diarrhea virus, yellow fever, and West African Nile viruses.  These observations, together with the finding that 2'-C-methyl-guanosine in particular has a favorable pharmacol. profile, suggest that this class of compds. may have broad utility in the treatment of HCV and other flavivirus infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7Zeuc5zFmbbVg90H21EOLACvtfcHk0lj-5MvPhW9pAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptlGrsL4%253D&md5=a7183ce208fe008e48c7a1a83ef66e85</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M305041200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M305041200%26sid%3Dliteratum%253Aachs%26aulast%3DMigliaccio%26aufirst%3DG.%26aulast%3DTomassini%26aufirst%3DJ.%2BE.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DTomei%26aufirst%3DL.%26aulast%3DAltamura%26aufirst%3DS.%26aulast%3DBhat%26aufirst%3DB.%26aulast%3DBartholomew%26aufirst%3DL.%26aulast%3DGosserman%26aufirst%3DM.%2BR.%26aulast%3DCeccacci%26aufirst%3DA.%26aulast%3DColwell%26aufirst%3DL.%2BF.%26aulast%3DCortese%26aufirst%3DR.%26aulast%3DEldrup%26aufirst%3DA.%2BB.%26aulast%3DGetty%26aufirst%3DK.%2BL.%26aulast%3DHou%26aufirst%3DX.%2BS.%26aulast%3DLaFemina%26aufirst%3DR.%2BL.%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26aulast%3DMacCoss%26aufirst%3DM.%26aulast%3DMcMasters%26aufirst%3DD.%2BR.%26aulast%3DStahlhut%26aufirst%3DM.%2BW.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DFlores%26aufirst%3DO.%2BA.%26atitle%3DCharacterization%2520of%2520Resistance%2520to%2520Non-Obligate%2520Chain-Terminating%2520Ribonucleoside%2520Analogs%2520That%2520Inhibit%2520Hepatitis%2520C%2520Virus%2520Replication%2520in%2520Vitro%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D49164%26epage%3D49170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Le Pagam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, W.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leveque, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajyaguru, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klumpp, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symons, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammack, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Najera, I.</span><span> </span><span class="NLM_article-title">In Vitro Selected Con1 Subgenomic Replicons Resistant to 2′-<i>C</i>-Methyl-cytidine or to R1479 Show Lack of Cross Resistance</span> <span class="citation_source-journal">Virology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">351</span><span class="NLM_x">, </span> <span class="NLM_fpage">349</span><span class="NLM_x">–</span> <span class="NLM_lpage">359</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=2006&pages=349-359&author=S.+Le+Pagamauthor=W.-R.+Jiangauthor=V.+Levequeauthor=S.+Rajyaguruauthor=H.+Maauthor=H.+Kangauthor=S.+Jiangauthor=M.+Singerauthor=S.+Aliauthor=K.+Klumppauthor=D.+Smithauthor=J.+Symonsauthor=N.+Cammackauthor=I.+Najera&title=In+Vitro+Selected+Con1+Subgenomic+Replicons+Resistant+to+2%E2%80%B2-C-Methyl-cytidine+or+to+R1479+Show+Lack+of+Cross+Resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BPagam%26aufirst%3DS.%26aulast%3DJiang%26aufirst%3DW.-R.%26aulast%3DLeveque%26aufirst%3DV.%26aulast%3DRajyaguru%26aufirst%3DS.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DKang%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DSinger%26aufirst%3DM.%26aulast%3DAli%26aufirst%3DS.%26aulast%3DKlumpp%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DSymons%26aufirst%3DJ.%26aulast%3DCammack%26aufirst%3DN.%26aulast%3DNajera%26aufirst%3DI.%26atitle%3DIn%2520Vitro%2520Selected%2520Con1%2520Subgenomic%2520Replicons%2520Resistant%2520to%25202%25E2%2580%25B2-C-Methyl-cytidine%2520or%2520to%2520R1479%2520Show%2520Lack%2520of%2520Cross%2520Resistance%26jtitle%3DVirology%26date%3D2006%26volume%3D351%26spage%3D349%26epage%3D359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Ali, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leveque, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pogam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philipp, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inocencio, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Najera, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klumpp, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symons, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammack, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, W. R.</span><span> </span><span class="NLM_article-title">Selected Replicon Variants with Low-Level in Vitro Resistance to the Hepatitis C Virus NS5B Polymerase Inhibitor PSI-6130 Lack Cross-Resistance with R1479</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4356</span><span class="NLM_x">–</span> <span class="NLM_lpage">4369</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=4356-4369&author=S.+Aliauthor=V.+Levequeauthor=S.+Le+Pogamauthor=+Ma.author=F.+Philippauthor=N.+Inocencioauthor=M.+Smithauthor=A.+Alkerauthor=H.+Kangauthor=I.+Najeraauthor=K.+Klumppauthor=J.+Symonsauthor=N.+Cammackauthor=W.+R.+Jiang&title=Selected+Replicon+Variants+with+Low-Level+in+Vitro+Resistance+to+the+Hepatitis+C+Virus+NS5B+Polymerase+Inhibitor+PSI-6130+Lack+Cross-Resistance+with+R1479"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAli%26aufirst%3DS.%26aulast%3DLeveque%26aufirst%3DV.%26aulast%3DLe%2BPogam%26aufirst%3DS.%26aulast%3DMa.%26aulast%3DPhilipp%26aufirst%3DF.%26aulast%3DInocencio%26aufirst%3DN.%26aulast%3DSmith%26aufirst%3DM.%26aulast%3DAlker%26aufirst%3DA.%26aulast%3DKang%26aufirst%3DH.%26aulast%3DNajera%26aufirst%3DI.%26aulast%3DKlumpp%26aufirst%3DK.%26aulast%3DSymons%26aufirst%3DJ.%26aulast%3DCammack%26aufirst%3DN.%26aulast%3DJiang%26aufirst%3DW.%2BR.%26atitle%3DSelected%2520Replicon%2520Variants%2520with%2520Low-Level%2520in%2520Vitro%2520Resistance%2520to%2520the%2520Hepatitis%2520C%2520Virus%2520NS5B%2520Polymerase%2520Inhibitor%2520PSI-6130%2520Lack%2520Cross-Resistance%2520with%2520R1479%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D4356%26epage%3D4369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Altomare, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burla, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camalli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cascarano, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giacovazzo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guagliardi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moliterni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polidori, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spagna, R.</span><span> </span><span class="NLM_article-title">SIR97: A New Tool for Crystal Structure Determination and Refinement</span> <span class="citation_source-journal">J. Appl. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">115</span><span class="NLM_x">–</span> <span class="NLM_lpage">116</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm100863x&amp;key=10.1107%2FS0021889898007717" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm100863x&amp;key=1%3ACAS%3A528%3ADyaK1MXhsFOrsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1999&pages=115-116&author=A.+Altomareauthor=M.+Burlaauthor=G.+Camalliauthor=G.+Cascaranoauthor=C.+Giacovazzoauthor=A.+Guagliardiauthor=A.+Moliterniauthor=G.+Polidoriauthor=R.+Spagna&title=SIR97%3A+A+New+Tool+for+Crystal+Structure+Determination+and+Refinement"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">SIR97: a new tool for crystal structure determination and refinement</span></div><div class="casAuthors">Altomare, Angela; Burla, Maria Cristina; Camalli, Mercedes; Cascarano, Giovanni Luca; Giacovazzo, Carmelo; Guagliardi, Antonietra; Moliterni, Anna Grazia Giuseppina; Polidori, Giampiero; Spagna, Riccardo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">115-119</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard International Publishers Ltd.</span>)
        </div><div class="casAbstract">SIR97 is the integration of two programs, SIR92 and CAOS, the 1st devoted to the soln. of crystal structures by direct methods, the 2nd to refinement via least-squares-Fourier procedures.  Several new features were introduced in SIR97 with respect to the previous version, SIR92: greater automatization, increased efficiency of the direct methods section, and a powerful graphics interface.  The program also provides publication tables and CIF files.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooMiXqY8IckrVg90H21EOLACvtfcHk0ljKwMzHNCQ8oQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhsFOrsbo%253D&md5=45ee00c9eedb9f7c188ec112dc45546e</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1107%2FS0021889898007717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889898007717%26sid%3Dliteratum%253Aachs%26aulast%3DAltomare%26aufirst%3DA.%26aulast%3DBurla%26aufirst%3DM.%26aulast%3DCamalli%26aufirst%3DG.%26aulast%3DCascarano%26aufirst%3DG.%26aulast%3DGiacovazzo%26aufirst%3DC.%26aulast%3DGuagliardi%26aufirst%3DA.%26aulast%3DMoliterni%26aufirst%3DA.%26aulast%3DPolidori%26aufirst%3DG.%26aulast%3DSpagna%26aufirst%3DR.%26atitle%3DSIR97%253A%2520A%2520New%2520Tool%2520for%2520Crystal%2520Structure%2520Determination%2520and%2520Refinement%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D1999%26volume%3D32%26spage%3D115%26epage%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Sheldrick, G. M.</span><span> </span><span class="NLM_article-title">A Short History of SHELX</span> <span class="citation_source-journal">Acta Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">A64</span><span class="NLM_x">, </span> <span class="NLM_fpage">112</span><span class="NLM_x">–</span> <span class="NLM_lpage">122</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm100863x&amp;key=10.1107%2FS0108767307043930" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm100863x&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVGhurzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=A64&publication_year=2008&pages=112-122&author=G.+M.+Sheldrick&title=A+Short+History+of+SHELX"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">A short history of SHELX</span></div><div class="casAuthors">Sheldrick, George M.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section A: Foundations of Crystallography</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">112-122</span>CODEN:
                <span class="NLM_cas:coden">ACACEQ</span>;
        ISSN:<span class="NLM_cas:issn">0108-7673</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">An account is given of the development of the SHELX system of computer programs from SHELX-76 to the present day.  In addn. to identifying useful innovations that have come into general use through their implementation in SHELX, a crit. anal. is presented of the less-successful features, missed opportunities and desirable improvements for future releases of the software.  An attempt is made to understand how a program originally designed for photog. intensity data, punched cards and computers over 10000 times slower than an av. modern personal computer has managed to survive for so long.  SHELXL is the most widely used program for small-mol. refinement and SHELXS and SHELXD are often employed for structure soln. despite the availability of objectively superior programs.  SHELXL also finds a niche for the refinement of macromols. against high-resoln. or twinned data; SHELXPRO acts as an interface for macromol. applications.  SHELXC, SHELXD and SHELXE are proving useful for the exptl. phasing of macromols., esp. because they are fast and robust and so are often employed in pipelines for high-throughput phasing.  This paper could serve as a general literature citation when one or more of the open-source SHELX programs (and the Bruker AXS version SHELXTL) are employed in the course of a crystal-structure detn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfLPYyJyJ2RbVg90H21EOLACvtfcHk0ljKwMzHNCQ8oQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVGhurzO&md5=8f91f10be4a9df74b2a9dad522c71e6e</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1107%2FS0108767307043930&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0108767307043930%26sid%3Dliteratum%253Aachs%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26atitle%3DA%2520Short%2520History%2520of%2520SHELX%26jtitle%3DActa%2520Crystallogr.%26date%3D2008%26volume%3DA64%26spage%3D112%26epage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group">Stuyver, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lostia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathew, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pai, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tharnish, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otto, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schinazi, R. F.</span><span> </span><span class="NLM_article-title">Antiviral Activities and Cellular Toxicities of Modified 2′,3′-Dideoxy-2′,3′-didehydrocytidine Analogues</span> <span class="citation_source-journal">Antimicrob Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3854</span><span class="NLM_x">–</span> <span class="NLM_lpage">3860</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2002&pages=3854-3860&author=L.+J.+Stuyverauthor=S.+Lostiaauthor=M.+Adamsauthor=J.+S.+Mathewauthor=B.+S.+Paiauthor=J.+Grierauthor=P.+M.+Tharnishauthor=Y.+Choiauthor=Y.+Chongauthor=H.+Chooauthor=C.+K.+Chuauthor=M.+J.+Ottoauthor=R.+F.+Schinazi&title=Antiviral+Activities+and+Cellular+Toxicities+of+Modified+2%E2%80%B2%2C3%E2%80%B2-Dideoxy-2%E2%80%B2%2C3%E2%80%B2-didehydrocytidine+Analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStuyver%26aufirst%3DL.%2BJ.%26aulast%3DLostia%26aufirst%3DS.%26aulast%3DAdams%26aufirst%3DM.%26aulast%3DMathew%26aufirst%3DJ.%2BS.%26aulast%3DPai%26aufirst%3DB.%2BS.%26aulast%3DGrier%26aufirst%3DJ.%26aulast%3DTharnish%26aufirst%3DP.%2BM.%26aulast%3DChoi%26aufirst%3DY.%26aulast%3DChong%26aufirst%3DY.%26aulast%3DChoo%26aufirst%3DH.%26aulast%3DChu%26aufirst%3DC.%2BK.%26aulast%3DOtto%26aufirst%3DM.%2BJ.%26aulast%3DSchinazi%26aufirst%3DR.%2BF.%26atitle%3DAntiviral%2520Activities%2520and%2520Cellular%2520Toxicities%2520of%2520Modified%25202%25E2%2580%25B2%252C3%25E2%2580%25B2-Dideoxy-2%25E2%2580%25B2%252C3%25E2%2580%25B2-didehydrocytidine%2520Analogues%26jtitle%3DAntimicrob%2520Agents%2520Chemother.%26date%3D2002%26volume%3D46%26spage%3D3854%26epage%3D3860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm100863x&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-19%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm100863x%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm100863x" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67995d9358f324d3","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
